7871435	Zinc (II) ion	Schoenherr CJ	The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.	Science	1995	260
8073293	Zinc (II) ion	Bush AI	Rapid induction of Alzheimer A beta amyloid formation by zinc.	Science	1994	187
8962159	Zinc (II) ion	Palmiter RD	ZnT-3, a putative transporter of zinc into synaptic vesicles.	Proceedings of the National Academy of Sciences of the United States of America	1996	128
9679147	Zinc (II) ion	tom Dieck S	Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals.	The Journal of cell biology	1998	102
10449787	Zinc (II) ion	Andrés ME	CoREST: a functional corepressor required for regulation of neural-specific gene expression.	Proceedings of the National Academy of Sciences of the United States of America	1999	155
10681270	Zinc (II) ion	Christen Y	Oxidative stress and Alzheimer disease.	The American journal of clinical nutrition	2000	111
11427894	Zinc (II) ion	Finnin MS	Structure of the histone deacetylase SIRT2.	Nature structural biology	2001	91
11940666	Zinc (II) ion	Coquelle FM	LIS1, CLIP-170's key to the dynein/dynactin pathway.	Molecular and cellular biology	2002	81
12875979	Zinc (II) ion	An WL	Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.	The American journal of pathology	2003	84
12960961	Zinc (II) ion	Wang X	Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.	Nature medicine	2003	129
16354688	Zinc (II) ion	Filion GJ	A family of human zinc finger proteins that bind methylated DNA and repress transcription.	Molecular and cellular biology	2006	73
16406505	Zinc (II) ion	Kasper M	GLI transcription factors: mediators of oncogenic Hedgehog signalling.	European journal of cancer	2006	122
17662965	Zinc (II) ion	Hennig AK	Regulation of photoreceptor gene expression by Crx-associated transcription factor network.	Brain research	2008	67
18235444	Zinc (II) ion	Wendt KS	Cohesin mediates transcriptional insulation by CCCTC-binding factor.	Nature	2008	450
18552350	Zinc (II) ion	Furukawa Y	Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	64
18554812	Zinc (II) ion	Treves A	What is the mammalian dentate gyrus good for?	Neuroscience	2008	83
19339596	Zinc (II) ion	Deshpande A	A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.	The Journal of neuroscience 	2009	67
19404260	Zinc (II) ion	Gielen M	Mechanism of differential control of NMDA receptor activity by NR2 subunits.	Nature	2009	120
19540598	Zinc (II) ion	Pogue AI	Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells.	Journal of inorganic biochemistry	2009	55
19701203	Zinc (II) ion	Han YG	Dual and opposing roles of primary cilia in medulloblastoma development.	Nature medicine	2009	134
20048154	Zinc (II) ion	Inoue K	Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels.	The Journal of biological chemistry	2010	43
20471444	Zinc (II) ion	Maes M	A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.	Progress in neuro-psychopharmacology & biological psychiatry	2011	105
20479761	Zinc (II) ion	Shelton RC	Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.	Molecular psychiatry	2011	104
20730621	Zinc (II) ion	Jomova K	Metals, oxidative stress and neurodegenerative disorders.	Molecular and cellular biochemistry	2010	164
20880502	Zinc (II) ion	Yenari MA	Microglial activation in stroke: therapeutic targets.	Neurotherapeutics 	2010	84
21376232	Zinc (II) ion	Shin JH	PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.	Cell	2011	255
21599891	Zinc (II) ion	Thirumoorthy N	A review of metallothionein isoforms and their role in pathophysiology.	World journal of surgical oncology	2011	39
21647776	Zinc (II) ion	Vašák M	Chemistry and biology of mammalian metallothioneins.	Journal of biological inorganic chemistry 	2011	35
22197082	Zinc (II) ion	Leonard B	Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.	Neuroscience and biobehavioral reviews	2012	83
22341971	Zinc (II) ion	Quadri M	Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.	American journal of human genetics	2012	65
22341972	Zinc (II) ion	Tuschl K	Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.	American journal of human genetics	2012	52
22635102	Zinc (II) ion	Bush AI	The metal theory of Alzheimer's disease.	Journal of Alzheimer's disease 	2013	32
22717236	Zinc (II) ion	Guo C	Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.	Neurobiology of aging	2013	27
22801742	Zinc (II) ion	Doecke JD	Blood-based protein biomarkers for diagnosis of Alzheimer disease.	Archives of neurology	2012	79
23123196	Zinc (II) ion	Yang W	EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.	Molecular cell	2012	61
23719379	Zinc (II) ion	DeGennaro M	orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET.	Nature	2013	71
23818228	Zinc (II) ion	Siebzehnrubl FA	The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.	EMBO molecular medicine	2013	76
24485196	Zinc (II) ion	Daniel C	Alu elements shape the primate transcriptome by cis-regulation of RNA editing.	Genome biology	2014	25
24710731	Zinc (II) ion	Kambe T	Current understanding of ZIP and ZnT zinc transporters in human health and diseases.	Cellular and molecular life sciences 	2014	30
25155142	Zinc (II) ion	Wild EJ	Targets for future clinical trials in Huntington's disease: what's in the pipeline?	Movement disorders 	2014	39
25162540	Zinc (II) ion	Tao R	Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.	JAMA psychiatry	2014	24
26343967	Zinc (II) ion	Valko M	Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.	Archives of toxicology	2016	38
26657039	Zinc (II) ion	Kaur SJ	Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.	Gene	2016	20
27995398	Zinc (II) ion	Riley LG	A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.	Journal of inherited metabolic disease	2017	7
28349823	Zinc (II) ion	Lv QL	Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.	Tumour biology 	2017	6
28536273	Zinc (II) ion	Aydemir TB	Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.	The Journal of neuroscience 	2017	6
8261513	ADP	Brown HA	ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity.	Cell	1993	177
8955160	ADP	Kaczmarek E	Identification and characterization of CD39/vascular ATP diphosphohydrolase.	The Journal of biological chemistry	1996	124
9395408	ADP	Colley WC	Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization.	Current biology 	1997	144
10631785	ADP	Wang KK	Calpain and caspase: can you tell the difference?	Trends in neurosciences	2000	142
10696506	ADP	Abbott NJ	Inflammatory mediators and modulation of blood-brain barrier permeability.	Cellular and molecular neurobiology	2000	149
11111826	ADP	von Kügelgen I	Molecular pharmacology of P2Y-receptors.	Naunyn-Schmiedeberg's archives of pharmacology	2000	107
11196645	ADP	Hollopeter G	Identification of the platelet ADP receptor targeted by antithrombotic drugs.	Nature	2001	211
11413167	ADP	Foster CJ	Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.	The Journal of clinical investigation	2001	88
12223530	ADP	Virág L	The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.	Pharmacological reviews	2002	280
14647276	ADP	Sheen VL	Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex.	Nature genetics	2004	75
15573402	ADP	Sullivan PG	Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?	Journal of neuroscience research	2005	86
16257449	ADP	von Kügelgen I	Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.	Pharmacology & therapeutics	2006	146
17287729	ADP	Jin D	CD38 is critical for social behaviour by regulating oxytocin secretion.	Nature	2007	142
18996916	ADP	Ferland RJ	Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia.	Human molecular genetics	2009	53
21498777	ADP	Leffler CW	Carbon monoxide as an endogenous vascular modulator.	American journal of physiology. Heart and circulatory physiology	2011	39
21781245	ADP	Nieswandt B	Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke.	Journal of thrombosis and haemostasis 	2011	42
21907261	ADP	Burnstock G	Purinergic signalling: from normal behaviour to pathological brain function.	Progress in neurobiology	2011	97
22215671	ADP	Rittiner JE	AMP is an adenosine A1 receptor agonist.	The Journal of biological chemistry	2012	42
22245314	ADP	Ebstein RP	The contributions of oxytocin and vasopressin pathway genes to human behavior.	Hormones and behavior	2012	67
22363216	ADP	Stafa K	GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.	PLoS genetics	2012	43
22674620	ADP	Koizumi S	Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.	Glia	2013	31
23099359	ADP	Cleeter MW	Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.	Neurochemistry international	2013	39
25821842	ADP	Moore CS	P2Y12 expression and function in alternatively activated human microglia.	Neurolog	2015	19
25920953	ADP	Mosienko V	Is L-lactate a novel signaling molecule in the brain?	Journal of cerebral blood flow and metabolism 	2015	21
26873625	ADP	Bamburg JR	Actin dynamics and cofilin-actin rods in alzheimer disease.	Cytoskeleton	2016	13
28002403	ADP	Hoch NC	XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.	Nature	2017	12
28528700	ADP	Douvaras P	Directed Differentiation of Human Pluripotent Stem Cells to Microglia.	Stem cell reports	2017	6
9305631	Adenosine triphosphate	Takayama S	BAG-1 modulates the chaperone activity of Hsp70/Hsc70.	The EMBO journal	1997	107
9987804	Adenosine triphosphate	Millan MJ	The induction of pain: an integrative review.	Progress in neurobiology	1999	203
10466143	Adenosine triphosphate	Magistretti PJ	Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	1999	136
10488066	Adenosine triphosphate	Okada T	Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7. Ca(2+)-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor.	The Journal of biological chemistry	1999	106
10508238	Adenosine triphosphate	Lipton P	Ischemic cell death in brain neurons.	Physiological reviews	1999	461
11054482	Adenosine triphosphate	White BC	Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.	Journal of the neurological sciences	2000	112
11282418	Adenosine triphosphate	Burnstock G	Purine-mediated signalling in pain and visceral perception.	Trends in pharmacological sciences	2001	88
11404227	Adenosine triphosphate	Gruetter R	A mathematical model of compartmentalized neurotransmitter metabolism in the human brain.	American journal of physiology. Endocrinology and metabolism	2001	93
11867640	Adenosine triphosphate	Tokumitsu H	STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.	The Journal of biological chemistry	2002	97
12535572	Adenosine triphosphate	Schinkel AH	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.	Advanced drug delivery reviews	2003	207
14576842	Adenosine triphosphate	Doyle L	Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).	Oncogene	2003	165
14576852	Adenosine triphosphate	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	169
14713298	Adenosine triphosphate	Bijur GN	Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.	Journal of neurochemistry	2003	94
14769489	Adenosine triphosphate	Veech RL	The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.	Prostaglandins, leukotrienes, and essential fatty acids	2004	142
15269217	Adenosine triphosphate	Wahrle SE	ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.	The Journal of biological chemistry	2004	114
15448079	Adenosine triphosphate	Levin BE	Neuronal glucosensing: what do we know after 50 years?	Diabetes	2004	116
15706348	Adenosine triphosphate	Kasper D	Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.	The EMBO journal	2005	71
15717060	Adenosine triphosphate	Löscher W	Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.	NeuroRx 	2005	111
15734146	Adenosine triphosphate	Plum L	The role of insulin receptor signaling in the brain.	Trends in endocrinology and metabolism	2005	111
15831501	Adenosine triphosphate	David DC	Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.	The Journal of biological chemistry	2005	81
15845415	Adenosine triphosphate	Leslie EM	Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.	Toxicology and applied pharmacology	2005	197
15914252	Adenosine triphosphate	Hanani M	Satellite glial cells in sensory ganglia: from form to function.	Brain research. Brain research reviews	2005	164
15988001	Adenosine triphosphate	Sofer A	Regulation of mTOR and cell growth in response to energy stress by REDD1.	Molecular and cellular biology	2005	145
16024622	Adenosine triphosphate	Patrawala L	Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.	Cancer research	2005	281
16124856	Adenosine triphosphate	Dean M	Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.	Annual review of genomics and human genetics	2005	132
16146333	Adenosine triphosphate	Mao Q	Role of the breast cancer resistance protein (ABCG2) in drug transport.	The AAPS journal	2005	86
16207713	Adenosine triphosphate	Koldamova R	Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.	The Journal of biological chemistry	2005	95
16357084	Adenosine triphosphate	Koehler RC	Role of astrocytes in cerebrovascular regulation.	Journal of applied physiology	2006	69
16378731	Adenosine triphosphate	Sultana R	Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.	Neurobiology of disease	2006	90
16452661	Adenosine triphosphate	Suadicani SO	P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling.	The Journal of neuroscience 	2006	154
16543131	Adenosine triphosphate	Ishibashi T	Astrocytes promote myelination in response to electrical impulses.	Neuron	2006	179
16685256	Adenosine triphosphate	Kanmogne GD	HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.	Journal of cerebral blood flow and metabolism 	2007	81
16835632	Adenosine triphosphate	Hertz L	Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis.	Journal of cerebral blood flow and metabolism 	2007	158
17275978	Adenosine triphosphate	Moffett JR	N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.	Progress in neurobiology	2007	272
17322922	Adenosine triphosphate	Lou H	Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.	Oncogene	2007	62
17360912	Adenosine triphosphate	Thies E	Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.	The Journal of neuroscience 	2007	85
17485642	Adenosine triphosphate	Di Fonzo A	ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.	Neurology	2007	64
17938633	Adenosine triphosphate	Klempan TA	Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.	Molecular psychiatry	2009	69
17942911	Adenosine triphosphate	Pyrko P	The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.	Cancer research	2007	125
17956292	Adenosine triphosphate	Brown GC	Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase.	Biochemical Society transactions	2007	81
18222991	Adenosine triphosphate	Zanna C	OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.	Brain 	2008	80
18319074	Adenosine triphosphate	Lagier-Tourenne C	ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency.	American journal of human genetics	2008	75
18325775	Adenosine triphosphate	Reed T	Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.	Neurobiology of disease	2008	66
18560012	Adenosine triphosphate	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	79
18691054	Adenosine triphosphate	Zhou SF	Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.	Current medicinal chemistry	2008	75
18704197	Adenosine triphosphate	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
18816186	Adenosine triphosphate	Orellana JA	Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.	Antioxidants & redox signaling	2009	60
18923405	Adenosine triphosphate	Altar CA	Target identification for CNS diseases by transcriptional profiling.	Neuropsychopharmacology 	2009	49
18971320	Adenosine triphosphate	Shukla S	Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.	Drug metabolism and disposition	2009	53
18991631	Adenosine triphosphate	Donnelly A	Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.	Current medicinal chemistry	2008	74
19056914	Adenosine triphosphate	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	66
19075717	Adenosine triphosphate	Krueger JM	The role of cytokines in sleep regulation.	Current pharmaceutical design	2008	87
19094056	Adenosine triphosphate	Dauchy S	ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.	Journal of neurochemistry	2008	53
19240739	Adenosine triphosphate	Zhao H	Ischemic postconditioning as a novel avenue to protect against brain injury after stroke.	Journal of cerebral blood flow and metabolism 	2009	61
19523516	Adenosine triphosphate	Serenó L	A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.	Neurobiology of disease	2009	69
19525944	Adenosine triphosphate	Orr AG	Adenosine A(2A) receptor mediates microglial process retraction.	Nature neuroscience	2009	75
19666625	Adenosine triphosphate	Peng W	Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.	Proceedings of the National Academy of Sciences of the United States of America	2009	128
19892975	Adenosine triphosphate	Cartier N	Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.	Science	2009	382
19948188	Adenosine triphosphate	Parpura V	Gliotransmission: Exocytotic release from astrocytes.	Brain research reviews	2010	102
20022389	Adenosine triphosphate	MacVicar BA	Non-junction functions of pannexin-1 channels.	Trends in neurosciences	2010	94
20101004	Adenosine triphosphate	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	66
20103563	Adenosine triphosphate	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	166
20170744	Adenosine triphosphate	Vance JE	Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.	Biochimica et biophysica acta	2010	41
20352044	Adenosine triphosphate	Cox LE	Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).	PloS one	2010	57
20513237	Adenosine triphosphate	Ross-Inta C	Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.	The Biochemical journal	2010	66
20658967	Adenosine triphosphate	Halestrap AP	A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.	Biochemical Society transactions	2010	79
20667897	Adenosine triphosphate	Kefas B	Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.	Neuro-oncology	2010	57
20669327	Adenosine triphosphate	Paisán-Ruiz C	Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.	Movement disorders 	2010	52
20812902	Adenosine triphosphate	Ni Z	Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).	Current drug metabolism	2010	48
20826314	Adenosine triphosphate	Nishijima T	Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.	Neuron	2010	57
21145355	Adenosine triphosphate	Reddy PH	Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.	Brain research reviews	2011	76
21196229	Adenosine triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21250988	Adenosine triphosphate	Matute C	Glutamate and ATP signalling in white matter pathology.	Journal of anatomy	2011	39
21317208	Adenosine triphosphate	Prasad G	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro-oncology	2011	48
21351087	Adenosine triphosphate	Tang SC	Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.	International journal of cancer	2012	37
21393861	Adenosine triphosphate	She H	Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.	The Journal of clinical investigation	2011	40
21568705	Adenosine triphosphate	Zhao R	Mechanisms of membrane transport of folates into cells and across epithelia.	Annual review of nutrition	2011	65
21576264	Adenosine triphosphate	Zaugg K	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes & development	2011	123
21707071	Adenosine triphosphate	Shawahna R	Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.	Molecular pharmaceutics	2011	55
21715610	Adenosine triphosphate	Eugenin EA	Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism.	The Journal of neuroscience 	2011	74
21724849	Adenosine triphosphate	Tan J	Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.	The Journal of biological chemistry	2011	37
21885853	Adenosine triphosphate	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21967057	Adenosine triphosphate	Sharom FJ	The P-glycoprotein multidrug transporter.	Essays in biochemistry	2011	73
22003197	Adenosine triphosphate	Hoegen T	The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.	Journal of immunology	2011	46
22072942	Adenosine triphosphate	Chen SD	Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia.	International journal of molecular sciences	2011	49
22077634	Adenosine triphosphate	Sheng B	Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.	Journal of neurochemistry	2012	66
22098950	Adenosine triphosphate	Nakanishi T	Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.	Chinese journal of cancer	2012	49
22108059	Adenosine triphosphate	Caprara C	From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease.	Progress in retinal and eye research	2012	40
22198378	Adenosine triphosphate	Gusdon AM	ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.	Neurobiology of disease	2012	39
22248732	Adenosine triphosphate	Natarajan K	Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.	Biochemical pharmacology	2012	80
22367557	Adenosine triphosphate	Cai Z	Roles of AMP-activated protein kinase in Alzheimer's disease.	Neuromolecular medicine	2012	34
22436748	Adenosine triphosphate	Hardie DG	AMPK: a nutrient and energy sensor that maintains energy homeostasis.	Nature reviews. Molecular cell biology	2012	780
22483867	Adenosine triphosphate	Kemp S	X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.	Biochimica et biophysica acta	2012	42
22487547	Adenosine triphosphate	Zhu XH	Quantitative imaging of energy expenditure in human brain.	NeuroImage	2012	33
22525272	Adenosine triphosphate	Galavotti S	The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.	Oncogene	2013	55
22544529	Adenosine triphosphate	Franke H	Pathophysiology of astroglial purinergic signalling.	Purinergic signalling	2012	34
22578011	Adenosine triphosphate	Ramesh V	Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway.	Journal of neuroinflammation	2012	34
22588883	Adenosine triphosphate	Vivanco I	Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.	Cancer discovery	2012	91
22613083	Adenosine triphosphate	Trang T	Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.	Neuron glia biology	2011	43
22647602	Adenosine triphosphate	Dehay B	Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2012	63
22700220	Adenosine triphosphate	Boison D	Adenosine dysfunction in epilepsy.	Glia	2012	32
22714048	Adenosine triphosphate	Simard JM	Sulfonylurea receptor 1 in central nervous system injury: a focused review.	Journal of cerebral blood flow and metabolism 	2012	42
22739839	Adenosine triphosphate	Pandi-Perumal SR	Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.	Neurotoxicity research	2013	33
22771709	Adenosine triphosphate	Dahl G	Pannexin: from discovery to bedside in 11±4 years?	Brain research	2012	43
22784115	Adenosine triphosphate	Srivastava R	Potassium channel KIR4.1 as an immune target in multiple sclerosis.	The New England journal of medicine	2012	80
22892528	Adenosine triphosphate	Onat OE	Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.	European journal of human genetics 	2013	30
22926141	Adenosine triphosphate	Manczak M	Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.	Human molecular genetics	2012	37
23271055	Adenosine triphosphate	Jinwal UK	Imbalance of Hsp70 family variants fosters tau accumulation.	FASEB journal 	2013	34
23291500	Adenosine triphosphate	Fujiwara Y	Discovery of a novel type of autophagy targeting RNA.	Autophagy	2013	30
23298398	Adenosine triphosphate	Strazielle N	Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.	Molecular pharmaceutics	2013	34
23374323	Adenosine triphosphate	Sun AX	MicroRNAs: regulators of neuronal fate.	Current opinion in cell biology	2013	64
23460667	Adenosine triphosphate	Golebiewska A	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.	Brain 	2013	28
23498975	Adenosine triphosphate	Bartolome F	Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.	Neuron	2013	38
23518715	Adenosine triphosphate	Coffey AJ	A genetic study of Wilson's disease in the United Kingdom.	Brain 	2013	31
23571587	Adenosine triphosphate	Reitz C	Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.	JAMA	2013	83
23625868	Adenosine triphosphate	Minkiewicz J	Human astrocytes express a novel NLRP2 inflammasome.	Glia	2013	48
23651857	Adenosine triphosphate	Hubert CG	Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.	Genes & development	2013	36
23688078	Adenosine triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23716663	Adenosine triphosphate	Jiang D	Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23776229	Adenosine triphosphate	Feng S	Canonical transient receptor potential 3 channels regulate mitochondrial calcium uptake.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23953109	Adenosine triphosphate	Hertz NT	A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.	Cell	2013	42
23994581	Adenosine triphosphate	Rettberg JR	Estrogen: a master regulator of bioenergetic systems in the brain and body.	Frontiers in neuroendocrinology	2014	43
24021215	Adenosine triphosphate	Stacy AE	Molecular pharmacology of ABCG2 and its role in chemoresistance.	Molecular pharmacology	2013	42
24393808	Adenosine triphosphate	Akula N	RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder.	Molecular psychiatry	2014	21
24398940	Adenosine triphosphate	de Rivero Vaccari JP	Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.	Journal of cerebral blood flow and metabolism 	2014	42
24568233	Adenosine triphosphate	Naeser MA	Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.	Journal of neurotrauma	2014	31
24619111	Adenosine triphosphate	Götzl JK	Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.	Acta neuropathologica	2014	38
24652937	Adenosine triphosphate	Morais VA	PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.	Science	2014	65
24656405	Adenosine triphosphate	Kitambi SS	RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.	Cell	2014	45
24770881	Adenosine triphosphate	Nelson PT	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	Acta neuropathologica	2014	23
24777293	Adenosine triphosphate	Shi L	miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.	Neuromolecular medicine	2014	24
24849361	Adenosine triphosphate	Boehm-Cagan A	Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.	The Journal of neuroscience 	2014	37
24979777	Adenosine triphosphate	Alavian KN	An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore.	Proceedings of the National Academy of Sciences of the United States of America	2014	110
24995978	Adenosine triphosphate	Pekkurnaz G	Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase.	Cell	2014	46
24998913	Adenosine triphosphate	Lee JV	Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.	Cell metabolism	2014	82
25156912	Adenosine triphosphate	Zhang X	GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.	Molecular carcinogenesis	2015	16
25188341	Adenosine triphosphate	Beecham GW	Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.	PLoS genetics	2014	54
25236865	Adenosine triphosphate	Mao Q	Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.	The AAPS journal	2015	45
25259783	Adenosine triphosphate	Hardie DG	AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.	Current opinion in cell biology	2015	80
25437566	Adenosine triphosphate	Brehme M	A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.	Cell reports	2014	69
25727638	Adenosine triphosphate	Zorec R	Astrocytic vesicles and gliotransmitters: Slowness of vesicular release and synaptobrevin2-laden vesicle nanoarchitecture.	Neuroscience	2016	10
25867026	Adenosine triphosphate	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
26159692	Adenosine triphosphate	Dibble CC	Regulation of mTORC1 by PI3K signaling.	Trends in cell biology	2015	103
26269525	Adenosine triphosphate	Bockaert J	mTOR in Brain Physiology and Pathologies.	Physiological reviews	2015	25
26519060	Adenosine triphosphate	Zhai L	Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.	Clinical cancer research 	2015	24
26549853	Adenosine triphosphate	Engel T	ATPergic signalling during seizures and epilepsy.	Neuropharmacology	2016	11
26553936	Adenosine triphosphate	Harikumar A	Chromatin remodeling and bivalent histone modifications in embryonic stem cells.	EMBO reports	2015	18
26803500	Adenosine triphosphate	Bhattacharya A	Role of neuro-immunological factors in the pathophysiology of mood disorders.	Psychopharmacology	2016	13
26947070	Adenosine triphosphate	Cárdenas C	Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria.	Cell reports	2016	22
27013346	Adenosine triphosphate	Robinson MB	Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.	Neurochemistry international	2016	20
27219534	Adenosine triphosphate	Bhattacharya A	The microglial ATP-gated ion channel P2X7 as a CNS drug target.	Glia	2016	17
27254664	Adenosine triphosphate	Ali YO	NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies.	PLoS biology	2016	13
27350397	Adenosine triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
27365148	Adenosine triphosphate	Cunha RA	How does adenosine control neuronal dysfunction and neurodegeneration?	Journal of neurochemistry	2016	19
27599716	Adenosine triphosphate	Kim DI	Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.	Biochimica et biophysica acta	2016	11
27816754	Adenosine triphosphate	Kim Y	Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model.	Biochimica et biophysica acta	2017	5
28057794	Adenosine triphosphate	Burnstock G	Purinergic Signaling in the Cardiovascular System.	Circulation research	2017	17
28165338	Adenosine triphosphate	Whittaker DE	The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.	The Journal of clinical investigation	2017	8
7493923	Guanosine triphosphate	Leung T	A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes.	The Journal of biological chemistry	1995	143
8402898	Guanosine triphosphate	Gout I	The GTPase dynamin binds to and is activated by a subset of SH3 domains.	Cell	1993	150
8772201	Guanosine triphosphate	Nakagawa O	ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.	FEBS letters	1996	163
8819477	Guanosine triphosphate	Showalter VM	Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.	The Journal of pharmacology and experimental therapeutics	1996	129
9323142	Guanosine triphosphate	Horiuchi H	A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function.	Cell	1997	176
10559861	Guanosine triphosphate	Takei K	Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis.	Nature cell biology	1999	194
11856727	Guanosine triphosphate	Fukuda M	Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport.	The Journal of biological chemistry	2002	84
15340059	Guanosine triphosphate	Li Y	Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.	Molecular and cellular biology	2004	77
15629704	Guanosine triphosphate	Brown TC	NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD.	Neuron	2005	78
15772076	Guanosine triphosphate	Smith EM	The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.	The Journal of biological chemistry	2005	136
15832810	Guanosine triphosphate	Xu C	Induction of phase I, II and III drug metabolism/transport by xenobiotics.	Archives of pharmacal research	2005	174
15854902	Guanosine triphosphate	Long X	Rheb binds and regulates the mTOR kinase.	Current biology 	2005	279
15878852	Guanosine triphosphate	Long X	Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.	The Journal of biological chemistry	2005	112
16980962	Guanosine triphosphate	Smith WW	Kinase activity of mutant LRRK2 mediates neuronal toxicity.	Nature neuroscience	2006	227
17928295	Guanosine triphosphate	Li Y	Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb.	The Journal of biological chemistry	2007	72
17991864	Guanosine triphosphate	Bai X	Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.	Science	2007	126
18497260	Guanosine triphosphate	Sancak Y	The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.	Science	2008	736
18550814	Guanosine triphosphate	Sun Y	Phospholipase D1 is an effector of Rheb in the mTOR pathway.	Proceedings of the National Academy of Sciences of the United States of America	2008	84
18765678	Guanosine triphosphate	Avruch J	Amino acid regulation of TOR complex 1.	American journal of physiology. Endocrinology and metabolism	2009	146
19299511	Guanosine triphosphate	Sato T	Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.	The Journal of biological chemistry	2009	72
20157015	Guanosine triphosphate	Yu-Wai-Man P	Multi-system neurological disease is common in patients with OPA1 mutations.	Brain 	2010	81
20696759	Guanosine triphosphate	Chang CR	A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division.	The Journal of biological chemistry	2010	53
22445341	Guanosine triphosphate	Ultanir SK	Chemical genetic identification of NDR1/2 kinase substrates AAK1 and Rabin8 Uncovers their roles in dendrite arborization and spine development.	Neuron	2012	38
23137377	Guanosine triphosphate	Ohtsuki S	Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.	Molecular pharmaceutics	2013	28
23241358	Guanosine triphosphate	Biosa A	GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.	Human molecular genetics	2013	28
24166846	Guanosine triphosphate	Thomas S	A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to the primary cilium.	Human mutation	2014	33
25643395	Guanosine triphosphate	Binotti B	The GTPase Rab26 links synaptic vesicles to the autophagy pathway.	eLife	2015	20
26067754	Guanosine triphosphate	Kollareddy M	Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.	Nature communications	2015	20
26194181	Guanosine triphosphate	Kim S	Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.	Molecular psychiatry	2016	24
19794443	Urea	Imig JD	Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.	Nature reviews. Drug discovery	2009	181
21082368	Urea	Johanson CE	The blood-cerebrospinal fluid barrier: structure and functional significance.	Methods in molecular biology	2011	41
25875215	Urea	Kölker S	The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.	Journal of inherited metabolic disease	2015	20
27070809	Urea	Miller PG	Design and demonstration of a pumpless 14 compartment microphysiological system.	Biotechnology and bioengineering	2016	14
19204207	Carmustine	van den Bent MJ	Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.	Journal of clinical oncology 	2009	123
20035051	Carmustine	Li J	Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.	The American journal of pathology	2010	45
20511192	Carmustine	Kunwar S	Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.	Neuro-oncology	2010	91
25105369	Carmustine	Adair JE	Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.	The Journal of clinical investigation	2014	20
25546364	Carmustine	Nash RA	High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.	JAMA neurology	2015	21
9131263	Iron	Maines MD	The heme oxygenase system: a regulator of second messenger gases.	Annual review of pharmacology and toxicology	1997	368
9989453	Iron	Smith KJ	Demyelination: the role of reactive oxygen and nitrogen species.	Brain pathology	1999	98
11438811	Iron	Curtis AR	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.	Nature genetics	2001	92
11479594	Iron	Zhou B	A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.	Nature genetics	2001	126
11719199	Iron	Vanduffel W	Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys.	Neuron	2001	108
11731783	Iron	Bulte JW	Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.	Nature biotechnology	2001	178
12510040	Iron	Hayflick SJ	Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	The New England journal of medicine	2003	88
15896810	Iron	Calabrese V	Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.	Journal of the neurological sciences	2005	66
16783378	Iron	Morgan NV	PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.	Nature genetics	2006	101
17101452	Iron	Rouault TA	Brain iron metabolism.	Seminars in pediatric neurology	2006	62
17127365	Iron	Mancuso C	Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.	Frontiers in bioscience 	2007	70
17261733	Iron	Hua Y	Brain injury after intracerebral hemorrhage: the role of thrombin and iron.	Stroke	2007	63
17379741	Iron	Boddaert N	Selective iron chelation in Friedreich ataxia: biologic and clinical implications.	Blood	2007	81
17623039	Iron	Uversky VN	Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.	Journal of neurochemistry	2007	134
18202189	Iron	Malik I	Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.	The American journal of pathology	2008	56
18305254	Iron	Shinzawa K	Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease.	The Journal of neuroscience 	2008	61
18443312	Iron	McNeill A	T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.	Neurology	2008	52
18570303	Iron	Paisan-Ruiz C	Characterization of PLA2G6 as a locus for dystonia-parkinsonism.	Annals of neurology	2009	75
18799783	Iron	Gregory A	Neurodegeneration associated with genetic defects in phospholipase A(2).	Neurology	2008	63
18981035	Iron	Gregory A	Clinical and genetic delineation of neurodegeneration with brain iron accumulation.	Journal of medical genetics	2009	63
19144359	Iron	Zamboni P	The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.	Journal of the neurological sciences	2009	50
19457088	Iron	Schipper HM	Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement.	Journal of neurochemistry	2009	59
19467991	Iron	Connor JR	Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.	Brain 	2009	59
19540040	Iron	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.	Cancer letters	2010	47
19624272	Iron	Adibhatla RM	Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2010	79
19781428	Iron	Förhécz Z	Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.	American heart journal	2009	90
19862561	Iron	Hung YH	Copper in the brain and Alzheimer's disease.	Journal of biological inorganic chemistry 	2010	48
19937043	Iron	Schrag M	Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.	Acta neuropathologica	2010	57
20484814	Iron	Liu M	The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.	The Journal of clinical investigation	2010	42
20619503	Iron	Paisán-Ruiz C	Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.	Neurobiology of aging	2012	42
20704549	Iron	Jazwa A	Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.	Current drug targets	2010	42
20736190	Iron	Péran P	Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.	Brain 	2010	90
21981780	Iron	Hartig MB	Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.	American journal of human genetics	2011	36
22232660	Iron	Jahanshad N	Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
22306201	Iron	Poulsen HE	RNA modifications by oxidation: a novel disease mechanism?	Free radical biology & medicine	2012	39
23144459	Iron	Kabil O	Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.	The Journal of biological chemistry	2012	33
23176820	Iron	Haack TB	Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.	American journal of human genetics	2012	66
23266600	Iron	Farina M	Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.	Neurochemistry international	2013	36
23302230	Iron	Alkins R	Focused ultrasound delivers targeted immune cells to metastatic brain tumors.	Cancer research	2013	37
23334592	Iron	Koeppen AH	Friedreich ataxia: neuropathology revised.	Journal of neuropathology and experimental neurology	2013	38
23435086	Iron	Saitsu H	De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood.	Nature genetics	2013	76
23474058	Iron	Boeve BF	Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.	Sleep medicine	2013	41
23687123	Iron	Hayflick SJ	β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.	Brain 	2013	33
23843466	Iron	Blazejewska AI	Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.	Neurology	2013	26
24334290	Iron	Baker PR 2nd	Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.	Brain 	2014	24
24622774	Iron	Schuh C	Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.	Acta neuropathologica	2014	20
24741667	Iron	Chang CF	(-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways.	Annals of clinical and translational neurology	2014	33
25315861	Iron	Simpson IA	A novel model for brain iron uptake: introducing the concept of regulation.	Journal of cerebral blood flow and metabolism 	2015	20
25734736	Iron	Chey WD	Irritable bowel syndrome: a clinical review.	JAMA	2015	86
25870938	Iron	Arber CE	Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.	Neuropathology and applied neurobiology	2016	15
25988319	Iron	Ayton S	Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.	Nature communications	2015	23
26894396	Iron	Zhang Z	Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage.	Molecular neurobiology	2017	16
27296779	Iron	Lowe VJ	An autoradiographic evaluation of AV-1451 Tau PET in dementia.	Acta neuropathologica communications	2016	57
7702443	Gamma-Aminobutyric acid	Akbarian S	Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.	Archives of general psychiatry	1995	250
9626555	Gamma-Aminobutyric acid	De Kloet ER	Brain corticosteroid receptor balance in health and disease.	Endocrine reviews	1998	358
9861036	Gamma-Aminobutyric acid	Impagnatiello F	A decrease of reelin expression as a putative vulnerability factor in schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	1998	165
9872316	Gamma-Aminobutyric acid	White JH	Heterodimerization is required for the formation of a functional GABA(B) receptor.	Nature	1998	201
11074872	Gamma-Aminobutyric acid	Guidotti A	Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.	Archives of general psychiatry	2000	319
11377828	Gamma-Aminobutyric acid	Zhao WQ	Role of insulin and insulin receptor in learning and memory.	Molecular and cellular endocrinology	2001	97
11814263	Gamma-Aminobutyric acid	Blatt GJ	Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study.	Journal of autism and developmental disorders	2001	86
11906697	Gamma-Aminobutyric acid	Mansvelder HD	Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.	Neuron	2002	218
12450487	Gamma-Aminobutyric acid	Avoli M	Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro.	Progress in neurobiology	2002	106
12600714	Gamma-Aminobutyric acid	Carrasco GA	Neuroendocrine pharmacology of stress.	European journal of pharmacology	2003	134
12605072	Gamma-Aminobutyric acid	Koob GF	Alcoholism: allostasis and beyond.	Alcoholism, clinical and experimental research	2003	244
12867516	Gamma-Aminobutyric acid	Hashimoto T	Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.	The Journal of neuroscience 	2003	302
12904794	Gamma-Aminobutyric acid	Passafaro M	Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2.	Nature	2003	93
14636960	Gamma-Aminobutyric acid	Koob GF	Neuroadaptive mechanisms of addiction: studies on the extended amygdala.	European neuropsychopharmacology 	2003	89
14960621	Gamma-Aminobutyric acid	Merali Z	Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.	The Journal of neuroscience 	2004	81
15024690	Gamma-Aminobutyric acid	Edenberg HJ	Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations.	American journal of human genetics	2004	249
15094074	Gamma-Aminobutyric acid	Zhao WQ	Insulin and the insulin receptor in experimental models of learning and memory.	European journal of pharmacology	2004	86
15121991	Gamma-Aminobutyric acid	Muhle R	The genetics of autism.	Pediatrics	2004	215
15193778	Gamma-Aminobutyric acid	Morimoto K	Kindling and status epilepticus models of epilepsy: rewiring the brain.	Progress in neurobiology	2004	150
15237077	Gamma-Aminobutyric acid	Woo TU	Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.	Archives of general psychiatry	2004	111
15263907	Gamma-Aminobutyric acid	Harrison PJ	Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.	Molecular psychiatry	2005	529
15457501	Gamma-Aminobutyric acid	Bowirrat A	Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	71
15620359	Gamma-Aminobutyric acid	Graf ER	Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.	Cell	2004	299
15684088	Gamma-Aminobutyric acid	Veldic M	In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.	Proceedings of the National Academy of Sciences of the United States of America	2005	78
15691526	Gamma-Aminobutyric acid	Torrey EF	Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.	Biological psychiatry	2005	122
15917474	Gamma-Aminobutyric acid	Yan Y	Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.	Stem cells	2005	130
15927244	Gamma-Aminobutyric acid	Viveros MP	Endocannabinoid system and stress and anxiety responses.	Pharmacology, biochemistry, and behavior	2005	85
16154288	Gamma-Aminobutyric acid	Hayley S	The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.	Neuroscience	2005	66
16162835	Gamma-Aminobutyric acid	Jia F	An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons.	Journal of neurophysiology	2005	102
16227993	Gamma-Aminobutyric acid	Dzhala VI	NKCC1 transporter facilitates seizures in the developing brain.	Nature medicine	2005	241
16230605	Gamma-Aminobutyric acid	Choudary PV	Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.	Proceedings of the National Academy of Sciences of the United States of America	2005	152
16373420	Gamma-Aminobutyric acid	Ojeda SR	Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach?	Endocrinology	2006	60
16427029	Gamma-Aminobutyric acid	Rujescu D	A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.	Biological psychiatry	2006	64
16709666	Gamma-Aminobutyric acid	Palma E	Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.	Proceedings of the National Academy of Sciences of the United States of America	2006	64
16759710	Gamma-Aminobutyric acid	Akbarian S	Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.	Brain research reviews	2006	128
17030651	Gamma-Aminobutyric acid	Lewis DA	Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.	Archives of neurology	2006	133
17146052	Gamma-Aminobutyric acid	Klaassen A	Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
17175134	Gamma-Aminobutyric acid	Watkins LR	Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.	Brain, behavior, and immunity	2007	89
17224405	Gamma-Aminobutyric acid	Kuramoto N	Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase.	Neuron	2007	62
17235515	Gamma-Aminobutyric acid	Yip J	Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications.	Acta neuropathologica	2007	77
17259994	Gamma-Aminobutyric acid	Brisbare-Roch C	Promotion of sleep by targeting the orexin system in rats, dogs and humans.	Nature medicine	2007	112
17339270	Gamma-Aminobutyric acid	Hogart A	15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.	Human molecular genetics	2007	75
17369310	Gamma-Aminobutyric acid	Ohlson J	Editing modifies the GABA(A) receptor subunit alpha3.	RNA	2007	82
17379385	Gamma-Aminobutyric acid	Zuccato C	Role of brain-derived neurotrophic factor in Huntington's disease.	Progress in neurobiology	2007	123
17471287	Gamma-Aminobutyric acid	Hashimoto T	Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.	Molecular psychiatry	2008	178
17499115	Gamma-Aminobutyric acid	Tepper JM	GABAergic control of substantia nigra dopaminergic neurons.	Progress in brain research	2007	60
17511618	Gamma-Aminobutyric acid	Rajkowska G	Gliogenesis and glial pathology in depression.	CNS & neurological disorders drug targets	2007	130
17512983	Gamma-Aminobutyric acid	Smith SS	Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.	Pharmacology & therapeutics	2007	69
17553960	Gamma-Aminobutyric acid	Benes FM	Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.	Proceedings of the National Academy of Sciences of the United States of America	2007	152
17693402	Gamma-Aminobutyric acid	Lee HH	Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2.	The Journal of biological chemistry	2007	72
17726539	Gamma-Aminobutyric acid	Huang HS	GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia.	PloS one	2007	73
17765749	Gamma-Aminobutyric acid	Dudek FE	Epileptogenesis in the dentate gyrus: a critical perspective.	Progress in brain research	2007	84
17767149	Gamma-Aminobutyric acid	Straub RE	Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression.	Molecular psychiatry	2007	98
17965125	Gamma-Aminobutyric acid	Bayatti N	A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone.	Cerebral cortex	2008	56
18160701	Gamma-Aminobutyric acid	Fink KB	5-HT receptor regulation of neurotransmitter release.	Pharmacological reviews	2007	81
18171687	Gamma-Aminobutyric acid	Cavallaro M	Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants.	Development	2008	52
18184780	Gamma-Aminobutyric acid	Terunuma M	Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.	The Journal of neuroscience 	2008	57
18203698	Gamma-Aminobutyric acid	Morris HM	Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.	Cerebral cortex	2008	77
18281411	Gamma-Aminobutyric acid	Hashimoto T	Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.	The American journal of psychiatry	2008	155
18287555	Gamma-Aminobutyric acid	Vierling-Claassen D	Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.	Journal of neurophysiology	2008	67
18495419	Gamma-Aminobutyric acid	Vezzani A	The role of cytokines in the pathophysiology of epilepsy.	Brain, behavior, and immunity	2008	100
18591488	Gamma-Aminobutyric acid	Szymusiak R	Hypothalamic regulation of sleep and arousal.	Annals of the New York Academy of Sciences	2008	53
18599766	Gamma-Aminobutyric acid	Klausberger T	Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.	Science	2008	584
18639864	Gamma-Aminobutyric acid	Poulter MO	GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes.	Biological psychiatry	2008	65
18769373	Gamma-Aminobutyric acid	Kahle KT	Roles of the cation-chloride cotransporters in neurological disease.	Nature clinical practice. Neurology	2008	112
18790874	Gamma-Aminobutyric acid	Olsen RW	International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.	Pharmacological reviews	2008	261
18830410	Gamma-Aminobutyric acid	Loerch PM	Evolution of the aging brain transcriptome and synaptic regulation.	PloS one	2008	95
18835857	Gamma-Aminobutyric acid	Hogart A	Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number.	Journal of medical genetics	2009	46
18991954	Gamma-Aminobutyric acid	Sinha R	Chronic stress, drug use, and vulnerability to addiction.	Annals of the New York Academy of Sciences	2008	315
19034899	Gamma-Aminobutyric acid	Palomero-Gallagher N	Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model.	Human brain mapping	2009	55
19167425	Gamma-Aminobutyric acid	Price TJ	Chloride regulation in the pain pathway.	Brain research reviews	2009	63
19188247	Gamma-Aminobutyric acid	Huang ZJ	Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond.	The Journal of physiology	2009	51
19321177	Gamma-Aminobutyric acid	Thompson M	Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.	Journal of psychiatric research	2009	50
19665974	Gamma-Aminobutyric acid	Rinehart J	Sites of regulated phosphorylation that control K-Cl cotransporter activity.	Cell	2009	79
19719810	Gamma-Aminobutyric acid	Lawrence YA	Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism.	Acta neurologica Scandinavica	2010	45
19727065	Gamma-Aminobutyric acid	Benes FM	Amygdalocortical circuitry in schizophrenia: from circuits to molecules.	Neuropsychopharmacology 	2010	54
19874574	Gamma-Aminobutyric acid	Tabakoff B	Genetical genomic determinants of alcohol consumption in rats and humans.	BMC biology	2009	84
19951690	Gamma-Aminobutyric acid	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	52
20043946	Gamma-Aminobutyric acid	Trotter J	NG2 cells: Properties, progeny and origin.	Brain research reviews	2010	65
20066485	Gamma-Aminobutyric acid	Fatemi SH	mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism.	Journal of autism and developmental disorders	2010	64
20100621	Gamma-Aminobutyric acid	Duncan CE	Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.	Journal of psychiatric research	2010	71
20152113	Gamma-Aminobutyric acid	Twelvetrees AE	Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.	Neuron	2010	71
20164566	Gamma-Aminobutyric acid	Ribeiro JA	Caffeine and adenosine.	Journal of Alzheimer's disease 	2010	43
20237240	Gamma-Aminobutyric acid	Christian CA	The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges.	Endocrine reviews	2010	61
20560996	Gamma-Aminobutyric acid	Seeman P	All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors.	CNS neuroscience & therapeutics	2011	51
20600929	Gamma-Aminobutyric acid	Lee HH	Tyrosine phosphorylation regulates the membrane trafficking of the potassium chloride co-transporter KCC2.	Molecular and cellular neurosciences	2010	46
20614802	Gamma-Aminobutyric acid	Nikolaus S	Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.	Reviews in the neurosciences	2010	52
20643379	Gamma-Aminobutyric acid	Wang LW	Fragile X: leading the way for targeted treatments in autism.	Neurotherapeutics 	2010	53
20722471	Gamma-Aminobutyric acid	Streeter CC	Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study.	Journal of alternative and complementary medicine	2010	54
20843900	Gamma-Aminobutyric acid	Beneyto M	Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.	Cerebral cortex	2011	50
20876035	Gamma-Aminobutyric acid	Dydak U	In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese.	Environmental health perspectives	2011	44
20881131	Gamma-Aminobutyric acid	Zhang TY	Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus.	The Journal of neuroscience 	2010	81
20888227	Gamma-Aminobutyric acid	Boy F	Individual differences in subconscious motor control predicted by GABA concentration in SMA.	Current biology 	2010	47
20888417	Gamma-Aminobutyric acid	Massone S	17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.	Neurobiology of disease	2011	46
20929730	Gamma-Aminobutyric acid	Lee S	Channel-mediated tonic GABA release from glia.	Science	2010	132
20940303	Gamma-Aminobutyric acid	Abramian AM	Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition.	The Journal of biological chemistry	2010	45
21041246	Gamma-Aminobutyric acid	Fung SJ	Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia.	The American journal of psychiatry	2010	126
21046567	Gamma-Aminobutyric acid	Lee M	Astrocytes are GABAergic cells that modulate microglial activity.	Glia	2011	40
21068836	Gamma-Aminobutyric acid	Haubensak W	Genetic dissection of an amygdala microcircuit that gates conditioned fear.	Nature	2010	226
21139075	Gamma-Aminobutyric acid	Jakovcevski I	Multiple origins of human neocortical interneurons are supported by distinct expression of transcription factors.	Cerebral cortex	2011	50
21215806	Gamma-Aminobutyric acid	Gaetz W	Relating MEG measured motor cortical oscillations to resting γ-aminobutyric acid (GABA) concentration.	NeuroImage	2011	56
21226980	Gamma-Aminobutyric acid	Sibille E	GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.	The international journal of neuropsychopharmacology	2011	59
21232602	Gamma-Aminobutyric acid	Tripp A	Reduced somatostatin in subgenual anterior cingulate cortex in major depression.	Neurobiology of disease	2011	39
21272009	Gamma-Aminobutyric acid	Crabbe JC	Preclinical studies of alcohol binge drinking.	Annals of the New York Academy of Sciences	2011	59
21315745	Gamma-Aminobutyric acid	Powell SB	Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.	Neuropharmacology	2012	46
21419704	Gamma-Aminobutyric acid	LeWitt PA	AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.	The Lancet. Neurology	2011	134
21632647	Gamma-Aminobutyric acid	Curley AA	Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.	The American journal of psychiatry	2011	92
21657944	Gamma-Aminobutyric acid	Alfonso-Loeches S	Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain.	Critical reviews in clinical laboratory sciences	2011	54
21708249	Gamma-Aminobutyric acid	Zou X	Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey.	Neurotoxicology and teratology	2011	43
21795557	Gamma-Aminobutyric acid	Hyde TM	Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.	The Journal of neuroscience 	2011	80
21856318	Gamma-Aminobutyric acid	Berretta S	Extracellular matrix abnormalities in schizophrenia.	Neuropharmacology	2012	34
21901839	Gamma-Aminobutyric acid	Blatt GJ	Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications.	Anatomical record	2011	43
21901840	Gamma-Aminobutyric acid	Fatemi SH	Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism.	Anatomical record	2011	37
22159125	Gamma-Aminobutyric acid	Volman V	Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity.	The Journal of neuroscience 	2011	47
22243422	Gamma-Aminobutyric acid	Chiara DC	Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with ³HTDBzl-etomidate, a photoreactive etomidate analogue.	Biochemistry	2012	45
22396415	Gamma-Aminobutyric acid	Pattwell SS	The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex.	The Journal of neuroscience 	2012	42
22424902	Gamma-Aminobutyric acid	Ma L	Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.	Cell stem cell	2012	83
22547529	Gamma-Aminobutyric acid	Ben-Ari Y	The GABA excitatory/inhibitory shift in brain maturation and neurological disorders.	The Neuroscientist 	2012	89
22626542	Gamma-Aminobutyric acid	Waite A	The dystrophin-glycoprotein complex in brain development and disease.	Trends in neurosciences	2012	36
22848101	Gamma-Aminobutyric acid	Daniel C	A distant cis acting intronic element induces site-selective RNA editing.	Nucleic acids research	2012	32
22938092	Gamma-Aminobutyric acid	Kulak A	Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.	Antioxidants & redox signaling	2013	26
22983435	Gamma-Aminobutyric acid	Volk DW	Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.	The American journal of psychiatry	2012	59
23049970	Gamma-Aminobutyric acid	Gelman BB	The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.	PloS one	2012	55
23110884	Gamma-Aminobutyric acid	Muthukumaraswamy SD	The effects of elevated endogenous GABA levels on movement-related network oscillations.	NeuroImage	2013	30
23128924	Gamma-Aminobutyric acid	Tripp A	Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.	The American journal of psychiatry	2012	55
23436129	Gamma-Aminobutyric acid	Erickson CA	Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.	Psychopharmacology	2013	25
23498139	Gamma-Aminobutyric acid	Silveri MM	Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.	Biological psychiatry	2013	31
23604284	Gamma-Aminobutyric acid	Liu Y	Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits.	Nature biotechnology	2013	59
23642365	Gamma-Aminobutyric acid	Maroof AM	Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells.	Cell stem cell	2013	153
23735822	Gamma-Aminobutyric acid	Lang UE	Molecular mechanisms of depression: perspectives on new treatment strategies.	Cellular physiology and biochemistry 	2013	43
23928500	Gamma-Aminobutyric acid	Liu Y	Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells.	Nature protocols	2013	56
24136292	Gamma-Aminobutyric acid	Li D	Association of gamma-aminobutyric acid A receptor α2 gene (GABRA2) with alcohol use disorder.	Neuropsychopharmacology 	2014	27
24149188	Gamma-Aminobutyric acid	Felipo V	Hepatic encephalopathy: effects of liver failure on brain function.	Nature reviews. Neuroscience	2013	39
24170294	Gamma-Aminobutyric acid	Georgiev D	Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.	The American journal of psychiatry	2014	22
24217255	Gamma-Aminobutyric acid	Glausier JR	Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.	Molecular psychiatry	2014	39
24395782	Gamma-Aminobutyric acid	Neman J	Human breast cancer metastases to the brain display GABAergic properties in the neural niche.	Proceedings of the National Academy of Sciences of the United States of America	2014	41
24650500	Gamma-Aminobutyric acid	Lewis DA	Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.	Current opinion in neurobiology	2014	41
24650502	Gamma-Aminobutyric acid	Kaila K	GABA actions and ionic plasticity in epilepsy.	Current opinion in neurobiology	2014	30
24791913	Gamma-Aminobutyric acid	Halson SL	Sleep in elite athletes and nutritional interventions to enhance sleep.	Sports medicine	2014	25
24923909	Gamma-Aminobutyric acid	Wu Z	Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's corrected disease model.	Nature communications	2014	27
24968779	Gamma-Aminobutyric acid	Trudeau LE	The multilingual nature of dopamine neurons.	Progress in brain research	2014	22
24993056	Gamma-Aminobutyric acid	Glausier JR	Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia.	Biological psychiatry	2015	15
25016186	Gamma-Aminobutyric acid	Sanchez C	Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.	Pharmacology & therapeutics	2015	35
25168736	Gamma-Aminobutyric acid	Ben-Ari Y	The GABA excitatory/inhibitory developmental sequence: a personal journey.	Neuroscience	2014	32
25380696	Gamma-Aminobutyric acid	Walls AB	The glutamine-glutamate/GABA cycle: function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism.	Neurochemical research	2015	18
25486982	Gamma-Aminobutyric acid	Gold PW	The organization of the stress system and its dysregulation in depressive illness.	Molecular psychiatry	2015	55
25738424	Gamma-Aminobutyric acid	Ruzicka WB	Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.	JAMA psychiatry	2015	23
25738457	Gamma-Aminobutyric acid	Besse A	The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.	Cell metabolism	2015	18
25904555	Gamma-Aminobutyric acid	Yuan H	Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.	Molecular pharmacology	2015	38
26041822	Gamma-Aminobutyric acid	Puts NA	Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome.	Journal of neurophysiology	2015	17
26106146	Gamma-Aminobutyric acid	Arnsten AF	Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.	Pharmacological reviews	2015	17
26152864	Gamma-Aminobutyric acid	Ben-Ari Y	Is birth a critical period in the pathogenesis of autism spectrum disorders?	Nature reviews. Neuroscience	2015	17
26186191	Gamma-Aminobutyric acid	Mariani J	FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders.	Cell	2015	105
26733678	Gamma-Aminobutyric acid	Tang X	KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2016	20
26743492	Gamma-Aminobutyric acid	Nakajima K	Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake.	Nature communications	2016	20
26772433	Gamma-Aminobutyric acid	Singh H	MaxiK channel interactome reveals its interaction with GABA transporter 3 and heat shock protein 60 in the mammalian brain.	Neuroscience	2016	10
26780170	Gamma-Aminobutyric acid	Kim HK	Neuropathological relationship between major depression and dementia: A hypothetical model and review.	Progress in neuro-psychopharmacology & biological psychiatry	2016	10
26830140	Gamma-Aminobutyric acid	Canetta S	Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.	Molecular psychiatry	2016	16
26869529	Gamma-Aminobutyric acid	Jarius S	Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.	Multiple sclerosis	2016	14
27023624	Gamma-Aminobutyric acid	Cooper AJ	Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain.	Biomolecules	2016	17
27225074	Gamma-Aminobutyric acid	Urban-Ciecko J	Somatostatin-expressing neurons in cortical networks.	Nature reviews. Neuroscience	2016	18
27419272	Gamma-Aminobutyric acid	Bandelow B	Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.	The world journal of biological psychiatry 	2017	6
27956747	Gamma-Aminobutyric acid	Mazzone CM	Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior.	Molecular psychiatry	2018	5
27986928	Gamma-Aminobutyric acid	Lee SJ	Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses.	The Journal of neuroscience 	2017	6
27986929	Gamma-Aminobutyric acid	Harris RA	Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents.	The Journal of neuroscience 	2017	10
9165306	Heme	Markesbery WR	Oxidative stress hypothesis in Alzheimer's disease.	Free radical biology & medicine	1997	272
15932948	Heme	Brunori M	Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes.	Proceedings of the National Academy of Sciences of the United States of America	2005	65
17625988	Heme	Atamna H	Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.	Mitochondrion	2007	58
18992768	Heme	Rohe HJ	PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.	Pharmacology & therapeutics	2009	49
20600583	Heme	Batarseh A	Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.	Molecular and cellular endocrinology	2010	63
21499987	Heme	Scapagnini G	Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.	Molecular neurobiology	2011	57
22513881	Heme	Lastres-Becker I	α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.	Human molecular genetics	2012	39
24277722	Heme	Lastres-Becker I	Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.	Brain 	2014	24
26011640	Heme	Schallner N	Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1.	The Journal of clinical investigation	2015	20
12377295	Gonadotropin releasing hormone	Tsigos C	Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.	Journal of psychosomatic research	2002	306
15219839	Gonadotropin releasing hormone	Matsui H	Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat.	Biochemical and biophysical research communications	2004	101
15452575	Gonadotropin releasing hormone	Sisk CL	The neural basis of puberty and adolescence.	Nature neuroscience	2004	196
16373418	Gonadotropin releasing hormone	Dungan HM	Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.	Endocrinology	2006	77
17904653	Gonadotropin releasing hormone	Kauffman AS	Emerging ideas about kisspeptin- GPR54 signaling in the neuroendocrine regulation of reproduction.	Trends in neurosciences	2007	62
18708085	Gonadotropin releasing hormone	Naor Z	Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.	Frontiers in neuroendocrinology	2009	66
20501670	Gonadotropin releasing hormone	Lehman MN	Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion.	Endocrinology	2010	146
20573725	Gonadotropin releasing hormone	Ramaswamy S	Neurokinin B stimulates GnRH release in the male monkey (Macaca mulatta) and is colocalized with kisspeptin in the arcuate nucleus.	Endocrinology	2010	85
23738509	Gonadotropin releasing hormone	Abreu AP	Central precocious puberty caused by mutations in the imprinted gene MKRN3.	The New England journal of medicine	2013	52
24056171	Gonadotropin releasing hormone	Thompson IR	GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression.	Molecular and cellular endocrinology	2014	20
26753790	Gonadotropin releasing hormone	Cimino I	Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.	Nature communications	2016	12
2549856	Cyclic AMP	Cohen P	The structure and regulation of protein phosphatases.	Annual review of biochemistry	1989	405
7846062	Cyclic AMP	Lovenberg TW	Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.	Proceedings of the National Academy of Sciences of the United States of America	1995	134
8387282	Cyclic AMP	Kitamura K	Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.	Biochemical and biophysical research communications	1993	185
9204917	Cyclic AMP	Glass M	Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.	The Journal of neuroscience 	1997	121
9634236	Cyclic AMP	Ludwig A	A family of hyperpolarization-activated mammalian cation channels.	Nature	1998	218
9826729	Cyclic AMP	Meucci O	Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	1998	178
9856955	Cyclic AMP	Kawasaki H	A family of cAMP-binding proteins that directly activate Rap1.	Science	1998	329
10433861	Cyclic AMP	Patel YC	Somatostatin and its receptor family.	Frontiers in neuroendocrinology	1999	184
10627585	Cyclic AMP	Banke TG	Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase.	The Journal of neuroscience 	2000	151
10835102	Cyclic AMP	Vaudry D	Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.	Pharmacological reviews	2000	164
11121511	Cyclic AMP	Elenkov IJ	The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.	Pharmacological reviews	2000	308
11448722	Cyclic AMP	Robbins J	KCNQ potassium channels: physiology, pathophysiology, and pharmacology.	Pharmacology & therapeutics	2001	111
11522260	Cyclic AMP	Chen B	Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.	Biological psychiatry	2001	182
11572963	Cyclic AMP	West AE	Calcium regulation of neuronal gene expression.	Proceedings of the National Academy of Sciences of the United States of America	2001	215
11579619	Cyclic AMP	Nestler EJ	Molecular neurobiology of addiction.	The American journal on addictions	2001	98
11967539	Cyclic AMP	Mantamadiotis T	Disruption of CREB function in brain leads to neurodegeneration.	Nature genetics	2002	174
12706957	Cyclic AMP	Manji HK	Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.	Biological psychiatry	2003	88
14623515	Cyclic AMP	Simpson ER	Sources of estrogen and their importance.	The Journal of steroid biochemistry and molecular biology	2003	126
14657344	Cyclic AMP	Stieber J	The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.	Proceedings of the National Academy of Sciences of the United States of America	2003	93
14744247	Cyclic AMP	Svenningsson P	DARPP-32: an integrator of neurotransmission.	Annual review of pharmacology and toxicology	2004	211
14999077	Cyclic AMP	Spires TL	Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.	The Journal of neuroscience 	2004	76
15464123	Cyclic AMP	Nestler EJ	Molecular mechanisms of drug addiction.	Neuropharmacology	2004	137
15541709	Cyclic AMP	Pang PT	Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF.	Ageing research reviews	2004	81
15548201	Cyclic AMP	Vaynman S	Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition.	The European journal of neuroscience	2004	269
15717292	Cyclic AMP	Abdolmaleky HM	Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	117
16651401	Cyclic AMP	Kotarsky K	Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes.	The Journal of pharmacology and experimental therapeutics	2006	77
16774927	Cyclic AMP	Lee CW	GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.	The Journal of biological chemistry	2006	120
16799259	Cyclic AMP	Miyamoto E	Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.	Journal of pharmacological sciences	2006	76
16908409	Cyclic AMP	Cheah JH	NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1.	Neuron	2006	66
17070667	Cyclic AMP	Pace TW	Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.	Brain, behavior, and immunity	2007	142
17135412	Cyclic AMP	Yasuhara T	Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.	The Journal of neuroscience 	2006	67
17197073	Cyclic AMP	Slominski A	Differential expression of HPA axis homolog in the skin.	Molecular and cellular endocrinology	2007	65
17241267	Cyclic AMP	Wang JZ	Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.	The European journal of neuroscience	2007	115
17277774	Cyclic AMP	Vijayraghavan S	Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.	Nature neuroscience	2007	255
17290303	Cyclic AMP	Meyer-Lindenberg A	Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.	The Journal of clinical investigation	2007	64
17301223	Cyclic AMP	Ahn JH	Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit.	Proceedings of the National Academy of Sciences of the United States of America	2007	87
17306374	Cyclic AMP	Doyle ME	Mechanisms of action of glucagon-like peptide 1 in the pancreas.	Pharmacology & therapeutics	2007	129
17434919	Cyclic AMP	Arnsten AF	Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.	Cerebral cortex	2007	68
17629356	Cyclic AMP	Qu K	Hydrogen sulfide: neurochemistry and neurobiology.	Neurochemistry international	2008	55
17640527	Cyclic AMP	Oliveria SF	AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling.	Neuron	2007	151
17646043	Cyclic AMP	Schiffmann SN	Adenosine A2A receptors and basal ganglia physiology.	Progress in neurobiology	2007	86
17903308	Cyclic AMP	Gottlieb DJ	Genome-wide association of sleep and circadian phenotypes.	BMC medical genetics	2007	74
18078445	Cyclic AMP	Peschke E	Melatonin, endocrine pancreas and diabetes.	Journal of pineal research	2008	51
18316612	Cyclic AMP	Sarkar D	Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.	Cancer research	2008	87
18356188	Cyclic AMP	Wang S	Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain.	Brain 	2008	77
18391177	Cyclic AMP	Linden R	Physiology of the prion protein.	Physiological reviews	2008	167
18457678	Cyclic AMP	Williams CM	Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels.	Free radical biology & medicine	2008	64
18571301	Cyclic AMP	Pandi-Perumal SR	Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.	Progress in neurobiology	2008	84
18577589	Cyclic AMP	Wayman GA	An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP.	Proceedings of the National Academy of Sciences of the United States of America	2008	223
19164583	Cyclic AMP	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	109
19228105	Cyclic AMP	Gordon T	The role of neurotrophic factors in nerve regeneration.	Neurosurgical focus	2009	60
19321517	Cyclic AMP	Manna PR	Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives.	Molecular human reproduction	2009	59
19756388	Cyclic AMP	Moonat S	Neuroscience of alcoholism: molecular and cellular mechanisms.	Cellular and molecular life sciences 	2010	51
19805477	Cyclic AMP	Vaudry D	Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.	Pharmacological reviews	2009	182
20037581	Cyclic AMP	Burgin AB	Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.	Nature biotechnology	2010	74
20100276	Cyclic AMP	Atwood BK	JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist.	British journal of pharmacology	2010	55
20168088	Cyclic AMP	Carloni S	Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia.	Autophagy	2010	54
20186705	Cyclic AMP	Yoshii A	Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.	Developmental neurobiology	2010	132
20223527	Cyclic AMP	Benito E	CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models.	Trends in neurosciences	2010	107
20493887	Cyclic AMP	Lakics V	Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.	Neuropharmacology	2010	63
20495567	Cyclic AMP	Sheng Z	A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.	Nature medicine	2010	53
21059906	Cyclic AMP	Magill ST	microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus.	Proceedings of the National Academy of Sciences of the United States of America	2010	155
21118894	Cyclic AMP	Alvarez-Saavedra M	miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock.	Human molecular genetics	2011	68
21149712	Cyclic AMP	Caccamo A	CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2010	60
21346730	Cyclic AMP	Altarejos JY	CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.	Nature reviews. Molecular cell biology	2011	233
21368041	Cyclic AMP	Pruunsild P	Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene.	The Journal of neuroscience 	2011	64
21395851	Cyclic AMP	Merz K	CREB in adult neurogenesis--master and partner in the development of adult-born neurons?	The European journal of neuroscience	2011	51
21476939	Cyclic AMP	Saura CA	The role of CREB signaling in Alzheimer's disease and other cognitive disorders.	Reviews in the neurosciences	2011	60
21490598	Cyclic AMP	Brennand KJ	Modelling schizophrenia using human induced pluripotent stem cells.	Nature	2011	374
21526220	Cyclic AMP	Merrill RA	Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1.	PLoS biology	2011	68
21796118	Cyclic AMP	Wang M	Neuronal basis of age-related working memory decline.	Nature	2011	98
21989194	Cyclic AMP	Robison AJ	Transcriptional and epigenetic mechanisms of addiction.	Nature reviews. Neuroscience	2011	244
22025720	Cyclic AMP	Cheng PL	Self-amplifying autocrine actions of BDNF in axon development.	Proceedings of the National Academy of Sciences of the United States of America	2011	46
22048463	Cyclic AMP	Funk AJ	Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.	Neuropsychopharmacology 	2012	33
22179319	Cyclic AMP	Jiang M	Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.	Nature medicine	2011	91
22243750	Cyclic AMP	Taniguchi M	Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import.	Neuron	2012	39
22341662	Cyclic AMP	Alberini CM	Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2.	Trends in neurosciences	2012	33
22525700	Cyclic AMP	Eyre H	Neuroplastic changes in depression: a role for the immune system.	Psychoneuroendocrinology	2012	47
22583753	Cyclic AMP	Kandel ER	The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB.	Molecular brain	2012	146
22584867	Cyclic AMP	Ayalew M	Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.	Molecular psychiatry	2012	105
22760556	Cyclic AMP	Rao JS	Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.	Translational psychiatry	2012	60
23019365	Cyclic AMP	Tan X	cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
23045699	Cyclic AMP	Guo C	Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23268191	Cyclic AMP	Marsden WN	Synaptic plasticity in depression: molecular, cellular and functional correlates.	Progress in neuro-psychopharmacology & biological psychiatry	2013	38
23296467	Cyclic AMP	Luo J	Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.	The Journal of experimental medicine	2013	39
23497056	Cyclic AMP	Suh HS	Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.	Journal of neuroinflammation	2013	40
23558954	Cyclic AMP	Dominguez CL	Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.	Cancer discovery	2013	27
23653680	Cyclic AMP	Pilakka-Kanthikeel S	Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.	PloS one	2013	31
23796953	Cyclic AMP	Jiang J	Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.	Trends in pharmacological sciences	2013	32
24042850	Cyclic AMP	Giese KP	The roles of protein kinases in learning and memory.	Learning & memory	2013	35
24113652	Cyclic AMP	Finsterwald C	Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies.	Neurobiology of learning and memory	2014	28
24213247	Cyclic AMP	Serafini G	The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.	Cellular and molecular neurobiology	2014	23
24375753	Cyclic AMP	Diggs-Andrews KA	Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.	Annals of neurology	2014	23
24431445	Cyclic AMP	Murphy JA	Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines.	The Journal of neuroscience 	2014	33
24618891	Cyclic AMP	Mühleisen TW	Genome-wide association study reveals two new risk loci for bipolar disorder.	Nature communications	2014	70
25150496	Cyclic AMP	He X	The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.	Nature medicine	2014	32
25197093	Cyclic AMP	Saponaro A	Structural basis for the mutual antagonism of cAMP and TRIP8b in regulating HCN channel function.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
25511446	Cyclic AMP	Kamat PK	Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.	Molecular neurobiology	2016	15
25788518	Cyclic AMP	Anastasaki C	Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.	Human molecular genetics	2015	18
25937398	Cyclic AMP	Kreutzmann JC	Sleep deprivation and hippocampal vulnerability: changes in neuronal plasticity, neurogenesis and cognitive function.	Neuroscience	2015	19
26412387	Cyclic AMP	Siuda ER	Optodynamic simulation of β-adrenergic receptor signalling.	Nature communications	2015	17
26419764	Cyclic AMP	Ehrlich DE	Plasticity-related genes in brain development and amygdala-dependent learning.	Genes, brain, and behavior	2016	10
26632666	Cyclic AMP	Duan S	PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.	Nature communications	2015	18
26706021	Cyclic AMP	Diaz-Gerevini GT	Beneficial action of resveratrol: How and why?	Nutrition	2016	22
27402953	Cyclic AMP	Inda C	Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling.	The Journal of cell biology	2016	11
27599210	Cyclic AMP	Geisler JG	DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya.	Alzheimer's & dementia 	2017	8
28242433	Cyclic AMP	Havekes R	The tired hippocampus: the molecular impact of sleep deprivation on hippocampal function.	Current opinion in neurobiology	2017	7
28462931	Cyclic AMP	Hasel P	Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.	Nature communications	2017	9
3107759	Serotonin	Oades RD	Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity.	Brain research	1987	166
7708925	Serotonin	Maes M	Evidence for an immune response in major depression: a review and hypothesis.	Progress in neuro-psychopharmacology & biological psychiatry	1995	119
7938165	Serotonin	Hoyer D	International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).	Pharmacological reviews	1994	339
9330355	Serotonin	Vertes RP	Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus.	Neuroscience	1997	124
9537821	Serotonin	Tatsumi M	Pharmacological profile of antidepressants and related compounds at human monoamine transporters.	European journal of pharmacology	1997	127
10202537	Serotonin	Shih JC	Monoamine oxidase: from genes to behavior.	Annual review of neuroscience	1999	149
10578452	Serotonin	Drevets WC	PET imaging of serotonin 1A receptor binding in depression.	Biological psychiatry	1999	124
10665620	Serotonin	Sargent PA	Brain serotonin1A receptor binding measured by positron emission tomography with 11CWAY-100635: effects of depression and antidepressant treatment.	Archives of general psychiatry	2000	105
10836796	Serotonin	Chen CX	A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.	RNA	2000	134
11106375	Serotonin	Cavaillé J	Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization.	Proceedings of the National Academy of Sciences of the United States of America	2000	162
11229973	Serotonin	Kapur S	Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.	The American journal of psychiatry	2001	108
11356815	Serotonin	Mitchell GS	Invited review: Intermittent hypoxia and respiratory plasticity.	Journal of applied physiology	2001	125
11458532	Serotonin	Weiss F	Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.	Annals of the New York Academy of Sciences	2001	116
11717408	Serotonin	Maas S	Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.	Proceedings of the National Academy of Sciences of the United States of America	2001	105
11744348	Serotonin	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	128
11873706	Serotonin	Seeman P	Atypical antipsychotics: mechanism of action.	Canadian journal of psychiatry. Revue canadienne de psychiatrie	2002	104
11906203	Serotonin	Bethea CL	Diverse actions of ovarian steroids in the serotonin neural system.	Frontiers in neuroendocrinology	2002	103
11988167	Serotonin	Gurevich I	Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.	Neuron	2002	106
12008958	Serotonin	Fujimura H	Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.	Thrombosis and haemostasis	2002	92
12082564	Serotonin	Capuron L	Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.	Molecular psychiatry	2002	106
12097496	Serotonin	Gras C	A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons.	The Journal of neuroscience 	2002	141
12559651	Serotonin	Blier P	Is there a role for 5-HT1A agonists in the treatment of depression?	Biological psychiatry	2003	81
12598679	Serotonin	Feldman JL	Breathing: rhythmicity, plasticity, chemosensitivity.	Annual review of neuroscience	2003	240
12973026	Serotonin	Ichise M	Linearized reference tissue parametric imaging methods: application to 11CDASB positron emission tomography studies of the serotonin transporter in human brain.	Journal of cerebral blood flow and metabolism 	2003	148
14612135	Serotonin	Rothman RB	Monoamine transporters and psychostimulant drugs.	European journal of pharmacology	2003	116
14642974	Serotonin	Meltzer HY	Serotonin receptors: their key role in drugs to treat schizophrenia.	Progress in neuro-psychopharmacology & biological psychiatry	2003	112
14736842	Serotonin	Neumeister A	Reduced serotonin type 1A receptor binding in panic disorder.	The Journal of neuroscience 	2004	72
15530638	Serotonin	Suzuki R	Bad news from the brain: descending 5-HT pathways that control spinal pain processing.	Trends in pharmacological sciences	2004	86
15592465	Serotonin	Heinz A	Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.	Nature neuroscience	2005	168
15629698	Serotonin	Zhang X	Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression.	Neuron	2005	83
15694227	Serotonin	Schiepers OJ	Cytokines and major depression.	Progress in neuro-psychopharmacology & biological psychiatry	2005	165
15758168	Serotonin	David SP	A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.	The Journal of neuroscience 	2005	77
15880108	Serotonin	Pezawas L	5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.	Nature neuroscience	2005	505
15893820	Serotonin	Maier SF	Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor.	Neuroscience and biobehavioral reviews	2005	196
15939761	Serotonin	Vitali P	ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.	The Journal of cell biology	2005	72
16012532	Serotonin	Maciag D	Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.	Neuropsychopharmacology 	2006	72
16093315	Serotonin	Canli T	Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task.	Proceedings of the National Academy of Sciences of the United States of America	2005	106
16300747	Serotonin	Levinson DF	The genetics of depression: a review.	Biological psychiatry	2006	154
16354910	Serotonin	Viemari JC	Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.	The Journal of neuroscience 	2005	95
16389202	Serotonin	Sekine Y	Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.	Archives of general psychiatry	2006	77
16390888	Serotonin	Parsey RV	Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain.	The American journal of psychiatry	2006	74
16442081	Serotonin	Hariri AR	Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.	Biological psychiatry	2006	106
16458264	Serotonin	Kaufman J	Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.	Biological psychiatry	2006	169
16530463	Serotonin	Hariri AR	Genetics of emotional regulation: the role of the serotonin transporter in neural function.	Trends in cognitive sciences	2006	202
16534505	Serotonin	Ebstein RP	The molecular genetic architecture of human personality: beyond self-report questionnaires.	Molecular psychiatry	2006	65
16642437	Serotonin	Hu XZ	Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.	American journal of human genetics	2006	321
16885432	Serotonin	Madras BK	Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.	The Journal of pharmacology and experimental therapeutics	2006	99
16963244	Serotonin	Chalon S	Omega-3 fatty acids and monoamine neurotransmission.	Prostaglandins, leukotrienes, and essential fatty acids	2006	71
16979141	Serotonin	Lanzenberger RR	Reduced serotonin-1A receptor binding in social anxiety disorder.	Biological psychiatry	2007	60
17032778	Serotonin	Canli T	Neural correlates of epigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	98
17060567	Serotonin	Wernicke JF	A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.	Neurology	2006	73
17088501	Serotonin	Meyer JH	Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.	Archives of general psychiatry	2006	83
17301183	Serotonin	Weaver IC	The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes.	The Journal of neuroscience 	2007	103
17457312	Serotonin	Müller N	The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.	Molecular psychiatry	2007	116
17482146	Serotonin	Kim JM	Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.	Biological psychiatry	2007	76
17678634	Serotonin	Cannon DM	Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and 11CDASB; comparison with bipolar disorder.	Biological psychiatry	2007	60
17712350	Serotonin	Minzenberg MJ	Modafinil: a review of neurochemical actions and effects on cognition.	Neuropsychopharmacology 	2008	145
17716089	Serotonin	Southwick SM	The psychobiology of depression and resilience to stress: implications for prevention and treatment.	Annual review of clinical psychology	2005	155
17726476	Serotonin	Canli T	Long story short: the serotonin transporter in emotion regulation and social cognition.	Nature neuroscience	2007	210
17919129	Serotonin	Pardo CA	The neurobiology of autism.	Brain pathology	2007	123
17949693	Serotonin	Munafò MR	Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis.	Biological psychiatry	2008	234
17956909	Serotonin	Kish SJ	Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.	Brain 	2008	72
18005940	Serotonin	Gotlib IH	HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.	Biological psychiatry	2008	139
18164737	Serotonin	Kaye W	Neurobiology of anorexia and bulimia nervosa.	Physiology & behavior	2008	83
18185497	Serotonin	Yang RJ	Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning.	Neuropsychopharmacology 	2008	52
18209729	Serotonin	Murphy DL	Targeting the murine serotonin transporter: insights into human neurobiology.	Nature reviews. Neuroscience	2008	119
18258310	Serotonin	Buckholtz JW	MAOA and the neurogenetic architecture of human aggression.	Trends in neurosciences	2008	63
18347599	Serotonin	Pezawas L	Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.	Molecular psychiatry	2008	73
18394726	Serotonin	Ogren SO	The role of 5-HT(1A) receptors in learning and memory.	Behavioural brain research	2008	51
18463263	Serotonin	Alia-Klein N	Brain monoamine oxidase A activity predicts trait aggression.	The Journal of neuroscience 	2008	55
18518925	Serotonin	Levran O	Genetic susceptibility to heroin addiction: a candidate gene association study.	Genes, brain, and behavior	2008	79
18534686	Serotonin	Brown GW	Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction.	Journal of affective disorders	2008	53
18536531	Serotonin	Oberlander TF	Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses.	Epigenetics	2008	319
18580840	Serotonin	Maes M	The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.	Neuro endocrinology letters	2008	54
18582529	Serotonin	Zhao ZQ	Neural mechanism underlying acupuncture analgesia.	Progress in neurobiology	2008	162
18639564	Serotonin	Le François B	Transcriptional regulation at a HTR1A polymorphism associated with mental illness.	Neuropharmacology	2008	55
18793712	Serotonin	Miller AH	Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.	Brain, behavior, and immunity	2009	54
18801471	Serotonin	Raison CL	Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.	Biological psychiatry	2009	100
18982004	Serotonin	Kato M	Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.	Molecular psychiatry	2010	87
19015103	Serotonin	Bakermans-Kranenburg MJ	Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting.	Social cognitive and affective neuroscience	2008	123
19085093	Serotonin	Maes M	The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.	Metabolic brain disease	2009	128
19120094	Serotonin	Lowry CA	Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus.	Annals of the New York Academy of Sciences	2008	72
19124686	Serotonin	Fakra E	Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety.	Archives of general psychiatry	2009	63
19125209	Serotonin	Anisman H	Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.	Journal of psychiatry & neuroscience 	2009	81
19175757	Serotonin	Lonsdorf TB	Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.	Psychological science	2009	66
19215635	Serotonin	Aguilera M	Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.	Psychological medicine	2009	73
19341763	Serotonin	Veenema AH	Early life stress, the development of aggression and neuroendocrine and neurobiological correlates: what can we learn from animal models?	Frontiers in neuroendocrinology	2009	50
19358877	Serotonin	Savitz JB	Imaging phenotypes of major depressive disorder: genetic correlates.	Neuroscience	2009	69
19373443	Serotonin	Capela JP	Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.	Molecular neurobiology	2009	48
19423077	Serotonin	Akimova E	The serotonin-1A receptor in anxiety disorders.	Biological psychiatry	2009	57
19439600	Serotonin	Pacheco J	Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism.	The Journal of neuroscience 	2009	54
19541429	Serotonin	Calabrese F	Neuronal plasticity: a link between stress and mood disorders.	Psychoneuroendocrinology	2009	70
19606083	Serotonin	Boldrini M	Antidepressants increase neural progenitor cells in the human hippocampus.	Neuropsychopharmacology 	2009	165
19864286	Serotonin	Chiao JY	Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene.	Proceedings. Biological sciences	2010	66
19933774	Serotonin	Marek GJ	Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?	Molecular pharmacology	2010	43
19963284	Serotonin	Homberg JR	New perspectives on the neurodevelopmental effects of SSRIs.	Trends in pharmacological sciences	2010	55
20147891	Serotonin	Frodl T	Childhood stress, serotonin transporter gene and brain structures in major depression.	Neuropsychopharmacology 	2010	42
20231323	Serotonin	Caspi A	Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.	The American journal of psychiatry	2010	365
20398062	Serotonin	Kinnally EL	Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques.	Genes, brain, and behavior	2010	56
20472064	Serotonin	Panula P	The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases.	Neurobiology of disease	2010	42
20497898	Serotonin	Parsey RV	Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.	Biological psychiatry	2010	50
20808944	Serotonin	Devlin AM	Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth.	PloS one	2010	64
20856249	Serotonin	Molendijk ML	Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.	Molecular psychiatry	2011	60
20962330	Serotonin	Alexander B	Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.	Science translational medicine	2010	41
21047622	Serotonin	Homberg JR	Looking on the bright side of serotonin transporter gene variation.	Biological psychiatry	2011	94
21074545	Serotonin	Guidotti A	Epigenetic GABAergic targets in schizophrenia and bipolar disorder.	Neuropharmacology	2011	64
21154909	Serotonin	Rudy B	Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons.	Developmental neurobiology	2011	272
21179162	Serotonin	Bevilacqua L	A population-specific HTR2B stop codon predisposes to severe impulsivity.	Nature	2010	55
21184583	Serotonin	Zlojutro M	Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2011	36
21185346	Serotonin	Maes M	The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.	Progress in neuro-psychopharmacology & biological psychiatry	2011	69
21397212	Serotonin	Barnes JJ	The molecular genetics of executive function: role of monoamine system genes.	Biological psychiatry	2011	43
21525407	Serotonin	Revel FG	TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
21550210	Serotonin	Abdolmaleky HM	Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.	Schizophrenia research	2011	41
21682946	Serotonin	Melas PA	Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.	The international journal of neuropsychopharmacology	2012	34
21731134	Serotonin	España RA	Sleep neurobiology from a clinical perspective.	Sleep	2011	40
21796103	Serotonin	Hannestad J	The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.	Neuropsychopharmacology 	2011	119
21835346	Serotonin	Bruchas MR	Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.	Neuron	2011	89
22169038	Serotonin	Libert S	SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive.	Cell	2011	45
22218094	Serotonin	Bath KG	BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.	Neuropsychopharmacology 	2012	41
22425650	Serotonin	Rojas C	Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.	European journal of pharmacology	2012	34
22488255	Serotonin	Murphy SE	The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis.	Molecular psychiatry	2013	50
22541438	Serotonin	Rajasethupathy P	A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity.	Cell	2012	125
22580182	Serotonin	Bufalino C	The role of immune genes in the association between depression and inflammation: a review of recent clinical studies.	Brain, behavior, and immunity	2013	37
22625422	Serotonin	Fernández-Ruiz J	Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?	British journal of clinical pharmacology	2013	32
22632977	Serotonin	Schmidt EF	Identification of the cortical neurons that mediate antidepressant responses.	Cell	2012	46
22652019	Serotonin	Boldrini M	Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression.	Biological psychiatry	2012	64
22691454	Serotonin	Savitz JB	Neuroreceptor imaging in depression.	Neurobiology of disease	2013	29
22751107	Serotonin	Kim H	Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression.	The Journal of clinical investigation	2012	64
22864611	Serotonin	Kurita M	HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.	Nature neuroscience	2012	61
22878161	Serotonin	Flint J	Candidate and non-candidate genes in behavior genetics.	Current opinion in neurobiology	2013	33
22894052	Serotonin	Slominski AT	Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.	Advances in anatomy, embryology, and cell biology	2012	158
22897747	Serotonin	Simmler LD	Pharmacological characterization of designer cathinones in vitro.	British journal of pharmacology	2013	117
23007189	Serotonin	Yeo GS	Unraveling the brain regulation of appetite: lessons from genetics.	Nature neuroscience	2012	61
23044468	Serotonin	Hashimoto K	Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.	Progress in neurobiology	2013	39
23154100	Serotonin	Bailer UF	Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.	Psychiatry research	2013	27
23178799	Serotonin	Baumann MH	Psychoactive "bath salts": not so soothing.	European journal of pharmacology	2013	43
23300088	Serotonin	Akama KT	Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines.	The Journal of biological chemistry	2013	37
23303074	Serotonin	Boldrini M	Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression.	Neuropsychopharmacology 	2013	50
23363473	Serotonin	Rilstone JJ	Brain dopamine-serotonin vesicular transport disease and its treatment.	The New England journal of medicine	2013	28
23401542	Serotonin	Mineur YS	Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.	Proceedings of the National Academy of Sciences of the United States of America	2013	56
23468190	Serotonin	Miller AH	Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.	Depression and anxiety	2013	70
23706576	Serotonin	Artigas F	Developments in the field of antidepressants, where do we go now?	European neuropsychopharmacology 	2015	15
23785166	Serotonin	Kometer M	Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.	The Journal of neuroscience 	2013	29
24048847	Serotonin	Muthukumaraswamy SD	Broadband cortical desynchronization underlies the human psychedelic state.	The Journal of neuroscience 	2013	38
24184687	Serotonin	Myint AM	Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.	Progress in neuro-psychopharmacology & biological psychiatry	2014	25
24323294	Serotonin	Uher R	Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search.	Social psychiatry and psychiatric epidemiology	2014	27
24627581	Serotonin	Mulak A	Sex hormones in the modulation of irritable bowel syndrome.	World journal of gastroenterology	2014	31
24757112	Serotonin	Halliday GM	The neurobiological basis of cognitive impairment in Parkinson's disease.	Movement disorders 	2014	43
24971825	Serotonin	Selvaraj S	Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies.	Neuroscience and biobehavioral reviews	2014	25
25017001	Serotonin	Uher R	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.	The American journal of psychiatry	2014	45
25036425	Serotonin	Halberstadt AL	Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.	Behavioural brain research	2015	30
25086606	Serotonin	Nikolova YS	Beyond genotype: serotonin transporter epigenetic modification predicts human brain function.	Nature neuroscience	2014	35
25433637	Serotonin	Su P	A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.	Neuron	2014	23
25444169	Serotonin	Klumpers F	Dorsomedial Prefrontal Cortex Mediates the Impact of Serotonin Transporter Linked Polymorphic Region Genotype on Anticipatory Threat Reactions.	Biological psychiatry	2015	17
25467702	Serotonin	Dutta A	Ketamine and other potential glutamate antidepressants.	Psychiatry research	2015	21
25505168	Serotonin	Howell LL	Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.	Pharmacological reviews	2015	31
25772380	Serotonin	Tremblay L	Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.	Movement disorders 	2015	24
25823514	Serotonin	Fakhoury M	Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.	Molecular neurobiology	2016	11
25891220	Serotonin	Gyurak A	Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.	Biological psychiatry	2016	12
26096838	Serotonin	Daniel SE	Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.	Neuropsychopharmacology 	2016	29
26381811	Serotonin	Battleday RM	Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.	European neuropsychopharmacology 	2015	17
26399744	Serotonin	Loebel M	Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.	Brain, behavior, and immunity	2016	17
26577932	Serotonin	Muller CL	The serotonin system in autism spectrum disorder: From biomarker to animal models.	Neuroscience	2016	27
26758213	Serotonin	Moreno JL	Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.	Science signaling	2016	12
26847689	Serotonin	Carhart-Harris RL	The paradoxical psychological effects of lysergic acid diethylamide (LSD).	Psychological medicine	2016	17
26903268	Serotonin	Gupta M	TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.	Molecular psychiatry	2016	13
27217150	Serotonin	Swartz JR	An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents.	Molecular psychiatry	2017	11
27306729	Serotonin	Smith GT	Integrating affect and impulsivity: The role of positive and negative urgency in substance use risk.	Drug and alcohol dependence	2016	13
27349436	Serotonin	Morris G	The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.	Molecular neurobiology	2017	8
28103749	Serotonin	O'Brien JT	Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.	Journal of psychopharmacology	2017	9
28179394	Serotonin	Goadsby PJ	Pathophysiology of Migraine: A Disorder of Sensory Processing.	Physiological reviews	2017	32
28386699	Serotonin	Kraehenmann R	Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.	Psychopharmacology	2017	7
17659528	Prostaglandin E2	Gordon GR	Astrocyte control of the cerebrovasculature.	Glia	2007	78
21846384	Prostaglandin E2	Rao JS	Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats.	Journal of neuroinflammation	2011	36
21946257	Prostaglandin E2	Baryawno N	Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.	The Journal of clinical investigation	2011	64
23401547	Prostaglandin E2	Jiang J	Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2013	44
23935251	Prostaglandin E2	More SV	Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.	Mediators of inflammation	2013	44
8557660	Adenosine monophosphate	Stapleton D	Mammalian AMP-activated protein kinase subfamily.	The Journal of biological chemistry	1996	142
10698692	Adenosine monophosphate	Cheung PC	Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.	The Biochemical journal	2000	148
14749508	Adenosine monophosphate	Bjørbaek C	Leptin signaling in the central nervous system and the periphery.	Recent progress in hormone research	2004	97
16054096	Adenosine monophosphate	Woods A	Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.	Cell metabolism	2005	364
16483933	Adenosine monophosphate	Liu L	Hypoxia-induced energy stress regulates mRNA translation and cell growth.	Molecular cell	2006	178
16604088	Adenosine monophosphate	Watt MJ	CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.	Nature medicine	2006	77
16709629	Adenosine monophosphate	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16805776	Adenosine monophosphate	Moncada S	Nitric oxide, cell bioenergetics and neurodegeneration.	Journal of neurochemistry	2006	98
17021375	Adenosine monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
17056128	Adenosine monophosphate	Boison D	Adenosine kinase, epilepsy and stroke: mechanisms and therapies.	Trends in pharmacological sciences	2006	79
17522440	Adenosine monophosphate	Sultana R	Proteomics analysis of the Alzheimer's disease hippocampal proteome.	Journal of Alzheimer's disease 	2007	66
18202144	Adenosine monophosphate	Ahima RS	Adipokines and the peripheral and neural control of energy balance.	Molecular endocrinology	2008	56
18809461	Adenosine monophosphate	Scharf MT	The energy hypothesis of sleep revisited.	Progress in neurobiology	2008	52
18977694	Adenosine monophosphate	Lage R	AMPK: a metabolic gauge regulating whole-body energy homeostasis.	Trends in molecular medicine	2008	101
19136996	Adenosine monophosphate	Villanueva EC	Leptin receptor signaling and the regulation of mammalian physiology.	International journal of obesity	2008	55
19363500	Adenosine monophosphate	Grill HJ	The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake.	International journal of obesity	2009	53
19387610	Adenosine monophosphate	Matthews VB	Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.	Diabetologia	2009	72
19393004	Adenosine monophosphate	Ronnett GV	AMPK in the brain: its roles in energy balance and neuroprotection.	Journal of neurochemistry	2009	55
19694967	Adenosine monophosphate	Schreurs M	Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.	Obesity reviews 	2010	50
19833968	Adenosine monophosphate	Lamia KA	AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation.	Science	2009	222
19958286	Adenosine monophosphate	Fogarty S	Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP.	The Biochemical journal	2010	44
20010958	Adenosine monophosphate	Li J	Effects of AMP-activated protein kinase in cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2010	45
20080969	Adenosine monophosphate	Vingtdeux V	AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.	The Journal of biological chemistry	2010	121
20209079	Adenosine monophosphate	Soscia SJ	The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.	PloS one	2010	162
20880848	Adenosine monophosphate	Zhang WB	Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.	The Journal of biological chemistry	2010	43
20957377	Adenosine monophosphate	Vingtdeux V	AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.	Acta neuropathologica	2011	54
21056618	Adenosine monophosphate	Rafalski VA	Energy metabolism in adult neural stem cell fate.	Progress in neurobiology	2011	56
21228397	Adenosine monophosphate	Wang H	Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain.	Science translational medicine	2011	48
21336308	Adenosine monophosphate	Zheng M	Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.	Nature cell biology	2011	56
21459634	Adenosine monophosphate	Monti JM	Serotonin control of sleep-wake behavior.	Sleep medicine reviews	2011	62
21768291	Adenosine monophosphate	Ju TC	Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease.	The Journal of cell biology	2011	51
22315316	Adenosine monophosphate	Martínez de Morentin PB	Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase.	Diabetes	2012	40
23197693	Adenosine monophosphate	Sato A	Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.	Stem cells translational medicine	2012	40
23278683	Adenosine monophosphate	Tacar O	Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.	The Journal of pharmacy and pharmacology	2013	184
23567191	Adenosine monophosphate	Chaturvedi RK	Mitochondrial diseases of the brain.	Free radical biology & medicine	2013	64
23583109	Adenosine monophosphate	Mairet-Coello G	The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.	Neuron	2013	71
23706743	Adenosine monophosphate	Leprivier G	The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.	Cell	2013	88
24419061	Adenosine monophosphate	Liu X	The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent.	Molecular cancer therapeutics	2014	43
24915455	Adenosine monophosphate	Contreras C	The brain and brown fat.	Annals of medicine	2015	24
25636177	Adenosine monophosphate	Hammack SE	Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.	Biological psychiatry	2015	18
25730670	Adenosine monophosphate	Xie Q	Mitochondrial control by DRP1 in brain tumor initiating cells.	Nature neuroscience	2015	49
26431379	Adenosine monophosphate	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
26565381	Adenosine monophosphate	Farago AF	Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.	Journal of thoracic oncology 	2015	19
26816379	Adenosine monophosphate	Toyama EQ	Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress.	Science	2016	82
26968531	Adenosine monophosphate	Bolaños JP	Bioenergetics and redox adaptations of astrocytes to neuronal activity.	Journal of neurochemistry	2016	13
27199291	Adenosine monophosphate	López M	Hypothalamic AMPK: a canonical regulator of whole-body energy balance.	Nature reviews. Endocrinology	2016	15
27381825	Adenosine monophosphate	Shi X	Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups.	Journal of cerebral blood flow and metabolism 	2017	7
28137967	Adenosine monophosphate	Zhang ZH	Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.	The Journal of neuroscience 	2017	7
28552616	Adenosine monophosphate	Li X	Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.	Molecular cell	2017	6
10998348	NAD	Penning TM	Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.	The Biochemical journal	2000	123
16751189	NAD	Qin W	Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.	The Journal of biological chemistry	2006	163
16939484	NAD	Sasaki T	Progressive loss of SIRT1 with cell cycle withdrawal.	Aging cell	2006	66
18332217	NAD	Pandithage R	The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.	The Journal of cell biology	2008	58
18607376	NAD	Palmieri L	Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.	Molecular psychiatry	2010	49
18629638	NAD	Calabrese V	Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.	Neurochemical research	2008	54
20668205	NAD	Satoh A	SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus.	The Journal of neuroscience 	2010	65
21826702	NAD	Guo W	Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.	Journal of neuroscience research	2011	46
22179316	NAD	Jeong H	Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.	Nature medicine	2011	91
22682224	NAD	Cantó C	The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.	Cell metabolism	2012	200
16467563	delta9-Tetrahydrocannabinol	Eggan SM	Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.	Cerebral cortex	2007	83
16596770	delta9-Tetrahydrocannabinol	Pertwee RG	Pharmacological actions of cannabinoids.	Handbook of experimental pharmacology	2005	120
16596779	delta9-Tetrahydrocannabinol	Mackie K	Distribution of cannabinoid receptors in the central and peripheral nervous system.	Handbook of experimental pharmacology	2005	111
21175579	delta9-Tetrahydrocannabinol	De Petrocellis L	Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.	British journal of pharmacology	2011	83
21595653	delta9-Tetrahydrocannabinol	McHugh D	Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.	British journal of pharmacology	2012	49
21970775	delta9-Tetrahydrocannabinol	Lapoint J	Severe toxicity following synthetic cannabinoid ingestion.	Clinical toxicology	2011	36
22343625	delta9-Tetrahydrocannabinol	Ahn KH	Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.	The Journal of biological chemistry	2012	50
22804774	delta9-Tetrahydrocannabinol	Mechoulam R	The endocannabinoid system and the brain.	Annual review of psychology	2013	116
23954677	delta9-Tetrahydrocannabinol	Piomelli D	More surprises lying ahead. The endocannabinoids keep us guessing.	Neuropharmacology	2014	34
24373053	delta9-Tetrahydrocannabinol	Ceccarini J	18FMK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.	Addiction biology	2015	16
24469251	delta9-Tetrahydrocannabinol	Tortoriello G	Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.	The EMBO journal	2014	26
24854329	delta9-Tetrahydrocannabinol	Devinsky O	Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.	Epilepsia	2014	65
25754762	delta9-Tetrahydrocannabinol	Justinova Z	Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.	Neuropsychopharmacology 	2015	17
26698193	delta9-Tetrahydrocannabinol	Lu HC	An Introduction to the Endogenous Cannabinoid System.	Biological psychiatry	2016	36
10542436	Acetylcholine 	Jones S	Nicotinic receptors in the brain: correlating physiology with function.	Trends in neurosciences	1999	96
12436423	Acetylcholine 	Zhou FM	Cholinergic interneuron characteristics and nicotinic properties in the striatum.	Journal of neurobiology	2002	120
12527804	Acetylcholine 	Nelson ME	Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.	Molecular pharmacology	2003	164
15858066	Acetylcholine 	Hurst RS	A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.	The Journal of neuroscience 	2005	145
15979501	Acetylcholine 	Giniatullin R	Desensitization of nicotinic ACh receptors: shaping cholinergic signaling.	Trends in neurosciences	2005	105
16275899	Acetylcholine 	Greig NH	Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.	Proceedings of the National Academy of Sciences of the United States of America	2005	67
18037926	Acetylcholine 	Exley R	Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.	British journal of pharmacology	2008	82
18381563	Acetylcholine 	Kuryatov A	Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.	Molecular pharmacology	2008	84
23641218	Acetylcholine 	Hendrickson LM	Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.	Frontiers in psychiatry	2013	35
25639674	Acetylcholine 	Dineley KT	Nicotinic ACh receptors as therapeutic targets in CNS disorders.	Trends in pharmacological sciences	2015	46
27059884	Acetylcholine 	Bonaz B	Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation.	The Journal of physiology	2016	15
8298639	Copper	Bull PC	The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.	Nature genetics	1993	208
9414160	Copper	Brown DR	The cellular prion protein binds copper in vivo.	Nature	1997	191
12955875	Copper	Ferenci P	Diagnosis and phenotypic classification of Wilson disease.	Liver international 	2003	80
18256395	Copper	Kaler SG	Neonatal diagnosis and treatment of Menkes disease.	The New England journal of medicine	2008	63
19815002	Copper	Volkening K	Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).	Brain research	2009	57
20534485	Copper	Patel JR	CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination.	Proceedings of the National Academy of Sciences of the United States of America	2010	58
20617034	Copper	Plum LM	The essential toxin: impact of zinc on human health.	International journal of environmental research and public health	2010	67
22036626	Copper	Agrawal L	HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.	Neurobiology of disease	2012	30
22115751	Copper	Zheng W	Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases.	Pharmacology & therapeutics	2012	40
22307640	Copper	You H	Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	54
23959870	Copper	Singh I	Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.	Proceedings of the National Academy of Sciences of the United States of America	2013	32
25830219	Copper	Cui L	A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.	ACS nano	2015	17
2981404	Calcium	McCord JM	Oxygen-derived free radicals in postischemic tissue injury.	The New England journal of medicine	1985	445
3266596	Calcium	Herz J	Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.	The EMBO journal	1988	171
7085651	Calcium	Castagna M	Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.	The Journal of biological chemistry	1982	625
7544443	Calcium	Lev S	Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions.	Nature	1995	246
7620916	Calcium	Zimmer DB	The S100 protein family: history, function, and expression.	Brain research bulletin	1995	126
7791877	Calcium	Li C	Ca(2+)-dependent and -independent activities of neural and non-neural synaptotagmins.	Nature	1995	133
7836469	Calcium	Kordeli E	AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier.	The Journal of biological chemistry	1995	127
9326665	Calcium	Ishii TM	A human intermediate conductance calcium-activated potassium channel.	Proceedings of the National Academy of Sciences of the United States of America	1997	130
9458167	Calcium	Griffin WS	Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.	Brain pathology	1998	126
9498163	Calcium	DeFelipe J	Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex.	Journal of chemical neuroanatomy	1997	108
9568714	Calcium	Molkentin JD	A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.	Cell	1998	578
9694809	Calcium	Strack S	Autophosphorylation-dependent targeting of calcium/ calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl- D-aspartate receptor.	The Journal of biological chemistry	1998	127
10358063	Calcium	Nath A	Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.	The Journal of biological chemistry	1999	107
10488080	Calcium	Christopherson KS	PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain.	The Journal of biological chemistry	1999	110
10571240	Calcium	D'Arcangelo G	Reelin is a ligand for lipoprotein receptors.	Neuron	1999	173
10676964	Calcium	An WF	Modulation of A-type potassium channels by a family of calcium sensors.	Nature	2000	275
10681545	Calcium	Wang HY	beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.	The Journal of biological chemistry	2000	152
10692449	Calcium	Brenner R	Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4.	The Journal of biological chemistry	2000	184
10792058	Calcium	Meera P	A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin.	Proceedings of the National Academy of Sciences of the United States of America	2000	131
10814708	Calcium	Luthi-Carter R	Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.	Human molecular genetics	2000	137
10828459	Calcium	Behrens R	hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family.	FEBS letters	2000	110
10851239	Calcium	Heise CE	Characterization of the human cysteinyl leukotriene 2 receptor.	The Journal of biological chemistry	2000	114
10977869	Calcium	de Gasparo M	International union of pharmacology. XXIII. The angiotensin II receptors.	Pharmacological reviews	2000	346
11063054	Calcium	Lewén A	Free radical pathways in CNS injury.	Journal of neurotrauma	2000	122
11158062	Calcium	Zehnder D	Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.	The Journal of clinical endocrinology and metabolism	2001	200
11245677	Calcium	Wolf JA	Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels.	The Journal of neuroscience 	2001	89
11373682	Calcium	DeMaria CD	Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels.	Nature	2001	132
11426226	Calcium	Bezzi P	CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.	Nature neuroscience	2001	208
11441182	Calcium	Davare MA	A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2.	Science	2001	146
11606325	Calcium	Bisogno T	Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.	British journal of pharmacology	2001	125
11799243	Calcium	Takasu MA	Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors.	Science	2002	126
11832226	Calcium	Tao X	A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF.	Neuron	2002	84
11994750	Calcium	Lisman J	The molecular basis of CaMKII function in synaptic and behavioural memory.	Nature reviews. Neuroscience	2002	444
12077604	Calcium	Xu H	TRPV3 is a calcium-permeable temperature-sensitive cation channel.	Nature	2002	182
12089530	Calcium	Panov AV	Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.	Nature neuroscience	2002	208
12140781	Calcium	Sklar P	Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.	Molecular psychiatry	2002	110
12151520	Calcium	Güler AD	Heat-evoked activation of the ion channel, TRPV4.	The Journal of neuroscience 	2002	213
12372661	Calcium	Beasley CL	Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.	Biological psychiatry	2002	101
12506128	Calcium	Perez-Reyes E	Molecular physiology of low-voltage-activated t-type calcium channels.	Physiological reviews	2003	365
12520530	Calcium	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
12641737	Calcium	Chawla S	Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5.	Journal of neurochemistry	2003	86
12645009	Calcium	Rothermundt M	S100B in brain damage and neurodegeneration.	Microscopy research and technique	2003	82
12684449	Calcium	Weeber EJ	Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.	The Journal of neuroscience 	2003	86
12728191	Calcium	Mattson MP	Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.	Neuromolecular medicine	2003	90
12909083	Calcium	Mattson MP	Neuronal and glial calcium signaling in Alzheimer's disease.	Cell calcium	2003	81
14523450	Calcium	Tang XD	Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels.	Nature	2003	77
14657205	Calcium	Sun GY	Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.	Journal of lipid research	2004	94
14691263	Calcium	Vriens J	Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4.	Proceedings of the National Academy of Sciences of the United States of America	2004	140
15193035	Calcium	Raghupathi R	Cell death mechanisms following traumatic brain injury.	Brain pathology	2004	111
15234332	Calcium	Wong K	Neuropathology provides clues to the pathophysiology of Gaucher disease.	Molecular genetics and metabolism	2004	92
15258588	Calcium	Bezzerides VJ	Rapid vesicular translocation and insertion of TRP channels.	Nature cell biology	2004	160
15261481	Calcium	Starkov AA	Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury.	Cell calcium	2004	84
15369669	Calcium	Xiong ZG	Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.	Cell	2004	282
15378036	Calcium	Stocker M	Ca(2+)-activated K+ channels: molecular determinants and function of the SK family.	Nature reviews. Neuroscience	2004	165
15459442	Calcium	Wang X	Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.	Stroke	2004	79
15467096	Calcium	Yu FH	The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis.	Science's STKE 	2004	137
15561405	Calcium	Simard M	The neurobiology of glia in the context of water and ion homeostasis.	Neuroscience	2004	120
15674243	Calcium	Qiu X	Induction of photosensitivity by heterologous expression of melanopsin.	Nature	2005	98
15721239	Calcium	Tolias KF	The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines.	Neuron	2005	132
15728379	Calcium	Kahlig KM	Amphetamine induces dopamine efflux through a dopamine transporter channel.	Proceedings of the National Academy of Sciences of the United States of America	2005	82
15863612	Calcium	Splawski I	Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.	Proceedings of the National Academy of Sciences of the United States of America	2005	171
15878779	Calcium	Lupica CR	Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.	Neuropharmacology	2005	69
15912889	Calcium	Bazan NG	Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.	Brain pathology	2005	68
15914466	Calcium	Hawkins BT	The blood-brain barrier/neurovascular unit in health and disease.	Pharmacological reviews	2005	508
16093311	Calcium	Noh KM	Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death.	Proceedings of the National Academy of Sciences of the United States of America	2005	69
16131542	Calcium	Kalanithi PS	Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2005	142
16395289	Calcium	Tang Y	Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.	Journal of cerebral blood flow and metabolism 	2006	76
16429133	Calcium	Yasuda R	Supersensitive Ras activation in dendrites and spines revealed by two-photon fluorescence lifetime imaging.	Nature neuroscience	2006	102
16443152	Calcium	Muralikrishna Adibhatla R	Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.	Free radical biology & medicine	2006	83
16484498	Calcium	Shalizi A	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Science	2006	190
16738244	Calcium	Deshpande A	Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons.	The Journal of neuroscience 	2006	119
16908408	Calcium	Fog JU	Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.	Neuron	2006	92
16968951	Calcium	Farooqui AA	Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.	Pharmacological reviews	2006	68
17081980	Calcium	Gomez-Ospina N	The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor.	Cell	2006	122
17132857	Calcium	Tedford HW	Direct G protein modulation of Cav2 calcium channels.	Pharmacological reviews	2006	73
17149751	Calcium	Aid T	Mouse and rat BDNF gene structure and expression revisited.	Journal of neuroscience research	2007	264
17222914	Calcium	Mehta SL	Molecular targets in cerebral ischemia for developing novel therapeutics.	Brain research reviews	2007	132
17234596	Calcium	Puopolo M	Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons.	The Journal of neuroscience 	2007	98
17261713	Calcium	Bano D	Ca2+ signals and neuronal death in brain ischemia.	Stroke	2007	56
17470522	Calcium	Brailoiu E	Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system.	The Journal of endocrinology	2007	136
17675408	Calcium	Rinaldi T	Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.	Proceedings of the National Academy of Sciences of the United States of America	2007	69
17715357	Calcium	Danzer KM	Different species of alpha-synuclein oligomers induce calcium influx and seeding.	The Journal of neuroscience 	2007	182
17785178	Calcium	Palop JJ	Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.	Neuron	2007	358
17873873	Calcium	Soto D	Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors.	Nature neuroscience	2007	73
17905198	Calcium	Tabata K	The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.	Biochemical and biophysical research communications	2007	75
18006501	Calcium	Kang Y	Induction of GABAergic postsynaptic differentiation by alpha-neurexins.	The Journal of biological chemistry	2008	53
18059270	Calcium	Vig M	Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels.	Nature immunology	2008	162
18184567	Calcium	Saneyoshi T	Activity-dependent synaptogenesis: regulation by a CaM-kinase kinase/CaM-kinase I/betaPIX signaling complex.	Neuron	2008	76
18184693	Calcium	Beveridge NJ	Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.	Human molecular genetics	2008	117
18190912	Calcium	He J	Increased MCP-1 and microglia in various regions of the human alcoholic brain.	Experimental neurology	2008	146
18250309	Calcium	Barrett CF	The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels.	Proceedings of the National Academy of Sciences of the United States of America	2008	66
18253054	Calcium	Raz L	Rapid estrogen signaling in the brain.	Neuro-Signals	2008	67
18272392	Calcium	Gómez-Ramos A	Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells.	Molecular and cellular neurosciences	2008	58
18407825	Calcium	Leung AW	Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.	Biochimica et biophysica acta	2008	89
18469813	Calcium	Dibbens LM	X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.	Nature genetics	2008	72
18478527	Calcium	Wojda U	Calcium ions in neuronal degeneration.	IUBMB life	2008	64
18579197	Calcium	Buell JS	Vitamin D and neurocognitive dysfunction: preventing "D"ecline?	Molecular aspects of medicine	2008	59
18753372	Calcium	Papaleo F	Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.	The Journal of neuroscience 	2008	103
18769546	Calcium	Tsigelny IF	Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.	PloS one	2008	77
18801879	Calcium	Piton A	Mutations in the calcium-related gene IL1RAPL1 are associated with autism.	Human molecular genetics	2008	56
18803808	Calcium	Yamasaki N	Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.	Molecular brain	2008	100
18832659	Calcium	Braun A	Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation.	Blood	2009	53
19023041	Calcium	Buccafusco JJ	Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.	The Journal of pharmacology and experimental therapeutics	2009	52
19036954	Calcium	Kim HJ	Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.	The Journal of neuroscience 	2008	54
19036964	Calcium	Chen X	Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.	The Journal of neuroscience 	2008	62
19065144	Calcium	Sullivan PF	Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.	Molecular psychiatry	2009	138
19091984	Calcium	Behrens MM	Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.	The Journal of neuroscience 	2008	76
19103291	Calcium	MacAskill AF	GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons.	Molecular and cellular neurosciences	2009	51
19162338	Calcium	Koehler RC	Astrocytes and the regulation of cerebral blood flow.	Trends in neurosciences	2009	135
19279265	Calcium	Oberheim NA	Uniquely hominid features of adult human astrocytes.	The Journal of neuroscience 	2009	215
19293237	Calcium	Mahad DJ	Mitochondrial changes within axons in multiple sclerosis.	Brain 	2009	82
19321461	Calcium	Correale J	Immunomodulatory effects of Vitamin D in multiple sclerosis.	Brain 	2009	115
19380828	Calcium	Oh YJ	HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.	Journal of immunology	2009	48
19394359	Calcium	Reddy PH	Mitochondrial structural and functional dynamics in Huntington's disease.	Brain research reviews	2009	45
19398778	Calcium	Blair NT	Intracellular calcium strongly potentiates agonist-activated TRPC5 channels.	The Journal of general physiology	2009	56
19451355	Calcium	Hagström E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	86
19587275	Calcium	Jourdi H	Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation.	The Journal of neuroscience 	2009	47
19616093	Calcium	Du H	Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.	Biochimica et biophysica acta	2010	43
19620237	Calcium	Turu G	Signal transduction of the CB1 cannabinoid receptor.	Journal of molecular endocrinology	2010	62
19631259	Calcium	Rossi D	Astrocytic dysfunction: insights on the role in neurodegeneration.	Brain research bulletin	2009	59
19638347	Calcium	Djakovic SN	Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II.	The Journal of biological chemistry	2009	64
19741117	Calcium	Daw MI	Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent.	The Journal of neuroscience 	2009	63
19786048	Calcium	Fan X	The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury.	Brain research reviews	2009	47
19804796	Calcium	Bruijnzeel AW	kappa-Opioid receptor signaling and brain reward function.	Brain research reviews	2009	58
19828810	Calcium	Abdul HM	Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.	The Journal of neuroscience 	2009	77
19917116	Calcium	Bitanihirwe BK	Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.	BMC psychiatry	2009	46
20032460	Calcium	Zhao WQ	Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.	The Journal of biological chemistry	2010	49
20053169	Calcium	Albrecht P	Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.	CNS & neurological disorders drug targets	2010	42
20089917	Calcium	Zadran S	Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation.	The Journal of neuroscience 	2010	42
20129495	Calcium	Saatman KE	Calpain as a therapeutic target in traumatic brain injury.	Neurotherapeutics 	2010	65
20164348	Calcium	Wu HY	Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.	The Journal of neuroscience 	2010	134
20186955	Calcium	van den Maagdenberg AM	High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice.	Annals of neurology	2010	44
20203163	Calcium	Matias PJ	Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.	Clinical journal of the American Society of Nephrology 	2010	45
20332425	Calcium	Mattson MP	ER calcium and Alzheimer's disease: in a state of flux.	Science signaling	2010	53
20405009	Calcium	Gómez Ravetti M	Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.	PloS one	2010	41
20410121	Calcium	Jiruska P	High-frequency network activity, global increase in neuronal activity, and synchrony expansion precede epileptic seizures in vitro.	The Journal of neuroscience 	2010	42
20415633	Calcium	Woo TU	Gamma oscillation deficits and the onset and early progression of schizophrenia.	Harvard review of psychiatry	2010	44
20480274	Calcium	Kasumu A	Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.	Cerebellum	2012	33
20484626	Calcium	Emmanouilidou E	Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.	The Journal of neuroscience 	2010	262
20554944	Calcium	Ding X	Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.	Journal of the National Cancer Institute	2010	46
20632969	Calcium	Ribeiro FM	Group I metabotropic glutamate receptor signalling and its implication in neurological disease.	CNS & neurological disorders drug targets	2010	42
20679588	Calcium	Erk S	Brain function in carriers of a genome-wide supported bipolar disorder variant.	Archives of general psychiatry	2010	48
20689558	Calcium	Tobaben S	Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons.	Cell death and differentiation	2011	41
20705090	Calcium	Chiu CT	Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.	Pharmacology & therapeutics	2010	59
20723845	Calcium	Durr A	Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.	The Lancet. Neurology	2010	94
20731583	Calcium	Wang S	Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza.	The Journal of infectious diseases	2010	40
20819988	Calcium	Bigos KL	Genetic variation in CACNA1C affects brain circuitries related to mental illness.	Archives of general psychiatry	2010	79
20971854	Calcium	Maezawa I	Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.	The Journal of biological chemistry	2011	60
21068725	Calcium	Guzman JN	Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.	Nature	2010	176
21076838	Calcium	Prodinger C	CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system.	Acta neuropathologica	2011	38
21084426	Calcium	Saad M	Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.	Human molecular genetics	2011	56
21118669	Calcium	Parpura V	Ca(2+) sources for the exocytotic release of glutamate from astrocytes.	Biochimica et biophysica acta	2011	35
21186355	Calcium	Altier C	The Cavβ subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels.	Nature neuroscience	2011	85
21192095	Calcium	de Groot J	Glutamate and the biology of gliomas.	Glia	2011	55
21273404	Calcium	Benali A	Theta-burst transcranial magnetic stimulation alters cortical inhibition.	The Journal of neuroscience 	2011	39
21451044	Calcium	Cavanaugh DJ	Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells.	The Journal of neuroscience 	2011	119
21485744	Calcium	Wolkowitz OM	Of sound mind and body: depression, disease, and accelerated aging.	Dialogues in clinical neuroscience	2011	56
21531043	Calcium	Bruno AM	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	Neurobiology of aging	2012	32
21740229	Calcium	Su SC	Cyclin-dependent kinases in brain development and disease.	Annual review of cell and developmental biology	2011	101
21808019	Calcium	Koo SJ	SNARE motif-mediated sorting of synaptobrevin by the endocytic adaptors clathrin assembly lymphoid myeloid leukemia (CALM) and AP180 at synapses.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21844361	Calcium	Qu J	S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.	Proceedings of the National Academy of Sciences of the United States of America	2011	45
21884755	Calcium	Surmeier DJ	The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.	Neuroscience	2011	48
21951193	Calcium	Frye CA	Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems.	Journal of neuroendocrinology	2012	37
22014436	Calcium	Vekrellis K	Pathological roles of α-synuclein in neurological disorders.	The Lancet. Neurology	2011	72
22064678	Calcium	Atwood BK	Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.	Molecular pharmacology	2012	35
22120178	Calcium	Paşca SP	Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome.	Nature medicine	2011	166
22130660	Calcium	Weiss N	A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis.	The Journal of biological chemistry	2012	34
22145907	Calcium	Michetti F	The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.	Journal of neurochemistry	2012	31
22157397	Calcium	Dockray GJ	Cholecystokinin.	Current opinion in endocrinology, diabetes, and obesity	2012	31
22186024	Calcium	Ramonet D	PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.	Human molecular genetics	2012	40
22249839	Calcium	Rajakulendran S	Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.	Nature reviews. Neurology	2012	35
22285841	Calcium	Risher WC	Thrombospondins as key regulators of synaptogenesis in the central nervous system.	Matrix biology 	2012	39
22307057	Calcium	Foster TC	Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity.	Progress in neurobiology	2012	47
22431676	Calcium	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22446186	Calcium	Selvaraj S	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	The Journal of clinical investigation	2012	42
22514303	Calcium	Sakrikar D	Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.	The Journal of neuroscience 	2012	41
22547800	Calcium	Yan J	BK potassium channel modulation by leucine-rich repeat-containing proteins.	Proceedings of the National Academy of Sciences of the United States of America	2012	73
22695026	Calcium	Monte-Silva K	Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation.	Brain stimulation	2013	90
22705413	Calcium	Bhat S	CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.	Progress in neurobiology	2012	63
22915123	Calcium	Oulès B	Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.	The Journal of neuroscience 	2012	45
22922446	Calcium	Schon EA	Mitochondria-associated ER membranes in Alzheimer disease.	Molecular and cellular neurosciences	2013	52
23039869	Calcium	Chami L	BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease.	Molecular neurodegeneration	2012	38
23043192	Calcium	Mitchell DM	Long-term follow-up of patients with hypoparathyroidism.	The Journal of clinical endocrinology and metabolism	2012	34
23093183	Calcium	Kang S	CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.	Nature communications	2012	36
23112146	Calcium	Harraz MM	MicroRNA-223 is neuroprotective by targeting glutamate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	46
23186989	Calcium	Mizwicki MT	1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.	Journal of Alzheimer's disease 	2013	28
23200863	Calcium	Charlesworth G	Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis.	American journal of human genetics	2012	49
23248295	Calcium	Jung J	Dynamic modulation of ANO1/TMEM16A HCO3(-) permeability by Ca2+/calmodulin.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
23307741	Calcium	Sun W	Glutamate-dependent neuroglial calcium signaling differs between young and adult brain.	Science	2013	129
23313911	Calcium	Krey JF	Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons.	Nature neuroscience	2013	79
23343770	Calcium	Bonora M	Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition.	Cell cycle	2013	100
23438480	Calcium	Rüb U	Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.	Progress in neurobiology	2013	45
23453885	Calcium	Cross-Disorder Group of the Psychiatric Genomics Consortium.	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	Lancet	2013	695
23467346	Calcium	Robison AJ	Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell.	The Journal of neuroscience 	2013	52
23469922	Calcium	Rajkowska G	Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.	Current drug targets	2013	65
23506867	Calcium	Khananshvili D	The SLC8 gene family of sodium-calcium exchangers (NCX) - structure, function, and regulation in health and disease.	Molecular aspects of medicine	2013	32
23620518	Calcium	Hedskog L	Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.	Proceedings of the National Academy of Sciences of the United States of America	2013	66
23686305	Calcium	Davis FM	Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.	Oncogene	2014	54
23913003	Calcium	Keller A	Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.	Nature genetics	2013	43
23943781	Calcium	Zotova E	Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.	Brain 	2013	42
23979604	Calcium	Gershon ES	A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain.	Molecular psychiatry	2014	25
23990563	Calcium	Li K	βCaMKII in lateral habenula mediates core symptoms of depression.	Science	2013	48
24012003	Calcium	Um JW	Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.	Neuron	2013	124
24046081	Calcium	Jantzie LL	Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.	Cerebral cortex	2015	20
24155668	Calcium	Willard SS	Glutamate, glutamate receptors, and downstream signaling pathways.	International journal of biological sciences	2013	34
24274740	Calcium	Wu LG	Exocytosis and endocytosis: modes, functions, and coupling mechanisms.	Annual review of physiology	2014	59
24298164	Calcium	Shipton OA	GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2014	49
24336167	Calcium	Logan CV	Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.	Nature genetics	2014	60
24361499	Calcium	Lai TW	Excitotoxicity and stroke: identifying novel targets for neuroprotection.	Progress in neurobiology	2014	106
24387768	Calcium	Xu W	Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1.	BMC medical genetics	2014	27
24401693	Calcium	Duan L	Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death.	Molecular neurodegeneration	2014	30
24447857	Calcium	Torres-Platas SG	Morphometric characterization of microglial phenotypes in human cerebral cortex.	Journal of neuroinflammation	2014	36
24463508	Calcium	Purcell SM	A polygenic burden of rare disruptive mutations in schizophrenia.	Nature	2014	354
24472175	Calcium	Stanisz H	Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry.	Pigment cell & melanoma research	2014	22
24570656	Calcium	Doll CA	Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models.	Frontiers in cellular neuroscience	2014	31
24586273	Calcium	Hartfield EM	Physiological characterisation of human iPS-derived dopaminergic neurons.	PloS one	2014	36
24627036	Calcium	Shahim P	Blood biomarkers for brain injury in concussed professional ice hockey players.	JAMA neurology	2014	55
24683526	Calcium	Striessnig J	L-type Ca2+ channels in heart and brain.	Wiley interdisciplinary reviews. Membrane transport and signaling	2014	39
24718920	Calcium	Nurnberger JI Jr	Identification of pathways for bipolar disorder: a meta-analysis.	JAMA psychiatry	2014	45
24733928	Calcium	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24858659	Calcium	Torres-Platas SG	Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.	Brain, behavior, and immunity	2014	51
24905578	Calcium	Schöndorf DC	iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.	Nature communications	2014	71
24934288	Calcium	Dragicevic E	Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.	Brain 	2014	25
24954676	Calcium	Schapira AH	Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.	Lancet	2014	60
24996399	Calcium	Berger SM	The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.	Cell and tissue research	2014	27
25023795	Calcium	Eberhardt M	H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.	Nature communications	2014	51
25029033	Calcium	Iannotti FA	Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.	ACS chemical neuroscience	2014	21
25116795	Calcium	Chen HM	Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients.	Translational psychiatry	2014	35
25152434	Calcium	Hall J	Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity.	Biological psychiatry	2015	62
25192047	Calcium	Herrmann DN	Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.	American journal of human genetics	2014	21
25378250	Calcium	Hormozdiari F	The discovery of integrated gene networks for autism and related disorders.	Genome research	2015	51
25403839	Calcium	Yoshimizu T	Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons.	Molecular psychiatry	2015	31
25453756	Calcium	Roussos P	A role for noncoding variation in schizophrenia.	Cell reports	2014	51
25478815	Calcium	Van Laar VS	Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.	Neurobiology of disease	2015	18
25601362	Calcium	Berretta S	Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.	Schizophrenia research	2015	24
25620733	Calcium	Pinggera A	CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels.	Biological psychiatry	2015	29
25661091	Calcium	Thornton C	Role of mitochondria in apoptotic and necroptotic cell death in the developing brain.	Clinica chimica acta; international journal of clinical chemistry	2015	15
25678561	Calcium	Bernard-Marissal N	Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration.	Brain 	2015	22
25705886	Calcium	Baker K	Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.	The Journal of clinical investigation	2015	15
25772239	Calcium	Vassallo I	WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.	Oncogene	2016	23
25966694	Calcium	Santulli G	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	Current molecular pharmacology	2015	49
26026923	Calcium	Daruich A	Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.	Progress in retinal and eye research	2015	38
26074866	Calcium	Di Battista AP	Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.	Frontiers in neurology	2015	16
26076170	Calcium	Korvatska O	R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.	JAMA neurology	2015	17
26247861	Calcium	Levy JM	Synaptic Consolidation Normalizes AMPAR Quantal Size following MAGUK Loss.	Neuron	2015	16
26286145	Calcium	Walker DG	Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.	Alzheimer's research & therapy	2015	30
26362469	Calcium	Zamponi GW	The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.	Pharmacological reviews	2015	72
26468182	Calcium	Olsen ML	New Insights on Astrocyte Ion Channels: Critical for Homeostasis and Neuron-Glia Signaling.	The Journal of neuroscience 	2015	23
26519901	Calcium	Björkholm C	BDNF - a key transducer of antidepressant effects.	Neuropharmacology	2016	26
26567335	Calcium	Segawa K	Human Type IV P-type ATPases That Work as Plasma Membrane Phospholipid Flippases and Their Regulation by Caspase and Calcium.	The Journal of biological chemistry	2016	14
26589592	Calcium	Johnson VE	SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injury.	Acta neuropathologica	2016	16
26639834	Calcium	Borkum JM	Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis.	Headache	2016	17
26663395	Calcium	Yan Z	Rab11a Mediates Vascular Endothelial-Cadherin Recycling and Controls Endothelial Barrier Function.	Arteriosclerosis, thrombosis, and vascular biology	2016	10
26826102	Calcium	Oaks AW	Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits.	Cerebral cortex	2017	8
26856814	Calcium	O'Sullivan C	The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.	Journal of neuroinflammation	2016	10
27007844	Calcium	Wells MF	Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice.	Nature	2016	16
27055244	Calcium	Wen Y	Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling.	PloS one	2016	14
27097283	Calcium	Dafinca R	C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.	Stem cells	2016	22
27240532	Calcium	Kushima I	High-resolution copy number variation analysis of schizophrenia in Japan.	Molecular psychiatry	2017	6
27309760	Calcium	Vidadala RS	Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.	Journal of medicinal chemistry	2016	14
27509850	Calcium	Chailangkarn T	A human neurodevelopmental model for Williams syndrome.	Nature	2016	15
27514990	Calcium	Balez R	Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.	Scientific reports	2016	11
27590583	Calcium	Surmeier DJ	Calcium and Parkinson's disease.	Biochemical and biophysical research communications	2017	12
27845201	Calcium	Tarantini S	Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.	Experimental gerontology	2017	13
28112735	Calcium	Koukouli F	Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.	Nature medicine	2017	6
28445465	Calcium	Birey F	Assembly of functionally integrated human forebrain spheroids.	Nature	2017	28
28622296	Calcium	Pihán P	BCL-2 family: integrating stress responses at the ER to control cell demise.	Cell death and differentiation	2017	6
28817799	Calcium	Sloan SA	Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells.	Neuron	2017	7
9776413	Lomustine	Cairncross JG	Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.	Journal of the National Cancer Institute	1998	190
17827463	Lomustine	Stupp R	Chemoradiotherapy in malignant glioma: standard of care and future directions.	Journal of clinical oncology 	2007	118
20980335	Lomustine	Bogdahn U	Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.	Neuro-oncology	2011	80
23071237	Lomustine	van den Bent MJ	Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.	Journal of clinical oncology 	2013	157
23095825	Lomustine	Weller M	Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.	Neuro-oncology	2012	31
23269986	Lomustine	Erdem-Eraslan L	Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.	Journal of clinical oncology 	2013	26
24516018	Lomustine	Cairncross JG	Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.	Journal of clinical oncology 	2014	65
26354927	Lomustine	Dubbink HJ	Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.	Neuro-oncology	2016	19
27370396	Lomustine	Wick W	Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.	Neuro-oncology	2016	11
7791878	Chloride ion	Fairman WA	An excitatory amino-acid transporter with properties of a ligand-gated chloride channel.	Nature	1995	176
15383648	Chloride ion	Lynch JW	Molecular structure and function of the glycine receptor chloride channel.	Physiological reviews	2004	190
15561411	Chloride ion	Brown PD	Molecular mechanisms of cerebrospinal fluid production.	Neuroscience	2004	77
17704762	Chloride ion	Zomot E	Mechanism of chloride interaction with neurotransmitter:sodium symporters.	Nature	2007	84
18445774	Chloride ion	Sontheimer H	An unexpected role for ion channels in brain tumor metastasis.	Experimental biology and medicine	2008	83
20570904	Chloride ion	Haas BR	Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.	Cancer research	2010	45
21543740	Chloride ion	Cuddapah VA	Ion channels and transporters corrected in cancer. 2. Ion channels and the control of cancer cell migration.	American journal of physiology. Cell physiology	2011	42
22566612	Chloride ion	McAfee Q	Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.	Proceedings of the National Academy of Sciences of the United States of America	2012	80
22705273	Chloride ion	Löscher W	Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.	Neuropharmacology	2013	46
22837036	Chloride ion	Beggs S	P2X4R+ microglia drive neuropathic pain.	Nature neuroscience	2012	63
24081981	Chloride ion	Vocke K	Calmodulin-dependent activation and inactivation of anoctamin calcium-gated chloride channels.	The Journal of general physiology	2013	27
25033378	Chloride ion	LaRusch J	Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.	PLoS genetics	2014	28
25234263	Chloride ion	Kaila K	Cation-chloride cotransporters in neuronal development, plasticity and disease.	Nature reviews. Neuroscience	2014	89
26370147	Chloride ion	Pilorge M	Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism.	Molecular psychiatry	2016	12
26862169	Chloride ion	Ayoglu B	Anoctamin 2 identified as an autoimmune target in multiple sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2016	11
28514446	Chloride ion	Chung S	Identification of preoptic sleep neurons using retrograde labelling and gene profiling.	Nature	2017	11
9425011	Glutathione	Keller JN	Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.	The Journal of neuroscience 	1998	123
15032713	Glutathione	Swanson RA	Astrocyte influences on ischemic neuronal death.	Current molecular medicine	2004	95
16011466	Glutathione	Burk RF	Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis.	Annual review of nutrition	2005	90
16410648	Glutathione	Yao JK	Altered glutathione redox state in schizophrenia.	Disease markers	2006	73
17921251	Glutathione	Gysin R	Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.	Proceedings of the National Academy of Sciences of the United States of America	2007	80
18171934	Glutathione	Langley B	Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.	The Journal of neuroscience 	2008	67
18367735	Glutathione	Levine S	Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans.	The New England journal of medicine	2008	201
18588971	Glutathione	Sorolla MA	Proteomic and oxidative stress analysis in human brain samples of Huntington disease.	Free radical biology & medicine	2008	57
18626009	Glutathione	van der Brug MP	RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways.	Proceedings of the National Academy of Sciences of the United States of America	2008	82
18762024	Glutathione	Seiler A	Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death.	Cell metabolism	2008	140
19448625	Glutathione	Herrero-Mendez A	The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.	Nature cell biology	2009	188
19694903	Glutathione	Lewerenz J	Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.	Journal of neurochemistry	2009	67
19748514	Glutathione	Fuller S	Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?	Mutation research	2010	50
20084018	Glutathione	Ansari MA	Oxidative stress in the progression of Alzheimer disease in the frontal cortex.	Journal of neuropathology and experimental neurology	2010	83
20164340	Glutathione	Steullet P	Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors.	The Journal of neuroscience 	2010	58
20357106	Glutathione	Li X	Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.	The Journal of neuroscience 	2010	56
20417696	Glutathione	Kantrowitz JT	N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?	Brain research bulletin	2010	118
20924967	Glutathione	Goel A	Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.	Nutrition and cancer	2010	83
21129940	Glutathione	Guerrero-Beltrán CE	Protective effect of sulforaphane against oxidative stress: recent advances.	Experimental and toxicologic pathology 	2012	49
21289278	Glutathione	Reitman ZJ	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2011	164
22015945	Glutathione	Pope WB	Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.	Journal of neuro-oncology	2012	62
22138445	Glutathione	Backos DS	The role of glutathione in brain tumor drug resistance.	Biochemical pharmacology	2012	31
22188542	Glutathione	Xue M	Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.	The Biochemical journal	2012	52
22887998	Glutathione	Wanka C	Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.	The Journal of biological chemistry	2012	41
23928499	Glutathione	Giustarini D	Analysis of GSH and GSSG after derivatization with N-ethylmaleimide.	Nature protocols	2013	28
24297161	Glutathione	Dunbar EM	Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.	Investigational new drugs	2014	31
24597893	Glutathione	Rojo AI	Redox control of microglial function: molecular mechanisms and functional significance.	Antioxidants & redox signaling	2014	30
24794031	Glutathione	Brown NC	An updated meta-analysis of oxidative stress markers in bipolar disorder.	Psychiatry research	2014	26
25283382	Glutathione	Shi J	Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.	Tumour biology 	2015	22
25798841	Glutathione	Sleire L	Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.	Oncogene	2015	17
26019222	Glutathione	Robert SM	SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.	Science translational medicine	2015	19
26669865	Glutathione	Emir UE	Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.	Cancer research	2016	19
26799654	Glutathione	Zhang Y	Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia.	PloS one	2016	13
28551354	Glutathione	Poprac P	Targeting Free Radicals in Oxidative Stress-Related Human Diseases.	Trends in pharmacological sciences	2017	10
1279431	Oxygen	Shweiki D	Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.	Nature	1992	672
9620775	Oxygen	Parkes TL	Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons.	Nature genetics	1998	166
9840812	Oxygen	Gu YZ	Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha.	Gene expression	1998	111
10601882	Oxygen	Floyd RA	Antioxidants, oxidative stress, and degenerative neurological disorders.	Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine	1999	117
10668900	Oxygen	del Zoppo G	Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.	Brain pathology	2000	109
11015506	Oxygen	Costeloe K	The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.	Pediatrics	2000	100
11029004	Oxygen	Burmester T	A vertebrate globin expressed in the brain.	Nature	2000	196
11461977	Oxygen	Lauderback CM	The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.	Journal of neurochemistry	2001	95
11487050	Oxygen	Nunomura A	Oxidative damage is the earliest event in Alzheimer disease.	Journal of neuropathology and experimental neurology	2001	359
11507045	Oxygen	Fukumura D	Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.	Cancer research	2001	91
11516994	Oxygen	Semenza GL	Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.	Trends in molecular medicine	2001	162
11786404	Oxygen	Coraci IS	CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.	The American journal of pathology	2002	100
11880482	Oxygen	Lebon V	Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.	The Journal of neuroscience 	2002	103
11927290	Oxygen	Semenza GL	HIF-1 and tumor progression: pathophysiology and therapeutics.	Trends in molecular medicine	2002	183
12042811	Oxygen	Xu J	Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.	Nature medicine	2002	150
12160938	Oxygen	Castegna A	Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.	Free radical biology & medicine	2002	117
12354300	Oxygen	Castegna A	Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.	Journal of neurochemistry	2002	110
12379907	Oxygen	Husemann J	Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system.	Glia	2002	87
12580704	Oxygen	Luchsinger JA	Antioxidant vitamin intake and risk of Alzheimer disease.	Archives of neurology	2003	88
12621155	Oxygen	Sun Y	Neuroglobin protects the brain from experimental stroke in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	93
12663857	Oxygen	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
12858170	Oxygen	Mattiasson G	Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma.	Nature medicine	2003	111
14572528	Oxygen	Horn NR	Response inhibition and impulsivity: an fMRI study.	Neuropsychologia	2003	119
14697204	Oxygen	Aarts M	A key role for TRPM7 channels in anoxic neuronal death.	Cell	2003	198
15073152	Oxygen	Pesah Y	Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.	Development	2004	133
15152194	Oxygen	Sharp FR	HIF1 and oxygen sensing in the brain.	Nature reviews. Neuroscience	2004	94
15326186	Oxygen	Bánfi B	NOX3, a superoxide-generating NADPH oxidase of the inner ear.	The Journal of biological chemistry	2004	106
15502868	Oxygen	Martinat C	Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.	PLoS biology	2004	81
15673663	Oxygen	Smolka MN	Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex.	The Journal of neuroscience 	2005	96
15791003	Oxygen	Zhang W	Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.	FASEB journal 	2005	259
15882775	Oxygen	Chong ZZ	Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.	Progress in neurobiology	2005	149
16204625	Oxygen	Haorah J	Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction.	Journal of leukocyte biology	2005	76
16210396	Oxygen	Caspersen C	Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.	FASEB journal 	2005	208
16473887	Oxygen	Neumann J	Microglia provide neuroprotection after ischemia.	FASEB journal 	2006	73
16505665	Oxygen	Vespa P	Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury.	Critical care medicine	2006	61
16565714	Oxygen	Bosco DA	Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.	Nature chemical biology	2006	67
16611807	Oxygen	Bertolino A	Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain.	The Journal of neuroscience 	2006	77
16678181	Oxygen	Hunt NH	Immunopathogenesis of cerebral malaria.	International journal for parasitology	2006	84
16903269	Oxygen	Long TC	Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity.	Environmental science & technology	2006	78
17055784	Oxygen	Weydt P	Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.	Cell metabolism	2006	191
17063156	Oxygen	Apud JA	Tolcapone improves cognition and cortical information processing in normal human subjects.	Neuropsychopharmacology 	2007	77
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17116235	Oxygen	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	109
17222916	Oxygen	Heneka MT	Inflammatory processes in Alzheimer's disease.	Journal of neuroimmunology	2007	171
17250680	Oxygen	Haorah J	Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.	Journal of neurochemistry	2007	79
17284606	Oxygen	Gruber M	Acute postnatal ablation of Hif-2alpha results in anemia.	Proceedings of the National Academy of Sciences of the United States of America	2007	157
17479184	Oxygen	Frangogiannis NG	Chemokines in ischemia and reperfusion.	Thrombosis and haemostasis	2007	69
17586731	Oxygen	Schreibelt G	Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.	FASEB journal 	2007	73
17643088	Oxygen	Jain RK	Angiogenesis in brain tumours.	Nature reviews. Neuroscience	2007	335
17704323	Oxygen	Zhao W	Oxidative damage pathways in relation to normal tissue injury.	The British journal of radiology	2007	56
17962575	Oxygen	Secher NH	Cerebral blood flow and metabolism during exercise: implications for fatigue.	Journal of applied physiology	2008	51
18160646	Oxygen	Boettiger CA	Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype.	The Journal of neuroscience 	2007	109
18245082	Oxygen	Devi L	Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.	The Journal of biological chemistry	2008	198
18325636	Oxygen	Fleisher AS	Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.	Neurobiology of aging	2009	66
18439825	Oxygen	Goense JB	Neurophysiology of the BOLD fMRI signal in awake monkeys.	Current biology 	2008	163
18535813	Oxygen	Bidlingmaier S	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.	Journal of molecular medicine	2008	83
18675321	Oxygen	Ridder DA	NF-kappaB signaling in cerebral ischemia.	Neuroscience	2009	77
18751914	Oxygen	Adibhatla RM	Altered lipid metabolism in brain injury and disorders.	Sub-cellular biochemistry	2008	78
19011099	Oxygen	Breckwoldt MO	Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.	Proceedings of the National Academy of Sciences of the United States of America	2008	78
19023125	Oxygen	Potkin SG	A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype.	Schizophrenia bulletin	2009	95
19023330	Oxygen	Moisoi N	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.	Cell death and differentiation	2009	47
19054280	Oxygen	Turchan-Cholewo J	Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.	Journal of neurochemistry	2009	47
19059306	Oxygen	Garrido AM	NADPH oxidases and angiotensin II receptor signaling.	Molecular and cellular endocrinology	2009	99
19087196	Oxygen	Amantea D	Post-ischemic brain damage: pathophysiology and role of inflammatory mediators.	The FEBS journal	2009	95
19101265	Oxygen	Slater JP	Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery.	The Annals of thoracic surgery	2009	62
19104049	Oxygen	Dreher JC	Variation in dopamine genes influences responsivity of the human reward system.	Proceedings of the National Academy of Sciences of the United States of America	2009	114
19135149	Oxygen	S Roriz-Filho J	(Pre)diabetes, brain aging, and cognition.	Biochimica et biophysica acta	2009	68
19285945	Oxygen	Gandhi S	PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.	Molecular cell	2009	170
19293146	Oxygen	Toda N	Cerebral blood flow regulation by nitric oxide: recent advances.	Pharmacological reviews	2009	66
19309263	Oxygen	Sorce S	NOX enzymes in the central nervous system: from signaling to disease.	Antioxidants & redox signaling	2009	122
19357304	Oxygen	Filippini N	Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.	Proceedings of the National Academy of Sciences of the United States of America	2009	499
19359588	Oxygen	Zhao S	Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.	Science	2009	301
19372578	Oxygen	McCord AM	Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.	Molecular cancer research 	2009	70
19632787	Oxygen	Domes G	Effects of intranasal oxytocin on emotional face processing in women.	Psychoneuroendocrinology	2010	130
19654589	Oxygen	Ramirez SH	Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.	Journal of cerebral blood flow and metabolism 	2009	59
19686841	Oxygen	Kahle PJ	DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.	Free radical biology & medicine	2009	79
19718046	Oxygen	Soeda A	Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.	Oncogene	2009	169
19751828	Oxygen	Niizuma K	Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.	Biochimica et biophysica acta	2010	61
19805328	Oxygen	Kanninen K	Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19805739	Oxygen	Brooks GA	Cell-cell and intracellular lactate shuttles.	The Journal of physiology	2009	122
19816235	Oxygen	Ballabh P	Intraventricular hemorrhage in premature infants: mechanism of disease.	Pediatric research	2010	84
19909994	Oxygen	Andropoulos DB	Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring.	The Journal of thoracic and cardiovascular surgery	2010	54
19919699	Oxygen	Lakhan SE	Inflammatory mechanisms in ischemic stroke: therapeutic approaches.	Journal of translational medicine	2009	196
20026663	Oxygen	Yin F	Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.	The Journal of experimental medicine	2010	137
20053346	Oxygen	Paakki JJ	Alterations in regional homogeneity of resting-state brain activity in autism spectrum disorders.	Brain research	2010	83
20057496	Oxygen	Zhang D	Disease and the brain's dark energy.	Nature reviews. Neurology	2010	251
20065135	Oxygen	Thambisetty M	APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.	Archives of neurology	2010	42
20116437	Oxygen	Stice E	Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4.	NeuroImage	2010	102
20140248	Oxygen	Xin H	Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.	PloS one	2010	42
20186336	Oxygen	Krebiehl G	Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.	PloS one	2010	88
20197461	Oxygen	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	59
20306310	Oxygen	Sun AY	Resveratrol as a therapeutic agent for neurodegenerative diseases.	Molecular neurobiology	2010	49
20309962	Oxygen	Pistollato F	Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.	Stem cells	2010	66
20357180	Oxygen	Gottlieb RA	Autophagy in health and disease. 5. Mitophagy as a way of life.	American journal of physiology. Cell physiology	2010	77
20372169	Oxygen	Chen JJ	Global cerebral oxidative metabolism during hypercapnia and hypocapnia in humans: implications for BOLD fMRI.	Journal of cerebral blood flow and metabolism 	2010	54
20463368	Oxygen	Michelakis ED	Metabolic modulation of glioblastoma with dichloroacetate.	Science translational medicine	2010	201
20478436	Oxygen	Reiter RJ	Melatonin: a multitasking molecule.	Progress in brain research	2010	69
20513808	Oxygen	Reitman ZJ	Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.	Journal of the National Cancer Institute	2010	110
20574517	Oxygen	Venkataraman S	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.	PloS one	2010	55
20581868	Oxygen	Bartkova J	Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.	Oncogene	2010	56
20632195	Oxygen	Heneka MT	Neuroinflammatory processes in Alzheimer's disease.	Journal of neural transmission	2010	92
20671264	Oxygen	Bar EE	Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.	The American journal of pathology	2010	93
20880500	Oxygen	Lull ME	Microglial activation and chronic neurodegeneration.	Neurotherapeutics 	2010	124
20921115	Oxygen	Nicodemus KK	Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.	Archives of general psychiatry	2010	41
20943885	Oxygen	Giordano C	Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.	Brain 	2011	42
21127501	Oxygen	Hjelmeland AB	Acidic stress promotes a glioma stem cell phenotype.	Cell death and differentiation	2011	92
21186346	Oxygen	Dickinson BC	Nox2 redox signaling maintains essential cell populations in the brain.	Nature chemical biology	2011	72
21196259	Oxygen	Chrissobolis S	Oxidative stress and endothelial dysfunction in cerebrovascular disease.	Frontiers in bioscience	2011	41
21211782	Oxygen	Le Belle JE	Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner.	Cell stem cell	2011	168
21245297	Oxygen	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
21307646	Oxygen	Chong ZZ	Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.	Oxidative medicine and cellular longevity	2010	56
21486813	Oxygen	Sato K	The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans.	The Journal of physiology	2011	43
21550379	Oxygen	Jeppesen DK	DNA repair deficiency in neurodegeneration.	Progress in neurobiology	2011	86
21616142	Oxygen	Batinic-Haberle I	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.	Free radical biology & medicine	2011	50
21692241	Oxygen	Pike LS	Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.	Biochimica et biophysica acta	2011	80
21712087	Oxygen	Fraser PA	The role of free radical generation in increasing cerebrovascular permeability.	Free radical biology & medicine	2011	37
21712410	Oxygen	Mathieu J	HIF induces human embryonic stem cell markers in cancer cells.	Cancer research	2011	146
21717292	Oxygen	Purohit V	Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.	Molecular neurobiology	2011	51
21810628	Oxygen	Rasetti R	Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A.	Archives of general psychiatry	2011	56
21836617	Oxygen	Heddleston JM	Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.	Cell death and differentiation	2012	41
21878650	Oxygen	Yadav S	miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2.	The Journal of biological chemistry	2011	50
21931738	Oxygen	Zotev V	Self-regulation of amygdala activation using real-time FMRI neurofeedback.	PloS one	2011	55
22016505	Oxygen	Felker GM	Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.	Circulation. Heart failure	2012	32
22057568	Oxygen	Suski JM	Relation between mitochondrial membrane potential and ROS formation.	Methods in molecular biology	2012	38
22098189	Oxygen	Choi DH	NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.	Antioxidants & redox signaling	2012	39
22240163	Oxygen	Qin L	NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration.	Journal of neuroinflammation	2012	76
22354151	Oxygen	del Zoppo GJ	Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.	Journal of cerebral blood flow and metabolism 	2012	37
22366799	Oxygen	Fischer MT	NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.	Brain 	2012	87
22367679	Oxygen	Kaur C	Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.	Journal of neuroimmune pharmacology 	2013	29
22388960	Oxygen	Wu LJ	The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke.	Nature neuroscience	2012	60
22461640	Oxygen	Munson JM	Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.	Science translational medicine	2012	37
22495584	Oxygen	Willie CK	Regional brain blood flow in man during acute changes in arterial blood gases.	The Journal of physiology	2012	89
22549002	Oxygen	Barone E	Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.	Free radical biology & medicine	2012	32
22566645	Oxygen	Magnotta VA	Detecting activity-evoked pH changes in human brain.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
22639965	Oxygen	Niu J	Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.	Journal of neurochemistry	2012	32
22753467	Oxygen	Geyfman M	Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis.	Proceedings of the National Academy of Sciences of the United States of America	2012	44
22764206	Oxygen	Cooper O	Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.	Science translational medicine	2012	116
22874567	Oxygen	Chen G	Autophagy is a protective response to ethanol neurotoxicity.	Autophagy	2012	44
22885059	Oxygen	Schapiro AC	Shaping of object representations in the human medial temporal lobe based on temporal regularities.	Current biology 	2012	73
22899010	Oxygen	Janiszewska M	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.	Genes & development	2012	68
22937798	Oxygen	Radermacher KA	Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.	Antioxidants & redox signaling	2013	30
22979952	Oxygen	White MG	FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity.	Genes, brain, and behavior	2012	41
23003569	Oxygen	Cheng G	Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.	British journal of pharmacology	2012	39
23115158	Oxygen	Li S	Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.	Neuro-oncology	2013	38
23240858	Oxygen	Courtney KE	Fronto-striatal functional connectivity during response inhibition in alcohol dependence.	Addiction biology	2013	31
23335372	Oxygen	Drewniak A	Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.	Blood	2013	59
23369945	Oxygen	Xiang W	Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.	Molecular and cellular neurosciences	2013	26
23407841	Oxygen	Fani N	FKBP5 and attention bias for threat: associations with hippocampal function and shape.	JAMA psychiatry	2013	43
23472786	Oxygen	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
23547621	Oxygen	Cornelius C	Traumatic brain injury: oxidative stress and neuroprotection.	Antioxidants & redox signaling	2013	46
23589885	Oxygen	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	148
23735260	Oxygen	Hacker CD	Resting state network estimation in individual subjects.	NeuroImage	2013	53
23745510	Oxygen	Bae SK	A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes.	Journal of the American Chemical Society	2013	31
24008734	Oxygen	Fann DY	Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.	Cell death & disease	2013	46
24048902	Oxygen	Park S	The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity.	Journal of immunology	2013	31
24185179	Oxygen	Sato A	Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.	Stem cell research	2014	26
24259479	Oxygen	Bilgic B	Fast quantitative susceptibility mapping with L1-regularization and automatic parameter selection.	Magnetic resonance in medicine	2014	22
24281743	Oxygen	Jickling GC	Hemorrhagic transformation after ischemic stroke in animals and humans.	Journal of cerebral blood flow and metabolism 	2014	49
24381719	Oxygen	Popa-Wagner A	ROS and brain diseases: the good, the bad, and the ugly.	Oxidative medicine and cellular longevity	2013	29
24418464	Oxygen	Pieper C	Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro.	Brain research	2014	27
24439479	Oxygen	Osorio RS	Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.	Neurobiology of aging	2014	25
24455696	Oxygen	Hsieh HL	Role of redox signaling in neuroinflammation and neurodegenerative diseases.	BioMed research international	2013	59
24462935	Oxygen	Urbanek T	Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation.	Brain research	2014	20
24522549	Oxygen	Gaki GS	Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.	Neuromolecular medicine	2014	22
24574503	Oxygen	McNeill A	Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.	Brain 	2014	39
24595981	Oxygen	Nguyen AQ	Erythropoietin: powerful protection of ischemic and post-ischemic brain.	Experimental biology and medicine	2014	22
24622944	Oxygen	Grimm O	Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.	JAMA psychiatry	2014	26
24702246	Oxygen	Gohel SR	Functional integration between brain regions at rest occurs in multiple-frequency bands.	Brain connectivity	2015	30
24835170	Oxygen	Trangmar SJ	Dehydration affects cerebral blood flow but not its metabolic rate for oxygen during maximal exercise in trained humans.	The Journal of physiology	2014	20
24865512	Oxygen	Abdul-Muneer PM	Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.	Molecular neurobiology	2015	36
24918289	Oxygen	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
24956047	Oxygen	Barkhof F	Resting-state functional MR imaging: a new window to the brain.	Radiology	2014	48
25091898	Oxygen	Bordt EA	NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?	Free radical biology & medicine	2014	23
25409632	Oxygen	Ma R	HIV Tat-Mediated Induction of Human Brain Microvascular Endothelial Cell Apoptosis Involves Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.	Molecular neurobiology	2016	10
25416158	Oxygen	Harischandra DS	α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.	Toxicological sciences 	2015	22
25476155	Oxygen	Reuter B	Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke.	Translational stroke research	2015	16
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25651941	Oxygen	Hind WH	Endocannabinoids modulate human blood-brain barrier permeability in vitro.	British journal of pharmacology	2015	15
25722131	Oxygen	Li L	ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms.	Cellular and molecular neurobiology	2015	32
25791797	Oxygen	van Tellingen O	Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.	Drug resistance updates 	2015	44
25855294	Oxygen	Kim D	SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.	Nature	2015	54
26057259	Oxygen	Palanca BJ	Resting-state Functional Magnetic Resonance Imaging Correlates of Sevoflurane-induced Unconsciousness.	Anesthesiology	2015	22
26129625	Oxygen	Nakagawa Y	Diversity and plasticity of microglial cells in psychiatric and neurological disorders.	Pharmacology & therapeutics	2015	17
26452729	Oxygen	Miners JS	Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.	Brain pathology	2016	10
26454217	Oxygen	Yeh PS	Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.	Cancer letters	2016	14
26543043	Oxygen	Camici GG	Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.	European heart journal	2015	22
26711459	Oxygen	Love S	Cerebrovascular disease in ageing and Alzheimer's disease.	Acta neuropathologica	2016	21
26801191	Oxygen	Patching SG	Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.	Molecular neurobiology	2017	7
26942675	Oxygen	Li X	Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.	Molecular cell	2016	19
26949123	Oxygen	Rubio-Araiz A	Disruption of blood-brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model.	Addiction biology	2017	15
26990284	Oxygen	Di Lisa F	New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.	British journal of pharmacology	2017	8
27127546	Oxygen	Minutoli L	ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.	Oxidative medicine and cellular longevity	2016	17
27267366	Oxygen	von Leden RE	Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets.	Journal of neurotrauma	2017	7
27321753	Oxygen	Ham PB 3rd	Mitochondrial function in hypoxic ischemic injury and influence of aging.	Progress in neurobiology	2017	17
27769868	Oxygen	Jiang T	Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.	Progress in neurobiology	2016	22
27814651	Oxygen	Onyango IG	Mitochondria in the pathophysiology of Alzheimer's and Parkinson's diseases.	Frontiers in bioscience	2017	6
28524116	Oxygen	Kim KY	Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.	International journal of molecular sciences	2017	10
7560060	Dexamethasone	Schinkel AH	Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.	The Journal of clinical investigation	1995	122
9626108	Dexamethasone	Rosmond R	Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.	The Journal of clinical endocrinology and metabolism	1998	135
11274650	Dexamethasone	Pariante CM	Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.	Biological psychiatry	2001	183
12944327	Dexamethasone	Raison CL	When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.	The American journal of psychiatry	2003	207
14638850	Dexamethasone	Rich JN	Phase II trial of gefitinib in recurrent glioblastoma.	Journal of clinical oncology 	2004	134
15094069	Dexamethasone	Banks WA	The source of cerebral insulin.	European journal of pharmacology	2004	90
16214171	Dexamethasone	de Kloet CS	Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.	Journal of psychiatric research	2006	86
16405512	Dexamethasone	Hermisson M	O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.	Journal of neurochemistry	2006	70
17236958	Dexamethasone	Gonzalez J	Effect of bevacizumab on radiation necrosis of the brain.	International journal of radiation oncology, biology, physics	2007	67
17825799	Dexamethasone	Heim C	The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.	Biological psychiatry	2008	66
18275977	Dexamethasone	Nieuwenhuizen AG	The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance.	Physiology & behavior	2008	66
19245695	Dexamethasone	Haram K	The HELLP syndrome: clinical issues and management. A Review.	BMC pregnancy and childbirth	2009	55
19349600	Dexamethasone	Nghiemphu PL	Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.	Neurology	2009	69
19406581	Dexamethasone	Lopez-Duran NL	Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.	Psychoneuroendocrinology	2009	85
19596121	Dexamethasone	Tyrka AR	Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.	Biological psychiatry	2009	81
20702575	Dexamethasone	Evanson NK	Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.	Endocrinology	2010	67
21483429	Dexamethasone	Anacker C	Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor.	Molecular psychiatry	2011	77
21801830	Dexamethasone	Pace TW	Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder.	Brain, behavior, and immunity	2012	46
21907973	Dexamethasone	Touma C	FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.	Biological psychiatry	2011	48
22055018	Dexamethasone	Wikgren M	Short telomeres in depression and the general population are associated with a hypocortisolemic state.	Biological psychiatry	2012	42
22740309	Dexamethasone	Melief J	Phenotyping primary human microglia: tight regulation of LPS responsiveness.	Glia	2012	34
23303060	Dexamethasone	Anacker C	Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.	Neuropsychopharmacology 	2013	38
23406438	Dexamethasone	Menke A	Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.	Genes, brain, and behavior	2013	41
23658244	Dexamethasone	Aboody KS	Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.	Science translational medicine	2013	60
24495607	Dexamethasone	Belvederi Murri M	HPA axis and aging in depression: systematic review and meta-analysis.	Psychoneuroendocrinology	2014	30
24661442	Dexamethasone	Yehuda R	Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder.	Biological psychiatry	2015	45
24888813	Dexamethasone	Pollack IF	Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.	Journal of clinical oncology 	2014	39
26305478	Dexamethasone	Kaminsky Z	Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder.	Translational psychiatry	2015	16
26547798	Dexamethasone	Belvederi Murri M	The HPA axis in bipolar disorder: Systematic review and meta-analysis.	Psychoneuroendocrinology	2016	12
27109623	Dexamethasone	Schwandt ML	The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.	Neuropsychopharmacology 	2016	25
1596899	Folic acid	Weitman SD	Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.	Cancer research	1992	138
9815541	Folic acid	Silver DA	Prostate-specific membrane antigen expression in normal and malignant human tissues.	Clinical cancer research 	1997	179
15607954	Folic acid	Fuso A	S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.	Molecular and cellular neurosciences	2005	67
16401840	Folic acid	Gurol ME	Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.	Neurology	2006	123
20404913	Folic acid	Golden E	Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.	PloS one	2010	50
21780182	Folic acid	de Jager CA	Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.	International journal of geriatric psychiatry	2012	58
22205763	Folic acid	Bowman GL	Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.	Neurology	2012	33
23267094	Folic acid	Momb J	Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
27431367	Folic acid	Smith AD	Homocysteine, B Vitamins, and Cognitive Impairment.	Annual review of nutrition	2016	21
10617473	Lithium	Bell DW	Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.	Science	1999	142
10995469	Lithium	Bhat RV	Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2000	96
12504922	Lithium	De Sarno P	Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.	Neuropharmacology	2002	134
15132987	Lithium	Chen G	Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.	FASEB journal 	2004	82
15145621	Lithium	Hashimoto K	Critical role of brain-derived neurotrophic factor in mood disorders.	Brain research. Brain research reviews	2004	84
17314294	Lithium	Rockenstein E	Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.	The Journal of neuroscience 	2007	79
17379666	Lithium	Roybal K	Mania-like behavior induced by disruption of CLOCK.	Proceedings of the National Academy of Sciences of the United States of America	2007	235
17533168	Lithium	Rigau V	Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.	Brain 	2007	73
20308311	Lithium	Fu J	Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines.	Neuro-oncology	2010	42
20546789	Lithium	Rong H	MicroRNA-134 plasma levels before and after treatment for bipolar mania.	Journal of psychiatric research	2011	43
22353757	Lithium	D'Addario C	Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.	Neuropsychopharmacology 	2012	32
24153177	Lithium	Han K	SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.	Nature	2013	82
26283638	Lithium	Niculescu AB	Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.	Molecular psychiatry	2015	17
26806518	Lithium	Hou L	Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.	Lancet	2016	14
27501770	Lithium	Villani A	Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.	The Lancet. Oncology	2016	22
27941079	Lithium	Fountoulakis KN	The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.	The international journal of neuropsychopharmacology	2017	6
16289003	Cyclic GMP	Nishikimi T	The role of natriuretic peptides in cardioprotection.	Cardiovascular research	2006	76
16672668	Cyclic GMP	Brahmachari S	Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide.	The Journal of neuroscience 	2006	85
19089336	Cyclic GMP	Potter LR	Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.	Handbook of experimental pharmacology	2009	85
22806632	Cyclic GMP	van Heerebeek L	Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.	Circulation	2012	63
23114600	Cyclic GMP	Engeli S	Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.	The Journal of clinical investigation	2012	33
9354812	N-Methyl-D-aspartic acid	Mattson MP	Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.	Physiological reviews	1997	138
9539790	N-Methyl-D-aspartic acid	Sakanaka M	In vivo evidence that erythropoietin protects neurons from ischemic damage.	Proceedings of the National Academy of Sciences of the United States of America	1998	155
9581761	N-Methyl-D-aspartic acid	Kim JH	SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family.	Neuron	1998	101
10234045	N-Methyl-D-aspartic acid	Tovar KR	The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro.	The Journal of neuroscience 	1999	230
10364548	N-Methyl-D-aspartic acid	Shi SH	Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.	Science	1999	292
10557334	N-Methyl-D-aspartic acid	Wolosker H	Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission.	Proceedings of the National Academy of Sciences of the United States of America	1999	141
10862698	N-Methyl-D-aspartic acid	Husi H	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	Nature neuroscience	2000	279
11024032	N-Methyl-D-aspartic acid	Nakazawa T	Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor.	The Journal of biological chemistry	2001	123
11301024	N-Methyl-D-aspartic acid	Strübing C	TRPC1 and TRPC5 form a novel cation channel in mammalian brain.	Neuron	2001	189
11312291	N-Methyl-D-aspartic acid	Scott DB	An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing.	The Journal of neuroscience 	2001	108
11477425	N-Methyl-D-aspartic acid	Roche KW	Molecular determinants of NMDA receptor internalization.	Nature neuroscience	2001	135
11732708	N-Methyl-D-aspartic acid	Lisman JE	Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine.	Hippocampus	2001	97
11923456	N-Methyl-D-aspartic acid	Park WK	Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens.	The Journal of neuroscience 	2002	96
12364586	N-Methyl-D-aspartic acid	Chumakov I	Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	2002	141
12670422	N-Methyl-D-aspartic acid	Kamenetz F	APP processing and synaptic function.	Neuron	2003	442
12716932	N-Methyl-D-aspartic acid	Tiruchinapalli DM	Activity-dependent trafficking and dynamic localization of zipcode binding protein 1 and beta-actin mRNA in dendrites and spines of hippocampal neurons.	The Journal of neuroscience 	2003	89
12718863	N-Methyl-D-aspartic acid	Nakazawa K	Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience.	Neuron	2003	136
12719654	N-Methyl-D-aspartic acid	Yamada K	Brain-derived neurotrophic factor/TrkB signaling in memory processes.	Journal of pharmacological sciences	2003	85
14622581	N-Methyl-D-aspartic acid	Krapivinsky G	The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.	Neuron	2003	121
15254094	N-Methyl-D-aspartic acid	Lavezzari G	Subunit-specific regulation of NMDA receptor endocytosis.	The Journal of neuroscience 	2004	83
15278097	N-Methyl-D-aspartic acid	Javitt DC	Glutamate as a therapeutic target in psychiatric disorders.	Molecular psychiatry	2004	108
15312654	N-Methyl-D-aspartic acid	Krapivinsky G	SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation.	Neuron	2004	84
15537897	N-Methyl-D-aspartic acid	Chung HJ	Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand.	The Journal of neuroscience 	2004	98
15803158	N-Methyl-D-aspartic acid	Xia Z	The role of calmodulin as a signal integrator for synaptic plasticity.	Nature reviews. Neuroscience	2005	110
15837930	N-Methyl-D-aspartic acid	Nam CI	Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter.	Proceedings of the National Academy of Sciences of the United States of America	2005	106
16055064	N-Methyl-D-aspartic acid	Lu W	PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.	Neuron	2005	84
16221846	N-Methyl-D-aspartic acid	Kwon OB	Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.	The Journal of neuroscience 	2005	72
16293343	N-Methyl-D-aspartic acid	Farr SA	Effects of leptin on memory processing.	Peptides	2006	98
16627622	N-Methyl-D-aspartic acid	Kauppinen TM	Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.	Proceedings of the National Academy of Sciences of the United States of America	2006	69
16767099	N-Methyl-D-aspartic acid	Hahn CG	Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.	Nature medicine	2006	187
16796601	N-Methyl-D-aspartic acid	Brabers NA	Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia.	European journal of clinical investigation	2006	86
17088105	N-Methyl-D-aspartic acid	Paoletti P	NMDA receptor subunits: function and pharmacology.	Current opinion in pharmacology	2007	196
17115806	N-Methyl-D-aspartic acid	Davis M	Neural systems involved in fear and anxiety measured with fear-potentiated startle.	The American psychologist	2006	154
17121744	N-Methyl-D-aspartic acid	Ivens S	TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis.	Brain 	2007	127
17156977	N-Methyl-D-aspartic acid	Bendikov I	A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.	Schizophrenia research	2007	66
17299517	N-Methyl-D-aspartic acid	Beneyto M	Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.	Neuropsychopharmacology 	2007	106
17412766	N-Methyl-D-aspartic acid	Lee CJ	Astrocytic control of synaptic NMDA receptors.	The Journal of physiology	2007	76
17440041	N-Methyl-D-aspartic acid	Tolias KF	The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development.	Proceedings of the National Academy of Sciences of the United States of America	2007	85
17553425	N-Methyl-D-aspartic acid	Tai CY	Activity-regulated N-cadherin endocytosis.	Neuron	2007	62
17582333	N-Methyl-D-aspartic acid	Kim J	Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons.	Neuron	2007	143
17643398	N-Methyl-D-aspartic acid	Maeng S	Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.	Biological psychiatry	2008	267
18033238	N-Methyl-D-aspartic acid	Beneyto M	Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.	Neuropsychopharmacology 	2008	83
18059437	N-Methyl-D-aspartic acid	Wang CZ	Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons.	Neuropsychopharmacology 	2008	50
18353558	N-Methyl-D-aspartic acid	Paoletti P	Zinc at glutamatergic synapses.	Neuroscience	2009	99
18509040	N-Methyl-D-aspartic acid	Richard KL	Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2008	87
18544550	N-Methyl-D-aspartic acid	Roopun AK	Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia.	Schizophrenia bulletin	2008	63
18952671	N-Methyl-D-aspartic acid	Balosso S	A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.	Brain 	2008	53
19020013	N-Methyl-D-aspartic acid	Li W	NMDA receptor activation by HIV-Tat protein is clade dependent.	The Journal of neuroscience 	2008	66
19268344	N-Methyl-D-aspartic acid	Song AH	A selective filter for cytoplasmic transport at the axon initial segment.	Cell	2009	120
19285736	N-Methyl-D-aspartic acid	Kauer JA	Hot flash: TRPV channels in the brain.	Trends in neurosciences	2009	55
19488045	N-Methyl-D-aspartic acid	Rao JS	Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.	Molecular psychiatry	2010	89
19594762	N-Methyl-D-aspartic acid	Mony L	Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.	British journal of pharmacology	2009	85
19639293	N-Methyl-D-aspartic acid	Stone TW	Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.	Handbook of experimental pharmacology	2009	46
19643201	N-Methyl-D-aspartic acid	Igarashi K	Modulation of cellular function by polyamines.	The international journal of biochemistry & cell biology	2010	120
19705571	N-Methyl-D-aspartic acid	Anwyl R	Metabotropic glutamate receptor-dependent long-term potentiation.	Neuropharmacology	2009	59
19744406	N-Methyl-D-aspartic acid	Machado-Vieira R	Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.	The Journal of clinical psychiatry	2009	47
19757208	N-Methyl-D-aspartic acid	Ondrejcak T	Alzheimer's disease amyloid beta-protein and synaptic function.	Neuromolecular medicine	2010	43
19803743	N-Methyl-D-aspartic acid	Kimura H	Hydrogen sulfide: from brain to gut.	Antioxidants & redox signaling	2010	79
19805234	N-Methyl-D-aspartic acid	Durakoglugil MS	Reelin signaling antagonizes beta-amyloid at the synapse.	Proceedings of the National Academy of Sciences of the United States of America	2009	55
20064393	N-Methyl-D-aspartic acid	Banerjee S	A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation.	Neuron	2009	95
20147364	N-Methyl-D-aspartic acid	Wonodi I	Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.	Schizophrenia bulletin	2010	43
20147539	N-Methyl-D-aspartic acid	Blundell J	Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.	The Journal of neuroscience 	2010	147
20175224	N-Methyl-D-aspartic acid	Kristiansen LV	Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia.	Synapse	2010	41
20197096	N-Methyl-D-aspartic acid	Stein JL	Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.	NeuroImage	2010	73
20307583	N-Methyl-D-aspartic acid	Rolls ET	A computational theory of episodic memory formation in the hippocampus.	Behavioural brain research	2010	63
20348922	N-Methyl-D-aspartic acid	Maroso M	Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.	Nature medicine	2010	168
20434997	N-Methyl-D-aspartic acid	Fritsch B	Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning.	Neuron	2010	253
20547867	N-Methyl-D-aspartic acid	Chen Y	ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling.	Proceedings of the National Academy of Sciences of the United States of America	2010	86
20688809	N-Methyl-D-aspartic acid	Marignier R	Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.	Brain 	2010	43
20810618	N-Methyl-D-aspartic acid	Bettini E	Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.	The Journal of pharmacology and experimental therapeutics	2010	43
20869595	N-Methyl-D-aspartic acid	Sanz-Clemente A	Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors.	Neuron	2010	71
20890276	N-Methyl-D-aspartic acid	Endele S	Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.	Nature genetics	2010	116
20921396	N-Methyl-D-aspartic acid	Faust TW	Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.	Proceedings of the National Academy of Sciences of the United States of America	2010	40
21035792	N-Methyl-D-aspartic acid	Karlsgodt KH	Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.	Biological psychiatry	2011	43
21036897	N-Methyl-D-aspartic acid	Sathyasaikumar KV	Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.	Schizophrenia bulletin	2011	50
21144859	N-Methyl-D-aspartic acid	Burgdorf J	Frequency-modulated 50 kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect.	Neuroscience and biobehavioral reviews	2011	38
21148011	N-Methyl-D-aspartic acid	Schwarz LA	Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway.	The Journal of neuroscience 	2010	63
21148657	N-Methyl-D-aspartic acid	Voscopoulos C	When does acute pain become chronic?	British journal of anaesthesia	2010	48
21349580	N-Methyl-D-aspartic acid	Texidó L	Amyloid β peptide oligomers directly activate NMDA receptors.	Cell calcium	2011	38
21635931	N-Methyl-D-aspartic acid	Jernigan CS	The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.	Progress in neuro-psychopharmacology & biological psychiatry	2011	74
21727251	N-Methyl-D-aspartic acid	Wonodi I	Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.	Archives of general psychiatry	2011	47
21795662	N-Methyl-D-aspartic acid	Martinez-Hernandez E	Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.	Neurology	2011	50
21808020	N-Methyl-D-aspartic acid	Etherton M	Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.	Proceedings of the National Academy of Sciences of the United States of America	2011	77
21831269	N-Methyl-D-aspartic acid	Steiner J	Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?	Journal of neuroinflammation	2011	88
21979451	N-Methyl-D-aspartic acid	Kittelberger K	Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.	Brain structure & function	2012	33
21985328	N-Methyl-D-aspartic acid	Trepanier CH	Regulation of NMDA receptors by the tyrosine kinase Fyn.	The FEBS journal	2012	41
22035455	N-Methyl-D-aspartic acid	Salomone S	New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.	British journal of clinical pharmacology	2012	54
22036038	N-Methyl-D-aspartic acid	Liu RJ	Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.	Biological psychiatry	2012	84
22055014	N-Methyl-D-aspartic acid	Kocsis B	Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.	Biological psychiatry	2012	43
22090472	N-Methyl-D-aspartic acid	Goebel-Goody SM	Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.	Pharmacological reviews	2012	51
22215208	N-Methyl-D-aspartic acid	Moroni F	Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery.	Journal of neural transmission	2012	31
22287710	N-Methyl-D-aspartic acid	Planas AM	Brain-derived antigens in lymphoid tissue of patients with acute stroke.	Journal of immunology	2012	32
22343826	N-Methyl-D-aspartic acid	Sanz-Clemente A	Diversity in NMDA receptor composition: many regulators, many consequences.	The Neuroscientist 	2013	70
22355184	N-Methyl-D-aspartic acid	Gonzalez-Burgos G	NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.	Schizophrenia bulletin	2012	90
22451162	N-Methyl-D-aspartic acid	Quek AM	Autoimmune epilepsy: clinical characteristics and response to immunotherapy.	Archives of neurology	2012	47
22530815	N-Methyl-D-aspartic acid	Andero R	Fear extinction and BDNF: translating animal models of PTSD to the clinic.	Genes, brain, and behavior	2012	49
22539258	N-Methyl-D-aspartic acid	Bien CG	Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.	Brain 	2012	74
22544902	N-Methyl-D-aspartic acid	Mikasova L	Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.	Brain 	2012	53
22676966	N-Methyl-D-aspartic acid	Duncan WC	Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.	The international journal of neuropsychopharmacology	2013	31
22717267	N-Methyl-D-aspartic acid	Coultrap SJ	CaMKII regulation in information processing and storage.	Trends in neurosciences	2012	89
22722512	N-Methyl-D-aspartic acid	Ibrahim L	A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.	Journal of clinical psychopharmacology	2012	47
22727665	N-Methyl-D-aspartic acid	Udagawa T	Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex.	Molecular cell	2012	44
22826346	N-Methyl-D-aspartic acid	Duman RS	A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2012	38
22833210	N-Methyl-D-aspartic acid	Tarabeux J	Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.	Translational psychiatry	2011	50
22833681	N-Methyl-D-aspartic acid	Mondragón-Rodríguez S	Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.	The Journal of biological chemistry	2012	40
22875940	N-Methyl-D-aspartic acid	Gleichman AJ	Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.	The Journal of neuroscience 	2012	49
23055518	N-Methyl-D-aspartic acid	Diniz LP	Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons.	The Journal of biological chemistry	2012	41
23062356	N-Methyl-D-aspartic acid	Monteggia LM	The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.	Biological psychiatry	2013	30
23065479	N-Methyl-D-aspartic acid	Dale RC	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.	Brain 	2012	49
23070074	N-Methyl-D-aspartic acid	Weickert CS	Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.	Molecular psychiatry	2013	63
23085848	N-Methyl-D-aspartic acid	Roberto M	The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides.	Cold Spring Harbor perspectives in medicine	2012	34
23100419	N-Methyl-D-aspartic acid	Arons MH	Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.	The Journal of neuroscience 	2012	45
23143522	N-Methyl-D-aspartic acid	Kwon HB	Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number.	Nature neuroscience	2012	50
23248274	N-Methyl-D-aspartic acid	Hikida T	Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
23431156	N-Methyl-D-aspartic acid	Kessels HW	Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression.	Proceedings of the National Academy of Sciences of the United States of America	2013	48
23525040	N-Methyl-D-aspartic acid	Suberbielle E	Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β.	Nature neuroscience	2013	92
23534055	N-Methyl-D-aspartic acid	Kavalali ET	Synaptic mechanisms underlying rapid antidepressant action of ketamine.	The American journal of psychiatry	2012	61
23543703	N-Methyl-D-aspartic acid	Snyder MA	NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia.	Frontiers in cellular neuroscience	2013	50
23553365	N-Methyl-D-aspartic acid	Potter MC	Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders.	Journal of neuroimmune pharmacology 	2013	29
23566496	N-Methyl-D-aspartic acid	Rao JS	RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.	Schizophrenia research	2013	36
23578284	N-Methyl-D-aspartic acid	Ye L	IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.	Journal of neurochemistry	2013	40
23618906	N-Methyl-D-aspartic acid	Tackenberg C	NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.	Cell death & disease	2013	30
23729812	N-Methyl-D-aspartic acid	Balu DT	Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.	Proceedings of the National Academy of Sciences of the United States of America	2013	53
23877059	N-Methyl-D-aspartic acid	Kayser MS	Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.	JAMA neurology	2013	51
23933820	N-Methyl-D-aspartic acid	Lesca G	GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.	Nature genetics	2013	68
23999527	N-Methyl-D-aspartic acid	Hammer C	Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.	Molecular psychiatry	2014	64
24254958	N-Methyl-D-aspartic acid	Morrison FG	From the neurobiology of extinction to improved clinical treatments.	Depression and anxiety	2014	20
24360484	N-Methyl-D-aspartic acid	Gresa-Arribas N	Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.	The Lancet. Neurology	2014	88
24436034	N-Methyl-D-aspartic acid	Balu DT	D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.	Cellular and molecular neurobiology	2014	31
24462240	N-Methyl-D-aspartic acid	Petit-Pedrol M	Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.	The Lancet. Neurology	2014	65
24463507	N-Methyl-D-aspartic acid	Fromer M	De novo mutations in schizophrenia implicate synaptic networks.	Nature	2014	388
24467911	N-Methyl-D-aspartic acid	Leng T	Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?	Progress in neurobiology	2014	20
24571856	N-Methyl-D-aspartic acid	Xu JY	Endocannabinoids in synaptic plasticity and neuroprotection.	The Neuroscientist 	2015	19
24655651	N-Methyl-D-aspartic acid	Weder N	Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry.	Journal of the American Academy of Child and Adolescent Psychiatry	2014	38
24700511	N-Methyl-D-aspartic acid	Titulaer MJ	Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.	Annals of neurology	2014	53
24733968	N-Methyl-D-aspartic acid	Duman RS	Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.	Dialogues in clinical neuroscience	2014	39
24853231	N-Methyl-D-aspartic acid	Dahm L	Seroprevalence of autoantibodies against brain antigens in health and disease.	Annals of neurology	2014	51
24912158	N-Methyl-D-aspartic acid	Gideons ES	Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.	Proceedings of the National Academy of Sciences of the United States of America	2014	45
24916964	N-Methyl-D-aspartic acid	Moscato EH	Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.	Annals of neurology	2014	51
25124710	N-Methyl-D-aspartic acid	Bay-Richter C	A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.	Brain, behavior, and immunity	2015	41
25155957	N-Methyl-D-aspartic acid	Incontro S	Efficient, complete deletion of synaptic proteins using CRISPR.	Neuron	2014	32
25175868	N-Methyl-D-aspartic acid	Crews FT	Neuroimmune basis of alcoholic brain damage.	International review of neurobiology	2014	28
25225386	N-Methyl-D-aspartic acid	Schreiweis C	Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance.	Proceedings of the National Academy of Sciences of the United States of America	2014	27
25315318	N-Methyl-D-aspartic acid	Hu W	The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.	Annals of the New York Academy of Sciences	2015	26
25369168	N-Methyl-D-aspartic acid	Peng X	Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies.	Annals of neurology	2015	24
25392198	N-Methyl-D-aspartic acid	Planagumà J	Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.	Brain 	2015	57
25436993	N-Methyl-D-aspartic acid	Leypoldt F	Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.	JAMA neurology	2015	19
25449711	N-Methyl-D-aspartic acid	Heckers S	GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.	Schizophrenia research	2015	34
25455350	N-Methyl-D-aspartic acid	Schwieler L	Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.	Journal of psychiatry & neuroscience 	2015	26
25619552	N-Methyl-D-aspartic acid	Volianskis A	Long-term potentiation and the role of N-methyl-D-aspartate receptors.	Brain research	2015	17
25892301	N-Methyl-D-aspartic acid	Telese F	LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation.	Neuron	2015	26
26098371	N-Methyl-D-aspartic acid	Attardo A	Impermanence of dendritic spines in live adult CA1 hippocampus.	Nature	2015	40
26134648	N-Methyl-D-aspartic acid	Speed HE	Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits.	The Journal of neuroscience 	2015	23
26169973	N-Methyl-D-aspartic acid	Gray AL	Sex differences in glutamate receptor gene expression in major depression and suicide.	Molecular psychiatry	2015	16
26290246	N-Methyl-D-aspartic acid	Muthukumaraswamy SD	Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.	The Journal of neuroscience 	2015	18
26472558	N-Methyl-D-aspartic acid	Dennis SH	Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus.	Cerebral cortex	2016	16
26549202	N-Methyl-D-aspartic acid	Wills TA	Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression.	Addiction biology	2017	6
26615780	N-Methyl-D-aspartic acid	Suberbielle E	DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice.	Nature communications	2015	23
26695754	N-Methyl-D-aspartic acid	Crews FT	Neuroimmune Function and the Consequences of Alcohol Exposure.	Alcohol research 	2015	19
26724279	N-Methyl-D-aspartic acid	Machado-Vieira R	New targets for rapid antidepressant action.	Progress in neurobiology	2017	5
26743041	N-Methyl-D-aspartic acid	Akhtar MW	Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.	Nature communications	2016	15
26966189	N-Methyl-D-aspartic acid	Herguedas B	Structure and organization of heteromeric AMPA-type glutamate receptors.	Science	2016	23
27180169	N-Methyl-D-aspartic acid	Foster TC	Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease.	Behavioural brain research	2017	7
27352782	N-Methyl-D-aspartic acid	Inta D	Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning.	Schizophrenia bulletin	2017	5
27502473	N-Methyl-D-aspartic acid	Castillo-Gómez E	All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.	Molecular psychiatry	2017	14
27543972	N-Methyl-D-aspartic acid	Kreye J	Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.	Brain 	2016	13
27595347	N-Methyl-D-aspartic acid	Clairfeuille T	A molecular code for endosomal recycling of phosphorylated cargos by the SNX27-retromer complex.	Nature structural & molecular biology	2016	12
27616483	N-Methyl-D-aspartic acid	Li D	GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.	American journal of human genetics	2016	21
27818011	N-Methyl-D-aspartic acid	Hu C	Human GRIN2B variants in neurodevelopmental disorders.	Journal of pharmacological sciences	2016	17
27839871	N-Methyl-D-aspartic acid	Swanger SA	Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.	American journal of human genetics	2016	17
28095420	N-Methyl-D-aspartic acid	Ogden KK	Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.	PLoS genetics	2017	15
28428746	N-Methyl-D-aspartic acid	Jagannath V	Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain.	Frontiers in neuroanatomy	2017	6
9348075	Potassium	Maruyama T	2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release.	Journal of biochemistry	1997	213
9430594	Potassium	Biervert C	A potassium channel mutation in neonatal human epilepsy.	Science	1998	167
9581771	Potassium	Smart SL	Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.	Neuron	1998	134
9836639	Potassium	Wang HS	KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.	Science	1998	313
10760300	Potassium	Kharkovets T	KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.	Proceedings of the National Academy of Sciences of the United States of America	2000	103
10816588	Potassium	Schroeder BC	KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.	The Journal of biological chemistry	2000	114
14762142	Potassium	Devaux JJ	KCNQ2 is a nodal K+ channel.	The Journal of neuroscience 	2004	126
15199405	Potassium	Dezawa M	Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.	The Journal of clinical investigation	2004	115
15269337	Potassium	Birnbaum SG	Structure and function of Kv4-family transient potassium channels.	Physiological reviews	2004	118
15345706	Potassium	Numakawa T	Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.	Human molecular genetics	2004	78
15561407	Potassium	Nagelhus EA	Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1.	Neuroscience	2004	116
15608631	Potassium	Peters HC	Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.	Nature neuroscience	2005	126
15872020	Potassium	Mendez I	Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.	Brain 	2005	108
16141270	Potassium	Kim J	Kv4 potassium channel subunits control action potential repolarization and frequency-dependent broadening in rat hippocampal CA1 pyramidal neurones.	The Journal of physiology	2005	102
16178029	Potassium	Vitaliani R	Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.	Annals of neurology	2005	80
16258232	Potassium	Miyata N	Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.	Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi	2005	74
16504945	Potassium	Schulte U	The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1.	Neuron	2006	78
16571880	Potassium	Strauss KA	Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.	The New England journal of medicine	2006	179
16917065	Potassium	Park KS	Graded regulation of the Kv2.1 potassium channel by variable phosphorylation.	Science	2006	118
17022810	Potassium	Hemmerlein B	Overexpression of Eag1 potassium channels in clinical tumours.	Molecular cancer	2006	63
17828261	Potassium	Lunn ML	A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction.	Nature neuroscience	2007	58
18498087	Potassium	Majdzadeh N	HDAC4 inhibits cell-cycle progression and protects neurons from cell death.	Developmental neurobiology	2008	55
19150373	Potassium	Ji RR	MAP kinase and pain.	Brain research reviews	2009	250
19349416	Potassium	Cha SK	Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho.	Molecular pharmacology	2009	65
19384554	Potassium	Franke B	Genome-wide association studies in ADHD.	Human genetics	2009	110
19420365	Potassium	Bockenhauer D	Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.	The New England journal of medicine	2009	134
19620517	Potassium	Pimenta E	Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.	Hypertension	2009	74
20133599	Potassium	Fukata Y	Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy.	Proceedings of the National Academy of Sciences of the United States of America	2010	66
20392939	Potassium	Glasscock E	Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy.	The Journal of neuroscience 	2010	51
20437582	Potassium	Malter MP	Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.	Annals of neurology	2010	67
20663977	Potassium	Irani SR	Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.	Brain 	2010	185
20724292	Potassium	Costigan M	Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.	Brain 	2010	71
21289184	Potassium	Bardai FH	Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.	The Journal of neuroscience 	2011	53
21387375	Potassium	Lancaster E	Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.	Annals of neurology	2011	89
21416487	Potassium	Irani SR	Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.	Annals of neurology	2011	100
21613484	Potassium	Piatti VC	The timing for neuronal maturation in the adult hippocampus is modulated by local network activity.	The Journal of neuroscience 	2011	61
21967988	Potassium	Arnoux JB	Congenital hyperinsulinism: current trends in diagnosis and therapy.	Orphanet journal of rare diseases	2011	39
22158511	Potassium	Li KX	Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy.	Nature neuroscience	2011	42
22220513	Potassium	Gunthorpe MJ	The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.	Epilepsia	2012	48
22387049	Potassium	Wolburg H	The disturbed blood-brain barrier in human glioblastoma.	Molecular aspects of medicine	2012	43
22431339	Potassium	Jan LY	Voltage-gated potassium channels and the diversity of electrical signalling.	The Journal of physiology	2012	36
22473710	Potassium	Irani SR	Morvan syndrome: clinical and serological observations in 29 cases.	Annals of neurology	2012	64
23225603	Potassium	Boronat A	Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.	Annals of neurology	2013	50
23647072	Potassium	Veeramah KR	Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.	Epilepsia	2013	59
23713082	Potassium	Pitt B	Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.	European heart journal	2013	31
23933981	Potassium	Bittner S	Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.	Nature medicine	2013	33
24014519	Potassium	Irani SR	Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.	Brain 	2013	55
24137016	Potassium	Nagelhus EA	Physiological roles of aquaporin-4 in brain.	Physiological reviews	2013	75
24318194	Potassium	Orhan G	Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.	Annals of neurology	2014	33
24323720	Potassium	Shah NH	Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.	Translational stroke research	2014	29
24696508	Potassium	Balint B	Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.	Neurology	2014	26
24756635	Potassium	Shah MM	Cortical HCN channels: function, trafficking and plasticity.	The Journal of physiology	2014	28
25164438	Potassium	Torkamani A	De novo KCNB1 mutations in epileptic encephalopathy.	Annals of neurology	2014	22
25320100	Potassium	Tobin WO	DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.	Neurology	2014	27
25393609	Potassium	Sokolow S	Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.	Journal of neurochemistry	2015	23
25401298	Potassium	Muona M	A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.	Nature genetics	2015	39
25540137	Potassium	de Baaij JH	Magnesium in man: implications for health and disease.	Physiological reviews	2015	67
25598355	Potassium	Morris G	The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.	Molecular neurobiology	2016	13
25751627	Potassium	Syrbe S	De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.	Nature genetics	2015	36
25908859	Potassium	Fox PD	Induction of stable ER-plasma-membrane junctions by Kv2.1 potassium channels.	Journal of cell science	2015	19
28115470	Potassium	Lang B	Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.	Journal of neurology, neurosurgery, and psychiatry	2017	6
7521911	L-Glutamic acid	Arriza JL	Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.	The Journal of neuroscience 	1994	161
10195903	L-Glutamic acid	Wang HG	Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.	Science	1999	214
14530974	L-Glutamic acid	Kanai Y	The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.	Pflugers Archiv 	2004	75
22113611	L-Glutamic acid	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	80
26141617	L-Glutamic acid	Cuyvers E	Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.	The Lancet. Neurology	2015	20
7550350	L-Phenylalanine	Steinlein OK	A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.	Nature genetics	1995	116
7845465	L-Phenylalanine	Games D	Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.	Nature	1995	321
10408445	L-Phenylalanine	Schenk D	Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.	Nature	1999	591
16384934	L-Phenylalanine	Olsen SK	Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.	Genes & development	2006	71
17517883	L-Phenylalanine	Oshiro N	The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.	The Journal of biological chemistry	2007	106
23072726	L-Phenylalanine	Felger JC	Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.	Brain, behavior, and immunity	2013	32
25881932	L-Phenylalanine	Cheng ML	Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.	Journal of the American College of Cardiology	2015	25
1302033	L-Asparagine	Mullan M	A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.	Nature genetics	1992	203
8810256	L-Asparagine	Hsiao K	Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.	Science	1996	977
11409420	L-Asparagine	Grabowski TJ	Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.	Annals of neurology	2001	120
11557028	L-Asparagine	Yanagida O	Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.	Biochimica et biophysica acta	2001	97
16847063	L-Asparagine	Anderson JP	Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.	The Journal of biological chemistry	2006	251
17015824	L-Asparagine	Dunfee RL	The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.	Proceedings of the National Academy of Sciences of the United States of America	2006	94
21614585	L-Asparagine	Mohorko E	Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation.	Journal of inherited metabolic disease	2011	45
22445064	L-Asparagine	King OD	The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.	Brain research	2012	177
23582646	L-Asparagine	Simons C	A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum.	American journal of human genetics	2013	32
25326800	L-Asparagine	Zhang Z	Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.	Nature medicine	2014	47
25381298	L-Asparagine	Shen XM	Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability.	Neurology	2014	24
8651649	L-Methionine	Parchi P	Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.	Annals of neurology	1996	139
10443888	L-Methionine	Parchi P	Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.	Annals of neurology	1999	224
12553913	L-Methionine	Egan MF	The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.	Cell	2003	777
12607822	L-Methionine	Butterfield DA	Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.	Free radical research	2002	95
14702260	L-Methionine	Diamond A	Genetic and neurochemical modulation of prefrontal cognitive functions in children.	The American journal of psychiatry	2004	80
14722078	L-Methionine	Choi J	Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.	The Journal of biological chemistry	2004	129
15128854	L-Methionine	Chen ZY	Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.	The Journal of neuroscience 	2004	188
15302196	L-Methionine	Peden AH	Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.	Lancet	2004	147
15901785	L-Methionine	Blasi G	Effect of catechol-O-methyltransferase val158met genotype on attentional control.	The Journal of neuroscience 	2005	96
15987945	L-Methionine	Chen ZY	Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway.	The Journal of neuroscience 	2005	104
16517609	L-Methionine	Choi J	Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.	The Journal of biological chemistry	2006	115
16818862	L-Methionine	Ho BC	Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.	Archives of general psychiatry	2006	64
16869232	L-Methionine	Bath KG	Variant BDNF (Val66Met) impact on brain structure and function.	Cognitive, affective & behavioral neuroscience	2006	76
17085664	L-Methionine	Balak MN	Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.	Clinical cancer research 	2006	213
17217930	L-Methionine	Gratacòs M	Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.	Biological psychiatry	2007	85
17696172	L-Methionine	Campbell DB	Disruption of cerebral cortex MET signaling in autism spectrum disorder.	Annals of neurology	2007	70
18413375	L-Methionine	Terakawa Y	Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.	Journal of nuclear medicine 	2008	57
19854267	L-Methionine	Butterfield DA	In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.	Free radical biology & medicine	2010	52
20068183	L-Methionine	Schiffman JD	Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.	Cancer research	2010	91
20070383	L-Methionine	Peden A	Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.	Haemophilia 	2010	43
20695009	L-Methionine	Zou WQ	Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.	Annals of neurology	2010	49
20955337	L-Methionine	Frielingsdorf H	Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder.	Annals of the New York Academy of Sciences	2010	45
21514925	L-Methionine	Dumontheil I	Influence of the COMT genotype on working memory and brain activity changes during development.	Biological psychiatry	2011	38
21577214	L-Methionine	Gerritsen L	BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects.	Molecular psychiatry	2012	33
21727254	L-Methionine	Lyoo IK	The neurobiological role of the dorsolateral prefrontal cortex in recovery from trauma. Longitudinal brain imaging study among survivors of the South Korean subway disaster.	Archives of general psychiatry	2011	35
22031526	L-Methionine	Peden AH	Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.	The Journal of general virology	2012	35
22138198	L-Methionine	Witte AV	Effects of COMT polymorphisms on brain function and behavior in health and disease.	Brain research bulletin	2012	37
23539183	L-Methionine	Lewis PW	Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.	Science	2013	226
24699458	L-Methionine	Watts JC	Evidence that bank vole PrP is a universal acceptor for prions.	PLoS pathogens	2014	23
25525250	L-Methionine	Funato K	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.	Science	2014	60
26204799	L-Methionine	Warnault V	The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation.	Biological psychiatry	2016	13
27121947	L-Methionine	Justin N	Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.	Nature communications	2016	42
28263307	L-Methionine	Piunti A	Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.	Nature medicine	2017	16
28263309	L-Methionine	Mohammad F	EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.	Nature medicine	2017	17
10366192	Deoxyuridine triphosphate	Heo JH	Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.	Journal of cerebral blood flow and metabolism 	1999	103
11041447	Progesterone	Challis JRG	Endocrine and paracrine regulation of birth at term and preterm.	Endocrine reviews	2000	161
14644820	Progesterone	Mastorakos G	Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.	Annals of the New York Academy of Sciences	2003	86
18343488	Progesterone	Thomas P	Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.	Frontiers in neuroendocrinology	2008	74
18374402	Progesterone	Brinton RD	Progesterone receptors: form and function in brain.	Frontiers in neuroendocrinology	2008	126
18753370	Progesterone	Clarkson J	Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge.	The Journal of neuroscience 	2008	139
18980022	Progesterone	Anders C	Understanding and treating triple-negative breast cancer.	Oncology	2008	67
18981013	Progesterone	Luu TH	A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.	Clinical cancer research 	2008	64
19410597	Progesterone	Bourque M	Neuroprotective actions of sex steroids in Parkinson's disease.	Frontiers in neuroendocrinology	2009	53
19828794	Progesterone	McCarthy MM	The epigenetics of sex differences in the brain.	The Journal of neuroscience 	2009	132
20735820	Progesterone	Cole LA	Biological functions of hCG and hCG-related molecules.	Reproductive biology and endocrinology 	2010	43
20813970	Progesterone	Esteva FJ	PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.	The American journal of pathology	2010	100
20863372	Progesterone	Hoefnagel LD	Receptor conversion in distant breast cancer metastases.	Breast cancer research 	2010	52
21472708	Progesterone	Anders CK	The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.	Cancer	2011	35
21762880	Progesterone	Zeidan MA	Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats.	Biological psychiatry	2011	66
21914172	Progesterone	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	50
22365820	Progesterone	Lischke A	Oxytocin increases amygdala reactivity to threatening scenes in females.	Psychoneuroendocrinology	2012	47
22474108	Progesterone	Cosgrove KP	Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers.	Archives of general psychiatry	2012	33
22544643	Progesterone	Lin NU	Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.	Cancer	2012	64
25124431	Progesterone	Rilling JK	The biology of mammalian parenting and its effect on offspring social development.	Science	2014	76
26109339	Progesterone	Hara Y	Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse.	Physiological reviews	2015	27
26773400	Progesterone	Stephens MA	Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones.	Psychoneuroendocrinology	2016	15
26874901	Progesterone	Chan A	Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2016	26
26909695	Progesterone	Rostami R	Brain metastasis in breast cancer: a comprehensive literature review.	Journal of neuro-oncology	2016	13
11053229	N-Acetyl-L-aspartic acid	Callicott JH	Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.	Cerebral cortex	2000	170
19398702	N-Acetyl-L-aspartic acid	Lentz MR	Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.	Neurology	2009	53
21246320	N-Acetyl-L-aspartic acid	Letendre SL	Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.	Journal of neurovirology	2011	40
22374882	N-Acetyl-L-aspartic acid	Brummelte S	Procedural pain and brain development in premature newborns.	Annals of neurology	2012	70
23253610	N-Acetyl-L-aspartic acid	Leone P	Long-term follow-up after gene therapy for canavan disease.	Science translational medicine	2012	55
12947396	Ceramide (d18:1/12:0)	Kolesnick R	Radiation and ceramide-induced apoptosis.	Oncogene	2003	105
14755730	Ceramide (d18:1/12:0)	Haughey NJ	Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia.	Annals of neurology	2004	92
14970312	Ceramide (d18:1/12:0)	Cutler RG	Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	223
18547682	Ceramide (d18:1/12:0)	He X	Deregulation of sphingolipid metabolism in Alzheimer's disease.	Neurobiology of aging	2010	103
19777393	Ceramide (d18:1/12:0)	de la Monte SM	Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.	Current opinion in investigational drugs	2009	47
21779331	Ceramide (d18:1/12:0)	Han X	Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.	PloS one	2011	79
21994399	Ceramide (d18:1/12:0)	Geekiyanage H	MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease.	The Journal of neuroscience 	2011	59
22258513	Ceramide (d18:1/12:0)	Filippov V	Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases.	Journal of Alzheimer's disease 	2012	33
22532571	Ceramide (d18:1/12:0)	Wang G	Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).	The Journal of biological chemistry	2012	73
23332916	Ceramide (d18:1/12:0)	Martin E	Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.	American journal of human genetics	2013	32
24477431	Ceramide (d18:1/12:0)	Murphy KE	Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.	Brain 	2014	69
11201742	L-Leucine	Fournier AE	Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.	Nature	2001	239
15541309	L-Leucine	Zimprich A	Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.	Neuron	2004	622
15680457	L-Leucine	Gilks WP	A common LRRK2 mutation in idiopathic Parkinson's disease.	Lancet	2005	161
16269541	L-Leucine	West AB	Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.	Proceedings of the National Academy of Sciences of the United States of America	2005	319
16365084	L-Leucine	Brosnan JT	Branched-chain amino acids: enzyme and substrate regulation.	The Journal of nutrition	2006	75
16365087	L-Leucine	Kimball SR	Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis.	The Journal of nutrition	2006	109
16437584	L-Leucine	Giasson BI	Biochemical and pathological characterization of Lrrk2.	Annals of neurology	2006	68
16622416	L-Leucine	Mao X	APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.	Nature cell biology	2006	168
17114044	L-Leucine	MacLeod D	The familial Parkinsonism gene LRRK2 regulates neurite process morphology.	Neuron	2006	223
17120249	L-Leucine	Biskup S	Localization of LRRK2 to membranous and vesicular structures in mammalian brain.	Annals of neurology	2006	186
17341485	L-Leucine	Hatano T	Leucine-rich repeat kinase 2 associates with lipid rafts.	Human molecular genetics	2007	60
17363510	L-Leucine	Sarkaria JN	Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.	Molecular cancer therapeutics	2007	101
17667961	L-Leucine	Francks C	LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.	Molecular psychiatry	2007	87
17722061	L-Leucine	Nakano I	Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.	Journal of neuroscience research	2008	64
18367605	L-Leucine	Wang L	The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.	The Journal of neuroscience 	2008	73
18397888	L-Leucine	Greggio E	The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.	The Journal of biological chemistry	2008	121
18539534	L-Leucine	Healy DG	Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.	The Lancet. Neurology	2008	283
18676370	L-Leucine	Wang X	Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.	The Journal of biological chemistry	2008	52
18827171	L-Leucine	Drummond MJ	Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids.	American journal of physiology. Endocrinology and metabolism	2008	55
19213730	L-Leucine	Andersen J	Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.	The Journal of biological chemistry	2009	48
19524782	L-Leucine	Lees AJ	Parkinson's disease.	Lancet	2009	382
19545277	L-Leucine	Gillardon F	Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?	Journal of neurochemistry	2009	78
19640926	L-Leucine	Alegre-Abarrategui J	LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.	Human molecular genetics	2009	148
19717560	L-Leucine	Donkor J	A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2.	The Journal of biological chemistry	2009	51
20139422	L-Leucine	Kwon SK	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	The Journal of biological chemistry	2010	45
20457952	L-Leucine	Dächsel JC	LRRK2 and Parkinson disease.	Archives of neurology	2010	53
20506312	L-Leucine	Nuytemans K	Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.	Human mutation	2010	105
20519524	L-Leucine	Siddiqui TJ	LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development.	The Journal of neuroscience 	2010	93
20584763	L-Leucine	Lech M	Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice.	International immunology	2010	44
20642453	L-Leucine	Nichols RJ	14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.	The Biochemical journal	2010	105
20659558	L-Leucine	Melrose HL	Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.	Neurobiology of disease	2010	88
20671708	L-Leucine	Gehrke S	Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.	Nature	2010	140
20876399	L-Leucine	Meixner A	A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.	Molecular & cellular proteomics 	2011	37
21168496	L-Leucine	Winner B	Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.	Neurobiology of disease	2011	54
21248115	L-Leucine	Dusonchet J	A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2.	The Journal of neuroscience 	2011	45
21307259	L-Leucine	Piccoli G	LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.	The Journal of neuroscience 	2011	83
21362567	L-Leucine	Nguyen HN	LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.	Cell stem cell	2011	194
21494637	L-Leucine	Ramonet D	Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.	PloS one	2011	103
21738687	L-Leucine	Thévenet J	Regulation of LRRK2 expression points to a functional role in human monocyte maturation.	PloS one	2011	36
21745188	L-Leucine	Hanke ML	Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.	Clinical science	2011	82
21804599	L-Leucine	Molina JR	PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.	Oncogene	2012	53
22405201	L-Leucine	O'Sullivan ML	FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development.	Neuron	2012	42
22539006	L-Leucine	Chen CY	(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.	Cell death and differentiation	2012	30
23125283	L-Leucine	Cho HJ	MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.	Human molecular genetics	2013	40
23455607	L-Leucine	Orenstein SJ	Interplay of LRRK2 with chaperone-mediated autophagy.	Nature neuroscience	2013	112
23560750	L-Leucine	Davies P	Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies.	The Biochemical journal	2013	30
23911103	L-Leucine	de Wit J	Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development.	Neuron	2013	32
23916833	L-Leucine	Manzoni C	Inhibition of LRRK2 kinase activity stimulates macroautophagy.	Biochimica et biophysica acta	2013	30
24243757	L-Leucine	Alcalay RN	Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.	Movement disorders 	2013	31
24510904	L-Leucine	Beilina A	Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.	Proceedings of the National Academy of Sciences of the United States of America	2014	69
25080504	L-Leucine	Gómez-Suaga P	LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.	Human molecular genetics	2014	30
25251388	L-Leucine	Martin I	LRRK2 pathobiology in Parkinson's disease.	Journal of neurochemistry	2014	28
25284317	L-Leucine	Schapansky J	The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.	Neuroscience	2015	24
25353650	L-Leucine	Henderson JL	Discovery and preclinical profiling of 3-4-(morpholin-4-yl)-7H-pyrrolo2,3-dpyrimidin-5-ylbenzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor.	Journal of medicinal chemistry	2015	18
25394468	L-Leucine	Um JW	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	Nature communications	2014	22
26078453	L-Leucine	Daher JP	Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.	The Journal of biological chemistry	2015	21
26101198	L-Leucine	Kumaran R	Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.	Human molecular genetics	2015	20
26251043	L-Leucine	Henry AG	Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression.	Human molecular genetics	2015	17
26656254	L-Leucine	de Wit J	Specification of synaptic connectivity by cell surface interactions.	Nature reviews. Neuroscience	2016	33
26739710	L-Leucine	Pedersen SF	Biophysics and Physiology of the Volume-Regulated Anion Channel (VRAC)/Volume-Sensitive Outwardly Rectifying Anion Channel (VSOR).	Pflugers Archiv 	2016	14
26908106	L-Leucine	Stanley CA	Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.	The Journal of clinical endocrinology and metabolism	2016	22
26979420	L-Leucine	Chamma I	Mapping the dynamics and nanoscale organization of synaptic adhesion proteins using monomeric streptavidin.	Nature communications	2016	16
27357661	L-Leucine	Guaitoli G	Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts.	Proceedings of the National Academy of Sciences of the United States of America	2016	13
27590293	L-Leucine	van Sonderen A	Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.	Neurology	2016	16
27893017	L-Leucine	Finke C	Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.	JAMA neurology	2017	11
17918267	Sphing-4-enine-1-phosphate	Miron VE	FTY720 modulates human oligodendrocyte progenitor process extension and survival.	Annals of neurology	2008	55
17965716	Sphing-4-enine-1-phosphate	Walzer T	Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor.	Nature immunology	2007	94
19723667	Sphing-4-enine-1-phosphate	Kapitonov D	Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.	Cancer research	2009	63
19814729	Sphing-4-enine-1-phosphate	Brinkmann V	FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.	British journal of pharmacology	2009	96
20413685	Sphing-4-enine-1-phosphate	Miron VE	Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.	The American journal of pathology	2010	54
21543615	Sphing-4-enine-1-phosphate	Takasugi N	BACE1 activity is modulated by cell-associated sphingosine-1-phosphate.	The Journal of neuroscience 	2011	40
23518370	Sphing-4-enine-1-phosphate	Groves A	Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.	Journal of the neurological sciences	2013	62
24239768	Sphing-4-enine-1-phosphate	Bigaud M	Second generation S1P pathway modulators: research strategies and clinical developments.	Biochimica et biophysica acta	2014	26
26715391	Sphing-4-enine-1-phosphate	Hunter SF	The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.	CNS drugs	2016	11
27318702	Sphing-4-enine-1-phosphate	Tsai HC	Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.	Drugs	2016	10
27879252	Sphing-4-enine-1-phosphate	Ruiz M	High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.	Arteriosclerosis, thrombosis, and vascular biology	2017	7
2690177	L-Alanine	Molyneux ME	Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.	The Quarterly journal of medicine	1989	199
7729684	L-Alanine	Matsuoka S	p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.	Genes & development	1995	194
8209258	L-Alanine	Gurney ME	Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.	Science	1994	813
12640453	L-Alanine	Amiel J	Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.	Nature genetics	2003	123
12897283	L-Alanine	van den Hout HM	The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.	Pediatrics	2003	90
15834418	L-Alanine	Chen L	Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.	Nature neuroscience	2005	162
15944382	L-Alanine	Smith WW	Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.	The Journal of neuroscience 	2005	68
16914578	L-Alanine	Wen PY	Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.	Clinical cancer research 	2006	100
17482549	L-Alanine	Shelly M	LKB1/STRAD promotes axon initiation during neuronal polarization.	Cell	2007	127
18178617	L-Alanine	Gorbatyuk OS	The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
20398666	L-Alanine	Park HW	Dynamic regulation of CFTR bicarbonate permeability by Cl-i and its role in pancreatic bicarbonate secretion.	Gastroenterology	2010	59
21123452	L-Alanine	Dijkgraaf GJ	Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.	Cancer research	2011	106
21321221	L-Alanine	Keunen O	Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2011	185
22472607	L-Alanine	Mizrahi R	Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand (18)F-FEPPA.	Journal of cerebral blood flow and metabolism 	2012	32
22894884	L-Alanine	Di Giacomo AM	Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.	The Lancet. Oncology	2012	53
23273292	L-Alanine	Metra M	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.	Journal of the American College of Cardiology	2013	63
24411639	L-Alanine	Reck M	Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.	The Lancet. Oncology	2014	129
25253695	L-Alanine	Benilova I	The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.	The Journal of biological chemistry	2014	30
25398948	L-Alanine	Yamakawa M	Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS.	Human molecular genetics	2015	32
26973324	L-Alanine	Kim DW	Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.	The Lancet. Oncology	2016	70
28602779	L-Alanine	Shaw AT	Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.	The Lancet. Oncology	2017	18
11801260	Homocysteine	Black PH	Stress, inflammation and cardiovascular disease.	Journal of psychosomatic research	2002	125
17011077	Homocysteine	Ravaglia G	Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.	Neurobiology of aging	2007	60
17101822	Homocysteine	Schaefer EJ	Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.	Archives of neurology	2006	117
17962588	Homocysteine	Khatri M	Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).	Stroke	2007	60
19172649	Homocysteine	Morra JH	Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.	Human brain mapping	2009	88
21680719	Homocysteine	Tan ZS	Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study.	Diabetes care	2011	46
21889590	Homocysteine	Raz N	Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants.	Biochimica et biophysica acta	2012	41
24401164	Homocysteine	Wiseman S	Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis.	Cerebrovascular diseases	2014	28
24706014	Homocysteine	Westwood AJ	Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.	Neurology	2014	22
12084879	Silver	Thal DR	Phases of A beta-deposition in the human brain and its relevance for the development of AD.	Neurology	2002	463
12122208	Silver	Lo Bianco C	alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2002	113
15753419	Silver	Bennett DA	Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.	Neurology	2005	177
15851731	Silver	Braak H	Cognitive status correlates with neuropathologic stage in Parkinson disease.	Neurology	2005	82
17159101	Silver	Arvanitakis Z	Diabetes is related to cerebral infarction but not to AD pathology in older persons.	Neurology	2006	91
18585468	Silver	Zaborszky L	Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain.	NeuroImage	2008	55
19273758	Silver	Tapiola T	Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.	Archives of neurology	2009	157
19557866	Silver	Kok E	Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.	Annals of neurology	2009	85
20150372	Silver	Raizer JJ	A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.	Neuro-oncology	2010	62
20488204	Silver	Minhas P	Electrodes for high-definition transcutaneous DC stimulation for applications in drug delivery and electrotherapy, including tDCS.	Journal of neuroscience methods	2010	47
22770526	Silver	Yang EJ	Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles.	Biomaterials	2012	36
23250390	Silver	Kostović I	Perinatal and early postnatal reorganization of the subplate and related cellular compartments in the human cerebral wall as revealed by histological and MRI approaches.	Brain structure & function	2014	33
23836404	Silver	Shulman JM	Genetic susceptibility for Alzheimer disease neuritic plaque pathology.	JAMA neurology	2013	38
25307057	Silver	Choi SH	A three-dimensional human neural cell culture model of Alzheimer's disease.	Nature	2014	143
26843106	Silver	Mytych J	Prolonged Effects of Silver Nanoparticles on p53/p21 Pathway-Mediated Proliferation, DNA Damage Response, and Methylation Parameters in HT22 Hippocampal Neuronal Cells.	Molecular neurobiology	2017	6
14610053	2-Arachidonylglycerol	Bisogno T	Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.	The Journal of cell biology	2003	237
16116451	2-Arachidonylglycerol	Makara JK	Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.	Nature neuroscience	2005	75
18657971	2-Arachidonylglycerol	Hoover HS	Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.	Bioorganic & medicinal chemistry letters	2008	51
19150370	2-Arachidonylglycerol	Anand P	Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.	Brain research reviews	2009	45
19962385	2-Arachidonylglycerol	Bertrand T	Structural basis for human monoglyceride lipase inhibition.	Journal of molecular biology	2010	40
21418147	2-Arachidonylglycerol	Savinainen JR	The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.	Acta physiologica	2012	41
22029953	2-Arachidonylglycerol	Heyman E	Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.	Psychoneuroendocrinology	2012	37
23127915	2-Arachidonylglycerol	Guindon J	Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.	Pharmacological research	2013	35
23142242	2-Arachidonylglycerol	Mulvihill MM	Therapeutic potential of monoacylglycerol lipase inhibitors.	Life sciences	2013	33
24035186	2-Arachidonylglycerol	Hill MN	Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.	Psychoneuroendocrinology	2013	34
24747340	2-Arachidonylglycerol	Ohno-Shosaku T	Endocannabinoid-mediated retrograde modulation of synaptic transmission.	Current opinion in neurobiology	2014	39
25378159	2-Arachidonylglycerol	Zhang J	Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2014	23
25466252	2-Arachidonylglycerol	Shonesy BC	Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation.	Cell reports	2014	23
25981172	2-Arachidonylglycerol	Jenniches I	Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.	Biological psychiatry	2016	23
26068727	2-Arachidonylglycerol	Morena M	Neurobiological Interactions Between Stress and the Endocannabinoid System.	Neuropsychopharmacology 	2016	41
11164622	Anandamide	Pertwee RG	Cannabinoid receptors and pain.	Progress in neurobiology	2001	111
12960289	Anandamide	Klein TW	The cannabinoid system and immune modulation.	Journal of leukocyte biology	2003	134
15354183	Anandamide	Giuffrida A	Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.	Neuropsychopharmacology 	2004	82
16387640	Anandamide	Eljaschewitsch E	The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.	Neuron	2006	97
19389627	Anandamide	Ahn K	Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.	Chemistry & biology	2009	145
20098669	Anandamide	Cencioni MT	Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.	PloS one	2010	58
24325918	Anandamide	Gunduz-Cinar O	Amygdala FAAH and anandamide: mediating protection and recovery from stress.	Trends in pharmacological sciences	2013	47
25731744	Anandamide	Dincheva I	FAAH genetic variation enhances fronto-amygdala function in mouse and human.	Nature communications	2015	46
12676175	Vasopressin	McKinley MJ	The brain renin-angiotensin system: location and physiological roles.	The international journal of biochemistry & cell biology	2003	102
15589267	Vasopressin	Landgraf R	Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication.	Frontiers in neuroendocrinology	2004	190
15996533	Vasopressin	Swaab DF	The stress system in the human brain in depression and neurodegeneration.	Ageing research reviews	2005	140
16303870	Vasopressin	Wismer Fries AB	Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior.	Proceedings of the National Academy of Sciences of the United States of America	2005	104
16890230	Vasopressin	Lim MM	Neuropeptidergic regulation of affiliative behavior and social bonding in animals.	Hormones and behavior	2006	139
17118932	Vasopressin	Hammock EA	Oxytocin, vasopressin and pair bonding: implications for autism.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2006	68
17208295	Vasopressin	Kim J	Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.	Biomaterials	2007	67
18053631	Vasopressin	Caldwell HK	Vasopressin: behavioral roles of an "original" neuropeptide.	Progress in neurobiology	2008	115
18614026	Vasopressin	Koob GF	A role for brain stress systems in addiction.	Neuron	2008	305
18655894	Vasopressin	Heinrichs M	Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans.	Progress in brain research	2008	84
18988842	Vasopressin	Donaldson ZR	Oxytocin, vasopressin, and the neurogenetics of sociality.	Science	2008	320
19084465	Vasopressin	Skuse DH	Dopaminergic-neuropeptide interactions in the social brain.	Trends in cognitive sciences	2009	68
20182426	Vasopressin	Tobin VA	An intrinsic vasopressin system in the olfactory bulb is involved in social recognition.	Nature	2010	47
20346754	Vasopressin	Insel TR	The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior.	Neuron	2010	214
20833240	Vasopressin	Aguilera G	HPA axis responsiveness to stress: implications for healthy aging.	Experimental gerontology	2011	36
21852800	Vasopressin	Meyer-Lindenberg A	Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.	Nature reviews. Neuroscience	2011	311
22079778	Vasopressin	Albers HE	The regulation of social recognition, social communication and aggression: vasopressin in the social behavior neural network.	Hormones and behavior	2012	48
22197271	Vasopressin	Churchland PS	Modulating social behavior with oxytocin: how does it work? What does it mean?	Hormones and behavior	2012	97
22265852	Vasopressin	Guastella AJ	A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions.	Hormones and behavior	2012	83
22285934	Vasopressin	Feldman R	Oxytocin and social affiliation in humans.	Hormones and behavior	2012	87
22504348	Vasopressin	McCall C	The animal and human neuroendocrinology of social cognition, motivation and behavior.	Nature neuroscience	2012	60
22840551	Vasopressin	Atzil S	Synchrony and specificity in the maternal and the paternal brain: relations to oxytocin and vasopressin.	Journal of the American Academy of Child and Adolescent Psychiatry	2012	33
22974560	Vasopressin	Neumann ID	Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.	Trends in neurosciences	2012	139
22981649	Vasopressin	Lukas M	Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders.	Behavioural brain research	2013	30
23040812	Vasopressin	Stoop R	Neuromodulation by oxytocin and vasopressin.	Neuron	2012	77
25102443	Vasopressin	Albers HE	Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network.	Frontiers in neuroendocrinology	2015	26
25416642	Vasopressin	Feng C	Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans.	Brain imaging and behavior	2015	18
25583178	Vasopressin	Koob GF	The dark side of emotion: the addiction perspective.	European journal of pharmacology	2015	31
25753944	Vasopressin	McKinley MJ	The median preoptic nucleus: front and centre for the regulation of body fluid, sodium, temperature, sleep and cardiovascular homeostasis.	Acta physiologica	2015	17
25951955	Vasopressin	Dumais KM	Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior.	Frontiers in neuroendocrinology	2016	36
26911439	Vasopressin	Freeman SM	Selective localization of oxytocin receptors and vasopressin 1a receptors in the human brainstem.	Social neuroscience	2017	9
15146179	Liothyronine	Scanlan TS	3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.	Nature medicine	2004	95
17315033	Liothyronine	Bernal J	Thyroid hormone receptors in brain development and function.	Nature clinical practice. Endocrinology & metabolism	2007	88
17318265	Liothyronine	Trajkovic M	Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.	The Journal of clinical investigation	2007	68
19190113	Liothyronine	Panicker V	Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.	The Journal of clinical endocrinology and metabolism	2009	47
20458138	Liothyronine	Freitas BC	Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells.	The Journal of clinical investigation	2010	47
19346482	Prunus inhibitor b	Reiman EM	Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	257
20008660	Prunus inhibitor b	Villemagne VL	High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.	Archives of neurology	2009	47
20231448	Prunus inhibitor b	Mosconi L	Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.	Proceedings of the National Academy of Sciences of the United States of America	2010	64
20538372	Prunus inhibitor b	Apostolova LG	3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.	Neurobiology of aging	2010	56
21280088	Prunus inhibitor b	Villemagne VL	Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.	Annals of neurology	2011	196
21422459	Prunus inhibitor b	Gupta VB	Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.	Neurology	2011	49
21529702	Prunus inhibitor b	Pike KE	Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.	Neuropsychologia	2011	49
22398958	Prunus inhibitor b	Villemagne VL	Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.	European journal of nuclear medicine and molecular imaging	2012	34
22693110	Prunus inhibitor b	Gomperts SN	Brain amyloid and cognition in Lewy body diseases.	Movement disorders 	2012	34
22961445	Prunus inhibitor b	Nordberg A	A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.	European journal of nuclear medicine and molecular imaging	2013	33
22972644	Prunus inhibitor b	Mielke MM	Indicators of amyloid burden in a population-based study of cognitively normal elderly.	Neurology	2012	37
23102118	Prunus inhibitor b	Toledo JB	Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative.	Alzheimer's & dementia 	2012	32
23243071	Prunus inhibitor b	Gomperts SN	Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.	Neurology	2013	43
23280791	Prunus inhibitor b	Vemuri P	Effect of lifestyle activities on Alzheimer disease biomarkers and cognition.	Annals of neurology	2012	43
23424091	Prunus inhibitor b	Gurol ME	Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.	Annals of neurology	2013	40
23954175	Prunus inhibitor b	Trzepacz PT	Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.	Neurobiology of aging	2014	21
24132374	Prunus inhibitor b	Hughes TM	Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.	Neurology	2013	37
24623839	Prunus inhibitor b	Yates PA	Incidence of cerebral microbleeds in preclinical Alzheimer disease.	Neurology	2014	23
24936411	Prunus inhibitor b	Racine AM	Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.	NeuroImage. Clinical	2014	28
24948815	Prunus inhibitor b	Wirth M	Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden.	The Journal of neuroscience 	2014	26
11520931	Oxytocin	Meaney MJ	Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations.	Annual review of neuroscience	2001	454
11589138	Oxytocin	Champagne F	Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity.	Progress in brain research	2001	87
12136507	Oxytocin	Teicher MH	Developmental neurobiology of childhood stress and trauma.	The Psychiatric clinics of North America	2002	82
16209725	Oxytocin	Depue RA	A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation.	The Behavioral and brain sciences	2005	105
17383819	Oxytocin	Jacob S	Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.	Neuroscience letters	2007	122
17435137	Oxytocin	Carter CS	Oxytocin: behavioral associations and potential as a salivary biomarker.	Annals of the New York Academy of Sciences	2007	63
17524488	Oxytocin	Bao AM	The stress system in depression and neurodegeneration: focus on the human hypothalamus.	Brain research reviews	2008	90
18061414	Oxytocin	Valassi E	Neuroendocrine control of food intake.	Nutrition, metabolism, and cardiovascular diseases 	2008	95
18601710	Oxytocin	Neumann ID	Brain oxytocin: a key regulator of emotional and social behaviours in both females and males.	Journal of neuroendocrinology	2008	134
18655867	Oxytocin	Goodson JL	Nonapeptides and the evolutionary patterning of sociality.	Progress in brain research	2008	56
19482229	Oxytocin	Lee HJ	Oxytocin: the great facilitator of life.	Progress in neurobiology	2009	169
19580564	Oxytocin	Barraza JA	Empathy toward strangers triggers oxytocin release and subsequent generosity.	Annals of the New York Academy of Sciences	2009	51
19934046	Oxytocin	Rodrigues SM	Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	156
20220015	Oxytocin	Tolson KP	Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression.	The Journal of neuroscience 	2010	51
20371820	Oxytocin	Hurlemann R	Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans.	The Journal of neuroscience 	2010	129
20435366	Oxytocin	Munesue T	Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.	Neuroscience research	2010	56
20538951	Oxytocin	De Dreu CK	The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans.	Science	2010	156
20558167	Oxytocin	Feldman R	The cross-generation transmission of oxytocin in humans.	Hormones and behavior	2010	41
20647384	Oxytocin	Tost H	A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function.	Proceedings of the National Academy of Sciences of the United States of America	2010	116
20720535	Oxytocin	Labuschagne I	Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder.	Neuropsychopharmacology 	2010	115
20832055	Oxytocin	Inoue H	Association between the oxytocin receptor gene and amygdalar volume in healthy adults.	Biological psychiatry	2010	46
21208749	Oxytocin	Furman DJ	Variant in oxytocin receptor gene is associated with amygdala volume.	Psychoneuroendocrinology	2011	43
21676095	Oxytocin	Feldman R	Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding.	Developmental science	2011	68
21696997	Oxytocin	Bartz JA	Social effects of oxytocin in humans: context and person matter.	Trends in cognitive sciences	2011	282
21840129	Oxytocin	Rilling JK	Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men.	Psychoneuroendocrinology	2012	76
21881566	Oxytocin	Atzil S	Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.	Neuropsychopharmacology 	2011	57
22189289	Oxytocin	Riem MM	No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter.	Neuropsychopharmacology 	2012	44
22336563	Oxytocin	Feldman R	Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes.	Biological psychiatry	2012	75
22369786	Oxytocin	Parker JA	Hypothalamic neuropeptides and the regulation of appetite.	Neuropharmacology	2012	35
22647521	Oxytocin	Sripada CS	Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex.	The international journal of neuropsychopharmacology	2013	39
22885871	Oxytocin	Burkett JP	The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.	Psychopharmacology	2012	48
22892716	Oxytocin	Unternaehrer E	Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF ) after acute psychosocial stress.	Translational psychiatry	2012	48
22957036	Oxytocin	Patisaul HB	Anxiogenic effects of developmental bisphenol A exposure are associated with gene expression changes in the juvenile rat amygdala and mitigated by soy.	PloS one	2012	34
22981834	Oxytocin	van Zuiden M	Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions.	Brain, behavior, and immunity	2013	28
22999263	Oxytocin	Weisman O	Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety.	Psychoneuroendocrinology	2013	28
23025690	Oxytocin	Pedersen CA	Intranasal oxytocin blocks alcohol withdrawal in human subjects.	Alcoholism, clinical and experimental research	2013	34
23135822	Oxytocin	Chapman CD	Intranasal treatment of central nervous system dysfunction in humans.	Pharmaceutical research	2013	34
23147382	Oxytocin	Grillon C	Oxytocin increases anxiety to unpredictable threat.	Molecular psychiatry	2013	31
23333868	Oxytocin	Rilling JK	The neural and hormonal bases of human parental care.	Neuropsychologia	2013	30
23508240	Oxytocin	Macdonald K	Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.	Frontiers in neuroscience	2013	35
23510581	Oxytocin	Domes G	Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.	Biological psychiatry	2013	45
23575742	Oxytocin	Shahrestani S	The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis.	Neuropsychopharmacology 	2013	39
23579082	Oxytocin	Neumann ID	Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice.	Psychoneuroendocrinology	2013	104
23872596	Oxytocin	Guzmán YF	Fear-enhancing effects of septal oxytocin receptors.	Nature neuroscience	2013	31
24012742	Oxytocin	Boccia ML	Immunohistochemical localization of oxytocin receptors in human brain.	Neuroscience	2013	34
24157401	Oxytocin	Rilling JK	Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction.	Psychoneuroendocrinology	2014	57
24190025	Oxytocin	Huang H	Chronic and acute intranasal oxytocin produce divergent social effects in mice.	Neuropsychopharmacology 	2014	38
24210138	Oxytocin	Kormos V	Role of neuropeptides in anxiety, stress, and depression: from animals to humans.	Neuropeptides	2013	36
24558199	Oxytocin	Patrick RP	Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism.	FASEB journal 	2014	36
24594871	Oxytocin	Dodhia S	Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.	Neuropsychopharmacology 	2014	31
24694924	Oxytocin	Scheele D	An oxytocin-induced facilitation of neural and emotional responses to social touch correlates inversely with autism traits.	Neuropsychopharmacology 	2014	31
25499958	Oxytocin	Paloyelis Y	A Spatiotemporal Profile of In Vivo Cerebral Blood Flow Changes Following Intranasal Oxytocin in Humans.	Biological psychiatry	2016	19
25526824	Oxytocin	Quintana DS	Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.	Neuroscience and biobehavioral reviews	2015	19
25563749	Oxytocin	Ziegler C	Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety.	Neuropsychopharmacology 	2015	20
25675509	Oxytocin	Puglia MH	Epigenetic modification of the oxytocin receptor gene influences the perception of anger and fear in the human brain.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25997760	Oxytocin	Feldman R	Sensitive periods in human social development: New insights from research on oxytocin, synchrony, and high-risk parenting.	Development and psychopathology	2015	17
26001309	Oxytocin	Grinevich V	Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain.	Biological psychiatry	2016	19
26061800	Oxytocin	Unternaehrer E	Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women.	Stress	2015	17
26208744	Oxytocin	Neumann ID	Oxytocin in General Anxiety and Social Fear: A Translational Approach.	Biological psychiatry	2016	28
26392129	Oxytocin	Feldman R	Oxytocin Pathway Genes: Evolutionary Ancient System Impacting on Human Affiliation, Sociality, and Psychopathology.	Biological psychiatry	2016	40
26410353	Oxytocin	Feifel D	A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.	Biological psychiatry	2016	14
26893121	Oxytocin	King LB	Variation in the Oxytocin Receptor Gene Predicts Brain Region-Specific Expression and Social Attachment.	Biological psychiatry	2016	18
26991328	Oxytocin	Lane A	Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory.	Journal of neuroendocrinology	2016	11
9048584	17a-Ethynylestradiol	Kuiper GG	Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.	Endocrinology	1997	594
9111344	17a-Ethynylestradiol	Hong H	GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.	Molecular and cellular biology	1997	125
9348186	17a-Ethynylestradiol	Couse JF	Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.	Endocrinology	1997	136
10227624	17a-Ethynylestradiol	Jack CR Jr	Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.	Neurology	1999	322
11040417	17a-Ethynylestradiol	Garcia-Segura LM	Neuroprotection by estradiol.	Progress in neurobiology	2001	124
12052919	17a-Ethynylestradiol	Simerly RB	Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain.	Annual review of neuroscience	2002	189
12400004	17a-Ethynylestradiol	Real PJ	Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.	Oncogene	2002	88
12697714	17a-Ethynylestradiol	Mitra SW	Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.	Endocrinology	2003	202
16139959	17a-Ethynylestradiol	Kajantie E	The effects of sex and hormonal status on the physiological response to acute psychosocial stress.	Psychoneuroendocrinology	2006	162
16310321	17a-Ethynylestradiol	De Vries GJ	Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints.	Neuroscience	2006	71
16621281	17a-Ethynylestradiol	Franceschini I	Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha.	Neuroscience letters	2006	99
16780796	17a-Ethynylestradiol	Funakoshi T	G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane.	Biochemical and biophysical research communications	2006	103
16931954	17a-Ethynylestradiol	Hicks DG	Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.	The American journal of surgical pathology	2006	71
17308356	17a-Ethynylestradiol	Zhao H	Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke.	Molecular neurobiology	2006	77
17361034	17a-Ethynylestradiol	Strum JC	Rosiglitazone induces mitochondrial biogenesis in mouse brain.	Journal of Alzheimer's disease 	2007	66
17488799	17a-Ethynylestradiol	Rometo AM	Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys.	The Journal of clinical endocrinology and metabolism	2007	88
17679729	17a-Ethynylestradiol	Blum W	Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.	Journal of clinical oncology 	2007	93
18443585	17a-Ethynylestradiol	Ben-Porath I	An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.	Nature genetics	2008	811
18614256	17a-Ethynylestradiol	Rance NE	Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback.	Peptides	2009	63
18829137	17a-Ethynylestradiol	Selvamani A	Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats.	Neurobiology of aging	2010	50
19389994	17a-Ethynylestradiol	Santen RJ	History of aromatase: saga of an important biological mediator and therapeutic target.	Endocrine reviews	2009	89
19416735	17a-Ethynylestradiol	Micevych P	Membrane estradiol signaling in the brain.	Frontiers in neuroendocrinology	2009	61
19428444	17a-Ethynylestradiol	Lebesgue D	Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.	Steroids	2009	61
19770291	17a-Ethynylestradiol	Oakley AE	Kisspeptin signaling in the brain.	Endocrine reviews	2009	176
20031276	17a-Ethynylestradiol	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20800582	17a-Ethynylestradiol	Rance NE	Neurokinin B and the hypothalamic regulation of reproduction.	Brain research	2010	54
21057539	17a-Ethynylestradiol	Patel JB	Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.	Oncogene	2011	39
21458561	17a-Ethynylestradiol	Meitzen J	Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways.	Journal of chemical neuroanatomy	2011	41
21471363	17a-Ethynylestradiol	Jacobs E	Estrogen shapes dopamine-dependent cognitive processes: implications for women's health.	The Journal of neuroscience 	2011	76
21736918	17a-Ethynylestradiol	Groeneweg FL	Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling.	Molecular and cellular endocrinology	2012	43
22151997	17a-Ethynylestradiol	Chimge NO	Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.	Breast cancer research 	2011	38
23079626	17a-Ethynylestradiol	Luine V	Interactions between estradiol, BDNF and dendritic spines in promoting memory.	Neuroscience	2013	38
23142339	17a-Ethynylestradiol	Baudry M	Progesterone-estrogen interactions in synaptic plasticity and neuroprotection.	Neuroscience	2013	29
23164950	17a-Ethynylestradiol	Volden PA	The influence of glucocorticoid signaling on tumor progression.	Brain, behavior, and immunity	2013	25
23283688	17a-Ethynylestradiol	Knickmeyer RC	Common variants in psychiatric risk genes predict brain structure at birth.	Cerebral cortex	2014	38
23689534	17a-Ethynylestradiol	Guintivano J	Antenatal prediction of postpartum depression with blood DNA methylation biomarkers.	Molecular psychiatry	2014	24
23697635	17a-Ethynylestradiol	Sarachana T	Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder.	Molecular autism	2013	34
23872331	17a-Ethynylestradiol	Rance NE	Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes.	Frontiers in neuroendocrinology	2013	29
23883676	17a-Ethynylestradiol	Xue B	Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen.	American journal of physiology. Regulatory, integrative and comparative physiology	2013	27
24077696	17a-Ethynylestradiol	Toro L	MaxiK channel and cell signalling.	Pflugers Archiv 	2014	26
24246855	17a-Ethynylestradiol	Handa RJ	Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.	Frontiers in neuroendocrinology	2014	53
24881463	17a-Ethynylestradiol	Pagani O	Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.	The New England journal of medicine	2014	93
24954179	17a-Ethynylestradiol	Bondesson M	Estrogen receptor signaling during vertebrate development.	Biochimica et biophysica acta	2015	23
25303530	17a-Ethynylestradiol	Liu Z	Enhancer activation requires trans-recruitment of a mega transcription factor complex.	Cell	2014	32
25495490	17a-Ethynylestradiol	Francis PA	Adjuvant ovarian suppression in premenopausal breast cancer.	The New England journal of medicine	2015	79
25960081	17a-Ethynylestradiol	Frick KM	Molecular mechanisms underlying the memory-enhancing effects of estradiol.	Hormones and behavior	2015	22
27557300	17a-Ethynylestradiol	Cardoso F	70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.	The New England journal of medicine	2016	91
27926948	17a-Ethynylestradiol	Priedigkeit N	Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.	JAMA oncology	2017	9
15685439	Guanine	Ohgaki H	Epidemiology and etiology of gliomas.	Acta neuropathologica	2005	228
22570426	Guanine	Zhang W	miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.	Neuro-oncology	2012	44
24842956	Guanine	Ostrom QT	The epidemiology of glioma in adults: a "state of the science" review.	Neuro-oncology	2014	127
26324104	Guanine	Sadeh N	SKA2 methylation is associated with decreased prefrontal cortical thickness and greater PTSD severity among trauma-exposed veterans.	Molecular psychiatry	2016	21
26587783	Guanine	Seroussi E	Identification of the Long-Sought Leptin in Chicken and Duck: Expression Pattern of the Highly GC-Rich Avian leptin Fits an Autocrine/Paracrine Rather Than Endocrine Function.	Endocrinology	2016	13
9809557	Thymidine	Eriksson PS	Neurogenesis in the adult human hippocampus.	Nature medicine	1998	1036
11687800	Thymidine	Mandel H	The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.	Nature genetics	2001	97
12177450	Thymidine	Bernier PJ	Newly generated neurons in the amygdala and adjoining cortex of adult primates.	Proceedings of the National Academy of Sciences of the United States of America	2002	105
16046395	Thymidine	Zhang Y	Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.	The Journal of biological chemistry	2005	182
16103070	Thymidine	Ali S	Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.	Cancer research	2005	71
18369324	Thymidine	Aboody KS	Stem and progenitor cell-mediated tumor selective gene therapy.	Gene therapy	2008	88
18523066	Thymidine	Bading JR	Imaging of cell proliferation: status and prospects.	Journal of nuclear medicine 	2008	63
19240794	Thymidine	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	87
19805493	Thymidine	Palazuelos J	Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.	Brain 	2009	78
19878914	Thymidine	Sato N	Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n.	American journal of human genetics	2009	54
21646517	Thymidine	Kohler SJ	Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months.	Proceedings of the National Academy of Sciences of the United States of America	2011	43
21912681	Thymidine	Skalsky RL	Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene.	PloS one	2011	51
22048458	Thymidine	Gavin DP	Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis.	Neuropsychopharmacology 	2012	36
23431204	Thymidine	Ponti G	Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	57
23850491	Thymidine	Westphal M	Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2013	33
1279432	L-Tyrosine	Plate KH	Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.	Nature	1992	346
2032290	L-Tyrosine	Boulton TG	ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.	Cell	1991	361
2649245	L-Tyrosine	Weidemann A	Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.	Cell	1989	192
7644498	L-Tyrosine	Chen HI	The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.	Proceedings of the National Academy of Sciences of the United States of America	1995	153
7842013	L-Tyrosine	Kaplitt MG	Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.	Nature genetics	1994	169
7852993	L-Tyrosine	Barbacid M	The Trk family of neurotrophin receptors.	Journal of neurobiology	1994	149
8052651	L-Tyrosine	Nishikawa R	A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	1994	242
8122112	L-Tyrosine	Morris SW	Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.	Science	1994	403
8640565	L-Tyrosine	Wilson JM	Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.	Nature medicine	1996	160
8654373	L-Tyrosine	Gupta S	Selective interaction of JNK protein kinase isoforms with transcription factors.	The EMBO journal	1996	260
8657309	L-Tyrosine	Treanor JJ	Characterization of a multicomponent receptor for GDNF.	Nature	1996	115
9006938	L-Tyrosine	Huang HS	The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.	The Journal of biological chemistry	1997	173
9651129	L-Tyrosine	Williams SM	Widespread origin of the primate mesofrontal dopamine system.	Cerebral cortex	1998	121
9720972	L-Tyrosine	Frölich L	Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.	Journal of neural transmission	1998	116
9771710	L-Tyrosine	Minassian BA	Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.	Nature genetics	1998	102
9889097	L-Tyrosine	Machesky LM	Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex.	Current biology 	1998	234
10837492	L-Tyrosine	Schaefer M	Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5.	The Journal of biological chemistry	2000	94
11036265	L-Tyrosine	Conover JC	Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone.	Nature neuroscience	2000	110
11062131	L-Tyrosine	Giasson BI	Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.	Science	2000	280
11923443	L-Tyrosine	Kirik D	Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.	The Journal of neuroscience 	2002	159
11983165	L-Tyrosine	Palmer A	EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase.	Molecular cell	2002	81
12045255	L-Tyrosine	Nguyen G	Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.	The Journal of clinical investigation	2002	273
12526739	L-Tyrosine	Arnaud L	Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.	Current biology 	2003	90
12601150	L-Tyrosine	Kirik D	Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	89
12845521	L-Tyrosine	Reuss B	Fibroblast growth factors and their receptors in the central nervous system.	Cell and tissue research	2003	79
12884910	L-Tyrosine	Summy JM	Src family kinases in tumor progression and metastasis.	Cancer metastasis reviews	2003	243
12912764	L-Tyrosine	Dwivedi Y	Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.	Archives of general psychiatry	2003	187
12953054	L-Tyrosine	Sariola H	Novel functions and signalling pathways for GDNF.	Journal of cell science	2003	134
14749507	L-Tyrosine	Myers MG Jr	Leptin receptor signaling and the regulation of mammalian physiology.	Recent progress in hormone research	2004	115
14999081	L-Tyrosine	Lee G	Phosphorylation of tau by fyn: implications for Alzheimer's disease.	The Journal of neuroscience 	2004	95
15329723	L-Tyrosine	Douma S	Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.	Nature	2004	163
15494733	L-Tyrosine	Ren XR	Focal adhesion kinase in netrin-1 signaling.	Nature neuroscience	2004	77
15520383	L-Tyrosine	Zhang EE	Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15720813	L-Tyrosine	Hoelzinger DB	Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.	Neoplasia	2005	99
15831234	L-Tyrosine	Giannini C	Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.	Neuro-oncology	2005	169
15930396	L-Tyrosine	Teng HK	ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.	The Journal of neuroscience 	2005	206
15967113	L-Tyrosine	Hu X	mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.	Neoplasia	2005	65
15987937	L-Tyrosine	Sánchez-González MA	The primate thalamus is a key target for brain dopamine.	The Journal of neuroscience 	2005	67
16052209	L-Tyrosine	Leyssen M	Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain.	The EMBO journal	2005	66
16099997	L-Tyrosine	Fu YS	Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.	Stem cells	2006	85
16212809	L-Tyrosine	Abounader R	Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.	Neuro-oncology	2005	80
16288224	L-Tyrosine	Natarajan M	HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.	Oncogene	2006	69
16488877	L-Tyrosine	Dewing P	Direct regulation of adult brain function by the male-specific factor SRY.	Current biology 	2006	94
16585512	L-Tyrosine	Vajkoczy P	Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16618748	L-Tyrosine	Nakamura K	Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.	Cancer research	2006	67
16939974	L-Tyrosine	Reichardt LF	Neurotrophin-regulated signalling pathways.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2006	483
17055279	L-Tyrosine	Chu Y	Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?	Neurobiology of disease	2007	101
17057709	L-Tyrosine	Roy NS	Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.	Nature medicine	2006	223
17090670	L-Tyrosine	Horvath S	Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.	Proceedings of the National Academy of Sciences of the United States of America	2006	215
17219439	L-Tyrosine	Shi Q	A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.	Molecular carcinogenesis	2007	61
17295177	L-Tyrosine	Villanueva A	Genomics and signaling pathways in hepatocellular carcinoma.	Seminars in liver disease	2007	156
17346182	L-Tyrosine	Laviola L	The IGF-I signaling pathway.	Current pharmaceutical design	2007	66
17431114	L-Tyrosine	Liu TJ	Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.	Molecular cancer therapeutics	2007	59
17504212	L-Tyrosine	Lykissas MG	The role of neurotrophins in axonal growth, guidance, and regeneration.	Current neurovascular research	2007	58
17627510	L-Tyrosine	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17646646	L-Tyrosine	Huang PH	Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2007	149
17699664	L-Tyrosine	Kauffman AS	The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior.	The Journal of neuroscience 	2007	57
17726474	L-Tyrosine	Martinowich K	New insights into BDNF function in depression and anxiety.	Nature neuroscience	2007	231
17855343	L-Tyrosine	Townsend M	Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.	The Journal of biological chemistry	2007	97
17906291	L-Tyrosine	Ryoo SR	DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.	The Journal of biological chemistry	2007	57
18079166	L-Tyrosine	Orimo S	Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.	Brain 	2008	77
18092308	L-Tyrosine	Xiao Z	Cell-specific internalization study of an aptamer from whole cell selection.	Chemistry	2008	66
18172262	L-Tyrosine	Hutterer M	Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.	Clinical cancer research 	2008	79
18264713	L-Tyrosine	Dickson DW	Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.	Acta neuropathologica	2008	68
18362333	L-Tyrosine	Diehn M	Identification of noninvasive imaging surrogates for brain tumor gene-expression modules.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
18404164	L-Tyrosine	Sithanandam G	The ERBB3 receptor in cancer and cancer gene therapy.	Cancer gene therapy	2008	64
18431473	L-Tyrosine	Curtin JF	Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.	PloS one	2008	51
18477770	L-Tyrosine	Porkka K	Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.	Blood	2008	64
19006193	L-Tyrosine	Kordower JH	Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.	Movement disorders 	2008	72
19074825	L-Tyrosine	Wykosky J	The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.	Molecular cancer research 	2008	98
19135109	L-Tyrosine	Robey RW	ABCG2: a perspective.	Advanced drug delivery reviews	2009	86
19157632	L-Tyrosine	Kim JE	Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.	Lung cancer	2009	48
19188609	L-Tyrosine	De Felice FG	Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19412429	L-Tyrosine	Pillay V	The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.	Neoplasia	2009	50
19478061	L-Tyrosine	Veeriah S	The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.	Proceedings of the National Academy of Sciences of the United States of America	2009	83
19478092	L-Tyrosine	Murakami T	Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability.	The Journal of biological chemistry	2009	82
19560099	L-Tyrosine	Nichol K	Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.	Alzheimer's & dementia 	2009	55
19674479	L-Tyrosine	Koshimizu H	Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival.	Molecular brain	2009	47
19711116	L-Tyrosine	Jellinger KA	Formation and development of Lewy pathology: a critical update.	Journal of neurology	2009	49
19855133	L-Tyrosine	Chen L	Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.	The Journal of clinical investigation	2009	58
19880500	L-Tyrosine	Li K	A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo.	Blood	2010	49
19927149	L-Tyrosine	Minichiello L	TrkB signalling pathways in LTP and learning.	Nature reviews. Neuroscience	2009	209
19960228	L-Tyrosine	Peereboom DM	Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.	Journal of neuro-oncology	2010	59
20030624	L-Tyrosine	Lo HW	EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.	Current molecular pharmacology	2010	42
20110609	L-Tyrosine	Kim W	Interneuronal transfer of human tau between Lamprey central neurons in situ.	Journal of Alzheimer's disease 	2010	47
20146086	L-Tyrosine	Clarke JL	High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.	Journal of neuro-oncology	2010	57
20167603	L-Tyrosine	Guo X	DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.	The Journal of biological chemistry	2010	75
20237271	L-Tyrosine	Yabut O	Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells.	The Journal of neuroscience 	2010	41
20458050	L-Tyrosine	Batchelor TT	Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.	Journal of clinical oncology 	2010	148
20489150	L-Tyrosine	Benedettini E	Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.	The American journal of pathology	2010	47
20515495	L-Tyrosine	Krakstad C	Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.	Molecular cancer	2010	72
20551596	L-Tyrosine	Nakamura T	The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.	Proceedings of the Japan Academy. Series B, Physical and biological sciences	2010	73
20627894	L-Tyrosine	Eichler AF	EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.	Neuro-oncology	2010	57
20675101	L-Tyrosine	Kim AH	MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.	Schizophrenia research	2010	86
20716591	L-Tyrosine	Sathornsumetee S	Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.	Neuro-oncology	2010	52
20716670	L-Tyrosine	Mimeault M	Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.	Pharmacological reviews	2010	48
20823226	L-Tyrosine	Ko HS	Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.	Proceedings of the National Academy of Sciences of the United States of America	2010	75
20872043	L-Tyrosine	Neyns B	Phase II study of sunitinib malate in patients with recurrent high-grade glioma.	Journal of neuro-oncology	2011	44
21029865	L-Tyrosine	Margolis SS	EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation.	Cell	2010	80
21126318	L-Tyrosine	Becker W	Activation, regulation, and inhibition of DYRK1A.	The FEBS journal	2011	36
21142802	L-Tyrosine	Tandon M	Emerging strategies for EphA2 receptor targeting for cancer therapeutics.	Expert opinion on therapeutic targets	2011	66
21156027	L-Tyrosine	Tejedor FJ	MNB/DYRK1A as a multiple regulator of neuronal development.	The FEBS journal	2011	58
21215389	L-Tyrosine	Juhasz G	The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.	Biological psychiatry	2011	42
21223646	L-Tyrosine	Thompson Ray M	Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.	Journal of psychiatry & neuroscience 	2011	79
21408136	L-Tyrosine	Gopal U	A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.	PloS one	2011	42
21425409	L-Tyrosine	Goulburn AL	A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives.	Stem cells	2011	45
21471286	L-Tyrosine	Hegi ME	Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial.	Molecular cancer therapeutics	2011	42
21488084	L-Tyrosine	Lam HA	Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.	Journal of neuroscience research	2011	41
21613408	L-Tyrosine	Lovly CM	Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.	Cancer research	2011	51
21677426	L-Tyrosine	Denver RJ	Evolution of leptin structure and function.	Neuroendocrinology	2011	44
21743492	L-Tyrosine	Quintavalle C	miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.	Oncogene	2012	58
21777652	L-Tyrosine	Wright JW	Brain renin-angiotensin--a new look at an old system.	Progress in neurobiology	2011	46
21778276	L-Tyrosine	Boye SL	Long-term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouse.	Investigative ophthalmology & visual science	2011	35
21915099	L-Tyrosine	Lefave CV	Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.	The EMBO journal	2011	48
21931021	L-Tyrosine	Paugh BS	Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.	Journal of clinical oncology 	2011	75
22057914	L-Tyrosine	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	40
22059152	L-Tyrosine	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
22080864	L-Tyrosine	Feng H	Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.	The Journal of clinical investigation	2011	39
22127113	L-Tyrosine	Brand TM	The nuclear epidermal growth factor receptor signaling network and its role in cancer.	Discovery medicine	2011	63
22137795	L-Tyrosine	Snuderl M	Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.	Cancer cell	2011	200
22167408	L-Tyrosine	Jamal-Hanjani M	Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.	Clinical cancer research 	2012	37
22197934	L-Tyrosine	Rademakers R	Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.	Nature genetics	2011	78
22268382	L-Tyrosine	Taylor TE	Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.	Current cancer drug targets	2012	43
22282022	L-Tyrosine	Doebele RC	Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.	Cancer	2012	55
22311673	L-Tyrosine	Little SE	Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.	Cancer research	2012	33
22322096	L-Tyrosine	Stokes MP	PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.	Molecular & cellular proteomics 	2012	35
22341689	L-Tyrosine	Fenner BM	Truncated TrkB: beyond a dominant negative receptor.	Cytokine & growth factor reviews	2012	32
22390767	L-Tyrosine	Prud'homme GJ	Cancer stem cells and novel targets for antitumor strategies.	Current pharmaceutical design	2012	36
22434142	L-Tyrosine	Gorbatyuk MS	Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.	Molecular therapy 	2012	40
22677429	L-Tyrosine	Park SJ	Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.	Lung cancer	2012	63
22696177	L-Tyrosine	Xi J	Specification of midbrain dopamine neurons from primate pluripotent stem cells.	Stem cells	2012	44
22710920	L-Tyrosine	Wang JZ	Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.	Journal of Alzheimer's disease 	2013	68
22730554	L-Tyrosine	Suo L	Protocadherin clusters and cell adhesion kinase regulate dendrite complexity through Rho GTPase.	Journal of molecular cell biology	2012	32
22733536	L-Tyrosine	Heon S	The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.	Clinical cancer research 	2012	36
22837387	L-Tyrosine	Singh D	Transforming fusions of FGFR and TACC genes in human glioblastoma.	Science	2012	184
22891331	L-Tyrosine	Fenton TR	Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22958829	L-Tyrosine	Rudie JD	Autism-associated promoter variant in MET impacts functional and structural brain networks.	Neuron	2012	57
23154552	L-Tyrosine	Weickhardt AJ	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.	Journal of thoracic oncology 	2012	97
23258844	L-Tyrosine	Kim KH	Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.	Neuro-oncology	2013	32
23281850	L-Tyrosine	Wade A	Proteoglycans and their roles in brain cancer.	The FEBS journal	2013	27
23407558	L-Tyrosine	Yu HA	Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.	Journal of thoracic oncology 	2013	57
23410976	L-Tyrosine	Day BW	EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.	Cancer cell	2013	44
23459077	L-Tyrosine	Paradowska-Gorycka A	Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12.	Human immunology	2013	30
23484006	L-Tyrosine	Navis AC	Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2.	PloS one	2013	28
23533263	L-Tyrosine	Akhavan D	De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.	Cancer discovery	2013	28
23916671	L-Tyrosine	Mantyh P	Bone cancer pain: causes, consequences, and therapeutic opportunities.	Pain	2013	36
23940216	L-Tyrosine	Batchelor TT	Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.	Journal of clinical oncology 	2013	91
24057103	L-Tyrosine	Woodbury ME	Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration.	Journal of neuroimmune pharmacology 	2014	25
24190997	L-Tyrosine	Batchelor TT	Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.	Proceedings of the National Academy of Sciences of the United States of America	2013	94
24269963	L-Tyrosine	Roskoski R Jr	The ErbB/HER family of protein-tyrosine kinases and cancer.	Pharmacological research	2014	150
24315443	L-Tyrosine	Miller JD	Human iPSC-based modeling of late-onset disease via progerin-induced aging.	Cell stem cell	2013	146
24368849	L-Tyrosine	Mathew LK	miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
24412932	L-Tyrosine	Mahul-Mellier AL	c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.	Human molecular genetics	2014	30
24440911	L-Tyrosine	Zhang Y	Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.	Cell death and differentiation	2014	21
24658326	L-Tyrosine	Knubel KH	MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.	Oncotarget	2014	22
24705251	L-Tyrosine	Wu G	The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.	Nature genetics	2014	141
24790650	L-Tyrosine	D'Antonio C	Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.	Therapeutic advances in medical oncology	2014	26
24806449	L-Tyrosine	Soppa U	The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.	Cell cycle	2014	27
24894073	L-Tyrosine	Chang KY	Light-inducible receptor tyrosine kinases that regulate neurotrophin signalling.	Nature communications	2014	21
24991953	L-Tyrosine	Mei L	Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.	Neuron	2014	88
25247337	L-Tyrosine	Hoffknecht P	Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.	Journal of thoracic oncology 	2015	42
25358781	L-Tyrosine	Hook V	Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.	Stem cell reports	2014	32
25468223	L-Tyrosine	Cohen AL	Glioma biology and molecular markers.	Cancer treatment and research	2015	30
25662504	L-Tyrosine	Kondapalli KC	A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.	Nature communications	2015	16
25707398	L-Tyrosine	van Bon BW	Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.	Molecular psychiatry	2016	31
25792358	L-Tyrosine	Collins VP	Pilocytic astrocytoma: pathology, molecular mechanisms and markers.	Acta neuropathologica	2015	17
25855404	L-Tyrosine	Furnari FB	Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma.	Nature reviews. Cancer	2015	51
25861727	L-Tyrosine	Costa PM	MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.	Journal of controlled release 	2015	22
25863279	L-Tyrosine	Gómez-Gálvez Y	Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.	Progress in neuro-psychopharmacology & biological psychiatry	2016	18
26032687	L-Tyrosine	Liffers K	Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition.	Targeted oncology	2016	11
26308162	L-Tyrosine	Russo A	A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.	Oncotarget	2015	38
26538619	L-Tyrosine	Stafford JH	Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.	Neuro-oncology	2016	23
26724471	L-Tyrosine	Lin JJ	Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.	Journal of thoracic oncology 	2016	24
26747862	L-Tyrosine	Olmos-Alonso A	Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.	Brain 	2016	43
26786898	L-Tyrosine	Kwon O	Leptin signalling pathways in hypothalamic neurons.	Cellular and molecular life sciences 	2016	16
27041571	L-Tyrosine	Zhang L	SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.	Oncogene	2016	13
27083334	L-Tyrosine	Park K	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.	The Lancet. Oncology	2016	78
27229180	L-Tyrosine	Tan DS	The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.	Journal of thoracic oncology 	2016	27
27237825	L-Tyrosine	Jiang T	EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.	Journal of thoracic oncology 	2016	11
27368100	L-Tyrosine	Gao H	Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.	Cell	2016	15
27601642	L-Tyrosine	Zhao X	TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
27602521	L-Tyrosine	Takeuchi T	Locus coeruleus and dopaminergic consolidation of everyday memory.	Nature	2016	28
27752082	L-Tyrosine	Xu J	Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.	Molecular psychiatry	2018	6
28109312	L-Tyrosine	Kelly SC	Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.	Acta neuropathologica communications	2017	10
28113019	L-Tyrosine	Magnuson WJ	Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.	Journal of clinical oncology 	2017	15
28148299	L-Tyrosine	Shimozawa A	Propagation of pathological α-synuclein in marmoset brain.	Acta neuropathologica communications	2017	8
28191785	L-Tyrosine	Teixeira FG	Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.	Stem cells translational medicine	2017	6
28306503	L-Tyrosine	Boeynaems S	Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics.	Molecular cell	2017	17
28426106	L-Tyrosine	Paz-Ares L	Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.	Annals of oncology 	2017	20
14755719	L-Lysine	Zarranz JJ	The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.	Annals of neurology	2004	635
15820677	L-Lysine	Rajan S	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Cell	2005	74
16805913	L-Lysine	Brown MA	Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.	Molecular cancer	2006	84
17392473	L-Lysine	Dompierre JP	Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.	The Journal of neuroscience 	2007	194
17540172	L-Lysine	Trojer P	L3MBTL1, a histone-methylation-dependent chromatin lock.	Cell	2007	144
17942719	L-Lysine	Huang HS	Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters.	The Journal of neuroscience 	2007	109
17994099	L-Lysine	Frescas D	JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.	Nature	2007	77
18042461	L-Lysine	Li H	Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger.	Molecular cell	2007	88
18312001	L-Lysine	Dayon L	Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.	Analytical chemistry	2008	132
18632683	L-Lysine	Mellios N	A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex.	Human molecular genetics	2008	86
21245904	L-Lysine	Kramer JM	Epigenetic regulation of learning and memory by Drosophila EHMT/G9a.	PLoS biology	2011	54
21338354	L-Lysine	Lin A	Nedd4-mediated AMPA receptor ubiquitination regulates receptor turnover and trafficking.	Journal of neurochemistry	2011	52
22549509	L-Lysine	Jiang X	Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans.	FASEB journal 	2012	32
22585859	L-Lysine	Bellail AC	A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.	Cancer discovery	2012	30
22711031	L-Lysine	Crea F	EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.	Cancer metastasis reviews	2012	44
22824796	L-Lysine	Wang P	Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.	Oncogene	2013	81
23012657	L-Lysine	Putz U	The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells.	Science signaling	2012	85
23184418	L-Lysine	Dubuc AM	Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.	Acta neuropathologica	2013	39
23185133	L-Lysine	Shulha HP	Human-specific histone methylation signatures at transcription start sites in prefrontal neurons.	PLoS biology	2012	40
23404370	L-Lysine	Reuss DE	Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.	Acta neuropathologica	2013	26
23423141	L-Lysine	James SJ	Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum.	Translational psychiatry	2013	33
23434587	L-Lysine	Hohl M	HDAC4 controls histone methylation in response to elevated cardiac load.	The Journal of clinical investigation	2013	43
24166615	L-Lysine	Belzil VV	Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.	Acta neuropathologica	2013	66
24496381	L-Lysine	Pastori C	BET bromodomain proteins are required for glioblastoma cell proliferation.	Epigenetics	2014	29
25176653	L-Lysine	Park DH	Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis.	Cell reports	2014	26
25428914	L-Lysine	Zhang K	Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.	Oncotarget	2015	53
25492968	L-Lysine	Penney J	Histone deacetylases in memory and cognition.	Science signaling	2014	27
26077434	L-Lysine	Vallianatos CN	Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.	Epigenomics	2015	22
26399631	L-Lysine	Castel D	Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.	Acta neuropathologica	2015	37
26754954	L-Lysine	Otowa T	Meta-analysis of genome-wide association studies of anxiety disorders.	Molecular psychiatry	2016	15
27041503	L-Lysine	Tracy TE	Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.	Neuron	2016	18
15953344	Pyruvic acid	Pierre K	Monocarboxylate transporters in the central nervous system: distribution, regulation and function.	Journal of neurochemistry	2005	112
16466929	Pyruvic acid	Butterfield DA	Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.	Neurobiology of disease	2006	107
16848698	Pyruvic acid	Cahill GF Jr	Fuel metabolism in starvation.	Annual review of nutrition	2006	146
18446519	Pyruvic acid	Ganapathy V	Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.	The AAPS journal	2008	54
19714445	Pyruvic acid	Marcus HJ	In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines.	Journal of neuro-oncology	2010	43
21242296	Pyruvic acid	Wolf A	Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.	The Journal of experimental medicine	2011	162
21807103	Pyruvic acid	Chaumeil MM	Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.	NeuroImage	2012	34
22056988	Pyruvic acid	Yang W	Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.	Nature	2011	239
22065843	Pyruvic acid	Draoui N	Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments.	Disease models & mechanisms	2011	54
22901803	Pyruvic acid	Yang W	PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.	Cell	2012	166
23178880	Pyruvic acid	Yang W	ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.	Nature cell biology	2012	151
23506875	Pyruvic acid	Halestrap AP	The SLC16 gene family - structure, role and regulation in health and disease.	Molecular aspects of medicine	2013	77
23690925	Pyruvic acid	Colca JR	Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.	PloS one	2013	41
23791887	Pyruvic acid	Yang W	Regulation and function of pyruvate kinase M2 in cancer.	Cancer letters	2013	43
24013426	Pyruvic acid	Yang W	Nuclear PKM2 regulates the Warburg effect.	Cell cycle	2013	31
24077665	Pyruvic acid	Desai S	Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.	Oncotarget	2014	32
24265240	Pyruvic acid	Halestrap AP	Monocarboxylic acid transport.	Comprehensive Physiology	2013	42
24316223	Pyruvic acid	Jiang Y	PKM2 regulates chromosome segregation and mitosis progression of tumor cells.	Molecular cell	2014	57
24951766	Pyruvic acid	Ryan JJ	The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.	Circulation research	2014	42
25412762	Pyruvic acid	Jiang Y	PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.	Nature communications	2014	26
25621950	Pyruvic acid	Fong MY	Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.	Nature cell biology	2015	93
25770102	Pyruvic acid	Yang W	Pyruvate kinase M2 at a glance.	Journal of cell science	2015	19
26045167	Pyruvic acid	Izquierdo-Garcia JL	IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.	Cancer research	2015	22
26993058	Pyruvic acid	Pérez-Escuredo J	Monocarboxylate transporters in the brain and in cancer.	Biochimica et biophysica acta	2016	12
10617630	Phosphate	Okochi M	Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.	The Journal of biological chemistry	2000	98
11985876	Phosphate	Kaneko T	Complementary distribution of vesicular glutamate transporters in the central nervous system.	Neuroscience research	2002	107
15028755	Phosphate	Montana V	Vesicular glutamate transporter-dependent glutamate release from astrocytes.	The Journal of neuroscience 	2004	106
15190058	Phosphate	Alonso Adel C	Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.	The Journal of biological chemistry	2004	72
17218400	Phosphate	Lee HJ	Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model.	Stem cells	2007	63
19247306	Phosphate	Beenken A	The FGF family: biology, pathophysiology and therapy.	Nature reviews. Drug discovery	2009	342
20061941	Phosphate	Chun J	Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.	Clinical neuropharmacology	2010	136
20678074	Phosphate	Iqbal K	Tau in Alzheimer disease and related tauopathies.	Current Alzheimer research	2010	114
21733911	Phosphate	Seiler S	The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.	European heart journal	2011	38
23183236	Phosphate	Robertson NJ	Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.	Brain 	2013	48
25938945	Phosphate	Legati A	Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.	Nature genetics	2015	21
8602746	Gadolinium	Jacobs LD	Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)	Annals of neurology	1996	259
11006365	Gadolinium	Jacobs LD	Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.	The New England journal of medicine	2000	142
15998902	Gadolinium	Galanis E	Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.	Journal of clinical oncology 	2005	155
18272891	Gadolinium	Hauser SL	B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.	The New England journal of medicine	2008	394
20035078	Gadolinium	Barr TL	Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.	Stroke	2010	46
20163990	Gadolinium	Wynn D	Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.	The Lancet. Neurology	2010	68
21372112	Gadolinium	Fleming JO	Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.	Multiple sclerosis	2011	54
21959118	Gadolinium	Elsadek B	Impact of albumin on drug delivery--new applications on the horizon.	Journal of controlled release 	2012	71
22047971	Gadolinium	Kappos L	Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.	Lancet	2011	125
22847020	Gadolinium	Phuphanich S	Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.	Cancer immunology, immunotherapy 	2013	76
24453078	Gadolinium	Sorensen PS	Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.	Neurology	2014	40
24829362	Gadolinium	Chin CW	High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis.	European heart journal	2014	33
26185773	Gadolinium	Constantinescu CS	Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.	Neurolog	2015	17
26700156	Gadolinium	Cao Y	Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.	AJR. American journal of roentgenology	2016	13
27888416	Gadolinium	Schwartzbach CJ	Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study.	Journal of neurology	2017	5
28229892	Gadolinium	Cadavid D	Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.	The Lancet. Neurology	2017	9
7611729	D-Glutamic acid	Rothstein JD	Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.	Annals of neurology	1995	205
7857653	D-Glutamic acid	Saido TC	Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.	Neuron	1995	125
7972084	D-Glutamic acid	Kim U	Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.	Proceedings of the National Academy of Sciences of the United States of America	1994	128
8559253	D-Glutamic acid	Melcher T	A mammalian RNA editing enzyme.	Nature	1996	152
10557349	D-Glutamic acid	Yrjänheikki J	A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.	Proceedings of the National Academy of Sciences of the United States of America	1999	224
10774732	D-Glutamic acid	Man HY	Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.	Neuron	2000	155
11348590	D-Glutamic acid	Shi S	Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons.	Cell	2001	288
11466413	D-Glutamic acid	Perez JL	PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2.	The Journal of neuroscience 	2001	101
12032354	D-Glutamic acid	Huber KM	Altered synaptic plasticity in a mouse model of fragile X mental retardation.	Proceedings of the National Academy of Sciences of the United States of America	2002	422
12202822	D-Glutamic acid	Biederer T	SynCAM, a synaptic adhesion molecule that drives synapse assembly.	Science	2002	218
12372652	D-Glutamic acid	Fatemi SH	Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.	Biological psychiatry	2002	125
12388773	D-Glutamic acid	Fremeau RT Jr	The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate.	Proceedings of the National Academy of Sciences of the United States of America	2002	138
12655598	D-Glutamic acid	Lazarini F	Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system.	Glia	2003	81
12700104	D-Glutamic acid	Jones BE	Arousal systems.	Frontiers in bioscience 	2003	115
12851636	D-Glutamic acid	Weickert CS	Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.	Molecular psychiatry	2003	109
14622580	D-Glutamic acid	Greger IH	AMPA receptor tetramerization is mediated by Q/R editing.	Neuron	2003	98
14723991	D-Glutamic acid	Eid T	Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy.	Lancet	2004	83
14985749	D-Glutamic acid	Kawahara Y	Glutamate receptors: RNA editing and death of motor neurons.	Nature	2004	123
15066264	D-Glutamic acid	Guirland C	Lipid rafts mediate chemotropic guidance of nerve growth cones.	Neuron	2004	70
15102489	D-Glutamic acid	Fremeau RT Jr	VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate.	Trends in neurosciences	2004	190
15124027	D-Glutamic acid	Talbot K	Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.	The Journal of clinical investigation	2004	117
15219735	D-Glutamic acid	Bear MF	The mGluR theory of fragile X mental retardation.	Trends in neurosciences	2004	530
15310849	D-Glutamic acid	Egan MF	Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	2004	105
15560956	D-Glutamic acid	Fatemi SH	GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.	Schizophrenia research	2005	73
15572176	D-Glutamic acid	Barbeito LH	A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.	Brain research. Brain research reviews	2004	84
15608650	D-Glutamic acid	Spanagel R	The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.	Nature medicine	2005	155
15758178	D-Glutamic acid	Priel A	Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors.	The Journal of neuroscience 	2005	86
15820696	D-Glutamic acid	Pelkey KA	mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition.	Neuron	2005	66
15927426	D-Glutamic acid	Kang DC	Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1.	Gene	2005	90
16429157	D-Glutamic acid	Ikeda Y	Spectrin mutations cause spinocerebellar ataxia type 5.	Nature genetics	2006	90
16452252	D-Glutamic acid	Nosyreva ED	Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.	Journal of neurophysiology	2006	131
16473439	D-Glutamic acid	Yi JH	Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.	Neurochemistry international	2006	96
16731806	D-Glutamic acid	Magistretti PJ	Neuron-glia metabolic coupling and plasticity.	The Journal of experimental biology	2006	158
16980328	D-Glutamic acid	Talbot K	Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.	Human molecular genetics	2006	63
17030429	D-Glutamic acid	Schwarzschild MA	Targeting adenosine A2A receptors in Parkinson's disease.	Trends in neurosciences	2006	91
17496890	D-Glutamic acid	Kiyonaka S	RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels.	Nature neuroscience	2007	79
17590478	D-Glutamic acid	Sekino Y	Role of actin cytoskeleton in dendritic spine morphogenesis.	Neurochemistry international	2007	90
17636131	D-Glutamic acid	Tan HY	Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function.	Proceedings of the National Academy of Sciences of the United States of America	2007	63
17726000	D-Glutamic acid	Tan HY	Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia.	Cerebral cortex	2007	68
18059328	D-Glutamic acid	Carvalho AL	Role of the brain-derived neurotrophic factor at glutamatergic synapses.	British journal of pharmacology	2008	72
18077569	D-Glutamic acid	Lipsky RH	Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.	Annals of the New York Academy of Sciences	2007	71
18160642	D-Glutamic acid	Narayanan U	FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A.	The Journal of neuroscience 	2007	97
18199763	D-Glutamic acid	Arlotta P	Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.	The Journal of neuroscience 	2008	87
18326497	D-Glutamic acid	Lee SG	Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.	The Journal of biological chemistry	2008	86
18345022	D-Glutamic acid	Thomas MJ	Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.	British journal of pharmacology	2008	155
18469825	D-Glutamic acid	Savaskan NE	Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.	Nature medicine	2008	61
18474609	D-Glutamic acid	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	90
18957214	D-Glutamic acid	Bassell GJ	Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.	Neuron	2008	405
19076369	D-Glutamic acid	Mattson MP	Glutamate and neurotrophic factors in neuronal plasticity and disease.	Annals of the New York Academy of Sciences	2008	116
19191304	D-Glutamic acid	Rothstein JD	Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.	Annals of neurology	2009	199
19455133	D-Glutamic acid	Fernández E	Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.	Molecular systems biology	2009	85
19457239	D-Glutamic acid	Harris LW	Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia.	BMC medical genomics	2009	49
19526364	D-Glutamic acid	Stepulak A	Expression of glutamate receptor subunits in human cancers.	Histochemistry and cell biology	2009	47
19640847	D-Glutamic acid	Schütt J	Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.	The Journal of biological chemistry	2009	49
19828788	D-Glutamic acid	Brandon NJ	Understanding the role of DISC1 in psychiatric disease and during normal development.	The Journal of neuroscience 	2009	64
20639914	D-Glutamic acid	Jarius S	AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.	Nature reviews. Neurology	2010	106
20664079	D-Glutamic acid	Golombek DA	Physiology of circadian entrainment.	Physiological reviews	2010	153
20884644	D-Glutamic acid	Geis C	Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.	Brain 	2010	44
20935652	D-Glutamic acid	Anliker B	Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.	Nature methods	2010	47
20970492	D-Glutamic acid	Yirmiya R	Immune modulation of learning, memory, neural plasticity and neurogenesis.	Brain, behavior, and immunity	2011	262
21084617	D-Glutamic acid	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	128
21090964	D-Glutamic acid	Krueger DD	Toward fulfilling the promise of molecular medicine in fragile X syndrome.	Annual review of medicine	2011	96
21435559	D-Glutamic acid	Weston MC	Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity.	Neuron	2011	36
21482951	D-Glutamic acid	Sokol DK	Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.	Neurology	2011	39
21606927	D-Glutamic acid	Durand CM	SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism.	Molecular psychiatry	2012	77
21820214	D-Glutamic acid	Xu J	Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling.	Neurobiology of aging	2011	38
21844870	D-Glutamic acid	González S	Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain.	Molecular psychiatry	2012	31
22013185	D-Glutamic acid	Lancaster E	Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.	Neurology	2011	50
22238332	D-Glutamic acid	Andronesi OC	Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.	Science translational medicine	2012	85
22275254	D-Glutamic acid	Rossi S	Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.	Annals of neurology	2012	35
22339950	D-Glutamic acid	Duric V	Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.	The international journal of neuropsychopharmacology	2013	53
22423117	D-Glutamic acid	Krishnadas R	Depression: an inflammatory illness?	Journal of neurology, neurosurgery, and psychiatry	2012	57
22442194	D-Glutamic acid	Sclafani A	Role of gut nutrient sensing in stimulating appetite and conditioning food preferences.	American journal of physiology. Regulatory, integrative and comparative physiology	2012	57
22449939	D-Glutamic acid	Hruska M	Ephrin regulation of synapse formation, function and plasticity.	Molecular and cellular neurosciences	2012	49
22483044	D-Glutamic acid	Bhakar AL	The pathophysiology of fragile X (and what it teaches us about synapses).	Annual review of neuroscience	2012	138
22592998	D-Glutamic acid	Coulter DA	Astrocytic regulation of glutamate homeostasis in epilepsy.	Glia	2012	60
22749718	D-Glutamic acid	Santello M	TNFα in synaptic function: switching gears.	Trends in neurosciences	2012	49
22841313	D-Glutamic acid	Akil O	Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy.	Neuron	2012	59
22956831	D-Glutamic acid	Trantham-Davidson H	Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training.	The Journal of neuroscience 	2012	49
23237660	D-Glutamic acid	Belousov AB	Neuronal gap junctions: making and breaking connections during development and injury.	Trends in neurosciences	2013	30
23348500	D-Glutamic acid	Noetzel MJ	A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling.	Molecular pharmacology	2013	25
23487788	D-Glutamic acid	Takeuchi K	Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
23523633	D-Glutamic acid	Iori V	Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.	Neurobiology of disease	2013	28
23583108	D-Glutamic acid	Schobel SA	Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.	Neuron	2013	103
23644052	D-Glutamic acid	Felger JC	Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.	Neuroscience	2013	84
23793099	D-Glutamic acid	Tönjes M	BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.	Nature medicine	2013	73
24335193	D-Glutamic acid	Walker AK	Neuroinflammation and comorbidity of pain and depression.	Pharmacological reviews	2014	30
24662927	D-Glutamic acid	Nagy C	Astrocytic abnormalities and global DNA methylation patterns in depression and suicide.	Molecular psychiatry	2015	39
24844246	D-Glutamic acid	Dixon SJ	Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis.	eLife	2014	74
24865427	D-Glutamic acid	Liu G	Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.	The Journal of clinical investigation	2014	20
24908571	D-Glutamic acid	Lopez JP	miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.	Nature medicine	2014	49
24927875	D-Glutamic acid	Vucic S	Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.	Trends in neurosciences	2014	40
25042998	D-Glutamic acid	Doré AS	Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.	Nature	2014	78
25043039	D-Glutamic acid	Lu P	Three-dimensional structure of human γ-secretase.	Nature	2014	82
25100593	D-Glutamic acid	Kozak R	Reduction of brain kynurenic acid improves cognitive function.	The Journal of neuroscience 	2014	21
25156701	D-Glutamic acid	DeLorenzo C	In vivo ketamine-induced changes in ¹¹CABP688 binding to metabotropic glutamate receptor subtype 5.	Biological psychiatry	2015	18
25225364	D-Glutamic acid	Chen R	Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
25362113	D-Glutamic acid	Villapol S	Neuroprotective effects of angiotensin receptor blockers.	American journal of hypertension	2015	18
25384799	D-Glutamic acid	Mesci P	System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.	Brain 	2015	16
25419706	D-Glutamic acid	Wetzel-Smith MK	A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.	Nature medicine	2014	26
25433904	D-Glutamic acid	MacDonald ML	Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia.	Biological psychiatry	2015	19
25592426	D-Glutamic acid	Steinhäuser C	Crucial role of astrocytes in temporal lobe epilepsy.	Neuroscience	2016	13
25673413	D-Glutamic acid	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
25706986	D-Glutamic acid	Izquierdo-Garcia JL	Metabolic reprogramming in mutant IDH1 glioma cells.	PloS one	2015	18
25834045	D-Glutamic acid	Petr GT	Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.	The Journal of neuroscience 	2015	32
25869804	D-Glutamic acid	Ibrahim-Verbaas CA	GWAS for executive function and processing speed suggests involvement of the CADM2 gene.	Molecular psychiatry	2016	17
25976297	D-Glutamic acid	Mantsch JR	Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.	Neuropsychopharmacology 	2016	60
26336637	D-Glutamic acid	Castro-Nallar E	Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls.	PeerJ	2015	26
26384381	D-Glutamic acid	Hernández C	Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.	Diabetes	2016	10
26439639	D-Glutamic acid	Gautier HO	Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.	Nature communications	2015	16
27348216	D-Glutamic acid	Hwang T	Dynamic regulation of RNA editing in human brain development and disease.	Nature neuroscience	2016	22
27365450	D-Glutamic acid	Twomey EC	Elucidation of AMPA receptor-stargazin complexes by cryo-electron microscopy.	Science	2016	12
27444795	D-Glutamic acid	Chung DW	Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.	The American journal of psychiatry	2016	12
27824355	D-Glutamic acid	Mechawar N	Neuropathology of mood disorders: do we see the stigmata of inflammation?	Translational psychiatry	2016	17
27908782	D-Glutamic acid	Raefsky SM	Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.	Free radical biology & medicine	2017	16
28100738	D-Glutamic acid	Mandolesi G	miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.	The Journal of neuroscience 	2017	6
28219683	D-Glutamic acid	Yuzaki M	The C1q complement family of synaptic organizers: not just complementary.	Current opinion in neurobiology	2017	7
1309946	Sodium	Gellens ME	Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.	Proceedings of the National Academy of Sciences of the United States of America	1992	146
9457173	Sodium	Missale C	Dopamine receptors: from structure to function.	Physiological reviews	1998	553
9697698	Sodium	Wallace RH	Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B.	Nature genetics	1998	168
10491605	Sodium	Huang Y	Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes.	Nature neuroscience	1999	108
11476832	Sodium	Wadsworth JD	Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.	Lancet	2001	165
11516394	Sodium	Ballas N	Regulation of neuronal traits by a novel transcriptional complex.	Neuron	2001	135
12849456	Sodium	Smith KJ	The role of nitric oxide in multiple sclerosis.	The Lancet. Neurology	2002	90
12930796	Sodium	Yu FH	Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2.	The Journal of neuroscience 	2003	115
14769680	Sodium	Wang TJ	Impact of obesity on plasma natriuretic peptide levels.	Circulation	2004	137
15263023	Sodium	Kögler G	A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.	The Journal of experimental medicine	2004	186
15664175	Sodium	Grieco TM	Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current.	Neuron	2005	99
15987683	Sodium	Dominguez D	Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.	The Journal of biological chemistry	2005	97
17347258	Sodium	Harkin LA	The spectrum of SCN1A-related infantile epileptic encephalopathies.	Brain 	2007	69
17460158	Sodium	ADAPT Research Group.	Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.	Neurology	2007	103
17519130	Sodium	Osborn JW	Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension.	Current hypertension reports	2007	84
17678857	Sodium	Goldfarb M	Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.	Neuron	2007	73
17942703	Sodium	Bodyak N	Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.	Proceedings of the National Academy of Sciences of the United States of America	2007	74
18804930	Sodium	Lossin C	A catalog of SCN1A variants.	Brain & development	2009	53
19427495	Sodium	Harrison DG	Oxidative stress and hypertension.	The Medical clinics of North America	2009	79
19465131	Sodium	Laezza F	FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels.	Molecular and cellular neurosciences	2009	47
19828790	Sodium	Vassar R	The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.	The Journal of neuroscience 	2009	161
20194124	Sodium	Catterall WA	NaV1.1 channels and epilepsy.	The Journal of physiology	2010	88
22365152	Sodium	Veeramah KR	De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP.	American journal of human genetics	2012	110
22495306	Sodium	Sanders SJ	De novo mutations revealed by whole-exome sequencing are strongly associated with autism.	Nature	2012	593
22541439	Sodium	Verret L	Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.	Cell	2012	191
22905747	Sodium	Oliva M	Sodium channels and the neurobiology of epilepsy.	Epilepsia	2012	33
23509259	Sodium	Geier EG	Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
23542692	Sodium	Dus M	Taste-independent nutrient selection is mediated by a brain-specific Na+ /solute co-transporter in Drosophila.	Nature neuroscience	2013	27
23568856	Sodium	Schmitt KC	Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.	The Journal of pharmacology and experimental therapeutics	2013	30
23741036	Sodium	Hargus NJ	Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis.	Journal of neurophysiology	2013	27
23773995	Sodium	Jiao J	Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.	Human molecular genetics	2013	30
24114175	Sodium	Pajor AM	Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family.	Pflugers Archiv 	2014	24
24194747	Sodium	O'Brien JE	Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability.	Frontiers in genetics	2013	48
24776970	Sodium	Huang J	Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.	Brain 	2014	44
24874546	Sodium	Estacion M	A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.	Neurobiology of disease	2014	32
24911152	Sodium	Hansen FH	Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.	The Journal of clinical investigation	2014	25
25239001	Sodium	de Kovel CG	Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.	Epilepsy research	2014	28
25414155	Sodium	Lovshin JA	Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.	Diabetes care	2015	18
25450227	Sodium	Farris SP	Transcriptome organization for chronic alcohol abuse in human brain.	Molecular psychiatry	2015	26
25568300	Sodium	Larsen J	The phenotypic spectrum of SCN8A encephalopathy.	Neurology	2015	45
25725044	Sodium	Blanchard MG	De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.	Journal of medical genetics	2015	29
25767285	Sodium	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
26005865	Sodium	Alakbarzade V	A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome.	Nature genetics	2015	15
26252990	Sodium	Boerma RS	Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach.	Neurotherapeutics 	2016	13
26291284	Sodium	Howell KB	SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.	Neurology	2015	26
26497848	Sodium	Chan MM	Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.	European journal of heart failure	2016	10
26700687	Sodium	Zaharieva IT	Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.	Brain 	2016	14
26803770	Sodium	Malan D	Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.	Basic research in cardiology	2016	15
27270488	Sodium	Meisler MH	SCN8A encephalopathy: Research progress and prospects.	Epilepsia	2016	17
28238546	Sodium	Makinson CD	Regulation of Thalamic and Cortical Network Synchrony by Scn8a.	Neuron	2017	9
8530621	Estradiol	Morishima A	Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.	The Journal of clinical endocrinology and metabolism	1995	136
11826265	Estradiol	Simpson ER	Aromatase--a brief overview.	Annual review of physiology	2002	123
21320576	Estradiol	Azcoitia I	Estradiol synthesis within the human brain.	Neuroscience	2011	46
21907136	Estradiol	Barros RP	Estrogen receptors and the metabolic network.	Cell metabolism	2011	78
22587940	Estradiol	Daniel JM	Estrogens, estrogen receptors, and female cognitive aging: the impact of timing.	Hormones and behavior	2013	29
26049025	Estradiol	Kuhn C	Emergence of sex differences in the development of substance use and abuse during adolescence.	Pharmacology & therapeutics	2015	20
26071095	Estradiol	Hay DL	Amylin: Pharmacology, Physiology, and Clinical Potential.	Pharmacological reviews	2015	22
15788542	L-Dopa	Williams DR	Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.	Brain 	2005	77
16237129	L-Dopa	McKeith IG	Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.	Neurology	2005	930
18401019	L-Dopa	Eberling JL	Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.	Neurology	2008	101
18656534	L-Dopa	del Amo EM	Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.	European journal of pharmaceutical sciences 	2008	56
19409267	L-Dopa	Mosharov EV	Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.	Neuron	2009	139
19433789	L-Dopa	O'Keeffe GC	Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
20592420	L-Dopa	Politis M	Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.	Science translational medicine	2010	60
21349901	L-Dopa	O'Sullivan SS	Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.	Brain 	2011	44
23404372	L-Dopa	Kiely AP	α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?	Acta neuropathologica	2013	85
23804577	L-Dopa	Quadri M	Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.	Human mutation	2013	35
25080285	L-Dopa	Nombela C	Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.	Brain 	2014	30
26616211	L-Dopa	Lindholm D	Current disease modifying approaches to treat Parkinson's disease.	Cellular and molecular life sciences 	2016	14
27766724	L-Dopa	Schlenstedt C	Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis.	European journal of neurology	2017	7
11306611	L-Lactic acid	Tikka T	Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.	The Journal of neuroscience 	2001	201
17384640	L-Lactic acid	Scheper GC	Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.	Nature genetics	2007	100
17414812	L-Lactic acid	Ferris LT	The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function.	Medicine and science in sports and exercise	2007	112
20634355	L-Lactic acid	Amann M	Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans.	Journal of applied physiology	2010	71
20952379	L-Lactic acid	Namavar Y	Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.	Brain 	2011	36
20962220	L-Lactic acid	Boumezbeur F	The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy.	The Journal of neuroscience 	2010	77
21550068	L-Lactic acid	Jarius S	Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.	Journal of the neurological sciences	2011	49
21558814	L-Lactic acid	Whitaker-Menezes D	Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.	Cell cycle	2011	117
21569296	L-Lactic acid	Cucullo L	The role of shear stress in Blood-Brain Barrier endothelial physiology.	BMC neuroscience	2011	57
21642515	L-Lactic acid	Pierga JY	High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.	Annals of oncology 	2012	61
21908873	L-Lactic acid	Ferraiuolo L	Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.	Brain 	2011	40
22492562	L-Lactic acid	Steenweg ME	Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.	Brain 	2012	59
22640478	L-Lactic acid	Ascierto PA	Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use.	Journal of translational medicine	2012	31
23258846	L-Lactic acid	Miranda-Gonçalves V	Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.	Neuro-oncology	2013	52
23643384	L-Lactic acid	Taft RJ	Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.	American journal of human genetics	2013	38
23838888	L-Lactic acid	Braunschweig D	Autism-specific maternal autoantibodies recognize critical proteins in developing brain.	Translational psychiatry	2013	45
24164734	L-Lactic acid	Coelho FG	Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease.	Journal of Alzheimer's disease 	2014	22
24366912	L-Lactic acid	Chesnelong C	Lactate dehydrogenase A silencing in IDH mutant gliomas.	Neuro-oncology	2014	32
25128877	L-Lactic acid	Skriver K	Acute exercise improves motor memory: exploring potential biomarkers.	Neurobiology of learning and memory	2014	27
25136121	L-Lactic acid	Crane CA	Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2014	28
26269128	L-Lactic acid	Valvona CJ	The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor.	Brain pathology	2016	18
27591677	L-Lactic acid	Talasila KM	The angiogenic switch leads to a metabolic shift in human glioblastoma.	Neuro-oncology	2017	11
2645527	D-Glucose	James DE	Molecular cloning and characterization of an insulin-regulatable glucose transporter.	Nature	1989	161
8101394	D-Glucose	Volkow ND	Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.	Synapse	1993	218
8592548	D-Glucose	Reiman EM	Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.	The New England journal of medicine	1996	330
10582706	D-Glucose	Zhong H	Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.	Cancer research	1999	534
10811879	D-Glucose	Small GW	Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2000	156
11022058	D-Glucose	Vila N	Proinflammatory cytokines and early neurological worsening in ischemic stroke.	Stroke	2000	110
11210998	D-Glucose	Wang GJ	Brain dopamine and obesity.	Lancet	2001	409
11248079	D-Glucose	Reiman EM	Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	146
11445252	D-Glucose	De Santi S	Hippocampal formation glucose metabolism and volume losses in MCI and AD.	Neurobiology of aging	2001	128
11729018	D-Glucose	Volkow ND	Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.	The American journal of psychiatry	2001	252
12162730	D-Glucose	Abbott NJ	Astrocyte-endothelial interactions and blood-brain barrier permeability.	Journal of anatomy	2002	180
12203114	D-Glucose	Budanov AV	Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.	Oncogene	2002	90
12589027	D-Glucose	Duan W	Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	116
12615957	D-Glucose	Mayo KE	International Union of Pharmacology. XXXV. The glucagon receptor family.	Pharmacological reviews	2003	94
12634421	D-Glucose	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
14688411	D-Glucose	Reiman EM	Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.	Proceedings of the National Academy of Sciences of the United States of America	2004	282
15094071	D-Glucose	Bondy CA	Signaling by insulin-like growth factor 1 in brain.	European journal of pharmacology	2004	72
15094078	D-Glucose	Hoyer S	Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.	European journal of pharmacology	2004	75
15249677	D-Glucose	Liu F	O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	132
15265818	D-Glucose	Meier U	Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.	Clinical chemistry	2004	118
15288712	D-Glucose	Benedict C	Intranasal insulin improves memory in humans.	Psychoneuroendocrinology	2004	120
15531540	D-Glucose	Spiegel K	Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin.	The Journal of clinical endocrinology and metabolism	2004	243
15750215	D-Glucose	Steen E	Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?	Journal of Alzheimer's disease 	2005	298
15837923	D-Glucose	Xu A	Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15911795	D-Glucose	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	80
15932949	D-Glucose	Reiman EM	Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.	Proceedings of the National Academy of Sciences of the United States of America	2005	124
15964100	D-Glucose	Reger MA	Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.	Neurobiology of aging	2006	123
16216937	D-Glucose	Jagust W	Central obesity and the aging brain.	Archives of neurology	2005	69
16627931	D-Glucose	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
16823473	D-Glucose	Plum L	Central insulin action in energy and glucose homeostasis.	The Journal of clinical investigation	2006	112
16873964	D-Glucose	de la Monte SM	Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.	Journal of Alzheimer's disease 	2006	67
16916571	D-Glucose	van der Heide LP	Insulin signaling in the central nervous system: learning to survive.	Progress in neurobiology	2006	92
16979422	D-Glucose	McEwen BS	Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.	Metabolism	2006	110
17051221	D-Glucose	Shen Y	Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.	Nature	2006	101
17077815	D-Glucose	Li Y	Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.	Journal of cerebral blood flow and metabolism 	2007	65
17079810	D-Glucose	Mosconi L	Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.	Journal of nuclear medicine 	2006	77
17116015	D-Glucose	Oby E	The blood-brain barrier and epilepsy.	Epilepsia	2006	82
17151862	D-Glucose	Krabbe KS	Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.	Diabetologia	2007	97
17200485	D-Glucose	Zhang Y	Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.	Neurology	2007	156
17225955	D-Glucose	Virgintino D	An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.	Angiogenesis	2007	60
17313687	D-Glucose	Zhou W	The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.	Nutrition & metabolism	2007	63
17327884	D-Glucose	Capuron L	Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.	Neuropsychopharmacology 	2007	67
17470495	D-Glucose	Huang C	Changes in network activity with the progression of Parkinson's disease.	Brain 	2007	94
17493050	D-Glucose	Chang L	Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.	Addiction	2007	139
17515892	D-Glucose	Seckl JR	Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.	Nature clinical practice. Endocrinology & metabolism	2007	119
17609686	D-Glucose	Cucullo L	Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.	Journal of cerebral blood flow and metabolism 	2008	51
17720148	D-Glucose	Mosconi L	Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.	Biological psychiatry	2008	57
17910982	D-Glucose	Ohno K	Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.	Frontiers in neuroendocrinology	2008	56
17928588	D-Glucose	Holst JJ	The physiology of glucagon-like peptide 1.	Physiological reviews	2007	487
17940659	D-Glucose	Dias WB	O-GlcNAc modification in diabetes and Alzheimer's disease.	Molecular bioSystems	2007	77
17942819	D-Glucose	Reger MA	Intranasal insulin improves cognition and modulates beta-amyloid in early AD.	Neurology	2008	173
18003925	D-Glucose	Mosconi L	Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2007	95
18332434	D-Glucose	Liang WS	Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.	Proceedings of the National Academy of Sciences of the United States of America	2008	143
18344986	D-Glucose	Lee KS	Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling.	Nature cell biology	2008	68
18402643	D-Glucose	Berthoud HR	Vagal and hormonal gut-brain communication: from satiation to satisfaction.	Neurogastroenterology and motility 	2008	66
18445751	D-Glucose	Copeland RJ	Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.	American journal of physiology. Endocrinology and metabolism	2008	95
18598772	D-Glucose	Volkow ND	Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.	NeuroImage	2008	155
18625459	D-Glucose	Landreth G	PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.	Neurotherapeutics 	2008	54
18707012	D-Glucose	Komulainen P	BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.	Neurobiology of learning and memory	2008	63
18726182	D-Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18854155	D-Glucose	Zhang X	Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.	Cell	2008	337
18929315	D-Glucose	Van Cauter E	Metabolic consequences of sleep and sleep loss.	Sleep medicine	2008	99
18984744	D-Glucose	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	64
19009016	D-Glucose	Rabe K	Adipokines and insulin resistance.	Molecular medicine	2008	141
19060908	D-Glucose	Lyssenko V	Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.	Nature genetics	2009	179
19076441	D-Glucose	Mosconi L	Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.	Annals of the New York Academy of Sciences	2008	100
19273754	D-Glucose	Qin W	PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.	Archives of neurology	2009	79
19349228	D-Glucose	Langbaum JB	Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).	NeuroImage	2009	105
19357959	D-Glucose	Jensen RL	Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.	Journal of neuro-oncology	2009	81
19376193	D-Glucose	Confavreux CB	A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.	Molecular and cellular endocrinology	2009	51
19451179	D-Glucose	Liu F	Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.	Brain 	2009	68
19460373	D-Glucose	Sassone J	Huntington's disease: the current state of research with peripheral tissues.	Experimental neurology	2009	46
19490822	D-Glucose	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19696361	D-Glucose	Pedersen BK	Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines.	Journal of applied physiology	2009	50
19723875	D-Glucose	Palmieri D	Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.	Molecular cancer research 	2009	52
19800254	D-Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
19896496	D-Glucose	Castañeda TR	Ghrelin in the regulation of body weight and metabolism.	Frontiers in neuroendocrinology	2010	78
20022465	D-Glucose	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20065132	D-Glucose	Baker LD	Effects of aerobic exercise on mild cognitive impairment: a controlled trial.	Archives of neurology	2010	223
20065246	D-Glucose	Honea RA	Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.	Neurology	2010	52
20190196	D-Glucose	Tao YX	The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.	Endocrine reviews	2010	93
20227367	D-Glucose	Godlewski J	MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.	Molecular cell	2010	134
20308787	D-Glucose	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	65
20353613	D-Glucose	Gallagher IJ	Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.	Genome medicine	2010	61
20357365	D-Glucose	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20444434	D-Glucose	Frisardi V	Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.	Ageing research reviews	2010	46
20489155	D-Glucose	Wang WX	miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.	The American journal of pathology	2010	61
20592257	D-Glucose	Landau SM	Comparing predictors of conversion and decline in mild cognitive impairment.	Neurology	2010	163
20647762	D-Glucose	Godlewski J	microRNA-451: A conditional switch controlling glioma cell proliferation and migration.	Cell cycle	2010	58
20688814	D-Glucose	Villain N	Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease.	Brain 	2010	58
20829514	D-Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	48
20837822	D-Glucose	Baker LD	Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.	Archives of neurology	2011	138
20847408	D-Glucose	Valla J	Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.	Journal of Alzheimer's disease 	2010	57
20881129	D-Glucose	Lane RF	Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.	The Journal of neuroscience 	2010	54
21035199	D-Glucose	Andrews ZB	The extra-hypothalamic actions of ghrelin on neuronal function.	Trends in neurosciences	2011	40
21035308	D-Glucose	Cunnane S	Brain fuel metabolism, aging, and Alzheimer's disease.	Nutrition	2011	93
21291474	D-Glucose	Uchida Y	Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.	Journal of neurochemistry	2011	93
21435176	D-Glucose	Bosco D	Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.	Journal of cellular and molecular medicine	2011	45
21489811	D-Glucose	Marino JS	Central insulin and leptin-mediated autonomic control of glucose homeostasis.	Trends in endocrinology and metabolism	2011	40
21598254	D-Glucose	Liu Y	Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.	The Journal of pathology	2011	91
21622984	D-Glucose	Xu L	Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).	The Journal of biological chemistry	2011	43
21633176	D-Glucose	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	117
21670386	D-Glucose	Lo RY	Longitudinal change of biomarkers in cognitive decline.	Archives of neurology	2011	66
21701065	D-Glucose	Masino SA	A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors.	The Journal of clinical investigation	2011	73
21917523	D-Glucose	Diano S	Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.	Trends in molecular medicine	2012	46
21939733	D-Glucose	Morris CJ	Circadian system, sleep and endocrinology.	Molecular and cellular endocrinology	2012	53
21986512	D-Glucose	Newbern D	Placental hormones and the control of maternal metabolism and fetal growth.	Current opinion in endocrinology, diabetes, and obesity	2011	57
22191795	D-Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22213821	D-Glucose	Carter SF	Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.	Journal of nuclear medicine 	2012	54
22500228	D-Glucose	Duarte AI	Insulin in central nervous system: more than just a peripheral hormone.	Journal of aging research	2012	50
22519295	D-Glucose	Salcedo I	Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.	British journal of pharmacology	2012	39
22820012	D-Glucose	Banks WA	Insulin in the brain: there and back again.	Pharmacology & therapeutics	2012	71
22936011	D-Glucose	Craft S	Insulin and Alzheimer's disease: untangling the web.	Journal of Alzheimer's disease 	2013	42
22972646	D-Glucose	Lo RY	Vascular burden and Alzheimer disease pathologic progression.	Neurology	2012	50
22984531	D-Glucose	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
23069842	D-Glucose	Willette AA	Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.	Diabetes care	2013	42
23134073	D-Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23146889	D-Glucose	Varela L	Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis.	EMBO reports	2012	63
23249272	D-Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23265947	D-Glucose	Vogt MC	CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.	Trends in endocrinology and metabolism	2013	39
23296339	D-Glucose	Liu CC	Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.	Nature reviews. Neurology	2013	318
23374353	D-Glucose	Sohn JW	Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons.	Cell	2013	70
23599929	D-Glucose	Protas HD	Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.	JAMA neurology	2013	31
23636237	D-Glucose	Tanaka T	Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.	The American journal of clinical nutrition	2013	48
23657158	D-Glucose	Ruiz-Núñez B	Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context.	The Journal of nutritional biochemistry	2013	26
23733199	D-Glucose	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
23781214	D-Glucose	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23850509	D-Glucose	Chen Z	Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.	Progress in neurobiology	2013	66
23886976	D-Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
23887638	D-Glucose	Chow WS	Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	32
23897112	D-Glucose	Thambisetty M	Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.	JAMA neurology	2013	39
23943882	D-Glucose	O'Carroll AM	The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.	The Journal of endocrinology	2013	37
23995067	D-Glucose	Flavahan WA	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.	Nature neuroscience	2013	83
24077098	D-Glucose	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	117
24153444	D-Glucose	Kerti L	Higher glucose levels associated with lower memory and reduced hippocampal microstructure.	Neurology	2013	33
24238363	D-Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24269021	D-Glucose	Johnson SC	Amyloid burden and neural function in people at risk for Alzheimer's Disease.	Neurobiology of aging	2014	35
24300239	D-Glucose	Dunn L	Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.	Neurobiology of aging	2014	23
24411018	D-Glucose	Morris JK	Impaired glycemia increases disease progression in mild cognitive impairment.	Neurobiology of aging	2014	23
24423324	D-Glucose	Colao A	Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.	The Journal of clinical endocrinology and metabolism	2014	30
24582776	D-Glucose	Bassil F	Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?	Progress in neurobiology	2014	38
24619488	D-Glucose	Hafez S	Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.	Translational stroke research	2014	22
24708805	D-Glucose	Sajja RK	Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.	Fluids and barriers of the CNS	2014	20
24760977	D-Glucose	Goldstone AP	Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.	The American journal of clinical nutrition	2014	23
24838911	D-Glucose	Liu Y	APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.	Journal of neurology, neurosurgery, and psychiatry	2015	23
24847886	D-Glucose	Deng D	Crystal structure of the human glucose transporter GLUT1.	Nature	2014	98
24931034	D-Glucose	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
25028522	D-Glucose	Heni M	Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.	Diabetes	2014	26
25086906	D-Glucose	Yan J	Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response.	Nature medicine	2014	29
25165877	D-Glucose	Milosch N	Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.	Cell death & disease	2014	21
25286408	D-Glucose	Yao Y	Ancestral exposure to stress epigenetically programs preterm birth risk and adverse maternal and newborn outcomes.	BMC medicine	2014	27
25287289	D-Glucose	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	35
25288136	D-Glucose	Coffee and Caffeine Genetics Consortium.	Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.	Molecular psychiatry	2015	24
25336656	D-Glucose	Zhu Y	The emerging link between O-GlcNAc and Alzheimer disease.	The Journal of biological chemistry	2014	36
25342129	D-Glucose	Kapogiannis D	Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.	FASEB journal 	2015	49
25392482	D-Glucose	van Praag H	Exercise, energy intake, glucose homeostasis, and the brain.	The Journal of neuroscience 	2014	25
25448601	D-Glucose	Sekar S	Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.	Neurobiology of aging	2015	25
25512305	D-Glucose	Harfmann BD	Circadian rhythms, the molecular clock, and skeletal muscle.	Journal of biological rhythms	2015	17
25525878	D-Glucose	Mashimo T	Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.	Cell	2014	120
25580592	D-Glucose	Fleisher AS	Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.	JAMA neurology	2015	29
25631608	D-Glucose	Wessel J	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Nature communications	2015	44
25662277	D-Glucose	Kumar Jha P	Circadian rhythms in glucose and lipid metabolism in nocturnal and diurnal mammals.	Molecular and cellular endocrinology	2015	18
25668019	D-Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25796566	D-Glucose	Perluigi M	mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.	Neurobiology of disease	2015	32
25826432	D-Glucose	Peake JM	Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects.	Exercise immunology review	2015	37
25892112	D-Glucose	Mlynarski EE	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.	American journal of human genetics	2015	21
26067718	D-Glucose	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
26084023	D-Glucose	Kolev M	Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.	Immunity	2015	27
26171719	D-Glucose	Hryhorczuk C	Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.	Neuropsychopharmacology 	2016	21
26373605	D-Glucose	Portelius E	Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.	Brain 	2015	34
26643952	D-Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26683796	D-Glucose	Mishra AK	Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota.	Metabolism	2016	15
26721390	D-Glucose	Lin AL	Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2017	12
26813969	D-Glucose	Rodriguez-Vieitez E	Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.	Brain 	2016	24
26962052	D-Glucose	Ossenkoppele R	Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.	Brain 	2016	82
27088965	D-Glucose	Risacher SL	Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.	JAMA neurology	2016	12
27106405	D-Glucose	Albert NL	Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.	Neuro-oncology	2016	24
27111510	D-Glucose	Jazayeri A	Extra-helical binding site of a glucagon receptor antagonist.	Nature	2016	25
27357347	D-Glucose	Smith R	18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.	Brain 	2016	25
27807285	D-Glucose	Kennedy ME	The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.	Science translational medicine	2016	18
28199306	D-Glucose	Wolfson RL	KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.	Nature	2017	19
28559417	D-Glucose	Kleinberger G	The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.	The EMBO journal	2017	6
28846098	D-Glucose	Emmerson PJ	The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.	Nature medicine	2017	12
1840645	Dopamine	Van Tol HH	Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.	Nature	1991	152
7830766	Dopamine	Tomac A	Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.	Nature	1995	117
8493557	Dopamine	Lin LF	GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.	Science	1993	389
8799184	Dopamine	Laruelle M	Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.	Proceedings of the National Academy of Sciences of the United States of America	1996	212
9126740	Dopamine	Volkow ND	Relationship between subjective effects of cocaine and dopamine transporter occupancy.	Nature	1997	133
9417971	Dopamine	Gunn RN	Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.	NeuroImage	1997	187
9429233	Dopamine	Thompson J	D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.	Pharmacogenetics	1997	114
9619147	Dopamine	Abi-Dargham A	Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.	The American journal of psychiatry	1998	139
9672901	Dopamine	Pohjalainen T	The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.	Molecular psychiatry	1998	142
9707588	Dopamine	Gogos JA	Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.	Proceedings of the National Academy of Sciences of the United States of America	1998	208
10395223	Dopamine	Jönsson EG	Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.	Molecular psychiatry	1999	154
10648446	Dopamine	Sabatini U	Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.	Brain 	2000	98
10649826	Dopamine	Heinz A	Genotype influences in vivo dopamine transporter availability in human striatum.	Neuropsychopharmacology 	2000	123
10689037	Dopamine	Swainson R	Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.	Neuropsychologia	2000	102
10753124	Dopamine	Rocheville M	Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.	Science	2000	90
11015620	Dopamine	Freeman ME	Prolactin: structure, function, and regulation of secretion.	Physiological reviews	2000	273
11130742	Dopamine	Zuckerman M	Personality and risk-taking: common biosocial factors.	Journal of personality	2000	124
11381111	Dopamine	Egan MF	Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	2001	561
11689280	Dopamine	Weinstock M	Alterations induced by gestational stress in brain morphology and behaviour of the offspring.	Progress in neurobiology	2001	104
11717374	Dopamine	Volkow ND	Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.	The Journal of neuroscience 	2001	182
11743939	Dopamine	Weinberger DR	Prefrontal neurons and the genetics of schizophrenia.	Biological psychiatry	2001	115
11925305	Dopamine	Malhotra AK	A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.	The American journal of psychiatry	2002	127
11988175	Dopamine	Pittenger C	Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.	Neuron	2002	129
11988536	Dopamine	Dunah AW	Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.	Science	2002	177
12151749	Dopamine	Picciotto MR	Effect of nicotine and nicotinic receptors on anxiety and depression.	Neuroreport	2002	96
12457396	Dopamine	Mill J	Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.	American journal of medical genetics	2002	85
12535946	Dopamine	Matsumoto M	Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function.	Neuroscience	2003	82
12587665	Dopamine	Ritchie T	Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.	Neurochemical research	2003	78
12669033	Dopamine	Gill SS	Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.	Nature medicine	2003	193
12716966	Dopamine	Mattay VS	Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.	Proceedings of the National Academy of Sciences of the United States of America	2003	258
12773616	Dopamine	Fan J	Mapping the genetic variation of executive attention onto brain activity.	Proceedings of the National Academy of Sciences of the United States of America	2003	86
12963670	Dopamine	Goldberg TE	Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.	Archives of general psychiatry	2003	153
13679416	Dopamine	Morón JA	Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.	The Journal of neuroscience 	2003	78
14593166	Dopamine	Dawson TM	Molecular pathways of neurodegeneration in Parkinson's disease.	Science	2003	362
14642968	Dopamine	Kapur S	Half a century of antipsychotics and still a central role for dopamine D2 receptors.	Progress in neuro-psychopharmacology & biological psychiatry	2003	102
15159175	Dopamine	Oswald LM	Opioids and alcoholism.	Physiology & behavior	2004	81
15293269	Dopamine	Ponsen MM	Idiopathic hyposmia as a preclinical sign of Parkinson's disease.	Annals of neurology	2004	101
15310843	Dopamine	Perrier AL	Derivation of midbrain dopamine neurons from human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	250
15457404	Dopamine	Chen J	Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.	American journal of human genetics	2004	370
15525797	Dopamine	Le Foll B	Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.	The Journal of pharmacology and experimental therapeutics	2005	67
15576511	Dopamine	Lo Bianco C	Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	75
15590952	Dopamine	Fahn S	Levodopa and the progression of Parkinson's disease.	The New England journal of medicine	2004	194
15777250	Dopamine	Nagatsu T	Inflammatory process in Parkinson's disease: role for cytokines.	Current pharmaceutical design	2005	72
15805310	Dopamine	Wood MA	Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.	Learning & memory	2005	118
15821730	Dopamine	Meyer-Lindenberg A	Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.	Nature neuroscience	2005	117
15872345	Dopamine	van Dyck CH	Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.	Journal of nuclear medicine 	2005	82
15916700	Dopamine	Arnsten AF	Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.	Behavioral and brain functions 	2005	93
15936806	Dopamine	Gardner EL	Endocannabinoid signaling system and brain reward: emphasis on dopamine.	Pharmacology, biochemistry, and behavior	2005	104
15950014	Dopamine	Madras BK	The dopamine transporter and attention-deficit/hyperactivity disorder.	Biological psychiatry	2005	76
16217123	Dopamine	Dubocovich ML	Functional MT1 and MT2 melatonin receptors in mammals.	Endocrine	2005	97
16361025	Dopamine	Tolosa E	The diagnosis of Parkinson's disease.	The Lancet. Neurology	2006	68
16571765	Dopamine	Leblois A	Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia.	The Journal of neuroscience 	2006	65
16616726	Dopamine	Munro CA	Sex differences in striatal dopamine release in healthy adults.	Biological psychiatry	2006	86
16716201	Dopamine	Savitz J	The molecular genetics of cognition: dopamine, COMT and BDNF.	Genes, brain, and behavior	2006	69
16769933	Dopamine	Pavese N	Microglial activation correlates with severity in Huntington disease: a clinical and PET study.	Neurology	2006	85
16774975	Dopamine	Li D	Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).	Human molecular genetics	2006	114
16786032	Dopamine	Meyer-Lindenberg A	Impact of complex genetic variation in COMT on human brain function.	Molecular psychiatry	2006	102
16818870	Dopamine	Brody AL	Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.	Archives of general psychiatry	2006	76
16930158	Dopamine	Koob GF	The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.	Addiction	2006	108
16950222	Dopamine	Bertolino A	Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype.	Biological psychiatry	2006	63
16984965	Dopamine	Abdolmaleky HM	Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.	Human molecular genetics	2006	112
17049611	Dopamine	Alex KD	Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.	Pharmacology & therapeutics	2007	112
17049922	Dopamine	Castrén E	Role of neurotrophic factors in depression.	Current opinion in pharmacology	2007	139
17050717	Dopamine	Scott DJ	Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity.	The Journal of neuroscience 	2006	81
17146014	Dopamine	Drabant EM	Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation.	Archives of general psychiatry	2006	87
17185007	Dopamine	Winter B	High impact running improves learning.	Neurobiology of learning and memory	2007	102
17279544	Dopamine	Nakabeppu Y	Oxidative damage in nucleic acids and Parkinson's disease.	Journal of neuroscience research	2007	63
17318414	Dopamine	Swanson JM	Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.	Neuropsychology review	2007	120
17362834	Dopamine	McKeith I	Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.	The Lancet. Neurology	2007	62
17483451	Dopamine	Yacubian J	Gene-gene interaction associated with neural reward sensitivity.	Proceedings of the National Academy of Sciences of the United States of America	2007	90
17507572	Dopamine	Cools R	Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory.	The Journal of neuroscience 	2007	86
17678633	Dopamine	Felger JC	Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.	Biological psychiatry	2007	59
17679637	Dopamine	Shaw P	Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.	Archives of general psychiatry	2007	63
17689985	Dopamine	Caldú X	Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.	NeuroImage	2007	62
17761882	Dopamine	Kim J	A MicroRNA feedback circuit in midbrain dopamine neurons.	Science	2007	367
17805313	Dopamine	Harrison PJ	Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders.	Neuropsychopharmacology 	2008	82
17881719	Dopamine	Parkinson Study Group PRECEPT Investigators.	Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.	Neurology	2007	69
17913879	Dopamine	Frank MJ	Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.	Proceedings of the National Academy of Sciences of the United States of America	2007	172
18057197	Dopamine	Tan HY	Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.	The Journal of neuroscience 	2007	58
18077373	Dopamine	Zhang Y	Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
18097655	Dopamine	Schlagenhauf F	Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.	Psychopharmacology	2008	61
18154498	Dopamine	Koob GF	Addiction and the brain antireward system.	Annual review of psychology	2008	352
18316420	Dopamine	Fehr C	Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.	The American journal of psychiatry	2008	65
18317466	Dopamine	Slifstein M	COMT genotype predicts cortical-limbic D1 receptor availability measured with 11CNNC112 and PET.	Molecular psychiatry	2008	59
18391962	Dopamine	Kordower JH	Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.	Nature medicine	2008	358
18497887	Dopamine	Tan HY	Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.	The Journal of clinical investigation	2008	55
18537670	Dopamine	Ferré S	An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.	Current pharmaceutical design	2008	53
18540916	Dopamine	Filbey FM	Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.	Alcoholism, clinical and experimental research	2008	58
18579413	Dopamine	Chang L	Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.	NeuroImage	2008	62
18588526	Dopamine	Gil JM	Mechanisms of neurodegeneration in Huntington's disease.	The European journal of neuroscience	2008	92
18591484	Dopamine	Brennan AR	Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.	Annals of the New York Academy of Sciences	2008	66
18617632	Dopamine	Binda F	Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.	Molecular pharmacology	2008	57
18620336	Dopamine	Durstewitz D	The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia.	Biological psychiatry	2008	119
18639865	Dopamine	Krishnan V	AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.	Biological psychiatry	2008	64
18653439	Dopamine	Koob GF	Review. Neurobiological mechanisms for opponent motivational processes in addiction.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2008	185
18702696	Dopamine	Fleming SM	Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.	The European journal of neuroscience	2008	51
18718885	Dopamine	van Winkel R	Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.	Schizophrenia bulletin	2008	69
18725236	Dopamine	Koob GF	Neurobiological substrates for the dark side of compulsivity in addiction.	Neuropharmacology	2009	133
18772040	Dopamine	Bubar MJ	Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.	Progress in brain research	2008	55
18829695	Dopamine	Bertolino A	Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.	Brain 	2009	50
18927395	Dopamine	Stice E	Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele.	Science	2008	252
18945945	Dopamine	Figlewicz DP	Insulin, leptin, and food reward: update 2008.	American journal of physiology. Regulatory, integrative and comparative physiology	2009	63
18958202	Dopamine	Nagel IE	Human aging magnifies genetic effects on executive functioning and working memory.	Frontiers in human neuroscience	2008	57
19091889	Dopamine	van de Giessen E	Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.	Journal of nuclear medicine 	2009	51
19104149	Dopamine	Brochard V	Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.	The Journal of clinical investigation	2009	191
19197069	Dopamine	McNab F	Changes in cortical dopamine D1 receptor binding associated with cognitive training.	Science	2009	112
19210038	Dopamine	Raz N	Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.	Neuropsychology	2009	55
19230552	Dopamine	Braak H	Neuroanatomy and pathology of sporadic Parkinson's disease.	Advances in anatomy, embryology, and cell biology	2009	59
19244517	Dopamine	Joshi PR	Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.	The Journal of neuroscience 	2009	59
19252484	Dopamine	Chambers SM	Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.	Nature biotechnology	2009	763
19293415	Dopamine	Volkow ND	Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.	JAMA	2009	135
19328819	Dopamine	Stice E	Relation of obesity to consummatory and anticipatory food reward.	Physiology & behavior	2009	69
19385059	Dopamine	Cannon JR	A highly reproducible rotenone model of Parkinson's disease.	Neurobiology of disease	2009	110
19417742	Dopamine	Mier D	Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis.	Molecular psychiatry	2010	134
19446012	Dopamine	Dickinson D	Genes, cognition and brain through a COMT lens.	Neuroscience	2009	56
19490899	Dopamine	Enard W	A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice.	Cell	2009	138
19540212	Dopamine	Govind AP	Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.	Biochemical pharmacology	2009	81
19564918	Dopamine	Tomasi D	Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention.	PloS one	2009	64
19571808	Dopamine	Stefansson H	Common variants conferring risk of schizophrenia.	Nature	2009	497
19620978	Dopamine	Frank MJ	Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation.	Nature neuroscience	2009	127
19661443	Dopamine	Gaskill PJ	Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.	The American journal of pathology	2009	45
19694908	Dopamine	Kitada T	Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.	Journal of neurochemistry	2009	58
19738093	Dopamine	Volkow ND	Evaluating dopamine reward pathway in ADHD: clinical implications.	JAMA	2009	133
19822738	Dopamine	Krugel LK	Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions.	Proceedings of the National Academy of Sciences of the United States of America	2009	71
19828868	Dopamine	Christine CW	Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.	Neurology	2009	103
19902317	Dopamine	Steele KE	Alterations of central dopamine receptors before and after gastric bypass surgery.	Obesity surgery	2010	61
19903734	Dopamine	Tong J	Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.	Brain 	2010	42
19914287	Dopamine	Ghitza UE	Role of BDNF and GDNF in drug reward and relapse: a review.	Neuroscience and biobehavioral reviews	2010	50
20082990	Dopamine	Ouchi Y	Neuroinflammation in the living brain of Parkinson's disease.	Parkinsonism & related disorders	2009	51
20194823	Dopamine	Kegeles LS	Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.	Archives of general psychiatry	2010	128
20201860	Dopamine	Schmitt KC	Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.	Annals of the New York Academy of Sciences	2010	64
20210846	Dopamine	Itoi K	The brainstem noradrenergic systems in stress, anxiety and depression.	Journal of neuroendocrinology	2010	52
20230849	Dopamine	Figlewicz DP	Energy regulatory signals and food reward.	Pharmacology, biochemistry, and behavior	2010	44
20331614	Dopamine	Rollema H	Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.	British journal of pharmacology	2010	54
20356854	Dopamine	Samaranch L	PINK1-linked parkinsonism is associated with Lewy body pathology.	Brain 	2010	47
20388498	Dopamine	Berridge KC	The tempted brain eats: pleasure and desire circuits in obesity and eating disorders.	Brain research	2010	157
20406573	Dopamine	Lukowski AF	Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory.	Nutritional neuroscience	2010	56
20534649	Dopamine	Garcia-Reitböck P	SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.	Brain 	2010	66
20590830	Dopamine	Aosaki T	Acetylcholine-dopamine balance hypothesis in the striatum: an update.	Geriatrics & gerontology international	2010	45
20643630	Dopamine	Seeman P	Dopamine D2 receptors as treatment targets in schizophrenia.	Clinical schizophrenia & related psychoses	2010	43
20691429	Dopamine	Hannestad J	Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.	Biological psychiatry	2010	53
20846908	Dopamine	Iranzo A	Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study corrected.	The Lancet. Neurology	2010	50
20856250	Dopamine	Volkow ND	Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.	Molecular psychiatry	2011	65
20858707	Dopamine	Duan H	Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.	The Journal of pharmacology and experimental therapeutics	2010	45
20962241	Dopamine	Stelzel C	Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density.	The Journal of neuroscience 	2010	44
20962767	Dopamine	Nair SG	Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine.	Neuropsychopharmacology 	2011	41
21048129	Dopamine	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	65
21112253	Dopamine	Kurian MA	Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.	The Lancet. Neurology	2011	44
21150907	Dopamine	Moyer RA	Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.	Neuropsychopharmacology 	2011	48
21152952	Dopamine	Domire JS	Dopamine receptor 1 localizes to neuronal cilia in a dynamic process that requires the Bardet-Biedl syndrome proteins.	Cellular and molecular life sciences 	2011	64
21246604	Dopamine	de la Fuente-Fernández R	Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.	Annals of neurology	2011	39
21383264	Dopamine	Alia-Klein N	Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.	Archives of general psychiatry	2011	39
21499141	Dopamine	Kim SH	Reduced striatal dopamine D2 receptors in people with Internet addiction.	Neuroreport	2011	47
21508242	Dopamine	Doll BB	Dopaminergic genes predict individual differences in susceptibility to confirmation bias.	The Journal of neuroscience 	2011	58
21592779	Dopamine	Enard W	FOXP2 and the role of cortico-basal ganglia circuits in speech and language evolution.	Current opinion in neurobiology	2011	37
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
21740894	Dopamine	Tuesta LM	Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.	Biochemical pharmacology	2011	41
21744309	Dopamine	Koob GF	Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.	Current topics in behavioral neurosciences	2013	99
21768599	Dopamine	Ahlskog JE	Does vigorous exercise have a neuroprotective effect in Parkinson disease?	Neurology	2011	53
21802993	Dopamine	Iranzo A	Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.	The Lancet. Neurology	2011	37
21812969	Dopamine	Liu X	Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.	BMC medical genetics	2011	47
21820648	Dopamine	DiNieri JA	Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.	Biological psychiatry	2011	36
21877920	Dopamine	Sánchez-Danés A	Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.	Human gene therapy	2012	34
21902800	Dopamine	Carnell S	Neuroimaging and obesity: current knowledge and future directions.	Obesity reviews 	2012	112
21951160	Dopamine	Strathearn L	Maternal neglect: oxytocin, dopamine and the neurobiology of attachment.	Journal of neuroendocrinology	2011	39
22134477	Dopamine	Izquierdo A	Reversal learning as a measure of impulsive and compulsive behavior in addictions.	Psychopharmacology	2012	67
22182688	Dopamine	Decressac M	Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.	Neurobiology of disease	2012	54
22196333	Dopamine	Mazei-Robison MS	Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.	Neuron	2011	37
22286059	Dopamine	Hino T	G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.	Nature	2012	67
22294258	Dopamine	Fusar-Poli P	Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis.	The American journal of psychiatry	2012	32
22315428	Dopamine	Lundblad M	Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.	Proceedings of the National Academy of Sciences of the United States of America	2012	71
22348642	Dopamine	Loubinoux I	Post-stroke depression: mechanisms, translation and therapy.	Journal of cellular and molecular medicine	2012	47
22364739	Dopamine	Farrell SM	COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.	Biological psychiatry	2012	37
22474070	Dopamine	Howes OD	The nature of dopamine dysfunction in schizophrenia and what this means for treatment.	Archives of general psychiatry	2012	171
22537794	Dopamine	Loland CJ	R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.	Biological psychiatry	2012	32
22539846	Dopamine	Groman SM	Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.	The Journal of neuroscience 	2012	33
22785313	Dopamine	Lim BK	Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens.	Nature	2012	93
22815523	Dopamine	Stice E	Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity.	The Journal of neuroscience 	2012	46
22992525	Dopamine	Lemos JC	Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.	Nature	2012	59
23167711	Dopamine	Boileau I	The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with 11C-(+)-propyl-hexahydro-naphtho-oxazin and 11Craclopride.	Addiction	2013	34
23220632	Dopamine	Decressac M	α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons.	Science translational medicine	2012	55
23248282	Dopamine	Chen X	Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23380716	Dopamine	Kaye WH	Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?	Biological psychiatry	2013	32
23395371	Dopamine	MacLeod DA	RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	Neuron	2013	138
23562390	Dopamine	Iranzo A	Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.	The Lancet. Neurology	2013	62
23610405	Dopamine	Decressac M	TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
23636255	Dopamine	Fisher BE	Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.	Neuroreport	2013	27
23650017	Dopamine	Eisenstein SA	A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-(11)Cmethyl)benperidol.	Synapse	2013	29
23657438	Dopamine	Felger JC	Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.	Neuropsychopharmacology 	2013	25
23747571	Dopamine	Koob GF	Addiction as a stress surfeit disorder.	Neuropharmacology	2014	96
23791072	Dopamine	Nakajima S	The potential role of dopamine D₃ receptor neurotransmission in cognition.	European neuropsychopharmacology 	2013	26
23921256	Dopamine	Payer DE	Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with 11C-+-PHNO.	Neuropsychopharmacology 	2014	34
23921954	Dopamine	Chefer VI	Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.	Neuropsychopharmacology 	2013	26
23934211	Dopamine	Mereu M	The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.	Psychopharmacology	2013	28
23966584	Dopamine	Kohno M	Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity.	Cerebral cortex	2015	32
23968837	Dopamine	Gordon EM	Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function.	Cerebral cortex	2015	20
23999914	Dopamine	Hölscher C	Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.	The Journal of endocrinology	2014	36
24061496	Dopamine	Faraone SV	Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.	Molecular psychiatry	2014	24
24082145	Dopamine	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
24102293	Dopamine	Calipari ES	Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine.	Journal of neurochemistry	2014	22
24247300	Dopamine	Chen HH	Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.	JAMA	2013	61
24267657	Dopamine	den Ouden HE	Dissociable effects of dopamine and serotonin on reversal learning.	Neuron	2013	34
24277856	Dopamine	Scheele D	Oxytocin enhances brain reward system responses in men viewing the face of their female partner.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
24296975	Dopamine	Morel C	Nicotine consumption is regulated by a human polymorphism in dopamine neurons.	Molecular psychiatry	2014	26
24613933	Dopamine	Ng J	Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.	Brain 	2014	27
24641197	Dopamine	Baimel C	Orexin/hypocretin role in reward: implications for opioid and other addictions.	British journal of pharmacology	2015	15
24654857	Dopamine	Jentsch JD	Dissecting impulsivity and its relationships to drug addictions.	Annals of the New York Academy of Sciences	2014	48
24658464	Dopamine	Li J	Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.	Oncotarget	2014	23
24677189	Dopamine	Peuskens J	The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.	CNS drugs	2014	31
24736453	Dopamine	Cebrián C	MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.	Nature communications	2014	37
24920625	Dopamine	Pifl C	Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.	The Journal of neuroscience 	2014	31
24995986	Dopamine	Rothwell PE	Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.	Cell	2014	81
25127144	Dopamine	Panman L	Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons.	Cell reports	2014	20
25307567	Dopamine	Koob GF	Neurocircuitry of alcohol addiction: synthesis from animal models.	Handbook of clinical neurology	2014	24
25377898	Dopamine	Perello M	Ghrelin signalling on food reward: a salient link between the gut and the mesolimbic system.	Journal of neuroendocrinology	2015	19
25555215	Dopamine	Wang L	Differentiation of hypothalamic-like neurons from human pluripotent stem cells.	The Journal of clinical investigation	2015	16
25556834	Dopamine	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	24
25562824	Dopamine	Cox SM	Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes.	NeuroImage	2015	26
25644383	Dopamine	Northcutt AL	DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.	Molecular psychiatry	2015	26
25652247	Dopamine	Modi ME	Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole.	Neuropsychopharmacology 	2015	15
25878269	Dopamine	Siciliano CA	Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.	The Journal of neuroscience 	2015	16
25915474	Dopamine	Laguna A	Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.	Nature neuroscience	2015	15
26093169	Dopamine	Paumier KL	Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.	Neurobiology of disease	2015	41
26100888	Dopamine	Bonaventura J	Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
26101377	Dopamine	Grattan DR	60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.	The Journal of endocrinology	2015	17
26406372	Dopamine	Zeng W	Sympathetic neuro-adipose connections mediate leptin-driven lipolysis.	Cell	2015	39
26552591	Dopamine	Felger JC	Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.	Molecular psychiatry	2016	36
26601965	Dopamine	Alam Q	Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.	Current pharmaceutical design	2016	16
26839413	Dopamine	Mazzulli JR	α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.	Proceedings of the National Academy of Sciences of the United States of America	2016	25
26857251	Dopamine	Ritz BR	Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.	Current environmental health reports	2016	11
26903621	Dopamine	Hirth N	Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence.	Proceedings of the National Academy of Sciences of the United States of America	2016	19
27110438	Dopamine	Dretsch MN	Brain-derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress.	Brain and behavior	2016	11
27300435	Dopamine	Dolma S	Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.	Cancer cell	2016	18
27445146	Dopamine	Mazzulli JR	Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.	The Journal of neuroscience 	2016	13
27514754	Dopamine	Würth R	Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.	Molecular neurobiology	2017	5
27523502	Dopamine	Datta D	Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.	The American journal of psychiatry	2017	6
27632223	Dopamine	Cilia R	Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.	Annals of neurology	2016	11
27647894	Dopamine	Crittenden JR	Striosome-dendron bouquets highlight a unique striatonigral circuit targeting dopamine-containing neurons.	Proceedings of the National Academy of Sciences of the United States of America	2016	13
27813530	Dopamine	Moreines JL	Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress.	Neuropsychopharmacology 	2017	7
27832841	Dopamine	Urs NM	New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy.	Biological psychiatry	2017	9
27956050	Dopamine	Chen C	The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels.	Frontiers in neuroendocrinology	2017	6
28180961	Dopamine	Doppler K	Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.	Acta neuropathologica	2017	8
28398344	Dopamine	Rivetti di Val Cervo P	Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.	Nature biotechnology	2017	11
7958843	L-Cysteine	Kumar S	Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.	Genes & development	1994	120
8242740	L-Cysteine	Yuan J	The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.	Cell	1993	352
9177350	L-Cysteine	Pan Y	Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.	Nature	1997	111
14665635	L-Cysteine	Olzmann JA	Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function.	The Journal of biological chemistry	2004	74
15094120	L-Cysteine	Bellail AC	Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.	The international journal of biochemistry & cell biology	2004	124
16362181	L-Cysteine	Büki A	All roads lead to disconnection?--Traumatic axonal injury revisited.	Acta neurochirurgica	2006	121
18003920	L-Cysteine	Fang J	S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	75
18316367	L-Cysteine	Karch CM	A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	50
19342591	L-Cysteine	Cho DH	S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.	Science	2009	300
19539236	L-Cysteine	Chabriat H	Cadasil.	The Lancet. Neurology	2009	135
19567589	L-Cysteine	Lucio-Eterovic AK	Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.	Clinical cancer research 	2009	75
21784859	L-Cysteine	Yoshida S	Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway.	The Journal of biological chemistry	2011	43
21820099	L-Cysteine	Nosková L	Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.	American journal of human genetics	2011	79
22048958	L-Cysteine	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22193716	L-Cysteine	Cohen TJ	Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.	The EMBO journal	2012	35
22229673	L-Cysteine	Kimura H	Hydrogen sulfide is a signaling molecule and a cytoprotectant.	Antioxidants & redox signaling	2012	60
22500636	L-Cysteine	Zhang YQ	Identification of CSPα clients reveals a role in dynamin 1 regulation.	Neuron	2012	38
23649698	L-Cysteine	Monet-Leprêtre M	Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.	Brain 	2013	25
24186977	L-Cysteine	Ke J	Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex.	Genes & development	2013	25
25823923	L-Cysteine	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	23
26119044	L-Cysteine	Gillrie MR	Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis.	Cellular microbiology	2015	22
17613235	Sulfate	Rosenberg GA	Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia.	Neurosurgical focus	2007	78
18052531	Sulfate	Avirutnan P	Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.	PLoS pathogens	2007	71
25282103	Sulfate	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	348
10918705	Cortisol	Heim C	Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.	JAMA	2000	334
11027914	Cortisol	Holsboer F	The corticosteroid receptor hypothesis of depression.	Neuropsychopharmacology 	2000	315
11282691	Cortisol	Heim C	Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.	The American journal of psychiatry	2001	137
11502812	Cortisol	Vgontzas AN	Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.	The Journal of clinical endocrinology and metabolism	2001	113
11862370	Cortisol	O'Malley SS	Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.	Psychopharmacology	2002	151
11920153	Cortisol	Gold PW	Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.	Molecular psychiatry	2002	233
12119665	Cortisol	Björntorp P	Do stress reactions cause abdominal obesity and comorbidities?	Obesity reviews 	2001	190
12764120	Cortisol	Benedetti F	Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.	The Journal of neuroscience 	2003	104
12764219	Cortisol	Schommer NC	Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress.	Psychosomatic medicine	2003	81
12832253	Cortisol	Capuron L	Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.	The American journal of psychiatry	2003	78
12845411	Cortisol	Sinha R	Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.	Psychopharmacology	2003	103
14575731	Cortisol	Kudielka BM	HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender.	Psychoneuroendocrinology	2004	127
15514410	Cortisol	O'Brien JT	A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.	The American journal of psychiatry	2004	84
15728214	Cortisol	Buckley TM	On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.	The Journal of clinical endocrinology and metabolism	2005	103
15944068	Cortisol	Weinstock M	The potential influence of maternal stress hormones on development and mental health of the offspring.	Brain, behavior, and immunity	2005	117
16472586	Cortisol	Dinan TG	Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?	Gastroenterology	2006	117
16781084	Cortisol	Black PH	The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.	Medical hypotheses	2006	62
16845409	Cortisol	Arck PC	Neuroimmunology of stress: skin takes center stage.	The Journal of investigative dermatology	2006	69
17408865	Cortisol	Wilhelm I	Is the cortisol awakening rise a response to awakening?	Psychoneuroendocrinology	2007	68
17543357	Cortisol	Adam TC	Stress, eating and the reward system.	Physiology & behavior	2007	246
17958710	Cortisol	Feldman R	Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding.	Psychological science	2007	120
18222063	Cortisol	Choi J	Reduced telomerase activity in human T lymphocytes exposed to cortisol.	Brain, behavior, and immunity	2008	74
18258663	Cortisol	Förster C	Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.	The Journal of physiology	2008	66
18339361	Cortisol	Tyrka AR	Childhood parental loss and adult hypothalamic-pituitary-adrenal function.	Biological psychiatry	2008	74
18359186	Cortisol	Witek-Janusek L	Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.	Brain, behavior, and immunity	2008	82
18394919	Cortisol	Bornstein SR	Dissociation of ACTH and glucocorticoids.	Trends in endocrinology and metabolism	2008	62
18440494	Cortisol	Miller GE	A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling.	Biological psychiatry	2008	147
18684212	Cortisol	Chang L	Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.	Neurogastroenterology and motility 	2009	56
18722511	Cortisol	Klehmet J	Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.	Neuroscience	2009	56
19393990	Cortisol	Yehuda R	Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks.	Biological psychiatry	2009	81
19433690	Cortisol	Rohleder N	Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways.	Journal of clinical oncology 	2009	57
19571587	Cortisol	Papadimitriou A	Regulation of the hypothalamic-pituitary-adrenal axis.	Neuroimmunomodulation	2009	50
20026350	Cortisol	Clow A	The cortisol awakening response: more than a measure of HPA axis function.	Neuroscience and biobehavioral reviews	2010	81
20227485	Cortisol	O'Donovan A	Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships.	Brain, behavior, and immunity	2010	49
20398008	Cortisol	Lange T	Effects of sleep and circadian rhythm on the human immune system.	Annals of the New York Academy of Sciences	2010	73
20854893	Cortisol	Bower JE	Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.	Brain, behavior, and immunity	2011	56
21257974	Cortisol	Stetler C	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosomatic medicine	2011	131
21508514	Cortisol	Sarapas C	Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks.	Disease markers	2011	37
21672499	Cortisol	Mondelli V	Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.	The Journal of clinical psychiatry	2011	42
21741804	Cortisol	Zohar J	High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies.	European neuropsychopharmacology 	2011	48
21792580	Cortisol	Sinha R	New findings on biological factors predicting addiction relapse vulnerability.	Current psychiatry reports	2011	38
22146091	Cortisol	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	49
22158016	Cortisol	Papakostas GI	Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.	Molecular psychiatry	2013	31
22663896	Cortisol	Aiello G	Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state.	Psychoneuroendocrinology	2012	30
22778226	Cortisol	Meyer JS	Minireview: Hair cortisol: a novel biomarker of hypothalamic-pituitary-adrenocortical activity.	Endocrinology	2012	41
22801723	Cortisol	Soares HD	Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.	Archives of neurology	2012	62
22998948	Cortisol	Reynolds RM	Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.	Psychoneuroendocrinology	2013	59
23089630	Cortisol	Lamers F	Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.	Molecular psychiatry	2013	78
23274505	Cortisol	Mahon PB	Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults.	Psychopharmacology	2013	34
23650397	Cortisol	Anacker C	Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2013	47
24439483	Cortisol	Révész D	Dysregulated physiological stress systems and accelerated cellular aging.	Neurobiology of aging	2014	22
24485481	Cortisol	Kaliman P	Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators.	Psychoneuroendocrinology	2014	28
24687146	Cortisol	Breen DP	Sleep and circadian rhythm regulation in early Parkinson disease.	JAMA neurology	2014	46
24722204	Cortisol	Hanin G	Competing targets of microRNA-608 affect anxiety and hypertension.	Human molecular genetics	2014	22
25355243	Cortisol	Vogel S	Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum.	Neuropsychopharmacology 	2015	16
25449699	Cortisol	Schmidt K	Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.	Psychopharmacology	2015	31
25462896	Cortisol	Skoluda N	Intra-individual psychological and physiological responses to acute laboratory stressors of different intensity.	Psychoneuroendocrinology	2015	17
25647344	Cortisol	Schrepf A	Diurnal cortisol and survival in epithelial ovarian cancer.	Psychoneuroendocrinology	2015	16
25875334	Cortisol	Braithwaite EC	Maternal prenatal depressive symptoms predict infant NR3C1 1F and BDNF IV DNA methylation.	Epigenetics	2015	32
26050039	Cortisol	Arloth J	Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.	Neuron	2015	21
26291403	Cortisol	Engler H	Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms.	Brain, behavior, and immunity	2016	12
26356039	Cortisol	Incollingo Rodriguez AC	Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review.	Psychoneuroendocrinology	2015	18
26997371	Cortisol	Houtepen LC	Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans.	Nature communications	2016	18
9613620	L(-)-Nicotine	Adler LE	Schizophrenia, sensory gating, and nicotinic receptors.	Schizophrenia bulletin	1998	109
10759066	L(-)-Nicotine	Paterson D	Neuronal nicotinic receptors in the human brain.	Progress in neurobiology	2000	114
11245666	L(-)-Nicotine	Buisson B	Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function.	The Journal of neuroscience 	2001	103
11356984	L(-)-Nicotine	Sarnyai Z	The role of corticotropin-releasing factor in drug addiction.	Pharmacological reviews	2001	107
12783266	L(-)-Nicotine	Hogg RC	Nicotinic acetylcholine receptors: from structure to brain function.	Reviews of physiology, biochemistry and pharmacology	2003	104
16928859	L(-)-Nicotine	Staley JK	Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.	The Journal of neuroscience 	2006	85
17349863	L(-)-Nicotine	Martin LF	Schizophrenia and the alpha7 nicotinic acetylcholine receptor.	International review of neurobiology	2007	72
17503330	L(-)-Nicotine	Lou XY	A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.	American journal of human genetics	2007	165
17597586	L(-)-Nicotine	Gotti C	Heterogeneity and complexity of native brain nicotinic receptors.	Biochemical pharmacology	2007	88
17825262	L(-)-Nicotine	Grady SR	The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.	Biochemical pharmacology	2007	108
18395805	L(-)-Nicotine	Lisman JE	Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.	Trends in neurosciences	2008	322
18414406	L(-)-Nicotine	Wang JC	Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence.	Molecular psychiatry	2009	107
18651175	L(-)-Nicotine	Smith RJ	Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.	Brain structure & function	2008	84
18690555	L(-)-Nicotine	Kenney JW	Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.	Molecular neurobiology	2008	89
19126755	L(-)-Nicotine	Albuquerque EX	Mammalian nicotinic acetylcholine receptors: from structure to function.	Physiological reviews	2009	403
19157986	L(-)-Nicotine	Knackstedt LA	Glutamate and reinstatement.	Current opinion in pharmacology	2009	65
19179847	L(-)-Nicotine	Le Foll B	Genetics of dopamine receptors and drug addiction: a comprehensive review.	Behavioural pharmacology	2009	82
19270530	L(-)-Nicotine	Hung SY	Autophagy protects neuron from Abeta-induced cytotoxicity.	Autophagy	2009	47
19443489	L(-)-Nicotine	Wang JC	Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.	Human molecular genetics	2009	87
20400469	L(-)-Nicotine	Jackson KJ	Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.	The Journal of pharmacology and experimental therapeutics	2010	58
20584212	L(-)-Nicotine	Saccone NL	Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans.	Genes, brain, and behavior	2010	50
20700436	L(-)-Nicotine	Saccone NL	Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.	PLoS genetics	2010	190
21048701	L(-)-Nicotine	Chatterjee S	Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.	Neuropsychopharmacology 	2011	58
21576462	L(-)-Nicotine	Ray R	Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21741954	L(-)-Nicotine	Wallace TL	Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.	Biochemical pharmacology	2011	47
23171716	L(-)-Nicotine	Brody AL	Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers.	The international journal of neuropsychopharmacology	2013	28
25012994	L(-)-Nicotine	Chenoweth MJ	Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.	Cancer epidemiology, biomarkers & prevention 	2014	28
25402857	L(-)-Nicotine	Grieder TE	VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.	Nature neuroscience	2014	26
25460185	L(-)-Nicotine	Zoli M	Diversity of native nicotinic receptor subtypes in mammalian brain.	Neuropharmacology	2015	30
25476971	L(-)-Nicotine	Antolin-Fontes B	The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.	Neuropharmacology	2015	20
26392368	L(-)-Nicotine	Schwantes-An TH	Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.	Behavior genetics	2016	21
26513517	L(-)-Nicotine	Smits JA	The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity: A Randomized Controlled Trial.	Psychosomatic medicine	2016	15
3399080	Choline	McGeer PL	Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.	Neurology	1988	446
9664076	Choline	Ring A	Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway.	The Journal of clinical investigation	1998	110
12541307	Choline	Kishi T	Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.	The Journal of comparative neurology	2003	150
12805474	Choline	Terry AV Jr	The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.	The Journal of pharmacology and experimental therapeutics	2003	106
15935057	Choline	Peng S	Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.	Journal of neurochemistry	2005	121
19941350	Choline	Kataoka Y	Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.	The Journal of comparative neurology	2010	111
21145918	Choline	Schliebs R	The cholinergic system in aging and neuronal degeneration.	Behavioural brain research	2011	152
22238333	Choline	Elkhaled A	Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.	Science translational medicine	2012	53
23318559	Choline	Ross RG	Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.	The American journal of psychiatry	2013	28
24529280	Choline	Perez SE	Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.	Biological psychiatry	2015	16
25062696	Choline	Hall H	Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.	Brain 	2014	32
15087549	Ethanol	Lustbader JW	ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.	Science	2004	302
15699277	Ethanol	Oei HH	Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.	Circulation	2005	84
15956766	Ethanol	Sulik KK	Genesis of alcohol-induced craniofacial dysmorphism.	Experimental biology and medicine	2005	70
15956769	Ethanol	Goodlett CR	Alcohol teratogenesis: mechanisms of damage and strategies for intervention.	Experimental biology and medicine	2005	96
16573591	Ethanol	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	104
16618939	Ethanol	Mulligan MK	Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis.	Proceedings of the National Academy of Sciences of the United States of America	2006	174
17344409	Ethanol	Gehlert DR	3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo1,2-bpyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.	The Journal of neuroscience 	2007	111
18286196	Ethanol	Onaivi ES	Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects.	PloS one	2008	61
18382230	Ethanol	Kempermann G	The contribution of failing adult hippocampal neurogenesis to psychiatric disorders.	Current opinion in psychiatry	2008	77
18514163	Ethanol	Marsland AL	Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults.	Biological psychiatry	2008	92
18575590	Ethanol	Ancuta P	Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.	PloS one	2008	198
18940959	Ethanol	Crews FT	Mechanisms of neurodegeneration and regeneration in alcoholism.	Alcohol and alcoholism	2009	165
18945226	Ethanol	Simpson TL	A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.	Alcoholism, clinical and experimental research	2009	70
19016889	Ethanol	Wiers RW	Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele.	Genes, brain, and behavior	2009	61
19029462	Ethanol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19124685	Ethanol	Ernst C	Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers.	Archives of general psychiatry	2009	52
19168210	Ethanol	Schuckit MA	Alcohol-use disorders.	Lancet	2009	89
19188543	Ethanol	Lubman DI	Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use.	Archives of general psychiatry	2009	47
19581569	Ethanol	Treutlein J	Genome-wide association study of alcohol dependence.	Archives of general psychiatry	2009	142
19853041	Ethanol	Flöel A	Physical activity and memory functions: are neurotrophins and cerebral gray matter volume the missing link?	NeuroImage	2010	53
20026088	Ethanol	Martin-Fardon R	Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.	Brain research	2010	42
20201924	Ethanol	Edenberg HJ	Genome-wide association study of alcohol dependence implicates a region on chromosome 11.	Alcoholism, clinical and experimental research	2010	139
20479755	Ethanol	Ramchandani VA	A genetic determinant of the striatal dopamine response to alcohol in men.	Molecular psychiatry	2011	98
20561675	Ethanol	O'Donnell MJ	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.	Lancet	2010	439
20702043	Ethanol	Bus BA	Determinants of serum brain-derived neurotrophic factor.	Psychoneuroendocrinology	2011	47
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21358359	Ethanol	Omalu B	Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes.	Neurosurgery	2011	76
21402143	Ethanol	Crews FT	Induction of innate immune genes in brain create the neurobiology of addiction.	Brain, behavior, and immunity	2011	97
21471458	Ethanol	Schumann G	Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21483437	Ethanol	Villafuerte S	Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism.	Molecular psychiatry	2012	57
21521424	Ethanol	Taqi MM	Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics.	Addiction biology	2011	49
22044102	Ethanol	Omalu B	Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide.	Neurosurgical focus	2011	54
22064162	Ethanol	Edwards AC	Genome-wide association study of comorbid depressive syndrome and alcohol dependence.	Psychiatric genetics	2012	35
22459870	Ethanol	Walker BM	Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.	Alcohol	2012	33
22459871	Ethanol	Pava MJ	A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.	Alcohol	2012	37
22521198	Ethanol	Leclercq S	Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects.	Brain, behavior, and immunity	2012	37
22661925	Ethanol	Zou J	Inflammasome-IL-1β Signaling Mediates Ethanol Inhibition of Hippocampal Neurogenesis.	Frontiers in neuroscience	2012	40
22670023	Ethanol	Lal C	Neurocognitive impairment in obstructive sleep apnea.	Chest	2012	53
22765916	Ethanol	Redies C	Cadherins and neuropsychiatric disorders.	Brain research	2012	63
23206318	Ethanol	Crews FT	High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.	Biological psychiatry	2013	76
23294766	Ethanol	Zorrilla EP	Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.	Drug and alcohol dependence	2013	30
23349641	Ethanol	Oksenberg N	Function and regulation of AUTS2, a gene implicated in autism and human evolution.	PLoS genetics	2013	29
23553547	Ethanol	Hu S	Changes in cerebral morphometry and amplitude of low-frequency fluctuations of BOLD signals during healthy aging: correlation with inhibitory control.	Brain structure & function	2014	25
23584111	Ethanol	Becker HC	Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption.	Alcohol research 	2012	34
23867237	Ethanol	Vetreno RP	Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.	Neurobiology of disease	2013	45
23919770	Ethanol	Jiang T	Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.	Current Alzheimer research	2013	27
24275185	Ethanol	Coleman LG Jr	Adolescent binge ethanol treatment alters adult brain regional volumes, cortical extracellular matrix protein and behavioral flexibility.	Pharmacology, biochemistry, and behavior	2014	29
24586787	Ethanol	Kietzman HW	The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 haploinsufficiency in the mouse.	PloS one	2014	28
24636458	Ethanol	Spanagel R	Stress and alcohol interactions: animal studies and clinical significance.	Trends in neurosciences	2014	27
24666346	Ethanol	Neasta J	mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse.	Journal of neurochemistry	2014	25
24726381	Ethanol	Hashimoto-Torii K	Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders.	Neuron	2014	27
25271633	Ethanol	Pinto JM	Olfactory dysfunction predicts 5-year mortality in older adults.	PloS one	2014	33
25330738	Ethanol	Darcq E	MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption.	Molecular psychiatry	2015	21
25409596	Ethanol	Kwako LE	The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.	Neuropsychopharmacology 	2015	30
25672924	Ethanol	Wang R	Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.	Neurology	2015	20
25787746	Ethanol	Crews FT	Mechanisms of neuroimmune gene induction in alcoholism.	Psychopharmacology	2016	34
26121746	Ethanol	Vendruscolo LF	Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.	The Journal of clinical investigation	2015	24
26210739	Ethanol	Hasin DS	The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.	Social psychiatry and psychiatric epidemiology	2015	36
26482880	Ethanol	Buch S	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.	Nature genetics	2015	35
26763658	Ethanol	Wang F	DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders.	Scientific reports	2016	10
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
27531626	Ethanol	Polimanti R	The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene.	Neuropsychopharmacology 	2017	7
27843151	Ethanol	Liu C	A DNA methylation biomarker of alcohol consumption.	Molecular psychiatry	2018	14
28107775	Ethanol	Varga ZV	β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.	British journal of pharmacology	2018	6
28118842	Ethanol	Coleman LG Jr	Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.	Journal of neuroinflammation	2017	10
28159648	Ethanol	Crews FT	The role of neuroimmune signaling in alcoholism.	Neuropharmacology	2017	9
28273337	Ethanol	Lawrimore CJ	Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron-Like SH-SY5Y and Microglia-Like BV2.	Alcoholism, clinical and experimental research	2017	6
15822191	Sulfite	Esteller M	Aberrant DNA methylation as a cancer-inducing mechanism.	Annual review of pharmacology and toxicology	2005	101
17591937	Sulfite	Mikeska T	Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.	The Journal of molecular diagnostics 	2007	56
18045775	Sulfite	Al-Mahdawi S	The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.	Human molecular genetics	2008	90
20375269	Sulfite	Nguyen A	Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.	FASEB journal 	2010	107
20583129	Sulfite	Toledo-Rodriguez M	Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2010	46
21610077	Sulfite	Kinney SM	Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.	The Journal of biological chemistry	2011	49
23325432	Sulfite	Varley KE	Dynamic DNA methylation across diverse human cell lines and tissues.	Genome research	2013	214
24183680	Sulfite	Bender S	Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.	Cancer cell	2013	114
24448211	Sulfite	Zhubi A	Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum.	Translational psychiatry	2014	45
24594098	Sulfite	Wen L	Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain.	Genome biology	2014	70
24806409	Sulfite	Liu EY	C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.	Acta neuropathologica	2014	42
24929637	Sulfite	Dempster EL	Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression.	Biological psychiatry	2014	31
26012557	Sulfite	Andoh-Noda T	Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.	Molecular brain	2015	18
26923874	Sulfite	Johann PD	Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.	Cancer cell	2016	31
26977886	Sulfite	Chun HE	Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.	Cancer cell	2016	14
17164235	Melatonin	Klein DC	Arylalkylamine N-acetyltransferase: "the Timezyme".	The Journal of biological chemistry	2007	81
19716732	Melatonin	Dijk DJ	PERIOD3, circadian phenotypes, and sleep homeostasis.	Sleep medicine reviews	2010	45
21415172	Melatonin	Cajochen C	Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.	Journal of applied physiology	2011	48
24449876	Melatonin	Archer SN	Mistimed sleep disrupts circadian regulation of the human transcriptome.	Proceedings of the National Academy of Sciences of the United States of America	2014	53
25640603	Melatonin	Wright KP Jr	Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.	Brain, behavior, and immunity	2015	18
7822316	Sirolimus	Sabers CJ	Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.	The Journal of biological chemistry	1995	184
12563289	Sirolimus	Jacinto E	Tor signalling in bugs, brain and brawn.	Nature reviews. Molecular cell biology	2003	151
12782577	Sirolimus	Choe G	Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.	Cancer research	2003	109
12842888	Sirolimus	Castro AF	Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.	The Journal of biological chemistry	2003	109
12869586	Sirolimus	Inoki K	Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.	Genes & development	2003	529
12906785	Sirolimus	Tee AR	Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.	Current biology 	2003	359
14607085	Sirolimus	Manning BD	Rheb fills a GAP between TSC and TOR.	Trends in biochemical sciences	2003	134
14729330	Sirolimus	Li Y	TSC2: filling the GAP in the mTOR signaling pathway.	Trends in biochemical sciences	2004	112
15094765	Sirolimus	Fingar DC	Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.	Oncogene	2004	333
15805275	Sirolimus	Dasgupta B	Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.	Cancer research	2005	81
16098202	Sirolimus	Li X	Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.	The FEBS journal	2005	68
16176982	Sirolimus	Nobukuni T	Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2005	255
16203860	Sirolimus	Yu WH	Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease.	The Journal of cell biology	2005	237
16341243	Sirolimus	Thomas GV	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	Nature medicine	2006	169
16354680	Sirolimus	Tzatsos A	Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.	Molecular and cellular biology	2006	125
16464865	Sirolimus	Chong-Kopera H	TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.	The Journal of biological chemistry	2006	64
16627617	Sirolimus	Yang Q	TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.	Proceedings of the National Academy of Sciences of the United States of America	2006	67
16714284	Sirolimus	Cao Y	Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.	The Journal of biological chemistry	2006	79
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16912159	Sirolimus	Wang MY	Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.	Cancer research	2006	100
16915281	Sirolimus	Bernardi R	PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.	Nature	2006	132
17671177	Sirolimus	Ma L	Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.	Cancer research	2007	58
17689501	Sirolimus	Morimoto N	Increased autophagy in transgenic mice with a G93A mutant SOD1 gene.	Brain research	2007	57
17698586	Sirolimus	Jossin Y	Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.	Molecular and cellular biology	2007	68
17804702	Sirolimus	Fan QW	A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.	Cancer research	2007	66
17913600	Sirolimus	Swiech L	Role of mTOR in physiology and pathology of the nervous system.	Biochimica et biophysica acta	2008	99
18089801	Sirolimus	Masri J	mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.	Cancer research	2007	92
18276609	Sirolimus	Tang G	Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.	Human molecular genetics	2008	53
18466115	Sirolimus	Huang J	The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.	The Biochemical journal	2008	331
18722871	Sirolimus	Curatolo P	Tuberous sclerosis.	Lancet	2008	171
19018475	Sirolimus	Kreisl TN	A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).	Journal of neuro-oncology	2009	48
19176518	Sirolimus	Fan QW	EGFR signals to mTOR through PKC and independently of Akt in glioma.	Science signaling	2009	66
19211884	Sirolimus	Zhou J	Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.	The Journal of neuroscience 	2009	149
19234517	Sirolimus	Hartman TR	The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.	Oncogene	2009	62
19420259	Sirolimus	Di Nardo A	Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.	The Journal of neuroscience 	2009	63
19556253	Sirolimus	Neves-Pereira M	Deregulation of EIF4E: a novel mechanism for autism.	Journal of medical genetics	2009	48
19651785	Sirolimus	Caccamo A	Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability.	The Journal of biological chemistry	2009	49
19778506	Sirolimus	Kim JY	DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.	Neuron	2009	128
19817806	Sirolimus	Wong M	Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.	Epilepsia	2010	59
19864431	Sirolimus	Foster KG	Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.	The Journal of biological chemistry	2010	58
19864570	Sirolimus	Spencer B	Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.	The Journal of neuroscience 	2009	171
19963289	Sirolimus	Hoeffer CA	mTOR signaling: at the crossroads of plasticity, memory and disease.	Trends in neurosciences	2010	292
20009104	Sirolimus	Guo D	EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.	Science signaling	2009	82
20028853	Sirolimus	Baryawno N	Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.	Cancer research	2010	44
20146692	Sirolimus	Orlova KA	The tuberous sclerosis complex.	Annals of the New York Academy of Sciences	2010	102
20174468	Sirolimus	Crews L	Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.	PloS one	2010	92
20472883	Sirolimus	Akhavan D	mTOR signaling in glioblastoma: lessons learned from bench to bedside.	Neuro-oncology	2010	50
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20616807	Sirolimus	Kang YJ	The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.	Cell death and differentiation	2011	42
20668162	Sirolimus	Goodman CA	A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.	Molecular biology of the cell	2010	42
20862226	Sirolimus	Ma T	Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.	PloS one	2010	74
21047224	Sirolimus	Krueger DA	Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.	The New England journal of medicine	2010	226
21115397	Sirolimus	Ehninger D	Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.	Trends in molecular medicine	2011	59
21138990	Sirolimus	Wang X	mTORC1 signaling: what we still don't know.	Journal of molecular cell biology	2011	49
21212100	Sirolimus	Ricciardi S	Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.	Human molecular genetics	2011	69
21228155	Sirolimus	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	42
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21460795	Sirolimus	Galan-Moya EM	Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.	EMBO reports	2011	44
21907282	Sirolimus	Carson RP	Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.	Neurobiology of disease	2012	57
22025691	Sirolimus	Goto J	Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.	Proceedings of the National Academy of Sciences of the United States of America	2011	61
22268788	Sirolimus	Hoeffer CA	Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.	Genes, brain, and behavior	2012	51
22349822	Sirolimus	Wen ZH	Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.	Oncogene	2013	29
22402744	Sirolimus	Weeraratne SD	Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.	Acta neuropathologica	2012	57
22431589	Sirolimus	Suh SS	MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
22574197	Sirolimus	Ögmundsdóttir MH	Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.	PloS one	2012	48
22580614	Sirolimus	Ciechomska IA	Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death.	Oncogene	2013	31
22729223	Sirolimus	Lee JH	De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.	Nature genetics	2012	135
22795129	Sirolimus	Dibble CC	TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.	Molecular cell	2012	136
22810227	Sirolimus	Urbanska M	Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons.	The Journal of biological chemistry	2012	34
22817723	Sirolimus	O'Neill C	Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.	Biochemical Society transactions	2012	38
22895726	Sirolimus	Weston MC	Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission.	The Journal of neuroscience 	2012	36
23064229	Sirolimus	Carrieri C	Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat.	Nature	2012	205
23081885	Sirolimus	Tsai V	Fetal brain mTOR signaling activation in tuberous sclerosis complex.	Cerebral cortex	2014	22
23123587	Sirolimus	Reith RM	Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.	Neurobiology of disease	2013	42
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23155049	Sirolimus	Avrahami L	Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.	The Journal of biological chemistry	2013	43
23158522	Sirolimus	Franz DN	Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.	Lancet	2013	129
23478858	Sirolimus	Suo L	Predictable chronic mild stress in adolescence increases resilience in adulthood.	Neuropsychopharmacology 	2013	30
23570274	Sirolimus	Theoharides TC	Focal brain inflammation and autism.	Journal of neuroinflammation	2013	30
23644232	Sirolimus	Wong M	Mammalian target of rapamycin (mTOR) pathways in neurological diseases.	Biomedical journal	2013	32
24165680	Sirolimus	Costa-Mattioli M	mTOR complexes in neurodevelopmental and neuropsychiatric disorders.	Nature neuroscience	2013	62
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24336570	Sirolimus	Johnson BE	Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.	Science	2014	244
24367102	Sirolimus	Weiler M	mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
24470557	Sirolimus	Wen PY	Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.	Neuro-oncology	2014	30
24474794	Sirolimus	Liu X	Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.	Proceedings of the National Academy of Sciences of the United States of America	2014	68
24585383	Sirolimus	Scheffer IE	Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.	Annals of neurology	2014	34
24603327	Sirolimus	Ma J	Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.	Cell death & disease	2014	21
24662006	Sirolimus	Chen J	Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders.	International journal of developmental neuroscience 	2014	23
24728411	Sirolimus	Ota KT	REDD1 is essential for stress-induced synaptic loss and depressive behavior.	Nature medicine	2014	50
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
25224527	Sirolimus	Kumari D	Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.	Human mutation	2014	21
25247581	Sirolimus	Jenwitheesuk A	Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.	International journal of molecular sciences	2014	20
25311365	Sirolimus	Oguro-Ando A	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.	Molecular psychiatry	2015	15
25374355	Sirolimus	Lipton JO	The neurology of mTOR.	Neuron	2014	71
25526733	Sirolimus	Ma DJ	A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.	Neuro-oncology	2015	18
25534823	Sirolimus	Kaul A	Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.	Neuro-oncology	2015	17
25599672	Sirolimus	D'Gama AM	Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.	Annals of neurology	2015	36
25645581	Sirolimus	Tramutola A	Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.	Journal of neurochemistry	2015	25
25791428	Sirolimus	Tang Z	mTor mediates tau localization and secretion: Implication for Alzheimer's disease.	Biochimica et biophysica acta	2015	19
25813405	Sirolimus	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	45
26018084	Sirolimus	Nakashima M	Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.	Annals of neurology	2015	26
26134657	Sirolimus	Du K	Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.	The Journal of neuroscience 	2015	21
26389641	Sirolimus	Park YY	Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.	Hepatology	2016	14
26742086	Sirolimus	Carroll B	Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.	eLife	2016	22
26818518	Sirolimus	Gentry EG	Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.	The Journal of neuroscience 	2016	10
26878385	Sirolimus	Garros-Regulez L	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.	Expert opinion on therapeutic targets	2016	14
27159400	Sirolimus	Mirzaa GM	Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.	JAMA neurology	2016	14
27226234	Sirolimus	Henske EP	Tuberous sclerosis complex.	Nature reviews. Disease primers	2016	22
27889578	Sirolimus	Switon K	Molecular neurobiology of mTOR.	Neuroscience	2017	17
28292440	Sirolimus	Fan Q	A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.	Cancer cell	2017	7
9153397	Adenosine	Burns CM	Regulation of serotonin-2C receptor G-protein coupling by RNA editing.	Nature	1997	290
18178553	Adenosine	Cenci C	Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.	The Journal of biological chemistry	2008	64
19478186	Adenosine	Li JB	Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing.	Science	2009	207
20394819	Adenosine	Morabito MV	Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.	Neurobiology of disease	2010	50
21145878	Adenosine	Gomes CV	Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.	Biochimica et biophysica acta	2011	60
23385980	Adenosine	Villar-Menéndez I	Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.	Neuromolecular medicine	2013	29
24169640	Adenosine	Hwang Y	Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.	Translational psychiatry	2013	38
24552284	Adenosine	Zhou Q	Early-onset stroke and vasculopathy associated with mutations in ADA2.	The New England journal of medicine	2014	47
25262373	Adenosine	Kim DG	A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability.	Molecular neurobiology	2015	15
25708366	Adenosine	Chen T	ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.	Cell research	2015	15
10882542	Cocaine	Ahima RS	Leptin regulation of neuroendocrine systems.	Frontiers in neuroendocrinology	2000	99
12079865	Cocaine	Jéquier E	Leptin signaling, adiposity, and energy balance.	Annals of the New York Academy of Sciences	2002	128
14614461	Cocaine	Kim SJ	Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1.	Nature	2003	102
16376315	Cocaine	Liu QR	Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine.	Brain research	2006	108
16876577	Cocaine	Lechan RM	The TRH neuron: a hypothalamic integrator of energy metabolism.	Progress in brain research	2006	79
16935329	Cocaine	Arora S	Role of neuropeptides in appetite regulation and obesity--a review.	Neuropeptides	2006	73
17084911	Cocaine	Lu L	Role of ERK in cocaine addiction.	Trends in neurosciences	2006	119
17895916	Cocaine	Li CS	Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men.	Neuropsychopharmacology 	2008	77
18199998	Cocaine	Brimijoin S	A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.	Neuropsychopharmacology 	2008	69
19703567	Cocaine	Chandrasekar V	microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity.	Molecular and cellular neurosciences	2009	85
19732758	Cocaine	McGinty JF	Brain-derived neurotrophic factor and cocaine addiction.	Brain research	2010	71
20223200	Cocaine	Hnasko TS	Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.	Neuron	2010	128
21307844	Cocaine	Chandrasekar V	Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference.	Neuropsychopharmacology 	2011	56
21795541	Cocaine	McGranahan TM	α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.	The Journal of neuroscience 	2011	45
21885214	Cocaine	Connolly CG	The neurobiology of cognitive control in successful cocaine abstinence.	Drug and alcohol dependence	2012	47
22714667	Cocaine	Clark KH	Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.	Neurotoxicity research	2013	42
23485852	Cocaine	Luo X	Error processing and gender-shared and -specific neural predictors of relapse in cocaine dependence.	Brain 	2013	37
23727437	Cocaine	Loweth JA	Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving.	Neuropharmacology	2014	33
25762666	Cocaine	Slaker M	Removal of perineuronal nets in the medial prefrontal cortex impairs the acquisition and reconsolidation of a cocaine-induced conditioned place preference memory.	The Journal of neuroscience 	2015	24
26202104	Cocaine	Taylor AM	Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine.	Neuropsychopharmacology 	2016	14
9861045	NADPH	Yrjänheikki J	Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.	Proceedings of the National Academy of Sciences of the United States of America	1998	214
19523965	NADPH	Behrens MM	Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?	Neuropharmacology	2009	51
20427748	NADPH	Labussière M	All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.	Neurology	2010	63
20877715	NADPH	Kleinschnitz C	Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.	PLoS biology	2010	124
21294650	NADPH	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants & redox signaling	2011	51
22107709	NADPH	Spencer JP	Neuroinflammation: modulation by flavonoids and mechanisms of action.	Molecular aspects of medicine	2012	45
22124756	NADPH	Agarwal D	Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR.	Basic research in cardiology	2011	40
23466554	NADPH	Abdul-Muneer PM	Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast.	Free radical biology & medicine	2013	51
23532369	NADPH	Cohen AL	IDH1 and IDH2 mutations in gliomas.	Current neurology and neuroscience reports	2013	54
24335533	NADPH	Loane DJ	Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation.	Journal of neuropathology and experimental neurology	2014	76
24992685	NADPH	Rochfort KD	Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.	PloS one	2014	30
25484314	NADPH	Kovac S	Nrf2 regulates ROS production by mitochondria and NADPH oxidase.	Biochimica et biophysica acta	2015	38
26551716	NADPH	Rochfort KD	The blood-brain barrier endothelium: a target for pro-inflammatory cytokines.	Biochemical Society transactions	2015	20
27309342	NADPH	Wilson C	Actin filaments-A target for redox regulation.	Cytoskeleton	2016	12
28095923	NADPH	Ma MW	NADPH oxidase in brain injury and neurodegenerative disorders.	Molecular neurodegeneration	2017	11
1683703	Creatine	Smith CD	Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1991	187
11246152	Creatine	Aksenov MY	Protein oxidation in the brain in Alzheimer's disease.	Neuroscience	2001	93
11592034	Creatine	Brockington M	Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.	American journal of human genetics	2001	112
15477419	Creatine	Latini R	Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.	Circulation	2004	86
19076459	Creatine	Chaturvedi RK	Mitochondrial approaches for neuroprotection.	Annals of the New York Academy of Sciences	2008	64
19556448	Creatine	Floriano PN	Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.	Clinical chemistry	2009	45
23547171	Creatine	Devaux Y	MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction.	Circulation. Cardiovascular genetics	2013	28
17878930	Cytosine	Siegmund KD	DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons.	PloS one	2007	139
19234457	Cytosine	McGowan PO	Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.	Nature neuroscience	2009	667
22037496	Cytosine	Szulwach KE	5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.	Nature neuroscience	2011	247
22090490	Cytosine	Chestnut BA	Epigenetic regulation of motor neuron cell death through DNA methylation.	The Journal of neuroscience 	2011	78
22829908	Cytosine	Orr BA	Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.	PloS one	2012	44
23042784	Cytosine	Wang T	Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum.	Human molecular genetics	2012	45
24362762	Cytosine	Guo JU	Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain.	Nature neuroscience	2014	185
25063673	Cytosine	Blanco S	Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.	The EMBO journal	2014	71
28213390	Cytosine	Hedman ÅK	Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.	Circulation. Cardiovascular genetics	2017	9
12595695	Pyrocatechol	Zubieta JK	COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.	Science	2003	226
16227987	Pyrocatechol	LaVoie MJ	Dopamine covalently modifies and functionally inactivates parkin.	Nature medicine	2005	113
16234808	Pyrocatechol	Gothelf D	COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.	Nature neuroscience	2005	85
16476412	Pyrocatechol	Tunbridge EM	Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.	Biological psychiatry	2006	187
17084978	Pyrocatechol	Nackley AG	Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.	Pain	2007	58
19225597	Pyrocatechol	Lindenberger U	Age-related decline in brain resources modulates genetic effects on cognitive functioning.	Frontiers in neuroscience	2008	55
19812213	Pyrocatechol	Williams-Gray CH	The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.	Brain 	2009	155
21543598	Pyrocatechol	Ursini G	Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity.	The Journal of neuroscience 	2011	56
22487033	Pyrocatechol	Collins AG	How much of reinforcement learning is working memory, not reinforcement learning? A behavioral, computational, and neurogenetic analysis.	The European journal of neuroscience	2012	48
18672400	Donepezil	Lannfelt L	Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.	The Lancet. Neurology	2008	119
20200346	Donepezil	Feldman HH	Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.	Neurology	2010	91
20946471	Donepezil	Brown WR	Review: cerebral microvascular pathology in ageing and neurodegeneration.	Neuropathology and applied neurobiology	2011	121
22245641	Donepezil	Li W	Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment.	NeuroImage	2012	36
9760699	Nitric oxide	Stoll G	Inflammation and glial responses in ischemic brain lesions.	Progress in neurobiology	1998	122
10483914	Nitric oxide	Fawcett JW	The glial scar and central nervous system repair.	Brain research bulletin	1999	287
10825356	Nitric oxide	Bitsch A	Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.	Brain 	2000	130
11588178	Nitric oxide	Paxinou E	Induction of alpha-synuclein aggregation by intracellular nitrative insult.	The Journal of neuroscience 	2001	98
11698024	Nitric oxide	Zimmermann M	Pathobiology of neuropathic pain.	European journal of pharmacology	2001	137
11773611	Nitric oxide	Roman RJ	P-450 metabolites of arachidonic acid in the control of cardiovascular function.	Physiological reviews	2002	329
12183632	Nitric oxide	Gu Z	S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.	Science	2002	227
12666098	Nitric oxide	Hunot S	Neuroinflammatory processes in Parkinson's disease.	Annals of neurology	2003	91
15375028	Nitric oxide	Navarro VM	Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54.	Endocrinology	2005	74
15831232	Nitric oxide	Kaur B	Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.	Neuro-oncology	2005	145
16357085	Nitric oxide	Andresen J	Endothelial influences on cerebrovascular tone.	Journal of applied physiology	2006	60
16771683	Nitric oxide	Saha RN	Regulation of inducible nitric oxide synthase gene in glial cells.	Antioxidants & redox signaling	2006	64
17229978	Nitric oxide	Guzik TJ	Adipocytokines - novel link between inflammation and vascular function?	Journal of physiology and pharmacology 	2006	87
17982277	Nitric oxide	Walter S	Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.	Cellular physiology and biochemistry 	2007	103
18031684	Nitric oxide	Serulle Y	A GluR1-cGKII interaction regulates AMPA receptor trafficking.	Neuron	2007	73
18410513	Nitric oxide	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	68
18801863	Nitric oxide	Cade WT	Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.	Physical therapy	2008	80
19075734	Nitric oxide	Tuttolomondo A	Inflammatory cytokines in acute ischemic stroke.	Current pharmaceutical design	2008	65
19234067	Nitric oxide	Fertuzinhos S	Selective depletion of molecularly defined cortical interneurons in human holoprosencephaly with severe striatal hypoplasia.	Cerebral cortex	2009	51
19298861	Nitric oxide	Zhou L	Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.	Nitric oxide 	2009	98
19411199	Nitric oxide	Wilkins A	Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.	Stem cell research	2009	60
20147544	Nitric oxide	Tricoire L	Common origins of hippocampal Ivy and nitric oxide synthase expressing neurogliaform cells.	The Journal of neuroscience 	2010	53
20385632	Nitric oxide	Elmahdy H	Human recombinant erythropoietin in asphyxia neonatorum: pilot trial.	Pediatrics	2010	40
20398920	Nitric oxide	Hastie AT	Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.	The Journal of allergy and clinical immunology	2010	93
21036891	Nitric oxide	Guazzi M	PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.	Circulation. Heart failure	2011	82
21729780	Nitric oxide	Eyler CE	Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.	Cell	2011	88
22311128	Nitric oxide	Rao JS	Neuroinflammation and synaptic loss.	Neurochemical research	2012	36
22496842	Nitric oxide	Kim B	Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.	PloS one	2012	49
22579290	Nitric oxide	Kwan KY	Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex.	Cell	2012	42
24357508	Nitric oxide	Katusic ZS	Endothelial nitric oxide: protector of a healthy mind.	European heart journal	2014	33
25391251	Nitric oxide	Lee RJ	Bitter and sweet taste receptors in the respiratory epithelium in health and disease.	Journal of molecular medicine	2014	22
25575647	Nitric oxide	Teich AF	Synaptic therapy in Alzheimer's disease: a CREB-centric approach.	Neurotherapeutics 	2015	17
25631124	Nitric oxide	Cantoni C	TREM2 regulates microglial cell activation in response to demyelination in vivo.	Acta neuropathologica	2015	29
25879545	Nitric oxide	Dange RB	Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension.	Journal of neuroinflammation	2015	18
1538563	Norepinephrine	Chrousos GP	The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.	JAMA	1992	410
12578875	Norepinephrine	Weinberg EO	Identification of serum soluble ST2 receptor as a novel heart failure biomarker.	Circulation	2003	82
12628948	Norepinephrine	Anand IS	Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).	Circulation	2003	88
17303246	Norepinephrine	Ramos BP	Adrenergic pharmacology and cognition: focus on the prefrontal cortex.	Pharmacology & therapeutics	2007	130
18255055	Norepinephrine	Valentino RJ	Convergent regulation of locus coeruleus activity as an adaptive response to stress.	European journal of pharmacology	2008	110
18550328	Norepinephrine	Lutgendorf SK	Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.	Brain, behavior, and immunity	2009	50
19332030	Norepinephrine	Koob GF	Brain stress systems in the amygdala and addiction.	Brain research	2009	105
19434554	Norepinephrine	Koob GF	Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.	Pharmacopsychiatry	2009	73
19488073	Norepinephrine	Chrousos GP	Stress and disorders of the stress system.	Nature reviews. Endocrinology	2009	284
20331902	Norepinephrine	Sturgess DJ	Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers.	Critical care	2010	43
20810473	Norepinephrine	Jabbour A	Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.	European journal of heart failure	2011	52
22488525	Norepinephrine	Bangasser DA	Sex differences in molecular and cellular substrates of stress.	Cellular and molecular neurobiology	2012	39
24048210	Norepinephrine	Pietrzak RH	Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.	JAMA psychiatry	2013	27
26883121	Norepinephrine	Di Battista AP	Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.	Journal of neuroinflammation	2016	12
12047726	Testosterone	Viau V	Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes.	Journal of neuroendocrinology	2002	99
18270261	Testosterone	Wu FC	Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.	The Journal of clinical endocrinology and metabolism	2008	96
18799683	Testosterone	Perrin JS	Growth of white matter in the adolescent brain: role of testosterone and androgen receptor.	The Journal of neuroscience 	2008	85
21359227	Testosterone	Sarachana T	Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism.	PloS one	2011	52
21849523	Testosterone	Khan AM	Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.	The Journal of clinical endocrinology and metabolism	2011	36
23118429	Testosterone	Groth KA	Clinical review: Klinefelter syndrome--a clinical update.	The Journal of clinical endocrinology and metabolism	2013	39
23225875	Testosterone	Flegr J	Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis.	The Journal of experimental biology	2013	35
23425925	Testosterone	Camacho EM	Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.	European journal of endocrinology	2013	42
23728177	Testosterone	Oury F	Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis.	The Journal of clinical investigation	2013	29
25948271	Testosterone	Braams BR	Longitudinal changes in adolescent risk-taking: a comprehensive study of neural responses to rewards, pubertal development, and risk-taking behavior.	The Journal of neuroscience 	2015	43
26055108	Testosterone	Zoch ML	New insights into the biology of osteocalcin.	Bone	2016	14
15748848	Glycine	Grudzinska J	The beta subunit determines the ligand binding properties of synaptic glycine receptors.	Neuron	2005	113
18396105	Glycine	Van Deerlin VM	TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.	The Lancet. Neurology	2008	207
20981015	Glycine	Mullasseril P	A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.	Nature communications	2010	49
21527325	Glycine	Wang H	Inhibitory neurotransmission in animal models of tinnitus: maladaptive plasticity.	Hearing research	2011	42
22563080	Glycine	Bentmann E	Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).	The Journal of biological chemistry	2012	70
22813743	Glycine	Trinh MA	Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility.	Cell reports	2012	35
23075850	Glycine	Liu GH	Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.	Nature	2012	82
23455423	Glycine	Kim HJ	Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.	Nature	2013	295
24928908	Glycine	Kahle KT	Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy.	EMBO reports	2014	23
27165289	Glycine	Lee ST	Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice.	Molecular neurobiology	2017	7
18421051	Lapatinib	Lin NU	Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.	Journal of clinical oncology 	2008	101
25025958	Lapatinib	Singh JC	HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development.	British journal of cancer	2014	25
25622903	Lapatinib	Zhang L	Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.	Neoplasia	2015	17
17847012	L-Arginine	Edvardson S	Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia.	American journal of human genetics	2007	110
18057375	L-Arginine	Ho KK	Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.	European journal of endocrinology	2007	65
20692206	L-Arginine	Dang L	IDH mutations in glioma and acute myeloid leukemia.	Trends in molecular medicine	2010	94
21746851	L-Arginine	Krumova P	Sumoylation inhibits alpha-synuclein aggregation and toxicity.	The Journal of cell biology	2011	54
21948231	L-Arginine	Sippel TR	Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.	Clinical cancer research 	2011	41
23328665	L-Arginine	Syed N	Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.	Cell death & disease	2013	29
23628989	L-Arginine	Barry G	The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.	Molecular psychiatry	2014	86
25284789	L-Arginine	Takai H	5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.	Cell reports	2014	22
25778475	L-Arginine	Chanda S	Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking.	Molecular psychiatry	2016	11
27174096	L-Arginine	Mahley RW	Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.	Arteriosclerosis, thrombosis, and vascular biology	2016	18
27248001	L-Arginine	Andreasson KI	Targeting innate immunity for neurodegenerative disorders of the central nervous system.	Journal of neurochemistry	2016	16
9267033	L-Glutamine	Davies SW	Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.	Cell	1997	464
9292723	L-Glutamine	Paulson HL	Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.	Neuron	1997	139
9398841	L-Glutamine	White JK	Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.	Nature genetics	1997	132
9620770	L-Glutamine	Cummings CJ	Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.	Nature genetics	1998	178
11007884	L-Glutamine	Kegel KB	Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.	The Journal of neuroscience 	2000	108
11264541	L-Glutamine	Nucifora FC Jr	Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.	Science	2001	212
11394998	L-Glutamine	Hara J	Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.	Neuron	2001	282
12062094	L-Glutamine	Humbert S	The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.	Developmental cell	2002	116
12191472	L-Glutamine	Lunkes A	Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.	Molecular cell	2002	93
12223539	L-Glutamine	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	85
12873381	L-Glutamine	Tang TS	Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.	Neuron	2003	120
15152038	L-Glutamine	Chevalier-Larsen ES	Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.	The Journal of neuroscience 	2004	72
15483602	L-Glutamine	Arrasate M	Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.	Nature	2004	553
15664989	L-Glutamine	Jana NR	Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.	The Journal of biological chemistry	2005	84
15811941	L-Glutamine	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	195
16076956	L-Glutamine	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16122429	L-Glutamine	Tsuda H	The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.	Cell	2005	77
16452635	L-Glutamine	Benchoua A	Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.	Molecular biology of the cell	2006	67
16473015	L-Glutamine	Chang DT	Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.	Neurobiology of disease	2006	75
16522639	L-Glutamine	Shibata M	Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1.	The Journal of biological chemistry	2006	134
16775137	L-Glutamine	Vessey JP	Dendritic localization of the translational repressor Pumilio 2 and its contribution to dendritic stress granules.	The Journal of neuroscience 	2006	65
17034350	L-Glutamine	Browne SE	Oxidative damage in Huntington's disease pathogenesis.	Antioxidants & redox signaling	2006	90
17190598	L-Glutamine	Lam YC	ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.	Cell	2006	120
17687326	L-Glutamine	Bennett EJ	Global changes to the ubiquitin system in Huntington's disease.	Nature	2007	184
18337722	L-Glutamine	Lim J	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.	Nature	2008	130
18434538	L-Glutamine	Johnson BS	A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2008	156
18550760	L-Glutamine	Gray M	Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.	The Journal of neuroscience 	2008	194
18599482	L-Glutamine	Winborn BJ	The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.	The Journal of biological chemistry	2008	93
18758459	L-Glutamine	Lee Y	miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.	Nature neuroscience	2008	70
19118166	L-Glutamine	Packer AN	The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.	The Journal of neuroscience 	2008	226
19153604	L-Glutamine	Todi SV	Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.	The EMBO journal	2009	48
19334076	L-Glutamine	Drouet V	Sustained effects of nonallele-specific Huntingtin silencing.	Annals of neurology	2009	78
19487684	L-Glutamine	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
19498170	L-Glutamine	Subramaniam S	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Science	2009	99
19608102	L-Glutamine	van der Burg JM	Beyond the brain: widespread pathology in Huntington's disease.	The Lancet. Neurology	2009	76
19710014	L-Glutamine	Aiken CT	Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.	The Journal of biological chemistry	2009	50
20026656	L-Glutamine	Thompson LM	IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.	The Journal of cell biology	2009	115
20236390	L-Glutamine	Han I	Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.	Journal of neurochemistry	2010	41
20451302	L-Glutamine	Persengiev S	Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis.	Neurobiology of aging	2011	38
20664076	L-Glutamine	Zuccato C	Molecular mechanisms and potential therapeutical targets in Huntington's disease.	Physiological reviews	2010	222
20670829	L-Glutamine	Miller JP	Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.	Neuron	2010	54
21109527	L-Glutamine	Kino Y	Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.	Nucleic acids research	2011	46
21163446	L-Glutamine	Ross CA	Huntington's disease: from molecular pathogenesis to clinical treatment.	The Lancet. Neurology	2011	293
21311053	L-Glutamine	Ehrnhoefer DE	Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.	The Neuroscientist 	2011	36
22017874	L-Glutamine	Matsumoto G	Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins.	Molecular cell	2011	148
22446390	L-Glutamine	Costa V	Shaping the role of mitochondria in the pathogenesis of Huntington's disease.	The EMBO journal	2012	37
22590724	L-Glutamine	Jia H	Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.	Neurobiology of disease	2012	40
22613578	L-Glutamine	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	72
22684686	L-Glutamine	Seidel K	Brain pathology of spinocerebellar ataxias.	Acta neuropathologica	2012	53
23160193	L-Glutamine	Kwan W	Mutant huntingtin impairs immune cell migration in Huntington disease.	The Journal of clinical investigation	2012	37
23768628	L-Glutamine	Labbadia J	Huntington's disease: underlying molecular mechanisms and emerging concepts.	Trends in biochemical sciences	2013	58
24333121	L-Glutamine	Emadi A	Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.	Experimental hematology	2014	37
24501367	L-Glutamine	Sosunov AA	Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain.	The Journal of neuroscience 	2014	29
24656866	L-Glutamine	Zhang X	Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.	American journal of human genetics	2014	24
25274774	L-Glutamine	Kino Y	Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins.	Human molecular genetics	2015	18
25974698	L-Glutamine	Horning KJ	Manganese Is Essential for Neuronal Health.	Annual review of nutrition	2015	27
26388396	L-Glutamine	Guedes-Dias P	Mitochondrial dynamics and quality control in Huntington's disease.	Neurobiology of disease	2016	13
26590344	L-Glutamine	Bañez-Coronel M	RAN Translation in Huntington Disease.	Neuron	2015	39
26724577	L-Glutamine	Bhutia YD	Glutamine transporters in mammalian cells and their functions in physiology and cancer.	Biochimica et biophysica acta	2016	12
7624036	L-Threonine	Goedert M	Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.	Neuroscience letters	1995	123
9228007	L-Threonine	Stokoe D	Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.	Science	1997	279
10391244	L-Threonine	Lu PJ	The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.	Nature	1999	169
11555628	L-Threonine	Altafaj X	Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.	Human molecular genetics	2001	87
12796778	L-Threonine	Toyo-oka K	14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome.	Nature genetics	2003	102
12857750	L-Threonine	Jacobs FM	FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.	The Journal of biological chemistry	2003	94
15013227	L-Threonine	Nguyen PV	Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases.	Progress in neurobiology	2003	92
15090593	L-Threonine	Dougherty MK	Unlocking the code of 14-3-3.	Journal of cell science	2004	108
15111319	L-Threonine	Bao L	Prevalent overexpression of prolyl isomerase Pin1 in human cancers.	The American journal of pathology	2004	96
15578447	L-Threonine	Chong ZZ	Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.	Histology and histopathology	2005	74
17406652	L-Threonine	Choi Y	Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models.	Neuropsychopharmacology 	2007	64
17482548	L-Threonine	Barnes AP	LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.	Cell	2007	151
18184784	L-Threonine	Zhang S	Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.	The Journal of neuroscience 	2008	54
21248166	L-Threonine	McCormick JA	The WNKs: atypical protein kinases with pleiotropic actions.	Physiological reviews	2011	78
21638088	L-Threonine	Capper D	Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.	Acta neuropathologica	2011	79
21924349	L-Threonine	Contreras-Vallejos E	Going out of the brain: non-nervous system physiological and pathological functions of Cdk5.	Cellular signalling	2012	37
22159035	L-Threonine	Coufal NG	Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	64
23770587	L-Threonine	Ebert DH	Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.	Nature	2013	59
24333164	L-Threonine	Hwang J	STRIPAK complexes: structure, biological function, and involvement in human diseases.	The international journal of biochemistry & cell biology	2014	38
24378367	L-Threonine	Desikan RS	The role of clusterin in amyloid-β-associated neurodegeneration.	JAMA neurology	2014	20
24705252	L-Threonine	Taylor KR	Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.	Nature genetics	2014	87
25963655	L-Threonine	Jung J	Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9.	Molecular and cellular biology	2015	53
25981171	L-Threonine	Datta D	Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.	Biological psychiatry	2015	24
26147946	L-Threonine	Sutphen CL	Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.	JAMA neurology	2015	41
26836182	L-Threonine	Melah KE	Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.	Journal of Alzheimer's disease 	2016	10
26859459	L-Threonine	Kim SH	Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.	Cancer cell	2016	26
27497832	L-Threonine	Wani WY	O-GlcNAcylation and neurodegeneration.	Brain research bulletin	2017	7
28847820	L-Threonine	Berger ND	ATM-dependent pathways of chromatin remodelling and oxidative DNA damage responses.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2017	7
7894480	L-Serine	Bione S	Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy.	Nature genetics	1994	166
9072970	L-Serine	Beals CR	Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3.	Science	1997	195
10564676	L-Serine	Ali IU	Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.	Journal of the National Cancer Institute	1999	118
10604470	L-Serine	Kojima M	Ghrelin is a growth-hormone-releasing acylated peptide from stomach.	Nature	1999	1062
11583623	L-Serine	Suzuki Y	A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.	Molecular cell	2001	185
11729324	L-Serine	Lee R	Regulation of cell survival by secreted proneurotrophins.	Science	2001	373
12629547	L-Serine	Plant PJ	A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl.	Nature cell biology	2003	105
14570712	L-Serine	Ceman S	Phosphorylation influences the translation state of FMRP-associated polyribosomes.	Human molecular genetics	2003	113
14654844	L-Serine	Lorenz K	Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.	Nature	2003	91
14734535	L-Serine	Ciani L	A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules.	The Journal of cell biology	2004	76
16702191	L-Serine	Gandhi S	PINK1 protein in normal human brain and Parkinson's disease.	Brain 	2006	83
17114460	L-Serine	Youn JH	Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.	Journal of immunology	2006	105
17573418	L-Serine	Shaw JL	Distribution of 15 human kallikreins in tissues and biological fluids.	Clinical chemistry	2007	69
17906618	L-Serine	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	151
18003639	L-Serine	Weihofen A	Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.	Human molecular genetics	2008	53
18343814	L-Serine	Paleologou KE	Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.	The Journal of biological chemistry	2008	91
18615096	L-Serine	Colin E	Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.	The EMBO journal	2008	104
18621108	L-Serine	Candelario-Jalil E	Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.	Neuroscience	2009	142
19065142	L-Serine	Basu AC	Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.	Molecular psychiatry	2009	83
19074459	L-Serine	Azeredo da Silveira S	Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.	Human molecular genetics	2009	58
19221179	L-Serine	Yuan Z	Regulation of neuronal cell death by MST1-FOXO1 signaling.	The Journal of biological chemistry	2009	51
19573808	L-Serine	Miao H	EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.	Cancer cell	2009	121
19655382	L-Serine	Borroni B	Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease.	Human mutation	2009	71
20159449	L-Serine	Kawabe H	Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development.	Neuron	2010	49
21572424	L-Serine	Adibekian A	Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.	Nature chemical biology	2011	55
22476196	L-Serine	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
22476197	L-Serine	Talbot K	Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.	The Journal of clinical investigation	2012	269
22942700	L-Serine	Dobolyi A	The neuroprotective functions of transforming growth factor beta proteins.	International journal of molecular sciences	2012	34
23065822	L-Serine	Diamanti-Kandarakis E	Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.	Endocrine reviews	2012	128
23297193	L-Serine	Blankman JL	ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC.	Proceedings of the National Academy of Sciences of the United States of America	2013	29
23728337	L-Serine	Feng H	EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.	Oncogene	2014	25
24488013	L-Serine	Miao H	EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.	Oncogene	2015	30
24657168	L-Serine	Rao F	Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.	Molecular cell	2014	24
25107476	L-Serine	Yarchoan M	Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.	Acta neuropathologica	2014	23
25698643	L-Serine	Prassas I	Unleashing the therapeutic potential of human kallikrein-related serine proteases.	Nature reviews. Drug discovery	2015	28
9314539	L-Proline	Mundel P	Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes.	The Journal of cell biology	1997	148
10433269	L-Proline	Tu JC	Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins.	Neuron	1999	229
10806096	L-Proline	Sheng M	The Shank family of scaffold proteins.	Journal of cell science	2000	136
17084877	L-Proline	Thomas ER	Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.	Virology	2007	73
18093523	L-Proline	Mani M	The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.	Neuron	2007	70
18183483	L-Proline	Dhariwala FA	An unusual member of the Cdk family: Cdk5.	Cellular and molecular neurobiology	2008	56
20237263	L-Proline	Kaneko M	Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation.	The Journal of neuroscience 	2010	46
22101681	L-Proline	Chen WJ	Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.	Nature genetics	2011	74
22120146	L-Proline	Wang JL	Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.	Brain 	2011	54
22243967	L-Proline	Heron SE	PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.	American journal of human genetics	2012	43
22464332	L-Proline	Nakamura K	Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease.	Cell	2012	54
23908769	L-Proline	Armbruster M	Dynamin phosphorylation controls optimization of endocytosis for brief action potential bursts.	eLife	2013	26
24052813	L-Proline	Cottee MA	Crystal structures of the CPAP/STIL complex reveal its role in centriole assembly and human microcephaly.	eLife	2013	33
25124924	L-Proline	Lu Z	Prolyl isomerase Pin1 in cancer.	Cell research	2014	25
26598493	L-Proline	Ebrahimi-Fakhari D	The evolving spectrum of PRRT2-associated paroxysmal diseases.	Brain 	2015	17
10936180	All-trans-retinoic acid	Encinas M	Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells.	Journal of neurochemistry	2000	134
15003116	All-trans-retinoic acid	Sempere LF	Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.	Genome biology	2004	524
19635812	All-trans-retinoic acid	Le MT	MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets.	Molecular and cellular biology	2009	91
19713529	All-trans-retinoic acid	Evangelisti C	MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.	FASEB journal 	2009	46
20603216	All-trans-retinoic acid	Cooper O	Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.	Molecular and cellular neurosciences	2010	65
21338381	All-trans-retinoic acid	Jadidi-Niaragh F	Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.	Scandinavian journal of immunology	2011	63
23769173	All-trans-retinoic acid	Yuan T	Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.	Stem cell research & therapy	2013	30
25231870	All-trans-retinoic acid	Perry JR	Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.	Nature	2014	93
15716560	Creatinine	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	81
15781736	Creatinine	Sackner-Bernstein JD	Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.	Circulation	2005	95
15811980	Creatinine	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
16157772	Creatinine	Kistorp C	Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.	Circulation	2005	110
19808325	Creatinine	Kuznetsova T	Prevalence of left ventricular diastolic dysfunction in a general population.	Circulation. Heart failure	2009	65
20525986	Creatinine	Shah RV	Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.	European journal of heart failure	2010	55
20659949	Creatinine	Damman K	Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.	Heart	2010	47
21791540	Creatinine	Maisel AS	Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.	European journal of heart failure	2011	44
18772396	Isocitric acid	Parsons DW	An integrated genomic analysis of human glioblastoma multiforme.	Science	2008	1568
18985363	Isocitric acid	Balss J	Analysis of the IDH1 codon 132 mutation in brain tumors.	Acta neuropathologica	2008	234
19636000	Isocitric acid	Sanson M	Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.	Journal of clinical oncology 	2009	197
19737147	Isocitric acid	Ohgaki H	Genetic alterations and signaling pathways in the evolution of gliomas.	Cancer science	2009	106
19805672	Isocitric acid	Weller M	Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.	Journal of clinical oncology 	2009	142
19903171	Isocitric acid	Capper D	Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.	Brain pathology	2010	89
19996293	Isocitric acid	Yan H	Mutant metabolic enzymes are at the origin of gliomas.	Cancer research	2009	46
20615753	Isocitric acid	Kloosterhof NK	Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?	The Lancet. Oncology	2011	47
20847235	Isocitric acid	Kranendijk M	IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.	Science	2010	48
21163902	Isocitric acid	Christensen BC	DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.	Journal of the National Cancer Institute	2011	92
21446051	Isocitric acid	Huse JT	Molecular subclassification of diffuse gliomas: seeing order in the chaos.	Glia	2011	77
22034964	Isocitric acid	SongTao Q	IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.	Cancer science	2012	39
22166263	Isocitric acid	Luchman HA	An in vivo patient-derived model of endogenous IDH1-mutant glioma.	Neuro-oncology	2012	47
22270850	Isocitric acid	Bleeker FE	Recent advances in the molecular understanding of glioblastoma.	Journal of neuro-oncology	2012	44
22281806	Isocitric acid	Choi C	2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.	Nature medicine	2012	150
22688054	Isocitric acid	Müller T	Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.	The American journal of pathology	2012	31
23104868	Isocitric acid	Kannan K	Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.	Oncotarget	2012	60
23204232	Isocitric acid	Jin G	Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.	Cancer research	2013	35
23904111	Isocitric acid	Wiestler B	ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.	Acta neuropathologica	2013	51
23999439	Isocitric acid	Andronesi OC	Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.	The Journal of clinical investigation	2013	32
24019001	Isocitric acid	Chaumeil MM	Non-invasive in vivo assessment of IDH1 mutational status in glioma.	Nature communications	2013	38
24510240	Isocitric acid	Molenaar RJ	The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.	Neuro-oncology	2014	26
25081751	Isocitric acid	Chan AK	TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.	Modern pathology 	2015	21
25135958	Isocitric acid	Bao ZS	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	Genome research	2014	41
25701198	Isocitric acid	Olar A	IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.	Acta neuropathologica	2015	21
25783747	Isocitric acid	Weller M	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	Acta neuropathologica	2015	28
26124478	Isocitric acid	Sandmann T	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.	Journal of clinical oncology 	2015	48
26188014	Isocitric acid	Waitkus MS	Isocitrate dehydrogenase mutations in gliomas.	Neuro-oncology	2016	25
26534967	Isocitric acid	Andronesi OC	Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.	Clinical cancer research 	2016	14
26691210	Isocitric acid	de la Fuente MI	Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.	Neuro-oncology	2016	22
26945349	Isocitric acid	Chen JR	Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.	Medicine	2016	13
26948350	Isocitric acid	Masui K	Molecular classification of gliomas.	Handbook of clinical neurology	2016	14
27353503	Isocitric acid	Zhang B	Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.	Neuro-oncology	2017	8
27370400	Isocitric acid	Garber ST	Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.	Neuro-oncology	2016	11
27820599	Isocitric acid	Miroshnikova YA	Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.	Nature cell biology	2016	12
28124097	Isocitric acid	Pusch S	Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.	Acta neuropathologica	2017	7
28202508	Isocitric acid	Lu Y	Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.	Cancer research	2017	11
28360267	Isocitric acid	Venteicher AS	Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.	Science	2017	29
14534160	Superoxide	Jonsson PA	Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.	Brain 	2004	77
14997933	Superoxide	Ferrer I	Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.	Brain pathology	2004	156
15673657	Superoxide	Willis D	Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons.	The Journal of neuroscience 	2005	139
15768029	Superoxide	Ralph GS	Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.	Nature medicine	2005	116
16330499	Superoxide	Jonsson PA	Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.	Brain 	2006	95
16687508	Superoxide	Esposito L	Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2006	78
16953112	Superoxide	Kim YS	Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.	Experimental & molecular medicine	2006	112
17272778	Superoxide	Kamada H	Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.	Stroke	2007	76
17469116	Superoxide	Mackenzie IR	Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.	Annals of neurology	2007	216
18044695	Superoxide	McGeer PL	Glial reactions in Parkinson's disease.	Movement disorders 	2008	155
19483195	Superoxide	Prudencio M	Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.	Human molecular genetics	2009	63
20493564	Superoxide	Goedert M	The propagation of prion-like protein inclusions in neurodegenerative diseases.	Trends in neurosciences	2010	107
21596768	Superoxide	Beers DR	Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.	Brain 	2011	83
21813273	Superoxide	Da Cruz S	Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.	Current opinion in neurobiology	2011	122
21857683	Superoxide	Deng HX	Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.	Nature	2011	264
21930926	Superoxide	Grad LI	Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	81
22009041	Superoxide	Cenini G	Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.	Biochimica et biophysica acta	2012	33
22028219	Superoxide	Jucker M	Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.	Annals of neurology	2011	153
22150926	Superoxide	Chen S	Autophagy dysregulation in amyotrophic lateral sclerosis.	Brain pathology	2012	42
22416121	Superoxide	Guareschi S	An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
23026746	Superoxide	Graffmo KS	Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis.	Human molecular genetics	2013	31
23378219	Superoxide	Philips T	Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.	Brain 	2013	45
23687121	Superoxide	Saccon RA	Is SOD1 loss of function involved in amyotrophic lateral sclerosis?	Brain 	2013	36
23740943	Superoxide	Koval ED	Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice.	Human molecular genetics	2013	44
25411487	Superoxide	Thomsen GM	Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.	The Journal of neuroscience 	2014	24
26344214	Superoxide	Philips T	Rodent Models of Amyotrophic Lateral Sclerosis.	Current protocols in pharmacology	2015	20
27064076	Superoxide	Parakh S	Protein folding alterations in amyotrophic lateral sclerosis.	Brain research	2016	12
27507699	Superoxide	van Zundert B	Silencing strategies for therapy of SOD1-mediated ALS.	Neuroscience letters	2017	8
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
8035924	Cholesterol	Breteler MM	Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.	Neurology	1994	143
11692019	Cholesterol	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	111
12658281	Cholesterol	Puglielli L	Alzheimer's disease: the cholesterol connection.	Nature neuroscience	2003	163
15583033	Cholesterol	Abad-Rodriguez J	Neuronal membrane cholesterol loss enhances amyloid peptide generation.	The Journal of cell biology	2004	71
16314544	Cholesterol	Ballantyne CM	Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.	Archives of internal medicine	2005	66
16424607	Cholesterol	Chmurzyńska A	The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.	Journal of applied genetics	2006	107
16709608	Cholesterol	Dumitrescu AM	Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.	Endocrinology	2006	70
17053810	Cholesterol	Herz J	Reelin, lipoprotein receptors and synaptic plasticity.	Nature reviews. Neuroscience	2006	159
17940007	Cholesterol	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
18039658	Cholesterol	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	82
18480203	Cholesterol	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
18987181	Cholesterol	Riddell DR	Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.	The Journal of neuroscience 	2008	93
19245965	Cholesterol	Frankel DS	Resistin, adiponectin, and risk of heart failure the Framingham offspring study.	Journal of the American College of Cardiology	2009	60
19339619	Cholesterol	Mandrekar S	Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.	The Journal of neuroscience 	2009	125
19339974	Cholesterol	Bu G	Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.	Nature reviews. Neuroscience	2009	264
19647672	Cholesterol	NP-C Guidelines Working Group.	Recommendations on the diagnosis and management of Niemann-Pick disease type C.	Molecular genetics and metabolism	2009	56
19651157	Cholesterol	Nuutinen T	Clusterin: a forgotten player in Alzheimer's disease.	Brain research reviews	2009	86
20213545	Cholesterol	Lund-Katz S	High density lipoprotein structure-function and role in reverse cholesterol transport.	Sub-cellular biochemistry	2010	67
20303415	Cholesterol	Vetrivel KS	Membrane rafts in Alzheimer's disease beta-amyloid production.	Biochimica et biophysica acta	2010	52
20404173	Cholesterol	Ho AJ	A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.	Proceedings of the National Academy of Sciences of the United States of America	2010	90
20847045	Cholesterol	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	46
20854368	Cholesterol	Zlokovic BV	Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.	Journal of neurochemistry	2010	67
20921964	Cholesterol	Harvie MN	The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.	International journal of obesity	2011	91
21119734	Cholesterol	Rupprecht R	Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.	Nature reviews. Drug discovery	2010	159
21436030	Cholesterol	Pipalia NH	Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
21900234	Cholesterol	Bate C	Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.	The Journal of biological chemistry	2011	40
22026577	Cholesterol	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22130662	Cholesterol	Lee CY	Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.	The Journal of biological chemistry	2012	45
22572546	Cholesterol	Patterson MC	Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update.	Molecular genetics and metabolism	2012	89
23386614	Cholesterol	Rushworth JV	Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.	The Journal of biological chemistry	2013	34
23585901	Cholesterol	Suzuki T	A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment.	PloS one	2013	29
24013639	Cholesterol	Westra HJ	Systematic identification of trans eQTLs as putative drivers of known disease associations.	Nature genetics	2013	432
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24378418	Cholesterol	Reed B	Associations between serum cholesterol levels and cerebral amyloidosis.	JAMA neurology	2014	36
24559670	Cholesterol	Kanekiyo T	ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?	Neuron	2014	83
24633158	Cholesterol	Holmen OL	Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.	Nature genetics	2014	57
24907980	Cholesterol	Vitali C	HDL and cholesterol handling in the brain.	Cardiovascular research	2014	27
25425283	Cholesterol	Vanier MT	Complex lipid trafficking in Niemann-Pick disease type C.	Journal of inherited metabolic disease	2015	33
25871773	Cholesterol	Hu J	Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.	Molecular neurodegeneration	2015	19
26049157	Cholesterol	Hoefer IE	Novel methodologies for biomarker discovery in atherosclerosis.	European heart journal	2015	18
26131930	Cholesterol	Joshi PK	Directional dominance on stature and cognition in diverse human populations.	Nature	2015	29
26503748	Cholesterol	Bergeron N	Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.	Circulation	2015	15
27350042	Cholesterol	Dekkers KF	Blood lipids influence DNA methylation in circulating cells.	Genome biology	2016	25
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
28314593	Cholesterol	Li C	25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model.	Immunity	2017	14
28399252	Cholesterol	Gottesman RF	Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.	JAMA	2017	16
8137918	Somatostatin	Mollereau C	ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.	FEBS letters	1994	135
20974464	Somatostatin	Yang Y	Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.	Biological psychiatry	2011	36
21745723	Somatostatin	Konradi C	Hippocampal interneurons are abnormal in schizophrenia.	Schizophrenia research	2011	72
24361861	Somatostatin	Hoftman GD	Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.	Schizophrenia bulletin	2015	37
24742460	Somatostatin	Vogt D	Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position.	Neuron	2014	28
24997035	Somatostatin	Holzer P	Neuropeptides and the microbiota-gut-brain axis.	Advances in experimental medicine and biology	2014	35
25043046	Somatostatin	Xue M	Equalizing excitation-inhibition ratios across visual cortical neurons.	Nature	2014	99
25937288	Somatostatin	Vogt D	The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.	Cell reports	2015	15
15041700	Temozolomide	Hegi ME	Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.	Clinical cancer research 	2004	146
15758010	Temozolomide	Hegi ME	MGMT gene silencing and benefit from temozolomide in glioblastoma.	The New England journal of medicine	2005	1193
16618716	Temozolomide	Hunter C	A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.	Cancer research	2006	90
17404084	Temozolomide	Cahill DP	Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.	Clinical cancer research 	2007	91
17522861	Temozolomide	Jordan JT	Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.	Cancer immunology, immunotherapy 	2008	77
18565887	Temozolomide	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	233
18757334	Temozolomide	Hegi ME	Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.	Journal of clinical oncology 	2008	179
19088037	Temozolomide	Pallini R	Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.	Clinical cancer research 	2008	95
19188675	Temozolomide	Brandes AA	Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.	Journal of clinical oncology 	2009	52
19265662	Temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
19269895	Temozolomide	Stupp R	Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.	The Lancet. Oncology	2009	1345
19536096	Temozolomide	Dunn J	Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.	British journal of cancer	2009	67
20146084	Temozolomide	Ardon H	Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.	Journal of neuro-oncology	2010	44
20167819	Temozolomide	De Witt Hamer PC	Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.	Neuro-oncology	2010	42
20388803	Temozolomide	Hattermann K	The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.	Cancer research	2010	81
20439646	Temozolomide	Stupp R	Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	99
20530668	Temozolomide	McEllin B	PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.	Cancer research	2010	81
20855119	Temozolomide	Minniti G	Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.	Radiotherapy and oncology 	2010	40
20921459	Temozolomide	Sampson JH	Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	205
20975057	Temozolomide	Houillier C	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.	Neurology	2010	92
21135282	Temozolomide	Lai A	Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.	Journal of clinical oncology 	2011	140
21149254	Temozolomide	Sampson JH	Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.	Neuro-oncology	2011	92
21156036	Temozolomide	Etcheverry A	DNA methylation in glioblastoma: impact on gene expression and clinical outcome.	BMC genomics	2010	58
21425258	Temozolomide	Felsberg J	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	International journal of cancer	2011	49
21606416	Temozolomide	de Groot JF	Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.	Journal of clinical oncology 	2011	47
21737504	Temozolomide	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	84
21768296	Temozolomide	Mitchell DA	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.	Blood	2011	45
21988793	Temozolomide	Beier D	Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.	Molecular cancer	2011	80
22035272	Temozolomide	Narayana A	A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.	Journal of neurosurgery	2012	39
22045118	Temozolomide	Johnson DR	Glioblastoma survival in the United States before and during the temozolomide era.	Journal of neuro-oncology	2012	152
22156195	Temozolomide	Agnihotri S	Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.	The Journal of clinical investigation	2012	32
22244911	Temozolomide	Silber JR	O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems.	Biochimica et biophysica acta	2012	30
22383993	Temozolomide	Sampson JH	A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.	PloS one	2012	33
22469979	Temozolomide	Wagner L	Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.	Oncogene	2013	28
22593187	Temozolomide	Janouskova H	Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.	Cancer research	2012	32
23047041	Temozolomide	Triscott J	Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.	Oncotarget	2012	33
23183822	Temozolomide	Asuthkar S	Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.	Oncotarget	2012	49
23908450	Temozolomide	Wieland A	Anticancer effects of niclosamide in human glioblastoma.	Clinical cancer research 	2013	30
24101040	Temozolomide	Gilbert MR	Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.	Journal of clinical oncology 	2013	119
24469053	Temozolomide	Zhang LH	TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.	Oncogene	2015	16
24552317	Temozolomide	Gilbert MR	A randomized trial of bevacizumab for newly diagnosed glioblastoma.	The New England journal of medicine	2014	381
24552318	Temozolomide	Chinot OL	Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.	The New England journal of medicine	2014	358
24608791	Temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
24861879	Temozolomide	Shi Z	MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.	Neuro-oncology	2014	36
24912512	Temozolomide	Wick W	MGMT testing--the challenges for biomarker-based glioma treatment.	Nature reviews. Neurology	2014	59
24980823	Temozolomide	Wang L	MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.	Oncotarget	2014	43
25093489	Temozolomide	Han S	Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.	British journal of cancer	2014	26
25163906	Temozolomide	Stupp R	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	126
25364264	Temozolomide	Lee JK	Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.	OncoTargets and therapy	2014	23
25411133	Temozolomide	Galldiks N	Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-18Ffluoroethyl)-L-tyrosine PET.	European journal of nuclear medicine and molecular imaging	2015	26
25586468	Temozolomide	Schuster J	A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.	Neuro-oncology	2015	66
25605243	Temozolomide	Wang Z	Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.	Oncotarget	2015	18
25609769	Temozolomide	Suchorska B	Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.	Neurology	2015	17
25762461	Temozolomide	Nabors LB	Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.	Neuro-oncology	2015	30
25959588	Temozolomide	Shao H	Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.	Nature communications	2015	43
26373279	Temozolomide	Kim J	Spatiotemporal Evolution of the Primary Glioblastoma Genome.	Cancer cell	2015	32
27020328	Temozolomide	Pitter KL	Corticosteroids compromise survival in glioblastoma.	Brain 	2016	14
27503138	Temozolomide	Arita H	A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.	Acta neuropathologica communications	2016	12
28187000	Temozolomide	Chen W	MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.	Oncotarget	2017	8
28233083	Temozolomide	Ludwig K	Molecular markers in glioma.	Journal of neuro-oncology	2017	9
28668966	Temozolomide	Li H	Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.	Cellular physiology and biochemistry 	2017	7
28844499	Temozolomide	Weller M	Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.	The Lancet. Oncology	2017	11
11724467	Docosahexaenoic acid	Salem N Jr	Mechanisms of action of docosahexaenoic acid in the nervous system.	Lipids	2001	165
16151530	Docosahexaenoic acid	Lukiw WJ	A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.	The Journal of clinical investigation	2005	177
16216871	Docosahexaenoic acid	Ariel A	The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.	The Journal of biological chemistry	2005	72
16684969	Docosahexaenoic acid	Farooqui AA	Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.	The Neuroscientist 	2006	63
17257165	Docosahexaenoic acid	Farooqui AA	Modulation of inflammation in brain: a matter of fat.	Journal of neurochemistry	2007	85
17716997	Docosahexaenoic acid	Ilieva EV	Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis.	Brain 	2007	71
19018037	Docosahexaenoic acid	Bazan NG	Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease.	Journal of lipid research	2009	53
21045096	Docosahexaenoic acid	Quinn JF	Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.	JAMA	2010	123
23515006	Docosahexaenoic acid	Stonehouse W	DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial.	The American journal of clinical nutrition	2013	39
24345162	Docosahexaenoic acid	Vandal M	Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.	Journal of neurochemistry	2014	22
25387473	Docosahexaenoic acid	Bazinet RP	Polyunsaturated fatty acids and their metabolites in brain function and disease.	Nature reviews. Neuroscience	2014	99
26381255	Docosahexaenoic acid	Lucke-Wold BP	Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy.	Journal of neurosurgery	2016	11
26869380	Docosahexaenoic acid	Prieto-Sánchez MT	Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes.	Clinical nutrition	2017	6
27532692	Docosahexaenoic acid	Yassine HN	Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.	JAMA neurology	2016	12
28114437	Docosahexaenoic acid	Yassine HN	Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.	JAMA neurology	2017	8
11431323	1-Phosphatidyl-D-myo-inositol	Sonoda Y	Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.	Cancer research	2001	90
12376533	1-Phosphatidyl-D-myo-inositol	Beffert U	Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.	The Journal of biological chemistry	2002	85
15289301	1-Phosphatidyl-D-myo-inositol	Broderick DK	Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas.	Cancer research	2004	84
15467468	1-Phosphatidyl-D-myo-inositol	Samuels Y	Oncogenic mutations of PIK3CA in human cancers.	Cell cycle	2004	131
16288007	1-Phosphatidyl-D-myo-inositol	García-Rostán G	Mutation of the PIK3CA gene in anaplastic thyroid cancer.	Cancer research	2005	84
16444268	1-Phosphatidyl-D-myo-inositol	Pyle AD	Neurotrophins mediate human embryonic stem cell survival.	Nature biotechnology	2006	68
16738242	1-Phosphatidyl-D-myo-inositol	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	98
17372210	1-Phosphatidyl-D-myo-inositol	Mehrian-Shai R	Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	62
17403556	1-Phosphatidyl-D-myo-inositol	De Felice FG	Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.	Neurobiology of aging	2008	109
17872411	1-Phosphatidyl-D-myo-inositol	Stommel JM	Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.	Science	2007	349
18467332	1-Phosphatidyl-D-myo-inositol	Reynolds CH	Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.	The Journal of biological chemistry	2008	60
18852283	1-Phosphatidyl-D-myo-inositol	Shimizu T	Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.	Molecular and cellular biology	2008	59
19789314	1-Phosphatidyl-D-myo-inositol	Platt FM	Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.	Clinical cancer research 	2009	71
21753002	1-Phosphatidyl-D-myo-inositol	Van Humbeeck C	Parkin interacts with Ambra1 to induce mitophagy.	The Journal of neuroscience 	2011	60
22065080	1-Phosphatidyl-D-myo-inositol	Koul D	Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.	Clinical cancer research 	2012	50
22619466	1-Phosphatidyl-D-myo-inositol	Wen PY	Current clinical development of PI3K pathway inhibitors in glioblastoma.	Neuro-oncology	2012	40
23602987	1-Phosphatidyl-D-myo-inositol	Leal G	BDNF-induced local protein synthesis and synaptic plasticity.	Neuropharmacology	2014	46
23838428	1-Phosphatidyl-D-myo-inositol	Beazley-Long N	VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.	The American journal of pathology	2013	25
24076665	1-Phosphatidyl-D-myo-inositol	Filbin MG	Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.	Nature medicine	2013	41
24867100	1-Phosphatidyl-D-myo-inositol	Wang F	MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.	Tumour biology 	2014	22
25275521	1-Phosphatidyl-D-myo-inositol	McKnight NC	Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex.	PLoS genetics	2014	21
25650317	1-Phosphatidyl-D-myo-inositol	Ghosh JC	Adaptive mitochondrial reprogramming and resistance to PI3K therapy.	Journal of the National Cancer Institute	2015	27
26977882	1-Phosphatidyl-D-myo-inositol	Pei Y	HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.	Cancer cell	2016	19
